Hemophilia A & B Inheritance X-linked recessive Clinical features Delayed/prolonged bleeding after mild trauma Hemarthrosis, intramuscular hematomas Gastrointestinal or genitourinary tract bleeding Intracranial hemorrhage Complications: hemophilic arthropathy Laboratory findings ↑ Activated PTT Normal platelet count & PT Absent or ↓ factor VIII (hemophilia A) or factor IX (hemophilia B) activity Treatment Factor replacement Desmopressin for mild hemophilia A Abnormal bleeding following tooth extractions or other surgical procedures can signify a quantitative or qualitative platelet defect, coagulopathy, or abnormal fibrinolysis.  This patient's male sex and family history of hemarthrosis in a maternal male relative suggest an X-linked coagulopathy such as hemophilia A (factor VIII deficiency) or hemophilia B (factor IX deficiency, Christmas disease).  Hemophilia A and B are indistinguishable clinically as both demonstrate similar symptoms and inheritance patterns.  Both conditions are characterized by isolated prolongation of partial thromboplastin time due to defects in the intrinsic coagulation pathway.  Prothrombin time [PT] and thrombin time [TT] are normal in patients with hemophilia. When endothelial injury occurs, platelets are activated and form a hemostatic plug first, followed by activation of the coagulation cascade.  Patients with hemophilia have normal platelet function and can form a platelet plug, so bleeding after procedures can be delayed rather than immediate, in contrast to patients with platelet disorders.  Manifestations include intramuscular hemorrhage, hemarthrosis, and prolonged or delayed bleeding after surgical procedures. (Choice A)  Low haptoglobin is a sign of hemolytic anemia.  Other associated findings include increased indirect bilirubin and lactate dehydrogenase. (Choice B)  This patient's hemoglobin level is likely normal since the oozing began recently and he has no history of chronic or recurrent bleeding. (Choice D)  Signs of thrombocytopenia include easy bruisability, petechiae, and mucocutaneous hemorrhage (eg, recurrent epistaxis, gingival hemorrhage).  The absence of petechiae and the delayed bleeding onset make a platelet disorder unlikely. (Choice E)  The platelet function analyzer (PFA-100) test monitors the time needed for a patient's blood to form a platelet-based hemostatic plug in an in vitro environment.  Abnormal results are seen in von Willebrand disease, inherited/acquired platelet dysfunction (eg, NSAID use), and thrombocytopenia. (Choice F)  PT reflects the extrinsic clotting pathway, which involves tissue factor, fibrinogen, and factors II, V, VII, and X.  Vitamin K deficiency and warfarin anticoagulant therapy are common causes of isolated PT prolongation as they lead to decreased activity of factors II, VII, IX, and X.  Inherited deficiencies of these clotting factors are very rare. (Choice G)  The TT measures the rate of conversion of fibrinogen to fibrin.  It is prolonged in patients with deficient or defective fibrinogen, which can be congenital or acquired.  The most common cause of acquired dysfibrinogenemia is liver disease. Educational objective: Hemophilia is an X-linked recessive coagulopathy that presents with intramuscular hemorrhage, hemarthroses, and delayed bleeding after procedures.  Laboratory results show partial thromboplastin time prolongation; other tests of hemostatic function are generally normal. Convert this UWorld question into ultra high-yield USMLE notes: 1. Diagnosis: 2. Key clue from question stem (1 line): 3. Why correct answer (max 2 lines): 4. Why others wrong (1 line each): 5. Buzzword trigger: 6. Trap / trick tested: 7. One-liner memory hook: Make it extremely concise. No paragraphs. use this formal everytime

Hemophilia A & B — Ultra High-Yield USMLE Notes


1. Diagnosis: Hemophilia A (Factor VIII deficiency) / Hemophilia B (Factor IX deficiency)

2. Key clue from question stem (1 line): Young male + delayed post-procedural bleeding + hemarthrosis in maternal uncle → X-linked coagulopathy

3. Why correct answer (max 2 lines): Hemophilia A/B causes isolated ↑aPTT (intrinsic pathway defect) with normal PT, TT, and platelet count. Delayed (not immediate) bleeding occurs because platelet plug forms normally — coagulation cascade fails downstream.

4. Why others wrong (1 line each):
  • Low haptoglobin: Marker of hemolytic anemia, not a coagulopathy
  • Low hemoglobin: Unlikely with acute/recent bleeding and no chronic bleeding history
  • Thrombocytopenia: Causes petechiae + immediate mucocutaneous bleeding, not delayed hemarthrosis
  • Abnormal PFA-100: Reflects platelet/vWF dysfunction, not factor deficiency
  • Prolonged PT: Extrinsic pathway (Factors II, V, VII, X); normal in hemophilia
  • Prolonged TT: Reflects fibrinogen conversion defect; normal in hemophilia

5. Buzzword trigger:
  • Hemarthrosis → Hemophilia
  • Maternal uncle bleeding → X-linked recessive
  • Isolated ↑aPTT + normal PT/platelet → Factor VIII or IX deficiency

6. Trap / trick tested: Bleeding is delayed, not immediate — students confuse this with platelet disorders (which cause immediate mucocutaneous bleeding). Absence of petechiae rules out thrombocytopenia.

7. One-liner memory hook:
"Eight (A) or Nine (B) — bleeds late, joints hate, aPTT great, platelets straight."

Pure red cell aplasia Etiology Autoimmune-mediated destruction of erythrocyte precursors in bone marrow → complete cessation of erythrocyte production → severe anemia (eg, exercise intolerance, severe pallor)   Causes: Neoplasm: thymoma, lymphoproliferative disorder Medication: antimicrobials, immunosuppressants Infection: parvovirus B19 Laboratory findings Blood cells: Normocytic, normochromic erythrocytes Normal quantity & morphology of platelets & leukocytes Severe reticulocytopenia Normal hemolysis markers (eg, LDH, schistocytes, bilirubin) Normal iron studies Diagnosis Bone marrow biopsy: normocellular bone marrow with dramatic erythrocytopenia This patient has severe anemia with normal platelet and leukocyte counts.  Because 2 of the 3 cell lines produced by the bone marrow are intact (ie, platelets and leukocytes), it is unlikely that this patient has a disorder that affects the entire bone marrow, such as neoplastic tumor infiltration (Choice A). The next step is to determine whether the anemia is due to impaired production or increased loss of erythrocytes.  The bone marrow normally releases immature erythrocytes (reticulocytes) in response to severe anemia to compensate for lost oxygen-carrying capacity.  For this reason, a high reticulocyte count suggests the anemia is due to a process outside the bone marrow, such as acute bleeding or hemolysis (eg, intravascular or splenic erythrocyte destruction) (Choice D).  In contrast, an inappropriately low reticulocyte count (as in this case) suggests a problem with the production of red blood cells in the bone marrow, which may be caused by 1 of the following: Low erythropoietin (EPO):  EPO is primarily produced in the cortical peritubular cells of the kidneys.  It travels to the bone marrow, where it stimulates the division and differentiation of erythroid progenitor cells.  A low level of EPO is primarily caused by fibrosis of the peritubular cells due to chronic renal failure.  This patient with a normal creatinine level is very unlikely to have low EPO (Choice B). Lack of nutrients (eg, vitamin B12, folate, iron):  Efficient erythropoiesis requires adequate levels of vitamin B12, folate, and iron.  Significant deficiencies in these nutrients usually alter the size of mature erythrocytes, leading to changes in mean corpuscular volume (MCV).  Low vitamin B12 or folate eventually causes macrocytosis (high MCV), and low iron eventually causes microcytosis (low MCV). Destruction of erythrocyte precursors:  Viruses (eg, parvovirus B19), medications, and autoantibodies can destroy erythrocyte progenitor cells, leading to severe anemia with morphologically normal platelets and leukocytes (ie, red cell aplasia).  This condition is common with certain tumor types, namely lymphoproliferative disorders (eg, chronic lymphocytic leukemia) and thymoma.  Thymoma often causes mediastinal mass with pulmonary symptoms (eg, persistent nonproductive cough) due to infringement on adjacent airways. Educational objective: Pure red cell aplasia is a rare form of bone marrow failure characterized by severe anemia with reticulocytopenia and morphologically normal platelets and leukocytes.  It is most common with thymoma, lymphocytic leukemia, and parvovirus B19 infection. same as above

Pure Red Cell Aplasia — Ultra High-Yield USMLE Notes


1. Diagnosis: Pure Red Cell Aplasia (PRCA)

2. Key clue from question stem (1 line): Severe normocytic anemia + normal WBC/platelets + low reticulocytes + thymoma/parvovirus B19/CLL history

3. Why correct answer (max 2 lines): PRCA = selective destruction of erythroid precursors → severe anemia with reticulocytopenia but intact platelet and leukocyte lines. Bone marrow biopsy confirms: normocellular marrow with near-absent erythroid precursors.

4. Why others wrong (1 line each):
  • Tumor infiltration (myelophthisis): Would suppress ALL 3 cell lines (pancytopenia), not just RBCs
  • Low EPO (renal failure): Normal creatinine makes chronic kidney disease–related EPO deficiency unlikely
  • Hemolysis: High reticulocyte count + elevated LDH/bilirubin/schistocytes expected; none present here
  • Nutrient deficiency (B12/folate/iron): Would alter MCV (macro- or microcytosis); MCV is normal here

5. Buzzword trigger:
  • Thymoma + anemia → PRCA
  • Parvovirus B19 + sickle cell / immunocompromised → aplastic crisis / PRCA
  • Isolated severe anemia + reticulocytopenia + normal WBC/platelets → PRCA

6. Trap / trick tested: Normal platelets and leukocytes mislead students toward non-bone marrow causes; the key is recognizing selective erythroid suppression. Also: low reticulocyte count = production problem, NOT blood loss or hemolysis.

7. One-liner memory hook:
"Thymoma Torches only the Red line — WBC/platelets fine, retics flatline, marrow's blind to erythroid design."

A 55-year-old woman is being evaluated for persistent nonproductive cough.  She also has had worsening exercise intolerance and fatigue for the past 4 weeks.  Physical examination shows conjunctival pallor.  Laboratory results are as follows: Complete blood count Hemoglobin 6.2 g/dL Mean corpuscular volume 90 µm3 Reticulocytes 0.1% Platelets 280,000/mm3 Leukocytes 6,700/mm3 Serum chemistry and kidney function test results are normal.  Iron studies and serum vitamin B12 and folic acid levels are within normal limits.  Chest imaging reveals an anterior mediastinal mass.  Which of the following is the most likely cause of this patient's hematologic disorder? this question stem

Pure Red Cell Aplasia — Ultra High-Yield USMLE Notes

(Applied to this specific question stem)

1. Diagnosis: Pure Red Cell Aplasia (PRCA) secondary to Thymoma

2. Key clue from question stem (1 line): 55F + anterior mediastinal mass + severe normocytic anemia + reticulocytes 0.1% + normal WBC/platelets/iron/B12/folate/creatinine

3. Why correct answer (max 2 lines): Thymoma causes autoimmune destruction of erythroid precursors → isolated severe anemia with near-zero reticulocytes and intact other cell lines. Anterior mediastinal mass + PRCA labs = thymoma until proven otherwise.

4. Why others wrong (1 line each):
  • Tumor marrow infiltration: Would cause pancytopenia (↓WBC + ↓platelets), not isolated anemia
  • Renal failure / low EPO: Normal creatinine/chemistry rules this out
  • Iron deficiency: Normal iron studies + normal MCV (90) excludes microcytic deficiency anemia
  • B12/folate deficiency: Normal levels + normal MCV (no macrocytosis) excludes megaloblastic cause
  • Hemolysis: Reticulocytes would be HIGH; LDH/bilirubin would be elevated — opposite of this picture

5. Buzzword trigger:
  • Anterior mediastinal mass → 4 T's: Thymoma, Teratoma, Terrible lymphoma, Thyroid mass
  • Thymoma + isolated severe normocytic anemia + reticulocytopenia → PRCA
  • Nonproductive cough + mediastinal mass = structural compression by thymoma

6. Trap / trick tested: Normal MCV (90) tricks students into ruling out a bone marrow production problem — but PRCA is normocytic. The near-zero reticulocyte count (0.1%) is the critical pivot away from hemolysis/bleeding toward failed erythroid production.

7. One-liner memory hook:
"Anterior mass + retics near zero + normal everything else = Thymoma stole the Red cells."

no above is also good notes combine 2 ntes and make a new one

Pure Red Cell Aplasia (PRCA) — Combined Ultra High-Yield USMLE Notes


1. Diagnosis: Pure Red Cell Aplasia (PRCA) — most commonly secondary to Thymoma, Parvovirus B19, or Lymphoproliferative disorder (CLL)

2. Key clue from question stem (1 line): Severe normocytic anemia + reticulocytes ~0% + normal WBC/platelets/iron/B12/folate/creatinine ± anterior mediastinal mass

3. Why correct answer (max 2 lines): PRCA = autoimmune destruction of erythroid precursors only → isolated severe normocytic anemia with near-zero reticulocytes, while platelets and leukocytes remain completely intact. Thymoma (anterior mediastinal mass + cough) is the classic USMLE trigger; confirmed by bone marrow biopsy showing normocellular marrow with absent erythroid precursors.

4. Why others wrong (1 line each):
  • Tumor marrow infiltration: Causes pancytopenia (all 3 lines ↓), not selective RBC suppression
  • Low EPO / renal failure: Normal creatinine rules out CKD-related EPO deficiency
  • Iron deficiency: Normal iron studies + normal MCV excludes microcytic picture
  • B12/folate deficiency: Normal levels + normal MCV (no macrocytosis) excludes megaloblastic cause
  • Hemolysis: Would show HIGH reticulocytes + ↑LDH/bilirubin/schistocytes — opposite of PRCA
  • Acute blood loss: Would also drive reticulocytosis, not reticulocytopenia

5. Buzzword triggers:
  • Anterior mediastinal mass → 4 T's: Thymoma, Teratoma, Terrible lymphoma, Thyroid
  • Thymoma + isolated severe normocytic anemia + retics ~0% → PRCA
  • Parvovirus B19 + sickle cell disease / immunocompromised → aplastic crisis / PRCA
  • CLL + isolated anemia + low retics → PRCA
  • Nonproductive cough + mediastinal mass → thymoma compressing adjacent airway

6. Trap / trick tested:
  • Normal MCV tricks students into ruling out a production problem — PRCA is normocytic, not macro/microcytic
  • Near-zero reticulocytes (0.1%) is the critical pivot: rules out hemolysis and bleeding, confirms failed erythroid production
  • Normal WBC/platelets mislead toward non-marrow etiology — recognize that PRCA selectively spares all non-erythroid lines

7. One-liner memory hook:
"Thymoma/Parvo/CLL Torch only the Red line — WBC/platelets fine, retics flatline, MCV stays 90, marrow blind to erythroid design."

A 7-year-old boy comes to the office for follow-up.  A week ago, the patient began having episodes of bloody diarrhea that have since resolved.  His current laboratory studies show elevated blood urea nitrogen and serum creatinine levels.  Complete blood count reveals anemia and thrombocytopenia.  Coagulation studies are within normal limits.  His peripheral blood smear is shown in the image below. the clinical presentation and the peripheral blood smear shown are typical of hemolytic uremic syndrome (HUS).  Most cases of childhood HUS are preceded by bloody diarrhea, often caused by Shiga-like toxin released from enterohemorrhagic Escherichia coli (particularly strain O157:H7).  Undercooked ground beef is a common cause of HUS. The smear contains classic schistocytes (fragmented red cells) and few platelets.  Schistocytes are diagnostic of a traumatic mechanism and indicate either microangiopathic hemolytic anemia (eg, HUS, thrombotic thrombocytopenic purpura [TTP], disseminated intravascular coagulation [DIC]) or mechanical damage (eg, prosthetic valve, severely calcified valves).  HUS and TTP lie on a spectrum.  Unlike in DIC, the coagulation system is not activated in HUS-TTP; therefore, coagulation studies (prothrombin time and partial thromboplastin time) are normal, as seen with this patient. (Choice A)  Autoimmune hemolytic anemia (AIHA) is due to an altered immune response and the production of antibodies against erythrocytes.  AIHA can occur following infections with Mycoplasma pneumoniae and Epstein-Barr virus but not usually following a diarrheal illness.  In addition, thrombocytopenia and renal failure are not associated with AIHA. (Choice B)  Erythropoietin deficiency results in normocytic, normochromic anemia; neither schistocytes nor decreased platelets are present.  In addition, erythropoietin deficiency is usually seen in chronic renal failure; this patient has acute renal failure. (Choice C)  Glucose-6-phosphate dehydrogenase (G6PD) deficiency causes hemolytic anemia due to oxidative stress.  It is not associated with thrombocytopenia or renal failure.  The peripheral smear usually shows bite cells. (Choice D)  Leukoerythroblastic peripheral smears (ie, nucleated red cells and immature white cells) are usually seen when the marrow is replaced with fibrosis (or metastatic cancer).  The red cells can be squeezed while passing through fibrous strands and appear on the peripheral smear as characteristic teardrop cells. Educational objective: Schistocytes suggest microangiopathic hemolytic anemia (eg, hemolytic-uremic syndrome [HUS], thrombotic thrombocytopenic purpura [TTP], disseminated intravascular coagulation [DIC]) or mechanical damage [eg, prosthetic valve]).  In childhood, HUS is often preceded by bloody diarrhea.  Coagulation studies (prothrombin time and partial thromboplastin time) are normal in HUS-TTP but abnormal in DIC

Hemolytic Uremic Syndrome (HUS) — Ultra High-Yield USMLE Notes


1. Diagnosis: Hemolytic Uremic Syndrome (HUS) — Shiga toxin–producing E. coli O157:H7 (STEC)

2. Key clue from question stem (1 line): 7-year-old boy + bloody diarrhea (resolved) + anemia + thrombocytopenia + ↑BUN/Cr + schistocytes on smear + normal coagulation studies

3. Why correct answer (max 2 lines): Classic triad of HUS = microangiopathic hemolytic anemia + thrombocytopenia + acute renal failure, preceded by STEC O157:H7 bloody diarrhea (undercooked beef). Shiga-like toxin damages renal microvasculature → fibrin strands shear RBCs → schistocytes; coagulation cascade is NOT activated → PT/aPTT normal (distinguishes from DIC).

4. Why others wrong (1 line each):
  • Autoimmune hemolytic anemia (AIHA): Follows Mycoplasma/EBV, not diarrheal illness; no thrombocytopenia or renal failure; no schistocytes
  • EPO deficiency: Causes normocytic anemia only; no schistocytes/thrombocytopenia; seen in chronic (not acute) renal failure
  • G6PD deficiency: Oxidative stress trigger (not diarrhea); shows bite cells, not schistocytes; no thrombocytopenia or renal failure
  • Leukoerythroblastic smear / marrow replacement: Shows teardrop cells + nucleated RBCs + immature WBCs; not schistocytes

5. Buzzword triggers:
  • Schistocytes → MAHA: HUS / TTP / DIC
  • Bloody diarrhea (child) + schistocytes + renal failure → HUS (STEC O157:H7)
  • Undercooked ground beef → E. coli O157:H7
  • MAHA + thrombocytopenia + normal PT/aPTT → HUS or TTP (NOT DIC)
  • MAHA + thrombocytopenia + abnormal PT/aPTTDIC
  • Neurologic symptoms + MAHA + thrombocytopenia (adult, no renal failure) → TTP

6. Trap / trick tested:
  • Normal PT/aPTT tricks students into ruling out a coagulopathy — but HUS/TTP intentionally spares the coagulation cascade; the key distinction from DIC
  • HUS vs TTP: HUS = children + renal failure + diarrheal prodrome; TTP = adults + neuro symptoms + ADAMTS13 deficiency — both have normal coags
  • Schistocytes ≠ only DIC — must think broader: HUS, TTP, prosthetic valve, DIC

7. One-liner memory hook:
"Bloody beef → bloody diarrhea → broken RBCs (schistocytes) + broken kidneys + broken platelets — but coags are fine, it's HUS not DIC."

1) Diagnosis: Typical HUS (Shiga toxin–associated; EHEC O157:H7) 2) Key clue (1 line): Child + bloody diarrhea 1 week ago → now AKI (↑BUN/Cr) + anemia + thrombocytopenia with normal PT/PTT 3) Why correct (≤2 lines): Shiga-like toxin damages endothelium → platelet microthrombi → MAHA (schistocytes) + thrombocytopenia + renal failure. Coags normal (not DIC). 4) Why others wrong (1 line each): AIHA: spherocytes/Coombs+, no thrombocytopenia or AKI; not post-diarrhea. EPO deficiency: chronic CKD → normocytic anemia only; no schistocytes/low platelets. G6PD deficiency: bite cells/Heinz bodies; no thrombocytopenia or AKI. Leukoerythroblastic smear: teardrop cells + immature cells from marrow infiltration/fibrosis; not MAHA. 5) Buzzword trigger: “Undercooked ground beef” + “bloody diarrhea” + “schistocytes” + “↑Cr” + “normal PT/PTT” 6) Trap / trick tested: Differentiate HUS/TTP vs DIC → HUS/TTP: normal coags; DIC: ↑PT/↑PTT. 7) One-liner memory hook: “EHEC → Shiga toxin → shred RBCs (schistocytes) + chew platelets + crush kidneys; coags OK.” thi sis my notes create like thi stoo , like for exampole in clues i wrote Inc.BUn?Creat - AKi like that now combine 2 and make notes

Hemolytic Uremic Syndrome (HUS) — Ultra High-Yield USMLE Notes


1. Diagnosis: Typical HUS (Shiga toxin–associated; EHEC O157:H7)

2. Key clue (1 line): Child + bloody diarrhea (resolved 1 wk ago) → ↑BUN/Cr (AKI) + anemia + ↓platelets + schistocytes on smear + normal PT/PTT

3. Why correct (≤2 lines): Shiga-like toxin damages renal microendothelium → fibrin/platelet microthrombi → strands shear RBCs → MAHA (schistocytes) + thrombocytopenia + AKI. Coagulation cascade NOT activated → PT/PTT normal; distinguishes HUS/TTP from DIC.

4. Why others wrong (1 line each):
  • AIHA: Spherocytes + Coombs+; no schistocytes, thrombocytopenia, or AKI; triggered by Mycoplasma/EBV, not diarrhea
  • EPO deficiency: Chronic CKD only → normocytic anemia; no schistocytes, no ↓platelets
  • G6PD deficiency: Bite cells + Heinz bodies; oxidative trigger (not diarrhea); no thrombocytopenia or AKI
  • Leukoerythroblastic smear: Teardrop cells + nucleated RBCs + immature WBCs; marrow infiltration/fibrosis; not MAHA

5. Buzzword triggers:
  • "Undercooked ground beef" → EHEC O157:H7
  • "Bloody diarrhea" (child, resolved) + schistocytes + ↑Cr → HUS
  • MAHA + ↓platelets + normal PT/PTT → HUS or TTP (NOT DIC)
  • MAHA + ↓platelets + ↑PT/↑PTTDIC
  • Adult + MAHA + neuro symptoms + no renal failure → TTP (ADAMTS13↓)

6. Trap / trick tested: HUS/TTP vs DIC: both have MAHA + ↓platelets — coags are the pivot; normal PT/PTT = HUS/TTP, abnormal = DIC. HUS vs TTP: HUS = child + AKI + diarrheal prodrome; TTP = adult + neuro + ADAMTS13 deficiency.

7. One-liner memory hook:
"EHEC → Shiga toxin → shred RBCs (schistocytes) + chew platelets + crush kidneys; coags OK = HUS not DIC."

i liked yours too i want both combined becoz i want all hy notes

Hemolytic Uremic Syndrome (HUS) — Combined Ultra High-Yield USMLE Notes


1. Diagnosis: Typical HUS (Shiga toxin–associated; EHEC O157:H7)

2. Key clue (1 line): Child + bloody diarrhea (resolved 1 wk ago) → ↑BUN/Cr (AKI) + anemia + ↓platelets + schistocytes on smear + normal PT/PTT

3. Why correct (≤2 lines): Shiga-like toxin damages renal microendothelium → fibrin/platelet microthrombi → strands shear RBCs → MAHA (schistocytes) + thrombocytopenia + AKI. Coagulation cascade NOT activated → PT/PTT normal; this is the key pivot distinguishing HUS/TTP from DIC.

4. Why others wrong (1 line each):
  • AIHA: Spherocytes + Coombs+; triggered by Mycoplasma/EBV not diarrhea; no schistocytes, thrombocytopenia, or AKI
  • EPO deficiency: Chronic CKD → normocytic anemia only; no schistocytes, no ↓platelets; this patient has acute renal failure
  • G6PD deficiency: Bite cells + Heinz bodies; oxidative stress trigger (not diarrhea); no thrombocytopenia or AKI
  • Leukoerythroblastic smear: Teardrop cells + nucleated RBCs + immature WBCs from marrow infiltration/fibrosis; not MAHA

5. Buzzword triggers:
  • "Undercooked ground beef" → EHEC O157:H7 → HUS
  • "Bloody diarrhea" (child, resolved) + schistocytes + ↑Cr (AKI) → HUS
  • Schistocytes → MAHA spectrum: HUS / TTP / DIC / prosthetic valve
  • MAHA + ↓platelets + normal PT/PTT → HUS or TTP
  • MAHA + ↓platelets + ↑PT/↑PTT + ↑fibrin split productsDIC
  • Adult + MAHA + neuro symptoms (confusion, seizure) + no/mild renal failure → TTP (ADAMTS13↓)
  • Child + MAHA + AKI + diarrheal prodrome → HUS

6. Trap / trick tested:
  • HUS/TTP vs DIC: Both = MAHA + ↓platelets — coags are the pivot: normal PT/PTT = HUS/TTP; ↑PT/PTT = DIC
  • HUS vs TTP: HUS = child + AKI dominant + bloody diarrhea prodrome; TTP = adult + neuro dominant + ADAMTS13 deficiency; both have normal coags
  • Schistocytes ≠ DIC only — must think broader MAHA causes
  • Normal PT/PTT tricks students into ruling out hematologic pathology — but HUS intentionally spares coagulation cascade

7. One-liner memory hook:
"EHEC → Shiga toxin → shred RBCs (schistocytes) + chew platelets + crush kidneys; coags OK = HUS not DIC."

A 5-year-old boy is brought to the office by his parents who say that he "looks yellow" and has been uncharacteristically tired lately.  He has had upper respiratory tract infection symptoms for the past 3 days, including cough, rhinorrhea, sneezing, and sore throat.  The parents say that "a lot of kids at daycare have been sick lately."  The patient has no prior medical problems.  He is consistently at the 50th percentile for height and weight.  He takes no medications, and his immunizations are up to date.  Pallor, scleral icterus, and palpable splenomegaly are seen on examination.  Laboratory results are as follows: Complete blood count Hemoglobin 9 g/dL Reticulocytes 10.8% Platelets 218,000/mm3 Leukocytes 7500/mm3 Liver studies Total bilirubin 3 mg/dL Direct bilirubin 0.3 mg/dL Alkaline phosphatase 95 U/L Aspartate aminotransferase (AST) 18 U/L Alanine aminotransferase (ALT) 15 U/L The patient recovers spontaneously after a few weeks.  Peripheral smear of the boy's blood after recovery is shown in the exhibit.  Which of the following is the most likely cause of this patient's condition? Explanation Hereditary spherocytosis Genetics Autosomal dominant inheritance (most cases) Pathogenesis RBC membrane defect (eg, spectrin, ankyrin) Spherocytes with ↓ deformability sequestered in spleen Extravascular hemolysis Clinical presentation Hemolytic anemia Jaundice Splenomegaly Laboratory findings ↑ MCHC Spherocytes on peripheral blood smear Negative Coombs test ↑ Osmotic fragility Treatment Splenectomy Complications Pigmented gallstones Aplastic crisis (with parvovirus B19 infection) RBC = red blood cell; MCHC = mean corpuscular hemoglobin concentration. This patient's peripheral smear shows spherocytes (small, round, hyperchromic red cells that lack central pallor), a finding consistent with hereditary spherocytosis (HS), an autosomal dominant hemolytic anemia caused by a red cell membrane cytoskeletal defect.  The mutation in HS most often affects the plasma-membrane scaffolding proteins spectrin and ankyrin.  Without this scaffolding, spherocytes are less deformable than normal RBCs and are prone to sequestration and subsequent accelerated destruction in the spleen. Clinical manifestations include hemolytic anemia, jaundice (increased RBC destruction results in greater bilirubin production), and splenomegaly (spherocytes have difficulty passing through the cords of Billroth and accumulate in the spleen).  Concurrent infections (often routine febrile viral illnesses) can increase splenic sequestration and RBC destruction, causing a hemolytic crisis with worsening anemia and jaundice and an elevated reticulocyte count. This is distinct from parvovirus B19–induced aplastic crisis, which causes abrupt anemia due to temporary bone marrow suppression and is associated with a low reticulocyte count. (Choice A)  Glucose-6-phosphate dehydrogenase (G6PD) enzyme deficiency anemia usually follows oxidative stress.  Common triggers include drugs (sulfonamide or antimalarial agents), fava beans, and infections (viral hepatitis, pneumonia, or typhoid).  Unlike this case, peripheral smears of G6PD deficiency anemia show bite cells and Heinz bodies. (Choice B)  An imbalance between alpha globin and beta globin chain production results in thalassemia.  In this patient, the peripheral smear has no morphologic variants associated with thalassemia, such as target cells or hypochromic microcytes. (Choice C)  A nuclear maturation defect due to defective DNA synthesis is the pathophysiologic mechanism of megaloblastic anemia, which is most commonly caused by vitamin B12 and folic acid deficiencies.  Enlarged oval cells and hypersegmented neutrophils would be expected on peripheral smear. (Choice D)  Polymerization of hemoglobin occurs in sickle cell anemia.  A missense mutation in the beta globin chain leads to the production of hemoglobin S, which has the capacity to polymerize in deoxygenated states.  This polymerization leads to red blood cell membrane injury and deformation to a "sickle" shape seen on peripheral smear. Educational objective: Hereditary spherocytosis results from red cell cytoskeleton abnormalities, most commonly spectrin and ankyrin.  Hemolytic anemia, jaundice, and splenomegaly are classic manifestations.  Spherocytes are seen on peripheral blood smear.

Hereditary Spherocytosis (HS) — Ultra High-Yield USMLE Notes


1. Diagnosis: Hereditary Spherocytosis (HS) — autosomal dominant RBC membrane defect (spectrin/ankyrin mutation)

2. Key clue (1 line): Child + jaundice + splenomegaly + hemolytic anemia (↑retics, ↑indirect bili, normal LFTs) + viral URI trigger + spherocytes on smear after recovery

3. Why correct (≤2 lines): Spectrin/ankyrin defect → spherocytes lose deformability → sequestered + destroyed in spleen → extravascular hemolysis (↑indirect bili + splenomegaly + ↑retics). Viral illness increases splenic sequestration → hemolytic crisis with worsening anemia + ↑jaundice + ↑retics (vs. parvovirus B19 → aplastic crisis with ↓retics).

4. Why others wrong (1 line each):
  • G6PD deficiency: Bite cells + Heinz bodies; triggered by oxidative stress (drugs/fava beans/hepatitis), not routine viral URI
  • Thalassemia: Target cells + hypochromic microcytes on smear; no spherocytes
  • Megaloblastic anemia: Macro-ovalocytes + hypersegmented neutrophils; B12/folate deficiency; no hemolysis or splenomegaly
  • Sickle cell anemia: Sickle-shaped cells on smear; HbS polymerization in deoxygenated state; different morphology entirely

5. Buzzword triggers:
  • Spherocytes + negative Coombs → HS (Coombs+ spherocytes = AIHA)
  • ↑MCHC + spherocytes + splenomegaly + ↑osmotic fragility → HS
  • Child + hemolytic anemia + jaundice + splenomegaly + viral trigger → HS hemolytic crisis
  • HS + parvovirus B19 → aplastic crisis (↓retics, sudden severe anemia)
  • HS + chronic hemolysis → pigmented (bilirubin) gallstones
  • Autosomal dominant hemolytic anemia → think HS first

6. Trap / trick tested:
  • Hemolytic crisis vs aplastic crisis in HS: Both cause sudden ↓Hgb — key pivot is reticulocyte count: viral URI → hemolytic crisis (↑↑retics); parvovirus B19 → aplastic crisis (↓↓retics, bone marrow suppressed)
  • Spherocytes ≠ always HS — Coombs test distinguishes: Coombs− = HS; Coombs+ = AIHA
  • Smear shown after recovery — spherocytes persist in HS even when asymptomatic; this is the baseline smear finding

7. One-liner memory hook:
"Spectrin/Ankyrin gone → Spheres stuck in spleen → Hemolysis + Jaundice + Splenomegaly; URI = hemolytic crisis (↑retics); Parvo = aplastic crisis (↓retics)."

A 59-year-old woman comes to the office due to progressive fatigue and occasional heart palpitations over the last 6 months.  The patient has been under a lot of stress recently due to problems at work.  She has no dietary restrictions, eats out at restaurants frequently, and drinks 2 or 3 cans of beer on the weekends.  The patient is postmenopausal and has not noticed any uterine bleeding, dark stools, or bleeding with bowel movements.  Her BMI is 25 kg/m2.  Hemoglobin is 8.5 g/dL.  Peripheral blood smear reveals pale, microcytic erythrocytes.  Which of the following is the most likely underlying cause of this patient's abnormal laboratory findings? Fatigue and heart palpitations are common manifestations of all forms of anemia.  This patient's peripheral smear findings indicate hypochromic, microcytic anemia, which most often arises in the setting of iron deficiency.  The primary, and most dangerous if overlooked, mechanism of iron deficiency is blood loss, and it should be excluded first.  Women of childbearing age are commonly iron deficient due to menstruation.  Men (especially over the age of 60) or postmenopausal women have no physiologic reason to be iron deficient and therefore should be evaluated for blood loss in the gastrointestinal (GI) tract (eg, due to malignancy).  GI blood loss is often occult, so the lack of dark or bright red stools in this patient should not rule out GI hemorrhage.  Iron studies (including ferritin) should be obtained, and the patient will likely require endoscopic evaluation. (Choice A)  Ingestion of the more commonly abused drugs is not associated with microcytic anemia. (Choice B)  Hematologic malignancies (eg, leukemia, lymphoma, multiple myeloma) tend to be associated with normochromic, normocytic anemia.  The decrease in erythropoiesis seen in these patients results from hypersplenism or tumor replacement of bone marrow mass. (Choice C)  Hemolysis often presents with a normochromic, normocytic anemia.  Spherocytes or schistocytes are often seen on peripheral blood smear. (Choice D)  The anemia of chronic liver disease is usually normocytic or slightly macrocytic with target cells on the peripheral blood smear.  Microcytic anemia occurs in <25% of cases, and most patients have only mild anemia with a hemoglobin level of 10-11 g/dL. (Choice F)  This patient has a normal BMI and no factors predisposing her to malnutrition (eg, dietary restrictions, chronic alcohol use).  A normal Western diet provides 6 mg of iron for every 1,000 calories, and the recommended intake for individuals age >50 is 8 mg per day.  As a result, men and postmenopausal women (ie, not menstruating, pregnant, or lactating) usually have no dietary iron shortage. Educational objective: Hypochromic, microcytic anemia is most commonly due to iron deficiency.  Blood loss, especially occult loss from the gastrointestinal tract, must be ruled out in a patient with iron deficiency anemia.

Iron Deficiency Anemia (IDA) — Ultra High-Yield USMLE Notes


1. Diagnosis: Iron Deficiency Anemia (IDA) — occult GI blood loss (most likely GI malignancy) in postmenopausal woman

2. Key clue (1 line): 59F + postmenopausal + fatigue + palpitations + Hgb 8.5 + hypochromic microcytic smear + no dietary restriction + no overt bleeding → occult GI loss

3. Why correct (≤2 lines): Microcytic + hypochromic anemia = IDA until proven otherwise; in postmenopausal women and men >60, no physiologic iron loss exists → occult GI hemorrhage (malignancy) must be excluded first. Absence of dark/bloody stools does NOT rule out GI bleeding — iron studies + endoscopy required.

4. Why others wrong (1 line each):
  • Drug/alcohol use: Common drugs of abuse not associated with microcytic anemia; mild weekend drinking insufficient for macrocytic/liver anemia
  • Hematologic malignancy: Causes normocytic/normochromic anemia via marrow replacement or hypersplenism; not microcytic
  • Hemolysis: Normocytic/normochromic + spherocytes or schistocytes on smear; not microcytic hypochromic
  • Chronic liver disease: Normocytic or macrocytic + target cells; microcytic in <25% and usually mild (Hgb 10-11)
  • Dietary iron deficiency: Normal BMI + normal Western diet (6 mg/1000 kcal) + postmenopausal → dietary cause extremely unlikely

5. Buzzword triggers:
  • Hypochromic + microcytic smear → IDA (most common), thalassemia, sideroblastic, ACD
  • Postmenopausal woman + IDA → occult GI malignancy until proven otherwise
  • Man >60 + IDA → GI malignancy until proven otherwise
  • IDA labs: ↓ferritin + ↓serum iron + ↑TIBC + ↓transferrin saturation
  • No dark stools ≠ no GI bleed → occult bleeding is common

6. Trap / trick tested:
  • Patient eats out frequently + drinks beer → distractors suggesting dietary/alcohol cause; postmenopausal + normal BMI + normal diet = dietary deficiency implausible
  • Absence of overt GI symptoms (no melena, no hematochezia) does NOT exclude occult GI blood loss — this is the core clinical trap
  • IDA in premenopausal woman → menstruation first; IDA in postmenopausal woman or any man → GI malignancy first

7. One-liner memory hook:
"Postmenopausal + microcytic/hypochromic = IDA → no periods to blame → scope the gut, rule out cancer."

A 3-year-old boy diagnosed with thalassemia major receives multiple transfusions to maintain his blood hemoglobin level.  On physical examination, his liver and spleen are mildly enlarged.  He also has glucose intolerance as demonstrated by an oral glucose tolerance test.  Which of the following therapies would prevent congestive cardiac failure in this patient? Many hemolytic diseases (eg, thalassemia major) require frequent, regular treatment with red blood cell transfusions for the maintenance of an adequate hemoglobin level.  Over time, these chronic red blood cell transfusions cause iron to accumulate within the reticuloendothelial system and organs such as the liver and heart.  Because iron cardiotoxicity may result in arrhythmias and congestive heart failure, it is important to implement chelation therapy within one to two years of beginning red blood cell transfusions. Chelation therapy allows for the removal of excessive iron from the body, and can delay or prevent the development of cardiac disease.  Deferoxamine is one of the more effective and safe iron chelators, as it complexes with ferric ions to form ferrioxamine, which is removed by the kidneys. (Choices A, B, D, and E)  Erythropoietin induces erythropoiesis and reticulocyte release from the bone marrow.  It is commonly used to treat the anemia of chronic kidney disease.  Cobalamin (vitamin B12) is necessary in the treatment of pernicious anemia.  Ascorbic acid (vitamin C) is used in the treatment of scurvy.  Digoxin causes increased cardiac contractility, enhanced vagal tone, and decreased ventricular rate.  As such, it is used in the treatment of congestive heart failure and supraventricular arrhythmias. None of these therapies are capable of preventing congestive heart failure secondary to iron cardiotoxicity, however. Educational objective: Chelation therapy with deferoxamine should be implemented in patients receiving chronic red blood cell transfusions.  Deferoxamine prevents iron-induced cardiotoxicity and congestive heart failure from developing in this patient population.

Thalassemia Major & Iron Overload — Ultra High-Yield USMLE Notes


1. Diagnosis: Iron overload cardiomyopathy/CHF secondary to chronic transfusions in Thalassemia Major → treated with Deferoxamine (iron chelation)

2. Key clue (1 line): Child + thalassemia major + multiple transfusions + hepatosplenomegaly + glucose intolerance → iron deposition in organs → prevent CHF with chelation

3. Why correct (≤2 lines): Chronic RBC transfusions → iron accumulates in reticuloendothelial system + liver + heart + pancreas → iron cardiotoxicity → arrhythmias + CHF. Deferoxamine chelates ferric ions (Fe³⁺) → forms ferrioxamine → renally excreted; must start within 1–2 years of beginning transfusions to prevent cardiac disease.

4. Why others wrong (1 line each):
  • Erythropoietin: Stimulates erythropoiesis; treats anemia of CKD; does not remove iron or prevent cardiotoxicity
  • Cobalamin (B12): Treats pernicious/megaloblastic anemia; no role in iron overload
  • Ascorbic acid (Vit C): Treats scurvy; no cardiac protection in iron overload (actually increases iron absorption)
  • Digoxin: Treats existing CHF/SVT; does NOT prevent iron-induced cardiomyopathy or address root cause

5. Buzzword triggers:
  • Thalassemia major + chronic transfusions → iron overload → chelation therapy
  • Iron overload organs: Heart (CHF/arrhythmia) + Liver (cirrhosis) + Pancreas (diabetes) + Skin (bronze) + Pituitary (hypogonadism)
  • Iron overload = "Bronze diabetes" / secondary hemochromatosis
  • Glucose intolerance in transfused child → pancreatic iron deposition
  • Deferoxamine → complexes Fe³⁺ → ferrioxamine → renally cleared
  • Oral chelators: Deferasirox, Deferiprone (alternatives to deferoxamine)

6. Trap / trick tested:
  • Digoxin treats CHF symptoms but does NOT prevent iron-induced cardiomyopathy — treating the consequence ≠ preventing the cause
  • Glucose intolerance is a distractor suggesting diabetes workup; it signals pancreatic iron deposition = systemic iron overload already occurring
  • Vitamin C increases GI iron absorption → potentially harmful in iron overload patients (opposite of desired effect)
  • Question asks to prevent CHF → answer is chelation, not cardiac treatment

7. One-liner memory hook:
"Transfusions fill organs with iron → Heart + Pancreas + Liver rust → Deferoxamine chelates Fe³⁺ out through kidneys → prevents rusty heart (CHF)."

A 2-week-old girl is brought to her primary care provider for a routine visit.  The patient was born by normal spontaneous vaginal delivery at 39 weeks gestation.  The mother is breastfeeding exclusively, and the infant has regained her birth weight.  Newborn screening results from hemoglobin electrophoresis are as follows: Hemoglobin F 70% Hemoglobin A 20% Hemoglobin S 10% The patient's mother has sickle cell trait, and a maternal cousin has sickle cell anemia.  Examination shows a well-appearing infant with no pallor or splenomegaly.  Which of the following is most likely true about this patient? Explanation Sickle cell trait Clinical features Usually no symptoms of sickle cell anemia More prevalent in African, Middle Eastern & Mediterranean countries; African American & Hispanic individuals No change in overall life expectancy Diagnosis Normal hemoglobin, reticulocyte count, RBC indices & morphology Hemoglobin electrophoresis shows both Hb A & Hb S, with the amount of Hb A greater than Hb S Hb A = hemoglobin A; Hb S = hemoglobin S; RBC = red blood cells. This patient's hemoglobin electrophoresis from her newborn screen is most consistent with sickle cell trait.  At birth, infants who are heterozygous for sickle cell trait typically have the greatest amount of fetal hemoglobin (Hb F), followed by hemoglobin A (Hb A), and the smallest amount of hemoglobin S (Hb S).  Hb A continues to be higher than Hb S throughout the lifetime of these patients as Hb F naturally declines, offering protection from sickle cell anemia, aplastic crises, and splenic sequestration.  Patients with sickle cell trait are usually asymptomatic with normal hemoglobin level, reticulocyte count, and red blood cell (RBC) indices.  However, they may develop hematuria, priapism, and increased incidence of urinary tract infections.  Splenic infarction at high altitudes has also been reported. Patients with sickle cell trait have relative protection from Plasmodium falciparum (malaria), resulting in lower rates of severe malaria and hospitalization than seen in the general population.  Possible mechanisms include increased sickling of parasitized sickle cell trait RBCs and accelerated removal of these cells by the splenic monocyte-macrophage system.  These patients are not immune to malaria, however, and those visiting malaria-endemic areas should still receive prophylaxis. (Choice A)  Life expectancy of patients with sickle cell trait is no different than that of the general population.  Patients who are homozygous for the sickle cell mutation have a decreased life expectancy due to significant complications of disease (eg, acute chest syndrome, infection from encapsulated organisms). (Choices B and C)  Patients with sickle cell trait typically have normal RBC indices and reticulocyte counts.  Individuals with sickle cell anemia (eg, no normal Hb A) will have an elevated reticulocyte count but will maintain a normal mean corpuscular volume. (Choice E)  It is unlikely that this patient will develop painful crises as she is protected by the predominance of Hb A (normal hemoglobin) over Hb S.  Vaso-occlusive pain crises that develop in patients with sickle cell anemia are thought to occur when Hb S polymerizes and causes the RBCs to assume a sickle shape, typically in response to a trigger (eg, cold weather, dehydration). Educational objective: Patients with sickle cell trait are typically asymptomatic and have relative protection from malaria caused by Plasmodium falciparum.  These patients usually have normal hemoglobin, reticulocyte, and red blood cell index values.  Life expectancy is the same as that of the general population.

Sickle Cell Trait — Ultra High-Yield USMLE Notes


1. Diagnosis: Sickle Cell Trait (HbAS) — heterozygous carrier; NOT sickle cell anemia

2. Key clue (1 line): Newborn electrophoresis: HbF 70% > HbA 20% > HbS 10% + mother has sickle trait + well-appearing infant + no anemia/splenomegaly → sickle cell trait

3. Why correct (≤2 lines): Heterozygous HbAS → HbA always predominates over HbS (throughout life as HbF declines) → insufficient HbS to polymerize → no sickling, no hemolysis, no crisis. Labs completely normal (Hgb, retics, RBC indices, morphology); life expectancy = general population.

4. Why others wrong (1 line each):
  • Decreased life expectancy: Only sickle cell anemia (HbSS) reduces life expectancy; trait does not
  • Elevated reticulocyte count: Seen in HbSS (chronic hemolysis); trait has normal retics
  • Abnormal RBC indices/microcytosis: Trait has normal MCV/MCH; HbSS has normal MCV but elevated retics
  • Will develop painful vaso-occlusive crises: HbA predominance prevents HbS polymerization; crises occur in HbSS not trait
  • Immune to malaria: Trait confers relative protection (↓severe disease) from P. falciparum, NOT full immunity; prophylaxis still needed

5. Buzzword triggers:
  • HbF > HbA > HbS on newborn screen → sickle cell trait
  • HbF > HbS only (no HbA) on newborn screen → sickle cell anemia (HbSS)
  • Sickle cell trait + high altitude → splenic infarction
  • Sickle cell trait + African/AA/Hispanic patient → relative malaria protection (P. falciparum)
  • Sickle cell trait complications: hematuria + priapism + ↑UTIs + splenic infarction at altitude
  • HbSS triggers for crisis: cold + dehydration + hypoxia + infection

6. Trap / trick tested:
  • HbA > HbS at all times in trait — as HbF declines with age, HbA rises, always staying above HbS; students confuse neonatal proportions with disease
  • Newborn screen order: HbSS shows FS (HbF then HbS, no A); sickle trait shows FAS (HbF > HbA > HbS) — memorize electrophoresis pattern
  • Relative protection ≠ immunity — sickle trait patients visiting malaria-endemic regions still need prophylaxis
  • Well-appearing infant + family history of sickle disease → do NOT assume disease; read the electrophoresis ratios carefully

7. One-liner memory hook:
"FAS = Fine And Symptom-free (sickle trait); FS = Full Sickling disease (HbSS); HbA > HbS = protected, no crisis, normal life."

A 53-year-old man comes to the clinic due to frequent headaches and dizziness.  The patient has a history of hypertension and peptic ulcer disease.  His medications include daily chlorthalidone and antacids as needed.  Temperature is 37 C (98.6 F), blood pressure is 146/92 mm Hg, pulse is 89/min, and respirations are 16/min.  BMI is 26 kg/m2.  Physical examination shows facial plethora and moderate splenomegaly.  Laboratory results are as follows: Complete blood count Hemoglobin 21.5 g/dL Hematocrit 64% Erythrocytes 7.6 million/mm3 Mean corpuscular volume 90 μm3 Mean corpuscular hemoglobin 31 pg/cell Mean corpuscular hemoglobin concentration 33% Hb/cell Red blood cell distribution width 14.0% (n = 10.3%-14.1%) Platelets 545,000/mm3 Leukocytes 15,500/mm3 This patient most likely has a mutation affecting which of the following types of protein? this patient's striking elevation in hemoglobin concentration (> 18.5 g/dL) is most likely due to polycythemia vera, a myeloproliferative disorder characterized by uncontrolled erythrocyte production.  Patients frequently experience nonspecific symptoms (eg, headache, dizziness); more specific symptoms include aquagenic pruritus and facial plethora/splenomegaly (vascular congestion).  Complications include peptic ulcer disease (altered mucosal blood flow due to increased viscosity) and gouty arthritis (higher erythrocyte turnover).  Laboratory studies show increased erythrocyte mass and low erythropoietin levels; thrombocytosis and leukocytosis are also characteristic of polycythemia vera.  Erythrocyte indices are usually normal. Polycythemia vera is caused by abnormal transduction of erythropoietin growth signals.  The erythropoietin receptor has no intrinsic kinase activity and must interact with Janus kinase 2 (JAK2), a non-receptor tyrosine kinase found in the cytoplasm, to initiate downstream signaling.  Almost all patients with polycythemia vera have a mutation in JAK2 that causes constitutive activation of the protein's kinase domain, resulting in clonal proliferation of myeloid cells.  JAK2 mutations have also been implicated in essential thrombocythemia, primary myelofibrosis, and other myeloproliferative disorders. (Choice A)  Burkitt lymphoma is characterized by translocation of the Myc oncogene on chromosome 8 to the Ig heavy chain region on chromosome 14.  This translocation results in constitutive expression of Myc, a growth-stimulating transcription factor. (Choice C)  Receptor tyrosine kinases are transmembrane receptors with intrinsic kinase activity that autophosphorylate and induce a downstream signaling cascade upon ligand binding.  Examples include the receptors for insulin, insulin-like growth factor, and epidermal growth factor.  Mutations causing excessive epidermal growth factor receptor activity occur in many solid tumors. (Choice D)  Mutations in the p53 tumor suppressor are associated with Li-Fraumeni syndrome, an autosomal dominant disorder that predisposes to various cancers, particularly sarcomas and tumors of the breast, brain, and adrenal cortex. (Choice E)  Expression of vascular endothelial growth factor (VEGF) is required for tumor angiogenesis, a critical step during tumor growth and metastasis.  VEGF upregulation occurs in most cancers. Educational objective: Polycythemia vera is a myeloproliferative disorder characterized by uncontrolled erythrocyte production.  Almost all patients with polycythemia vera have a mutation in the JAK2 gene, which encodes a non-receptor (cytoplasmic) tyrosine kinase associated with the erythropoietin receptor.

Polycythemia Vera (PV) — Ultra High-Yield USMLE Notes


1. Diagnosis: Polycythemia Vera (PV) — myeloproliferative disorder; JAK2 mutation (non-receptor/cytoplasmic tyrosine kinase)

2. Key clue (1 line): 53M + headache/dizziness + facial plethora + splenomegaly + Hgb 21.5 + Hct 64% + ↑platelets + ↑WBC + normal MCV + Hx PUD → PV with JAK2 mutation

3. Why correct (≤2 lines): PV caused by JAK2 point mutation → constitutive activation of cytoplasmic (non-receptor) tyrosine kinase → EPO-independent clonal myeloid proliferation → ↑↑RBCs + ↑platelets + ↑WBC + ↓EPO. JAK2 is a non-receptor tyrosine kinase (cytoplasmic, no transmembrane domain) that associates with the EPO receptor to transduce growth signals.

4. Why others wrong (1 line each):
  • Transcription factor (Myc/t(8;14)): Burkitt lymphoma mechanism; constitutive gene expression, not kinase activation
  • Receptor tyrosine kinase (transmembrane): Insulin/EGF receptors have intrinsic kinase + transmembrane domain; JAK2 is cytoplasmic with no transmembrane domain
  • Tumor suppressor (p53): Li-Fraumeni syndrome; loss-of-function mutation; causes sarcomas/breast/brain tumors, not erythrocytosis
  • VEGF (angiogenic factor): Promotes tumor angiogenesis/metastasis; not involved in myeloproliferation

5. Buzzword triggers:
  • Facial plethora + aquagenic pruritus + splenomegaly + ↑Hgb/Hct → PV
  • PV labs: ↑RBC mass + ↑platelets + ↑WBC + ↓EPO + normal MCV
  • JAK2 V617F mutation → PV, essential thrombocythemia, primary myelofibrosis
  • PV complications: PUD (↑viscosity → mucosal ischemia) + gout (↑RBC turnover → ↑uric acid) + thrombosis + aquagenic pruritus (↑histamine from basophils)
  • Non-receptor tyrosine kinases: JAK2, ABL (CML), Src family
  • EPO receptor → no intrinsic kinase → recruits JAK2 → downstream signaling

6. Trap / trick tested:
  • Question asks about protein type, not the disease itself — answer is "non-receptor (cytoplasmic) tyrosine kinase," not just "JAK2"
  • Receptor TK vs Non-receptor TK: Receptor TK = transmembrane + intrinsic kinase (insulin, EGF, PDGF receptors); Non-receptor TK = cytoplasmic, no transmembrane domain (JAK2, ABL, Src)
  • PUD history + PV → PUD is a complication of PV (hyperviscosity → altered mucosal blood flow), not a separate coincidental finding
  • Aquagenic pruritus (itching after hot shower) not mentioned here but classic USMLE buzzword for PV

7. One-liner memory hook:
"JAK2 mutates → Jacks up RBCs without EPO → Plethora + Pruritus (aquagenic) + Peptic ulcers + Platelets up → cytoplasmic kinase gone rogue."

A 28-year-old man starts taking a prophylactic medication before leaving on a business trip to Costa Rica.  Five days later, he comes to the emergency department due to jaundice and dark urine.  Laboratory results are as follows: Hemoglobin 8.2 g/dL Reticulocytes 8% Total bilirubin 3.5 mg/dL Direct bilirubin 0.5 mg/dL Lactate dehydrogenase 342 U/L Haptoglobin 42 mg/dL (normal: 50-150) A peripheral smear shows red blood cells with dark inclusions when stained with crystal violet, a supravital stain.  This patient's condition most likely demonstrates which of the following inheritance patterns? Glucose-6-phosphate dehydrogenase deficiency Epidemiology Hemolytic anemia due to oxidative stress (infection, sulfa drugs, fava beans) X-linked: Asian, African, or Middle Eastern descent Manifestations Pallor & fatigue Dark urine, jaundice & icterus Abdominal/back pain Laboratory findings Hemolysis: ↓ hemoglobin, ↓ haptoglobin, ↑ bilirubin & LDH, ↑ reticulocytes Peripheral smear: bite cells & Heinz bodies Negative Coombs test ↓ G6PD activity level (may be normal during attack) Management Remove or treat responsible agent/condition Provide supportive care G6PD = glucose-6-phosphate dehydrogenase; LDH = lactate dehydrogenase. This patient developed acute hemolytic anemia (eg, jaundice, dark urine, low haptoglobin) after taking a new medication, suggesting glucose-6-phosphate dehydrogenase (G6PD) deficiency.  G6PD catalyzes production of NADPH in erythrocytes; loss of G6PD function limits regeneration of reduced glutathione, impairing the ability of erythrocytes to handle increased oxidative stress (eg, foods, medications).  The trigger in this case was likely primaquine prescribed for malaria prophylaxis. Manifestations of G6PD deficiency typically begin within 2-5 days and often include pallor, dark urine, and jaundice.  Laboratory evaluation reveals signs of erythrocyte lysis such as elevated bilirubin, elevated lactate dehydrogenase, and low haptoglobin (protein that binds free heme).  The bone marrow responds by releasing young erythrocytes, leading to reticulocytosis.  Peripheral smear will demonstrate signs of denatured hemoglobin precipitation such as intraerythrocytic dark inclusions (Heinz bodies). G6PD deficiency is an X-linked recessive disorder; males (46,XY) who carry the mutation are affected because all erythrocytes have the defective G6PD gene.  Females (46,XX) who carry a copy of the defective gene (heterozygous) are usually unaffected because random inactivation of the X chromosome (lyonization) results in ~50% of erythrocytes with the normal gene.  However, heterozygous females can develop acute hemolysis when lyonization is skewed toward expression of the mutated gene. (Choice A)  Most structural erythrocyte abnormalities (eg, hereditary spherocytosis) are inherited in an autosomal dominant manner.  Although jaundice from hemolysis can be seen, peripheral smear would not show Heinz bodies. (Choice B)  In contrast to G6PD deficiency, most other erythrocyte enzyme deficiencies (eg, pyruvate kinase [PK] deficiency) are inherited in an autosomal recessive pattern.  PK catalyzes the last step in glycolysis; because erythrocytes rely solely on glycolysis for ATP production (due to a lack of mitochondria), patients develop chronic (not episodic) hemolysis. (Choice C)  Mitochondrial DNA is of maternal origin.  Mitochondrial diseases generally limit cellular ATP generation due to impaired oxidative phosphorylation and often present with neuromuscular dysfunction.  Heinz bodies would not be seen; in addition, hemolysis following medication exposure indicates likely G6PD deficiency. (Choice D)  X-linked dominant disorders affect males and females equally.  Nearly all cases of symptomatic G6PD deficiency occur in males, indicating an X-linked recessive inheritance pattern. Educational objective: Glucose-6-phosphate dehydrogenase deficiency is an X-linked recessive disorder that causes acute hemolysis after exposure to oxidizing medications, foods, or acute infection.  Nearly all affected persons are male, but heterozygous females can become symptomatic due to skewed lyonization.

G6PD Deficiency — Ultra High-Yield USMLE Notes


1. Diagnosis: Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency — X-linked recessive; triggered by primaquine (malaria prophylaxis)

2. Key clue (1 line): 28M + travel to Costa Rica + new medication (primaquine) + jaundice + dark urine + ↓Hgb + ↑retics + ↑LDH + ↑indirect bili + ↓haptoglobin + Heinz bodies (dark inclusions on crystal violet stain)

3. Why correct (≤2 lines): G6PD deficiency → ↓NADPH → ↓reduced glutathione → RBCs cannot neutralize oxidative stress → hemoglobin denatures → Heinz bodies → splenic macrophages bite them out → bite cells → intravascular + extravascular hemolysis within 2–5 days of trigger. X-linked recessive → nearly all symptomatic patients are male; heterozygous females protected by lyonization (~50% normal RBCs).

4. Why others wrong (1 line each):
  • Autosomal dominant (HS): Hereditary spherocytosis → spherocytes, not Heinz bodies; chronic not episodic hemolysis
  • Autosomal recessive (PK deficiency): Pyruvate kinase deficiency → chronic hemolysis (not episodic/drug-triggered); no Heinz bodies
  • Mitochondrial inheritance: Maternal transmission; causes neuromuscular/ATP disorders; no Heinz bodies or drug-triggered hemolysis
  • X-linked dominant: Would affect males AND females equally; G6PD overwhelmingly affects males → X-linked recessive pattern

5. Buzzword triggers:
  • Travel to malaria region + primaquine/dapsone/sulfonamides → G6PD deficiency
  • Fava beans + hemolysis → G6PD deficiency
  • Heinz bodies (crystal violet/supravital stain) → denatured Hgb precipitates → G6PD
  • Bite cells (regular stain) → splenic removal of Heinz bodies → G6PD
  • Episodic hemolysis (not chronic) + oxidative trigger → G6PD (vs PK deficiency = chronic)
  • G6PD activity level: may be falsely normal during acute attack (old deficient RBCs already lysed; young retics have higher G6PD)
  • Negative Coombs → not immune-mediated hemolysis

6. Trap / trick tested:
  • G6PD level may be normal during acute attack — test after recovery when retic count normalizes; young RBCs have higher G6PD masking true deficiency
  • Heinz bodies ≠ bite cells — Heinz bodies seen on supravital stain (crystal violet); bite cells seen on regular peripheral smear; both indicate G6PD
  • Heterozygous females CAN be symptomatic if lyonization skewed toward mutant X — not always protected
  • PK deficiency vs G6PD: PK = chronic hemolysis + autosomal recessive; G6PD = episodic + X-linked recessive

7. One-liner memory hook:
"Primaquine/Sulfa/Fava → oxidative stress → G6PD gone → no NADPH → no glutathione → Hgb denatures → Heinz bodies → bite cells → episodic hemolysis in males."

G6PD Deficiency — Ultra High-Yield USMLE Notes 1. Diagnosis: Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency — X-linked recessive; triggered by primaquine (malaria prophylaxis) 2. Key clue (1 line): 28M + travel to Costa Rica + new medication (primaquine) + jaundice + dark urine + ↓Hgb + ↑retics + ↑LDH + ↑indirect bili + ↓haptoglobin + Heinz bodies (dark inclusions on crystal violet stain) 3. Why correct (≤2 lines): G6PD deficiency → ↓NADPH → ↓reduced glutathione → RBCs cannot neutralize oxidative stress → hemoglobin denatures → Heinz bodies → splenic macrophages bite them out → bite cells → intravascular + extravascular hemolysis within 2–5 days of trigger. X-linked recessive → nearly all symptomatic patients are male; heterozygous females protected by lyonization (~50% normal RBCs). 4. Why others wrong (1 line each): Autosomal dominant (HS): Hereditary spherocytosis → spherocytes, not Heinz bodies; chronic not episodic hemolysis Autosomal recessive (PK deficiency): Pyruvate kinase deficiency → chronic hemolysis (not episodic/drug-triggered); no Heinz bodies Mitochondrial inheritance: Maternal transmission; causes neuromuscular/ATP disorders; no Heinz bodies or drug-triggered hemolysis X-linked dominant: Would affect males AND females equally; G6PD overwhelmingly affects males → X-linked recessive pattern 5. Buzzword triggers: Travel to malaria region + primaquine/dapsone/sulfonamides → G6PD deficiency Fava beans + hemolysis → G6PD deficiency Heinz bodies (crystal violet/supravital stain) → denatured Hgb precipitates → G6PD Bite cells (regular stain) → splenic removal of Heinz bodies → G6PD Episodic hemolysis (not chronic) + oxidative trigger → G6PD (vs PK deficiency = chronic) G6PD activity level: may be falsely normal during acute attack (old deficient RBCs already lysed; young retics have higher G6PD) Negative Coombs → not immune-mediated hemolysis 6. Trap / trick tested: G6PD level may be normal during acute attack — test after recovery when retic count normalizes; young RBCs have higher G6PD masking true deficiency Heinz bodies ≠ bite cells — Heinz bodies seen on supravital stain (crystal violet); bite cells seen on regular peripheral smear; both indicate G6PD Heterozygous females CAN be symptomatic if lyonization skewed toward mutant X — not always protected PK deficiency vs G6PD: PK = chronic hemolysis + autosomal recessive; G6PD = episodic + X-linked recessive 7. One-liner memory hook: "Primaquine/Sulfa/Fava → oxidative stress → G6PD gone → no NADPH → no glutathione → Hgb denatures → Heinz bodies → bite cells → episodic hemolysis in males." All of the choices represent mechanisms for anemia.  The key to answering this question is this patient's history and peripheral smear.  Red blood cell (RBC)fragments and helmet cells (a type of schisctocyte with crescent shapes) are consistent with traumatic hemolysis, which can result from either microangiopathic hemolytic anemia or mechanical damage (eg, prosthetic valve). Prosthetic valves produce excessive shear and turbulence in the cardiac circulation, causing mechanical trauma to the RBCs and schistocytes. (Choice A)  Microvascular thrombi are the pathophysiologic mechanism for microangiopathic hemolytic anemia, which causes thrombocytopenia.  In this patient, platelet count is normal. (Choice B)  Cytoskeleton abnormalities describe an intracorpuscular defect characteristic of a group of anemias that includes hereditary spherocytosis, hereditary elliptocytosis, and hereditary stomatocytosis.  Respectively, spherocytes, elliptocytes, or stomatocytes are characteristically seen in the peripheral blood smear. (Choice C)  Impaired DNA synthesis is the pathophysiologic mechanism for megaloblastic anemia.  Ovalo-macrocytes are the associated morphologic RBC variant seen in this group of anemia.  In addition, hypersegmented neutrophils are also characteristic. (Choice D)  Gastrointestinal blood loss results in hypochromic, microcytic anemia due to iron deficiency. (Choice E)  Mutation of the beta globin chain results in beta thalassemia; target cells are the RBC morphologic variant commonly seen. (Choice F)  Paroxysmal nocturnal hemoglobinuria is an episodic hemolysis caused by a complement-mediated mechanism.  Leukopenia and thrombocytopenia (pancytopenia) are commonly associated. Educational objective: Red blood cell fragments and helmet cells are associated with either microangiopathic hemolytic anemia or mechanical red cell destruction. In patients with prosthetic valves, red blood cells are exposed to excessive shear and turbulence in the circulation, causing damage from mechanical trauma.

Mechanical Hemolytic Anemia (Prosthetic Valve) — Ultra High-Yield USMLE Notes


1. Diagnosis: Mechanical Hemolytic Anemia — RBC destruction from prosthetic heart valve (excessive shear/turbulence)

2. Key clue (1 line): Hx of prosthetic valve + anemia + schistocytes/helmet cells on smear + normal platelet count → mechanical (not microangiopathic) hemolysis

3. Why correct (≤2 lines): Prosthetic valves generate excessive shear forces → mechanical trauma fragments RBCs → schistocytes + helmet cells on smear → intravascular hemolysis (↑LDH + ↑indirect bili + ↓haptoglobin + ↑retics). Normal platelets distinguish mechanical hemolysis from MAHA (HUS/TTP/DIC), where thrombocytopenia is expected.

4. Why others wrong (1 line each):
  • Microvascular thrombi (MAHA — HUS/TTP/DIC): Also causes schistocytes BUT thrombocytopenia present; platelets normal here → not MAHA
  • Cytoskeleton defect (HS/elliptocytosis): Spherocytes or elliptocytes on smear; no schistocytes/helmet cells; chronic compensated hemolysis
  • Impaired DNA synthesis (megaloblastic): Macro-ovalocytes + hypersegmented neutrophils; no schistocytes
  • GI blood loss (IDA): Microcytic/hypochromic smear; no schistocytes or hemolysis markers
  • Beta-globin mutation (β-thalassemia): Target cells on smear; microcytic; no schistocytes
  • PNH (complement-mediated): Episodic hemolysis + pancytopenia (↓WBC + ↓platelets); no schistocytes

5. Buzzword triggers:
  • Schistocytes + helmet cells → MAHA or mechanical destruction
  • Schistocytes + ↓platelets → MAHA (HUS/TTP/DIC)
  • Schistocytes + normal platelets + prosthetic valve → mechanical hemolysis
  • Schistocyte causes: HUS / TTP / DIC / prosthetic valve / severely calcified valve / HELLP
  • Helmet cells = crescent-shaped schistocytes = traumatic RBC fragmentation
  • PNH: episodic hemolysis + pancytopenia + venous thrombosis (esp. portal/hepatic) + dark morning urine

6. Trap / trick tested:
  • Schistocytes alone ≠ automatically MAHA — check platelet count first: normal platelets → mechanical; low platelets → MAHA
  • PNH vs mechanical: both cause intravascular hemolysis — PNH has pancytopenia + complement mechanism + thrombosis; prosthetic valve has normal CBC except anemia
  • Helmet cells are a subtype of schistocyte — not a separate diagnosis; both indicate traumatic fragmentation

7. One-liner memory hook:
"Prosthetic valve = RBC blender → schistocytes + helmet cells; platelets fine = mechanical not MAHA; check the valve, not the clot."

A 23-year-old African American man comes to the emergency department due to back and lower extremity pain for 2 days.  He has had several similar episodes over the last 15 years that have required hospitalization.  His pain is not responsive to over-the-counter analgesics, and review of his prior records shows that he has needed treatment with opioids for adequate pain relief.  The patient does not use tobacco, alcohol, or illicit drugs.  On physical examination, he has scleral icterus and tenderness over his lower back and long bones of his thighs.  Laboratory evaluation shows a hemoglobin level of 6.7 g/dL. Item 1 of 2 Histopathologic evaluation of this patient's spleen is most likely to reveal which of the following? patient with frequent episodes of bony pain likely has sickle cell disease (SCD), an autosomal recessive condition characterized by hemolytic anemia and vaso-occlusion.  The hemolytic anemia causes jaundice (due to unconjugated hyperbilirubinemia) and promotes formation of pigmented gallstones.  Vaso-occlusion by sickled red blood cells occurs in various tissues, causing hypoxia and acidosis (vaso-occlusive pain episodes).  Microvascular occlusion nearly always affects the spleen due to the trapping of sickle cells by the rigid splenic cords; autoinfarction begins in early childhood and can precipitate splenic sequestration crisis in infants.  However, repeated infarction eventually leads to significant scarring, fibrosis, and atrophy of the spleen, which would likely be present in this adult patient. Asplenic patients are more susceptible to infections with encapsulated bacteria (eg, group B Streptococcus, Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Salmonella typhi). (Choice A)  Splenic congestion occurs during a splenic sequestration crisis (marked hemoglobin decrease, rapidly enlarging spleen), which develops due to vaso-occlusion within the cords of Billroth and splenic pooling of erythrocytes.  However, repeated infarction leads to functional asplenia and autosplenectomy (splenic atrophy) by late childhood/adolescence. (Choices B and D)  Splenic cyst formation typically occurs due to infection.  Splenic infiltration can be seen with metastatic neoplasms but is not a feature of SCD. (Choice E)  The white pulp of the spleen is composed of lymphoid tissue.  Lymphoid hyperplasia may represent infection or malignancy. Educational objective: Sickle cell disease is characterized by repeated splenic infarctions that ultimately result in splenic atrophy and fibrosis, a process that is typically complete by late childhood/adolescence.  After autosplenectomy, patients are predisposed to infections with encapsulated bacterial organisms.

Sickle Cell Disease — Autosplenectomy — Ultra High-Yield USMLE Notes


1. Diagnosis: Sickle Cell Disease (HbSS) — Autosplenectomy (splenic atrophy/fibrosis from repeated infarctions)

2. Key clue (1 line): Young AA man + recurrent bony pain episodes since childhood + opioid-requiring crises + scleral icterus + Hgb 6.7 → SCD → adult spleen = fibrosis/atrophy (autosplenectomy)

3. Why correct (≤2 lines): Sickled RBCs repeatedly occlude splenic microvasculature → progressive infarction → fibrosis + atrophy → functional asplenia (autosplenectomy) complete by late childhood/adolescence. Histology shows fibrotic, atrophic spleen with scarring; no functional splenic tissue remains → ↑susceptibility to encapsulated bacteria.

4. Why others wrong (1 line each):
  • Splenic congestion: Seen in acute sequestration crisis (infants, early childhood) — rapidly enlarging spleen + ↓↓Hgb; NOT the chronic adult picture
  • Splenic cyst: Typically infectious/parasitic (eg, Echinococcus); not a feature of SCD
  • Splenic infiltration: Metastatic neoplasm finding; no cancer history here
  • Lymphoid hyperplasia (white pulp): Seen in infection or lymphoid malignancy; not SCD pathology

5. Buzzword triggers:
  • SCD + adult → autosplenectomy (fibrosis/atrophy)
  • SCD + infant/young child → splenic sequestration crisis (congestion, enlarging spleen)
  • Autosplenectomy → encapsulated bacteria susceptibility: S. pneumoniae, H. influenzae, N. meningitidis, Salmonella typhi, Group B Strep
  • SCD + bone pain → vaso-occlusive crisis (hypoxia + acidosis trigger)
  • SCD + osteomyelitis → Salmonella (most common organism, unlike general population where Staph aureus #1)
  • SCD complications: HASHIHemolysis + Acute chest syndrome + Stroke + Hand-foot syndrome (dactylitis, infants) + Infarction (bone/spleen/retina)

6. Trap / trick tested:
  • Age matters for spleen in SCD: Infant = sequestration (congested, enlarged); Adult = autosplenectomy (atrophic, fibrotic) — same disease, opposite histology at different ages
  • Splenic sequestration = emergency (transfuse); autosplenectomy = chronic consequence (vaccinate)
  • Salmonella osteomyelitis trap: general population osteomyelitis = Staph aureus; SCD osteomyelitis = Salmonella (USMLE favorite)
  • Functional asplenia despite physical spleen being present earlier — the spleen exists but is non-functional long before complete atrophy

7. One-liner memory hook:
"Sickle cells clog the spleen repeatedly → spleen scars, shrinks, dies (autosplenectomy) → encapsulated bugs take over → Pneumococcus, Salmonella win; infant = big congested spleen; adult = shriveled fibrotic raisin."

The patient is admitted to the hospital and receives opioid analgesics and intravenous fluids.  He has no evidence of active infection.  His hemoglobin electrophoresis results are consistent with sickle cell disease (hemoglobin SS).  Further laboratory evaluation shows a mean corpuscular volume of 113 µm3 and a reticulocyte index of 1.5, which is low given the patient's severe anemia.  Which of the following is the most likely cause of this patient's macrocytosis? patient has macrocytic anemia (mean corpuscular volume [MCV] >100 µm3).  Severe macrocytosis (MCV >110 µm3) is usually due to megaloblastic anemia, a subtype of macrocytic anemia caused by impaired DNA synthesis.  Cytoplasmic components then accumulate within the slowly dividing erythrocytes, producing cells that are larger than normal (macrocytes). Patients with sickle cell disease (SCD) or other hemolytic anemias have increased folic acid requirements due to increased erythrocyte turnover.  As such, they are prone to developing relative folic acid deficiency and megaloblastic anemia. (Choice A)  Extramedullary erythropoiesis can occur in SCD and lead to an elevated reticulocyte count and MCV, as the reticulocytes produced are larger than those released by the bone marrow.  However, this patient's low reticulocyte index (representing the reticulocyte percentage corrected for the degree of anemia) suggests an inadequate response to anemia and a lack of erythropoiesis. (Choice C)  Patients with SCD may receive multiple transfusions for treatment of severe or symptomatic anemia.  Transfusion related iron overload can cause severe liver disease, but would be unlikely to produce an MCV >110 µm3. (Choice D)  Macrocytosis can occur in liver failure due to an increase in circulating phospholipids and cholesterol that adsorb onto erythrocytes, resulting in membrane expansion.  However, liver-associated macrocytosis is generally mild (<110 µm3) and this patient does not have any findings to suggest advanced liver disease (eg, ascities/edema, bleeding). (Choice E)  A disease of the elderly, myelodysplastic syndrome can cause macrocytic anemia.  In the setting of a young patient with SCD and hemolytic anemia, however, folic acid deficiency is much more likely. Educational objective: An MCV >110 µm3 is highly suggestive of megaloblastic anemia, such as that caused by folic acid or vitamin B12 deficiency.  Patients with chronic hemolytic anemia have increased folic acid requirements due to increased erythrocyte turnover and are predisposed to developing macrocytosis.

Sickle Cell Disease + Folic Acid Deficiency (Megaloblastic Anemia) — Ultra High-Yield USMLE Notes


1. Diagnosis: Folic Acid Deficiency → Megaloblastic Anemia superimposed on Sickle Cell Disease (chronic hemolytic anemia)

2. Key clue (1 line): SCD patient + MCV 113 µm³ (severe macrocytosis >110) + low reticulocyte index (1.5) despite severe anemia → impaired erythropoiesis → folate deficiency

3. Why correct (≤2 lines): Chronic hemolysis in SCD → ↑RBC turnover → ↑folate consumption → relative folate deficiency → impaired DNA synthesis → megaloblastic anemia (MCV >110 + ↓retics = inadequate marrow response). Folate deficiency = most common megaloblastic cause in hemolytic anemia patients; cytoplasm accumulates while nucleus divides slowly → large cells + low retic output.

4. Why others wrong (1 line each):
  • Extramedullary erythropoiesis: Would cause ↑↑retics + mild ↑MCV; this patient has low retic index → inadequate production, not compensatory
  • Transfusion iron overload: Causes liver disease/organ damage; does NOT produce severe macrocytosis (MCV >110)
  • Liver failure macrocytosis: Phospholipid membrane expansion → mild macrocytosis only (MCV <110); no signs of liver failure here
  • Myelodysplastic syndrome (MDS): Disease of elderly; very unlikely in young SCD patient; folate deficiency far more probable

5. Buzzword triggers:
  • MCV >110megaloblastic (folate or B12 deficiency) until proven otherwise
  • MCV 100–110 → liver disease, hypothyroidism, alcohol, reticulocytosis
  • Chronic hemolytic anemia (SCD, thalassemia, HS) + macrocytosis → folate deficiency (↑demand)
  • Low reticulocyte index + severe anemia → production failure (not compensating)
  • Megaloblastic anemia smear: macro-ovalocytes + hypersegmented neutrophils (≥5 lobes)
  • Folate deficiency vs B12: both → megaloblastic; B12 also causes subacute combined degeneration (posterior + lateral columns); folate does NOT

6. Trap / trick tested:
  • SCD baseline = normocytic (normal MCV); finding MCV >110 in SCD = superimposed folate deficiency, NOT part of SCD itself
  • Low retic index in severe anemia = paradox — expected high retics in anemia; low retics = bone marrow failing to respond = production problem (megaloblastic)
  • Reticulocytosis itself causes mild ↑MCV (reticulocytes are large) — but retics are low here, so macrocytosis must be from megaloblastic cause
  • MCV cutoff matters: >110 = megaloblastic; <110 = think liver/alcohol/hypothyroid/drugs

7. One-liner memory hook:
"SCD burns through folate (churning RBCs) → tank runs empty → DNA synthesis fails → giant cells (MCV >110) + marrow gives up (↓retics) = folate deficiency on top of sickle."

A 35-year-old woman comes to the office due to reduced energy and fatigue.  She reports heavy menstrual bleeding over the past 6 months.  The patient is found to have hypochromic microcytic anemia.  Iron supplementation is prescribed.  A week later, a peripheral blood smear shows numerous enlarged red blood cells that have a bluish hue on Wright-Giemsa staining.  The bluish color of these red blood cells is best explained by the presence of which of the following? this patient has iron deficiency anemia (most likely due to menstrual blood loss), characterized by the presence of microcytic (ie, small), hypochromic (ie, pale) red blood cells (RBCs).  Patients with iron deficiency anemia who receive iron replacement therapy experience enhanced erythropoiesis and accelerated release of reticulocytes into the bloodstream as the bone marrow attempts to correct the anemia. Reticulocytes (immature RBCs) are anucleate (like mature RBCs) but are enlarged and have a blue-gray hue on Wright-Giemsa staining.  This bluish color (ie, polychromatophilia) is due to the presence of large amounts of ribosomal RNA necessary for adequate hemoglobin synthesis.  The ribosomal RNA can be distinguished using a supravital stain that binds RNA (eg, new methylene blue) and appears as a blue, reticular (ie, net-like) substance. Ribosomal RNA is gradually degraded as the reticulocyte matures.  After spending a day or more in the bloodstream, the maturation process is complete, and the reticulocyte transforms into a mature RBC, which has a lifespan of approximately 120 days. (Choices A and D)  Young reticulocytes contain organelles necessary for cell development, including mitochondria and remnants of Golgi apparatus, which are also removed as the reticulocyte matures.  However, it is the ribosomal RNA that imparts the bluish color on Wright-Giemsa staining. (Choice B)  Heinz bodies consist of denatured hemoglobin precipitate and are associated with glucose-6-phosphate dehydrogenase deficiency.  They cannot be seen on Wright-Giemsa staining but appear as round, peripheral RBC inclusions using a supravital stain. (Choice C)  Histone proteins are found in the nucleus.  During erythropoiesis, the erythroblast ejects its nucleus, forming a reticulocyte; because the reticulocyte does not have a nucleus, it does not contain histones. (Choice E)  Howell-Jolly bodies are nuclear remnants visible on Wright-Giemsa staining as purple, round, peripheral RBC inclusions.  They are associated with asplenia or hyposplenia because the spleen typically removes these nuclear remnants. Educational objective: Reticulocytes (immature red blood cells) appear as blue-gray (ie, polychromatophilic) red blood cells on Wright-Giemsa staining due to the presence of ribosomal RNA.  In patients with iron deficiency anemia, iron supplementation results in increased bone marrow erythropoiesis and accelerated release of reticulocytes into the bloodstream.

Reticulocytes & Polychromatophilia — Ultra High-Yield USMLE Notes


1. Diagnosis: Reticulocytosis (polychromatophilia) — bone marrow response to iron supplementation in IDA; bluish hue = ribosomal RNA

2. Key clue (1 line): 35F + heavy menstrual bleeding + microcytic/hypochromic anemia + iron started 1 week ago → now enlarged blue-gray RBCs on Wright-Giemsa → reticulocytes (rRNA)

3. Why correct (≤2 lines): Reticulocytes = immature anucleate RBCs released early from marrow → contain large amounts of ribosomal RNA for ongoing Hgb synthesis → rRNA stains blue-gray on Wright-Giemsa (polychromatophilia). Iron replacement → corrects IDA → marrow accelerates erythropoiesis → reticulocyte surge within 5–10 days of therapy; rRNA degrades as reticulocyte matures into RBC (~1 day in blood).

4. Why others wrong (1 line each):
  • Mitochondria: Present in young reticulocytes but do NOT cause bluish color on Wright-Giemsa; removed during maturation
  • Heinz bodies (denatured Hgb): G6PD deficiency; NOT visible on Wright-Giemsa; seen on supravital stain (crystal violet) as peripheral inclusions
  • Histone proteins: Nuclear proteins; reticulocytes are anucleate → no nucleus → no histones
  • Golgi remnants: Present in early reticulocytes but do NOT impart blue color on Wright-Giemsa
  • Howell-Jolly bodies (nuclear remnants): Purple round inclusions on Wright-Giemsa; seen in asplenia/hyposplenia; not the cause of blue hue

5. Buzzword triggers:
  • Blue-gray RBCs on Wright-Giemsa → polychromatophilia → reticulocytes → rRNA
  • Supravital stain (new methylene blue) + net-like blue substance in RBC → reticulocytes (rRNA)
  • Polychromatophilia + ↑retics → active erythropoiesis (hemolysis, hemorrhage, treatment response)
  • Howell-Jolly bodies (purple, round, Wright-Giemsa) → asplenia/hyposplenia → nuclear remnants not cleared
  • Heinz bodies (round, peripheral, supravital stain only) → G6PD / oxidative damage → denatured Hgb
  • Basophilic stippling (blue dots, Wright-Giemsa) → lead poisoning / thalassemia → aggregated ribosomes

6. Trap / trick tested:
  • Stain matters: Wright-Giemsa shows polychromatophilia (rRNA as blue hue); supravital stain (new methylene blue) shows net-like rRNA pattern in reticulocytes AND Heinz bodies — different stains, different appearances, same RNA
  • Heinz bodies ≠ Howell-Jolly bodies ≠ polychromatophilia — all are RBC inclusions but different causes, stains, and associations
  • Reticulocytes are anucleate → no DNA, no histones; "bluish" = RNA not nuclear material
  • Timing clue: blue-gray cells appear 1 week after iron started = reticulocyte response peak (not immediate)

7. One-liner memory hook:
"Iron refuels the marrow → reticulocytes flood out carrying rRNA → rRNA = blue-gray on Wright-Giemsa = polychromatophilia; not Heinz, not Howell-Jolly, just RNA making Hgb."

A 22-year-old woman comes to the office due to worsening dyspnea and heart pounding with exercise for the last week.  She has no chronic medical conditions but reports aches and pains over the past several weeks.  The patient takes ibuprofen as needed but no other medications.  Temperature is 37.2 C (99 F), blood pressure is 138/86 mm Hg, and pulse is 90/min.  BMI is 18 kg/m2.  Physical examination shows an erythematous rash in sun-exposed regions.  The lungs are clear to auscultation.  A midsystolic click and systolic murmur are heard best at the apex without radiation.  There is mild tenderness of joints.  Laboratory results are as follows: Hemoglobin 7.8 g/dL Reticulocytes 6% Platelets 205,000/mm3 Leukocytes 11,200/mm3 Creatinine 1.4 mg/dL Which of the following is the most likely cause of this patient's hematologic findings? his patient with dyspnea and heart pounding with exercise has symptomatic anemia.  Her other findings, including the presence of joint pain, a photosensitive rash, and mild renal insufficiency, raise suspicion for systemic lupus erythematosus (SLE), an autoimmune disease primarily seen in young women.  SLE frequently causes anemia due to a combination of factors, including chronic inflammation (anemia of chronic disease), gastrointestinal serositis (iron deficiency from bleeding), and/or autoimmune hemolytic anemia (AIHA). Approximately 10% of patients with SLE develop AIHA due to immune dysregulation, which results in the formation of IgG autoantibodies against the erythrocyte membrane.  Erythrocytes coated with IgG are subsequently identified by the Fc-receptor on splenic macrophages and partially or wholly phagocytized, leading to extravascular hemolysis.  Laboratory assessment typically reveals elevated reticulocyte count (ie, reticulocytosis) because interstitial fibroblasts in the kidney sense tissue hypoxia and increase the release of erythropoietin; this drives the bone marrow to increase erythrocytosis, leading to the presence of immature red cells in the peripheral blood (normoblasts, reticulocytes). (Choices A and C)  The presence of significant reticulocytosis (eg, >4-5%) rules out causes of anemia associated with an impaired bone marrow response, including bone marrow suppression from cancer or infection (eg, parvovirus), anemia of chronic disease (cytokine-mediated retention of iron), and vitamin deficiency (eg, vitamin B12 deficiency from intrinsic factor antibodies, iron deficiency). (Choice D)  A normal platelet count effectively rules out anemia due to a microangiopathic process associated with intravascular platelet consumption (eg, thrombotic microangiopathy). (Choice E)  Although traumatic intravascular hemolysis can occur with a mechanical heart valve or severe aortic stenosis, it is uncommon in otherwise healthy young individuals.  Furthermore, this patient's heart murmur is most consistent with mitral valve prolapse, which is common in patients with SLE but rarely causes traumatic hemolysis. Educational objective: Anemia with an elevated reticulocyte count (ie, reticulocytosis) indicates that the bone marrow is responding appropriately to the anemia by generating new erythrocytes.  Reticulocytosis is commonly seen in patients with hemolysis or acute bleeding.  Many other causes of anemia are associated with low reticulocyte count, including bone marrow suppression (eg, parvovirus), iron deficiency anemia, vitamin B12/folate deficiency, and anemia of chronic disease.

Autoimmune Hemolytic Anemia (AIHA) in SLE — Ultra High-Yield USMLE Notes


1. Diagnosis: Autoimmune Hemolytic Anemia (AIHA) — warm IgG antibodies; secondary to Systemic Lupus Erythematosus (SLE)

2. Key clue (1 line): Young woman + photosensitive rash + joint pain + ↑Cr (renal insufficiency) + Hgb 7.8 + ↑retics 6% + normal platelets → SLE-associated AIHA (extravascular hemolysis)

3. Why correct (≤2 lines): SLE → immune dysregulation → IgG autoantibodies coat RBCs → splenic macrophages recognize Fc region → partial/complete phagocytosis → extravascular hemolysis → ↑retics (marrow compensating via EPO). Normal platelets + ↑retics + SLE context = AIHA, not MAHA/TMA or production failure.

4. Why others wrong (1 line each):
  • Bone marrow suppression (parvovirus/cancer): Causes ↓↓retics (production failure); retics 6% = marrow responding normally → rules out suppression
  • Vitamin B12/iron deficiency: Both cause ↓retics + abnormal MCV; reticulocytosis >4–5% rules out production/nutrient deficiency
  • Anemia of chronic disease: ↓retics (iron sequestered by hepcidin/cytokines); high retics incompatible with ACD
  • Microangiopathic hemolysis (TMA/TTP): Requires ↓platelets (intravascular consumption); platelets normal here → rules out MAHA
  • Mechanical/traumatic hemolysis (valve): Murmur = mitral valve prolapse (midsystolic click = MVP hallmark); MVP rarely causes traumatic hemolysis

5. Buzzword triggers:
  • Young woman + malar/photosensitive rash + arthritis + renal disease → SLE
  • SLE + hemolytic anemia + ↑reticsAIHA (warm IgG)
  • Midsystolic click at apex → Mitral Valve Prolapse (common in SLE; not hemolysis cause)
  • AIHA diagnosis: Coombs test (direct antiglobulin test, DAT)positive (IgG-coated RBCs)
  • Warm AIHA (IgG): SLE, CLL, methyldopa, penicillin → extravascular hemolysis → spherocytes
  • Cold AIHA (IgM): Mycoplasma, EBV, lymphoma → intravascular hemolysis → agglutination
  • ↑retics (>4–5%) = marrow responding = hemolysis or acute blood loss (NOT deficiency/suppression)

6. Trap / trick tested:
  • Reticulocyte count is the first pivot: ↑retics → hemolysis/bleeding; ↓retics → production failure (IDA, B12, ACD, marrow suppression)
  • Normal platelets definitively rule out MAHA — students may see anemia + SLE and jump to TTP/TMA without checking platelets
  • MVP murmur (midsystolic click + systolic murmur at apex) ≠ mechanical hemolysis; aortic stenosis/prosthetic valves cause mechanical hemolysis, not MVP
  • SLE can cause BOTH AIHA and ACD — ↑retics distinguishes active hemolysis (AIHA) from ACD (↓retics)

7. One-liner memory hook:
"SLE → IgG coats RBCs → spleen eats them → hemolysis + ↑retics + positive Coombs; platelets fine = not TTP; retics up = not deficiency; midsystolic click = MVP not valve hemolysis."

A 16-year-old girl comes to the office due to fatigue for the past few months.  She attends high school and plays on the school soccer team but says that her endurance has decreased.  The patient sleeps 9 hours a night and has been a vegetarian for the past 6 months.  She reached menarche at age 13 and has had regular menses for the past 6 months.  Blood pressure is 110/60 mm Hg, pulse is 70/min, and BMI is 21 kg/m2.  Physical examination shows a well-nourished teenage girl with pale conjunctivae.  Hemoglobin is 9.2 g/dL.  Which of the following sets of additional laboratory findings are most likely to be seen in this patient? Serum ferritin Circulating transferrin Mean corpuscular volume Hypersegmented neutrophils Serum folate  A. Normal Normal 74 None Normal  (1%)  B. Low High 76 None Normal  (55%)  C. Low Low 84 None Normal  (7%)  D. High Low 95 None Normal  (1%)  E. Normal Normal 108 Present Normal  (15%)  F. Normal Normal 115 Present Low  (18%) his girl with fatigue, conjunctival pallor, and a low hemoglobin level has anemia.  Women of childbearing age are at risk for iron-deficiency anemia due to menstrual cycle blood loss, especially teenage girls who have higher iron requirements due to growth.  In this patient, decreased consumption of dietary iron (eg, vegetarianism) is an additional risk factor.  As iron deficiency develops, the following sequence can be seen: Decreased bone marrow iron stores (ferritin and hemosiderin) Decreased serum ferritin Increased serum total iron-binding capacity, reflecting increased transferrin (Choice C) Decreased serum iron concentration Decreased hemoglobin Appearance of microcytic, hypochromic red blood cells (low mean corpuscular volume [MCV]) Ferritin is an intracellular iron-storage protein that is used as a serum marker of total body iron stores.  It is decreased in iron deficiency and elevated in iron overload or during infection/inflammation (acute phase reaction).  Transferrin transports iron through the plasma.  When iron levels are normal, approximately one third of circulating transferrin is bound to iron.  In iron deficiency, hepatic synthesis of transferrin increases but transferrin saturation drops due to decreased release of iron into the plasma from intracellular stores. (Choice A)  The earliest signs of iron deficiency are low serum ferritin and high serum transferrin, which manifest before overt anemia develops.  This pattern of findings is more consistent with α- or β-thalassemia, which usually cause microcytic anemia with normal ferritin and transferrin levels. (Choice D)  Low hemoglobin in the setting of a normal MCV, low circulating transferrin, and high serum ferritin is suggestive of anemia of chronic disease, which is often associated with infections and inflammatory conditions.  Other acute phase reactants (eg, C-reactive protein, sedimentation rate) are usually elevated in these patients. (Choices E and F)  Hypersegmented neutrophils are characteristic of megaloblastic anemias, which can be caused by folate and vitamin B12 deficiency.  Folate deficiency is unlikely in this patient, as folate is found in many vegetable products.  Although vegetarians are at risk for vitamin B12 deficiency, depletion of hepatic B12 stores takes several years, and this patient has been a vegetarian only for the past 6 months. Educational objective: Anemia in women of childbearing age is typically caused by iron deficiency secondary to menstrual blood loss.  Iron deficiency is associated with decreased serum ferritin, increased total iron-binding capacity (transferrin), and microcytic, hypochromic red blood cells.

Iron Deficiency Anemia (IDA) — Lab Pattern — Ultra High-Yield USMLE Notes


1. Diagnosis: Iron Deficiency Anemia (IDA) — menstrual loss + vegetarian diet → ↓ferritin + ↑transferrin (TIBC) + ↓MCV + no hypersegmented neutrophils

2. Key clue (1 line): 16F + vegetarian 6 months + regular menses + ↓Hgb 9.2 + pale conjunctivae → IDA = ↓ferritin + ↑transferrin + low MCV (~76) + normal folate + no hyperseg neutrophils

3. Why correct (≤2 lines): Iron deficiency → ↓stored iron → ↓ferritin (first to fall) → liver upregulates transferrin synthesis but saturation drops → ↑circulating transferrin (↑TIBC) → insufficient iron for Hgb → microcytic/hypochromic RBCs (↓MCV). No impaired DNA synthesis → no megaloblastic changes → normal folate + no hypersegmented neutrophils.

4. Why others wrong (1 line each):
  • Choice A (normal ferritin/transferrin + low MCV): Pattern of thalassemia (intrinsic RBC defect, not iron deficient); iron stores intact
  • Choice C (↓ferritin + ↓transferrin + normal MCV): ↓transferrin = protein deficiency/liver disease/nephrotic syndrome; not IDA (IDA = ↑transferrin)
  • Choice D (↑ferritin + ↓transferrin + normal MCV): Anemia of chronic disease — ferritin elevated (acute phase reactant), transferrin ↓, iron sequestered by hepcidin
  • Choice E (normal ferritin/transferrin + MCV 108 + hyperseg neutrophils + normal folate): Megaloblastic → B12 deficiency pattern; B12 stores last years (not 6 months of vegetarianism)
  • Choice F (normal ferritin/transferrin + MCV 115 + hyperseg + ↓folate): Folate deficiency megaloblastic; unlikely — folate abundant in vegetables; vegetarian diet protects folate

5. Buzzword triggers:
  • ↓Ferritin + ↑TIBC/transferrin + ↓MCV → IDA
  • ↑Ferritin + ↓TIBC + normal MCV + chronic illness → Anemia of Chronic Disease (ACD)
  • Normal ferritin + normal TIBC + ↓MCV → Thalassemia
  • ↓MCV + target cells + normal ferritin → Thalassemia
  • Hypersegmented neutrophils + ↑MCV → Megaloblastic (B12 or folate deficiency)
  • Vegetarian <1 year → worry iron/folate; vegetarian >2–3 years → worry B12 (hepatic stores last years)
  • Menstruating teenage girl + vegetarian → IDA classic scenario

6. Trap / trick tested:
  • IDA = ↑transferrin (TIBC) — students confuse transferrin with ferritin; ferritin ↓ (stores empty), transferrin ↑ (liver compensates to carry more iron)
  • ACD vs IDA: Both microcytic; key difference = ferritin: ↓ in IDA, ↑ in ACD; TIBC: ↑ in IDA, ↓ in ACD
  • B12 deficiency in vegetarians takes years (large hepatic stores); this patient = 6 months → B12 deficiency impossible this early
  • Folate deficiency in vegetarians is unlikely — vegetables are rich in folate; folate deficiency = alcoholics, malnutrition, pregnancy
  • Sequence of IDA: ↓ferritin first → ↑transferrin → ↓serum iron → ↓Hgb → ↓MCV (microcytosis is late)

7. One-liner memory hook:
"IDA = Empty stores (↓ferritin) → liver panics → sends more trucks (↑transferrin/TIBC) → but no iron to load → small pale RBCs (↓MCV); ACD = iron locked up (↑ferritin, ↓TIBC); Thal = normal ferritin/TIBC + ↓MCV."

A 20-year-old woman comes to the emergency department due to bloody stools.  Approximately an hour ago, the patient had a bowel movement that appeared grossly bloody.  For the past month, she has also had decreased energy.  Temperature is 37 C (98.6 F), blood pressure is 110/60 mm Hg, pulse is 110/min, and respirations are 20/min.  The patient appears tired.  Cardiopulmonary examination reveals mild tachycardia.  The abdomen is soft without organomegaly.  Skin examination shows pallor and scattered bruises in various stages of healing throughout the trunk.  Complete blood count results are as follows: Hemoglobin 7.2 g/dL Mean corpuscular volume 90 µm3 Platelets 10,000/mm3 Leukocytes 1,050/mm3 Neutrophils 5% Lymphocytes 95% Which of the following is the most likely cause of this patient's condition? Explanation Causes of pancytopenia Bone marrow aplasia Aplastic anemia Infection (eg, parvovirus, HIV, viral hepatitis) Nutritional deficiency (eg, vitamin B12/folate) Medications (eg, hydroxyurea) Bone marrow infiltration Cancer (eg, hematologic, metastatic) Myelofibrosis Infection (eg, tuberculosis, fungal infection) Mature blood cell destruction Intravascular (eg, DIC, TTP) Extravascular (eg, hypersplenism) DIC = disseminated intravascular coagulation; TTP = thrombotic thrombocytopenic purpura. This patient has gastrointestinal bleeding and ecchymosis secondary to thrombocytopenia; although anemia (eg, pallor) would be expected with significant bleeding, her low leukocyte count indicates pancytopenia, which is generally caused by one of the following: Bone marrow aplasia: Hematopoietic stem cells in the bone marrow are unable to proliferate and differentiate into mature blood cells due to aplastic anemia, nutritional impairment, infection (eg, parvovirus, HIV), or cytotoxic medications. Bone marrow infiltration: Cancer, fibrosis, or infection (eg, tuberculosis) fills the bone marrow and crowds out hematologic cells, thereby preventing blood cell replication and maturation. Mature blood cell destruction: Circulating mature blood cells may be destroyed due to disseminated intravascular coagulation or thrombotic thrombocytopenic purpura; extravascular mature blood cells may be destroyed or sequestered in the spleen due to hypersplenism. Based on this patient's laboratory and physical examination results, several answer choices can be eliminated.  The presence of a normal MCV makes vitamin B12 or folate deficiency unlikely because these are associated with macrocytic (not normocytic) anemia (Choice E).  Hypersplenism is also unlikely because abdominal examination would show significant splenomegaly (Choice C).  Chronic myelogenous leukemia, an infiltrative cancer associated with constitutively active tyrosine kinase, is also unlikely because this condition is usually associated with dramatic leukocytosis (not leukopenia) (Choice B). Therefore, the most likely cause of this patient's pancytopenia is aplastic anemia (AA).  Although AA is linked to certain medications, infections, toxins, or radiation, most cases are idiopathic and thought to be caused by autoimmune-induced loss of multipotent hematologic stem cells.  In idiopathic AA, an underlying insult (eg, mutation, virus) causes alteration of surface antigens on multipotent stem cells, making them appear foreign and triggering a cytotoxic T-cell response.  Cytokines released by T-helper cells (type 1 cytokines) also contribute to the pathogenesis, most notably interferon-gamma, which triggers apoptotic cell death due to the stimulation of a destructive cytokine cascade and the increased expression of the Fas receptor on the hematologic stem cell surface. (Choice D)  Autoantibodies against glycoprotein IIb/IIIa cause immune thrombocytopenia, which is marked by thrombocytopenia and no change in the other cell lines. Educational objective: Aplastic anemia is a form of bone marrow failure in which patients have decreased production of all cell lines (platelets, erythrocytes, and leukocytes).  It is primarily caused by the autoimmune destruction of multipotent hematologic stem cells due to an alteration in their surface antigens, leading to a cytotoxic T-cell response and release of interferon-gamma from T-helper cells (triggers apoptotic cell death).

Aplastic Anemia — Ultra High-Yield USMLE Notes


1. Diagnosis: Aplastic Anemia (AA) — autoimmune destruction of multipotent hematopoietic stem cells → pancytopenia

2. Key clue (1 line): 20F + bloody stools + bruising + fatigue + ↓Hgb + ↓↓platelets (10k) + ↓↓WBC (1050) + normal MCV + lymphocyte predominance → pancytopenia = aplastic anemia

3. Why correct (≤2 lines): Idiopathic AA: altered HSC surface antigens → cytotoxic T-cell attack + IFN-γ release from Th1 cells → Fas receptor upregulation → HSC apoptosis → all 3 cell lines fail (↓RBC + ↓WBC + ↓platelets) with normocytic anemia (no DNA synthesis defect). Bone marrow biopsy confirms: hypocellular marrow replaced by fat cells (hallmark).

4. Why others wrong (1 line each):
  • CML (tyrosine kinase mutation): Causes dramatic leukocytosis (not leukopenia); BCR-ABL constitutive activation; not pancytopenia
  • Hypersplenism: Requires significant splenomegaly on exam; abdomen soft + no organomegaly → rules out
  • ITP (anti-GpIIb/IIIa autoantibodies): Causes isolated thrombocytopenia only; WBC and RBC normal → not pancytopenia
  • B12/folate deficiency: Causes macrocytic anemia (↑MCV) + hypersegmented neutrophils; MCV 90 (normal) here → rules out

5. Buzzword triggers:
  • Pancytopenia + normal MCV + hypocellular marrowAplastic anemia
  • AA causes: idiopathic (most common) > drugs (chloramphenicol, sulfonamides, NSAIDs, carbamazepine) > radiation > infections (parvovirus, HIV, hepatitis) > toxins (benzene)
  • Pancytopenia causes: aplasia / infiltration / destruction — determine by marrow biopsy
  • AA pathogenesis: mutated HSC surface antigen → CD8+ T-cell attack + IFN-γ → Fas/apoptosis
  • AA treatment: allogeneic HSCT (young, matched donor) or immunosuppression (ATG + cyclosporine if no donor)
  • AA → ↑risk of PNH and MDS later (clonal evolution)
  • Fanconi anemia: congenital AA + short stature + thumb anomalies + café-au-lait spots

6. Trap / trick tested:
  • Normal MCV in pancytopenia → aplastic anemia (not B12/folate); macrocytosis expected with megaloblastic cause
  • Lymphocyte predominance (95% lymphocytes) in differential is a relative finding — absolute lymphocyte count is actually low; lymphocytes appear dominant only because neutrophils are destroyed preferentially
  • ITP vs AA: both present with bleeding/bruising — key difference = other cell lines: ITP = isolated ↓platelets; AA = ↓ALL three lines
  • Pancytopenia + hypercellular marrow → infiltration (leukemia, myelofibrosis); Pancytopenia + hypocellular marrow → aplastic anemia

7. One-liner memory hook:
"Aplastic anemia = T-cells kill the stem cell factory → empty marrow (fat cells) → no RBCs + no WBCs + no platelets; normal MCV + pancytopenia = think aplastic, not B12."

Aplastic Anemia — Ultra High-Yield USMLE Notes 1. Diagnosis: Aplastic Anemia (AA) — autoimmune destruction of multipotent hematopoietic stem cells → pancytopenia 2. Key clue (1 line): 20F + bloody stools + bruising + fatigue + ↓Hgb + ↓↓platelets (10k) + ↓↓WBC (1050) + normal MCV + lymphocyte predominance → pancytopenia = aplastic anemia 3. Why correct (≤2 lines): Idiopathic AA: altered HSC surface antigens → cytotoxic T-cell attack + IFN-γ release from Th1 cells → Fas receptor upregulation → HSC apoptosis → all 3 cell lines fail (↓RBC + ↓WBC + ↓platelets) with normocytic anemia (no DNA synthesis defect). Bone marrow biopsy confirms: hypocellular marrow replaced by fat cells (hallmark). 4. Why others wrong (1 line each): CML (tyrosine kinase mutation): Causes dramatic leukocytosis (not leukopenia); BCR-ABL constitutive activation; not pancytopenia Hypersplenism: Requires significant splenomegaly on exam; abdomen soft + no organomegaly → rules out ITP (anti-GpIIb/IIIa autoantibodies): Causes isolated thrombocytopenia only; WBC and RBC normal → not pancytopenia B12/folate deficiency: Causes macrocytic anemia (↑MCV) + hypersegmented neutrophils; MCV 90 (normal) here → rules out 5. Buzzword triggers: Pancytopenia + normal MCV + hypocellular marrow → Aplastic anemia AA causes: idiopathic (most common) > drugs (chloramphenicol, sulfonamides, NSAIDs, carbamazepine) > radiation > infections (parvovirus, HIV, hepatitis) > toxins (benzene) Pancytopenia causes: aplasia / infiltration / destruction — determine by marrow biopsy AA pathogenesis: mutated HSC surface antigen → CD8+ T-cell attack + IFN-γ → Fas/apoptosis AA treatment: allogeneic HSCT (young, matched donor) or immunosuppression (ATG + cyclosporine if no donor) AA → ↑risk of PNH and MDS later (clonal evolution) Fanconi anemia: congenital AA + short stature + thumb anomalies + café-au-lait spots 6. Trap / trick tested: Normal MCV in pancytopenia → aplastic anemia (not B12/folate); macrocytosis expected with megaloblastic cause Lymphocyte predominance (95% lymphocytes) in differential is a relative finding — absolute lymphocyte count is actually low; lymphocytes appear dominant only because neutrophils are destroyed preferentially ITP vs AA: both present with bleeding/bruising — key difference = other cell lines: ITP = isolated ↓platelets; AA = ↓ALL three lines Pancytopenia + hypercellular marrow → infiltration (leukemia, myelofibrosis); Pancytopenia + hypocellular marrow → aplastic anemia 7. One-liner memory hook: "Aplastic anemia = T-cells kill the stem cell factory → empty marrow (fat cells) → no RBCs + no WBCs + no platelets; normal MCV + pancytopenia = think aplastic, not B12." Causes of polycythemia Etiology Plasma volume RBC mass SaO2 EPO Relative Dehydration ↓ Normal Normal Normal Absolute Primary Polycythemia vera (ie, JAK2 mutation)* Normal ↑ Normal ↓ Secondary Physiologic response to hypoxemia Normal ↑ ↓ ↑ Inappropriate (eg, EPO-producing tumor, testosterone excess) Normal ↑ Normal ↑ *Polycythemia vera accounts for ~95% of primary polycythemia cases, with rare mutations other than JAK2 accounting for the remainder. EPO = erythropoietin; RBC = red blood cell; SaO2 = oxygen saturation. Polycythemia vera (PV) is a clonal myeloproliferative disease of pluripotent hematopoietic stem cells.  Approximately 95% of patients with PV have a V617F mutation involving the JAK2 gene, a signal transduction molecule that stimulates cell growth.  This mutation replaces a valine with phenylalanine, allowing constitutive proliferation of hematopoietic cells independent of circulating growth factor (eg, erythropoietin, thrombopoietin) levels. PV presents with increased RBC mass and low erythropoietin levels.  Additional manifestations can include an elevated platelet and/or WBC count, thrombotic events (from blood hyperviscosity), peptic ulceration and aquagenic pruritus (due to histamine release from basophils), and gouty arthritis (from increased cell turnover). Physical examination typically shows a plethoric, reddened face and splenomegaly.  Diagnosis is established by confirming low serum erythropoietin levels and cytogenetic studies showing a JAK2 mutation.  Treatment involves serial phlebotomy as necessary to keep the hematocrit < 45%. (Choice A)  Dehydration or excessive diuresis can also cause elevated hematocrit, mild leukocytosis, and thrombocytosis due to low effective circulating volume.  However, splenomegaly and symptoms such as pruritus would not be seen. (Choice B)  Hypoxia is a strong stimulus for erythropoietin production.  SaO2 < 92% (PaO2 < 65 mm Hg) appears to be the threshold for the development of (physiologic) secondary polycythemia.  Conditions such as chronic obstructive pulmonary disease and obstructive sleep apnea can cause secondary polycythemia.  However, these will not cause leukocytosis, thrombocytosis, or splenomegaly. (Choice D)  Increased red cell life span would not be expected to cause leukocytosis and thrombocytosis. (Choice E)  EPO-producing tumors (eg, renal cell carcinoma, hepatocellular carcinoma) can cause secondary polycythemia due to abnormal erythropoietin production.  Workup will show an elevated erythropoietin level.  However, the combination of multiple elevated cell lines and splenomegaly is unlikely to result from a process causing secondary polycythemia. Educational objective: Polycythemia vera (PV) is a clonal myeloproliferative disease characterized by an increased RBC mass and low erythropoietin levels.  PV can be differentiated from secondary polycythemia by the presence of leukocytosis, thrombocytosis, and/or splenomegaly.  The majority of patients with PV have a JAK2 mutation causing hematopoietic stem cells to proliferate uncontrollably.

Polycythemia Vera (PV) — Ultra High-Yield USMLE Notes


1. Diagnosis: Polycythemia Vera (PV) — clonal myeloproliferative disorder; JAK2 V617F mutation → EPO-independent RBC proliferation

2. Key clue (1 line): ↑↑RBC mass + ↑platelets + ↑WBC + ↓EPO + normal SaO2 + facial plethora + splenomegaly + aquagenic pruritus → PV (not secondary polycythemia)

3. Why correct (≤2 lines): JAK2 V617F (Val→Phe) → constitutive activation of cytoplasmic tyrosine kinase → EPO-independent clonal proliferation of all myeloid lines → ↑RBC + ↑WBC + ↑platelets + ↓EPO (feedback suppressed by RBC mass). Splenomegaly + leukocytosis + thrombocytosis = hallmarks distinguishing PV from ALL secondary causes.

4. Why others wrong (1 line each):
  • Dehydration/relative polycythemia: ↓plasma volume only; normal RBC mass; no splenomegaly, pruritus, or ↑WBC/platelets
  • Hypoxia-driven secondary polycythemia (COPD/OSA): ↓SaO2 + ↑EPO; only RBCs elevated; no leukocytosis, thrombocytosis, or splenomegaly
  • EPO-producing tumor (RCC/HCC): ↑EPO (not ↓); only RBCs elevated; no leukocytosis, thrombocytosis, or splenomegaly
  • Increased RBC lifespan: Would NOT cause leukocytosis or thrombocytosis; no such clinical entity

5. Buzzword triggers:
  • Facial plethora + aquagenic pruritus + splenomegaly + ↑Hgb → PV
  • ↑RBC + ↑WBC + ↑platelets + ↓EPO + normal SaO2PV (JAK2)
  • ↑RBC + ↓EPO → primary polycythemia (PV)
  • ↑RBC + ↑EPO + ↓SaO2 → secondary physiologic (hypoxia)
  • ↑RBC + ↑EPO + normal SaO2 → secondary inappropriate (EPO tumor)
  • ↑RBC + ↓plasma volume + normal EPO/SaO2 → relative/pseudopolycythemia (dehydration)
  • JAK2 V617F → also in essential thrombocythemia + primary myelofibrosis
  • PV complications: thrombosis (hyperviscosity) + PUD (↑histamine/basophils) + gout (↑cell turnover) + aquagenic pruritus
  • PV treatment: phlebotomy (keep Hct <45%) ± hydroxyurea

6. Trap / trick tested:
  • EPO level is the pivot: ↓EPO = primary (PV); ↑EPO = secondary (hypoxia or tumor) — always check EPO to distinguish
  • SaO2 is normal in PV — hypoxia-driven polycythemia requires ↓SaO2 <92%; normal SaO2 + ↑RBC = not hypoxic
  • Secondary polycythemia (any cause) = only RBCs elevated; PV = all 3 myeloid lines elevated + splenomegaly
  • Aquagenic pruritus trap: students think skin/allergic condition; it is histamine release from basophils in PV — itching after hot shower = PV until proven otherwise

7. One-liner memory hook:
"JAK2 fires without EPO → RBCs + WBCs + Platelets all up, EPO down, SaO2 normal; pruritus after shower + plethora + splenomegaly = PV; EPO up = secondary, EPO down = primary."

A 6-year-old boy is brought to the emergency department due to bleeding after a dental extraction earlier this morning.  The patient's past medical history is significant for painful swelling of his knee joints after minor trauma.  Aspiration of the joints during several occasions yielded frank blood, and he was diagnosed with hemarthrosis.  He has no known allergies.  Currently, hemostasis in this patient most likely can be achieved by the administration of which of the following? history of prolonged bleeding following procedures (eg, dental extractions, surgeries) and spontaneous hemorrhages into the joints (hemarthrosis) is typical for hemophilia, an X-linked recessive bleeding disorder due to decreased levels of factor VIII (hemophilia A) or factor IX (hemophilia B). Factors VIII and IX are components of the intrinsic coagulation pathway and activate factor X; activated factor X (Xa) then catalyzes the conversion of prothrombin (factor II) into thrombin as part of the final common pathway.  In the absence of factors VIII or IX, activation of factor X and subsequent conversion of prothrombin into thrombin do not occur.  Administration of thrombin, however, will make up for the deficiency and lead to blood clotting.  In practice, prothrombin complex concentrates (containing factors II, VII, IX, and X, which lead to thrombin formation) were used for management of hemophilia B, although thrombogenic risks have limited their application. In both types of hemophilia, the bleeding time and platelet count are normal.  The prothrombin time (PT) is also normal as it tests the extrinsic clotting pathway and reflects the function of factors II, V, VII, and X (mnemonic: PeT).  However, the activated partial thromboplastin time (PTT) is prolonged as it assesses the activity of factors II, V, VIII, IX, X, XI and XII, the intrinsic clotting pathway (mnemonic: PiTT).  Diagnoses of hemophilia A and B are made by measuring plasma levels of factors VIII and IX, respectively. (Choice A)  Factor XII (Hageman) is synthesized by the liver and is activated by endothelial injury.  It triggers the intrinsic coagulation pathway by activating factor XI.  The addition of factor XII does not clot the blood of patients with hemophilia because the downstream clotting factors VIII or IX are deficient. (Choice B)  Fibrinogen is a protein synthesized by the liver.  Thrombin mediates cleavage of fibrinogen to form fibrin, the main component of thrombi; therefore, without thrombin, fibrinogen administration alone would not be helpful. (Choice C)  Protein C is a vitamin K-dependent factor synthesized in the liver.  It is a physiologic anticoagulant that degrades factors Va and VIIIa. (Choice E)  Urokinase is a thrombolytic agent used for treatment of myocardial infarction and pulmonary embolism.  It acts by converting plasminogen to plasmin, which then breaks down fibrinogen and fibrin into their respective degradation products.  The addition of urokinase would prevent thrombosis. Educational objective: Bleeding after a tooth extraction and history of hemarthrosis are suggestive of hemophilia.  Decreased levels of factor VIII or IX lead to failure to convert prothrombin into thrombin and deficient thrombus formation.  The addition of thrombin to the blood of a patient with hemophilia results in clotting.

Hemophilia A & B — Coagulation Pathway & Treatment — Ultra High-Yield USMLE Notes


1. Diagnosis: Hemophilia A (Factor VIII↓) or B (Factor IX↓) — X-linked recessive; dental bleeding + hemarthrosis → thrombin bypasses the defect

2. Key clue (1 line): 6-year-old boy + prolonged post-dental bleeding + recurrent hemarthrosis after minor trauma → hemophilia → Factor VIII/IX absent → thrombin not generated → administer thrombin directly

3. Why correct (≤2 lines): Hemophilia A/B → deficient Factor VIII or IX → intrinsic pathway fails → Factor X not activated → prothrombin NOT converted to thrombin → no fibrin clot formed. Administering thrombin directly bypasses the entire intrinsic pathway defect → cleaves fibrinogen → fibrin clot formed immediately.

4. Why others wrong (1 line each):
  • Factor XII: Triggers intrinsic pathway at top; still hits the VIII/IX block downstream → clot still fails
  • Fibrinogen: Thrombin is needed to cleave fibrinogen → without thrombin, fibrinogen is useless substrate
  • Protein C: Vitamin K-dependent anticoagulant; degrades Factors Va + VIIIa → worsens bleeding
  • Urokinase: Thrombolytic (plasminogen → plasmin → dissolves clots) → opposite of what is needed

5. Buzzword triggers:
  • Hemarthrosis + post-procedure delayed bleeding + male → Hemophilia A or B
  • Hemophilia labs: ↑aPTT + normal PT + normal platelets + normal bleeding time
  • aPTT tests intrinsic pathway: Factors XII, XI, IX, VIII, X, V, II (mnemonic: PiTT)
  • PT tests extrinsic pathway: Factors VII, X, V, II, fibrinogen (mnemonic: PeT)
  • Hemophilia A treatment: Factor VIII concentrate or desmopressin (DDAVP) for mild disease
  • Hemophilia B treatment: Factor IX concentrate (Christmas disease)
  • Both hemophilias: normal platelet plug forms → bleeding delayed (not immediate)
  • Intrinsic pathway: XII → XI → IX → VIII → X → prothrombin → thrombin → fibrinogen → fibrin

6. Trap / trick tested:
  • Question asks what achieves hemostasis — not what treats hemophilia in practice; thrombin bypasses the defect entirely (concept question, not clinical management question)
  • Fibrinogen trap: Students think adding clotting substrate helps; but without thrombin to cleave it, fibrinogen is useless
  • Factor XII trap: Adding upstream factors still hits the VIII/IX roadblock; must go downstream of the defect (thrombin) to bypass it
  • Protein C is an anticoagulant — vitamin K-dependent but degrades clotting factors; easy trap in a bleeding question

7. One-liner memory hook:
"Hemophilia kills the VIII/IX bridge → Factor X never activates → prothrombin stays pro → no thrombin → no clot; skip the broken bridge, give thrombin directly → fibrinogen cleaved → clot saved."

his patient's presentation is consistent with paroxysmal nocturnal hemoglobinuria (PNH), a disorder due to complement-mediated hemolysis.  PNH is usually due to a mutated phosphatidylinositol glycan class A (PIGA) gene, which helps synthesize the glycosylphosphatidylinositol (GPI) anchor protein.  This protein helps attach several cell surface proteins (eg, CD55 decay accelerating factor, CD59 MAC inhibitory protein) that inactivate complement.  Absence of these proteins leads to uncontrolled complement-mediated hemolysis. Manifestations of PNH include the following: Fatigue and jaundice due to hemolytic anemia (elevated bilirubin and lactate dehydrogenase, low haptoglobin, hemoglobinuria [which may be nocturnal]) Thrombosis at atypical sites (eg, hepatic, portal, or cerebral veins) possibly due to the release of prothrombotic factors from lysed red blood cells and platelets (mesenteric vein thrombosis may explain this patient's abdominal pain) Pancytopenia due to stem cell injury Chronic hemolysis with breakdown of iron-containing erythrocytes can also lead to iron deposition in the kidney (hemosiderosis), which can interfere with proximal tubule function and cause interstitial scarring and cortical infarcts.  The hemosiderosis combined with microvascular thrombosis can increase the risk of chronic kidney disease. (Choices A and C)  Cast nephropathy is usually seen in multiple myeloma and is due to large amounts of monoclonal free chain deposition in the kidney.  Interstitial nephritis (inflammation in the area surrounding the renal tubules) is most commonly due to drugs (eg, analgesics, antibiotics), recent infection, or systemic conditions (eg, sarcoidosis). (Choices D and E)  Membranous glomerulonephritis can be associated with systemic lupus erythematosus, drugs (eg, nonsteroidal anti-inflammatory drugs [NSAIDs]), hepatitis B and C, or solid tumor malignancies (eg, lung, prostate, gastrointestinal).  Minimal change disease can be associated with drugs (eg, NSAIDs), hematologic malignancies (eg, lymphoma, leukemia), or allergens (eg, fungi). Educational objective: Paroxysmal nocturnal hemoglobinuria is due to a gene defect that leads to uncontrolled complement-mediated hemolysis.  The classic triad includes hemolytic anemia (hemoglobinuria), pancytopenia, and thrombosis at atypical sites.  Chronic hemolysis can cause iron deposition in the kidney (hemosiderosis). A 63-year-old man comes to the emergency department due to abdominal pain.  Physical examination shows abdominal tenderness without guarding or rebound.  His laboratory test results are as follows: Hemoglobin 8.9 g/dL Platelets 134,000/mm3 Total bilirubin 6.3 mg/dL Lactate dehydrogenase 740 U/L Haptoglobin Low On further investigation, magnetic resonance angiography of the abdomen reveals mesenteric vein thrombosis.  Flow cytometry shows absence of CD55 on the surface of red blood cells.  Which of the following is the most likely pathologic renal finding in this patient ?

Paroxysmal Nocturnal Hemoglobinuria (PNH) — Ultra High-Yield USMLE Notes


1. Diagnosis: Paroxysmal Nocturnal Hemoglobinuria (PNH) — PIGA mutation → absent GPI anchor (CD55/CD59) → uncontrolled complement-mediated hemolysis → renal hemosiderosis

2. Key clue (1 line): 63M + hemolytic anemia + ↑LDH + ↑bili + ↓haptoglobin + mesenteric vein thrombosis (atypical site) + absent CD55 on flow cytometry → PNH → renal pathology = hemosiderosis

3. Why correct (≤2 lines): PNH → chronic intravascular hemolysis → free Hgb filtered by kidney → iron deposits in renal tubular cells → hemosiderosis → proximal tubule dysfunction + interstitial scarring + cortical infarcts + ↑CKD risk. Microvascular thrombosis compounds renal injury alongside iron deposition.

4. Why others wrong (1 line each):
  • Cast nephropathy: Multiple myeloma → monoclonal free light chains (Bence Jones proteins) clog tubules; no paraprotein here
  • Interstitial nephritis: Drug (NSAIDs/antibiotics), infection, or sarcoidosis-mediated; no such history; not from hemolysis
  • Membranous glomerulonephritis: SLE, hepatitis B/C, NSAIDs, solid tumors; not a hemolytic/PNH complication
  • Minimal change disease: NSAIDs, lymphoma, allergens; no proteinuria pattern or relevant history here

5. Buzzword triggers:
  • PNH classic triad: Hemolytic anemia (hemoglobinuria) + pancytopenia + thrombosis at atypical sites (hepatic/portal/mesenteric/cerebral veins)
  • Absent CD55 (DAF) or CD59 (MIRL) on flow cytometry → PNH (diagnostic)
  • PIGA mutation → no GPI anchor → CD55 + CD59 absent → complement runs unchecked → RBC lysis
  • Dark morning urine (hemoglobinuria after nocturnal complement activation) → PNH
  • PNH → chronic hemolysis → hemosiderosis (iron in renal tubules) → CKD
  • PNH → ↑risk of aplastic anemia and AML (clonal evolution)
  • PNH treatment: Eculizumab (anti-C5 monoclonal antibody → blocks terminal complement)
  • CD55 = decay accelerating factor (degrades C3/C5 convertases); CD59 = MAC inhibitory protein (blocks C5b-9)

6. Trap / trick tested:
  • Thrombosis at atypical sites (mesenteric, portal, hepatic, cerebral veins) in a hemolytic anemia patient → PNH first (not DVT/PE pattern)
  • PNH vs other hemolytic anemias: PNH uniquely causes pancytopenia + thrombosis + hemoglobinuria; others do not
  • Renal question trap: students expect glomerular disease (membranous, minimal change) in renal pathology questions; PNH causes tubular/interstitial iron deposition — not glomerular
  • Flow cytometry showing absent CD55/CD59 = gold standard PNH diagnosis (replaced Ham test/sucrose lysis)
  • Nocturnal hemolysis explanation: during sleep, mild respiratory acidosis → complement activation; but hemolysis actually occurs throughout the day

7. One-liner memory hook:
"PNH = PIGA broken → no GPI anchor → CD55/CD59 gone → complement destroys RBCs all day → dark urine + atypical vein clots + pancytopenia; iron floods kidneys → hemosiderosis → CKD; treat with Eculizumab (block C5)."

A 25-year-old woman comes to the office due to significant fatigue.  Several weeks ago, the patient had a weeklong episode of intermittent fever and severe body aches.  Over the last 2 weeks, she has been too tired to complete her normal jogging routine in the mornings and has had to take naps after returning home from work.  The patient has no chronic medical conditions and takes no medications.  Temperature is 37.2 C (99 F), pulse is 110/min, and respirations are 20/min.  Examination shows pale lips and conjunctivae.  The abdomen is soft and there is no hepatosplenomegaly.  Examination of the extremities is unremarkable, and no lymphadenopathy is present.  Laboratory results are as follows: Hemoglobin 7.0 g/dL Mean corpuscular volume 90 μm3 Reticulocytes 0.1% Platelets 40,000/mm3 Leukocytes 2,000/mm3 PT 13 sec PTT 30 sec Peripheral blood smear reveals normocytic, normochromic red blood cells, and other cell types appear morphologically normal.  This patient's bone marrow biopsy would most likely show which of the following patterns? Explanation Aplastic anemia Pathogenesis Multipotent hematopoietic stem cells are destroyed by cytotoxic T cells or direct cytotoxic injury → bone marrow aplasia/hypoplasia → lack of circulating peripheral blood cells Common triggers Autoimmune Drugs: cytotoxic chemotherapy, immunosuppressants, idiosyncratic reactions Ionizing radiation & toxins Viral infections (eg, viral hepatitis, HIV) Manifestations Anemia (eg, fatigue, weakness, pallor) Thrombocytopenia (eg, bleeding, bruising) Leukopenia (eg, recurrent infections) Diagnosis Bone marrow biopsy: hypocellular marrow with abundance of stromal & fat cells This patient with pancytopenia has inappropriately low reticulocyte count, morphologically normal cell lines on peripheral smear, and no splenomegaly on physical examination, raising strong suspicion for aplastic anemia. Aplastic anemia is a form of bone marrow failure caused by direct toxic injury or cytotoxic T-cell destruction of multipotent hematopoietic stem cells in the bone marrow.  Because these stem cells generate progenitor cells that produce all blood cells, damage results in a dramatic reduction of immature and mature blood cells in the bone marrow and peripheral blood.  This is reflected on bone marrow biopsy as marked hypocellularity with an abundance of fat cells and other marrow stroma; aspiration classically produces a "dry tap." Although aplastic anemia is usually idiopathic (no clear cause), it can be triggered by viral infection (eg, hepatitis, HIV), chemical or radiation exposure, or medications (eg, carbamazepine).  Patients typically have manifestations of pancytopenia such as severe fatigue and pale mucous membranes (anemia), bleeding/bruising (thrombocytopenia), or infection (eg, leukopenia).  No significant extramedullary hematopoiesis occurs (eg, no splenomegaly) because few hematopoietic stem cells continue to function. (Choice A)  Acute leukemias (eg, acute myeloid leukemia) are usually associated with a hypercellular marrow with increased blasts.  Although anemia and thrombocytopenia may be present, most patients have mild leukocytosis.  In addition, blasts would be seen on peripheral smear. (Choice B)  Chronic myeloid leukemia, a myeloproliferative neoplasm of granulocytes associated with the BCR-ABL fusion gene, is marked by a hypercellular marrow with increased granulocytes and megakaryocytes.  Patients typically have significant peripheral leukocytosis and thrombocytosis; in addition, hepatosplenomegaly is generally present. (Choice D)  Myelofibrosis, a chronic hematopoietic neoplasm, is marked by hypocellular marrow with extensive fibrosis.  Although pancytopenia is typically present, peripheral blood smear usually shows teardrop-shaped and nucleated erythrocytes; significant extramedullary hematopoiesis also occurs, so dramatic splenomegaly is usually present. (Choice E)  Acute promyelocytic leukemia is associated with promyelocytes with Auer rods (rod-shaped cytoplasmic inclusions).  This type of acute myeloid leukemia is characterized clinically by disseminated intravascular coagulation (acquired hypercoagulability and bleeding), which is not seen in this patient (normal PT and PTT); immature leukocytes would also be seen on peripheral smear. Educational objective: Aplastic anemia is a form of bone marrow failure due to destruction of multipotent hematopoietic stem cells.  It is marked by pancytopenia and profound hypocellularity of the bone marrow with an abundance of fat cells and stroma.  Impaired reticulocytosis and an absence of splenomegaly are important features.

Aplastic Anemia — Bone Marrow Biopsy Pattern — Combined Ultra High-Yield USMLE Notes


1. Diagnosis: Aplastic Anemia (AA) — HSC destruction → hypocellular marrow replaced by fat cells ("dry tap" on aspiration)

2. Key clue (1 line): 25F + viral prodrome weeks ago + pancytopenia (↓Hgb + ↓↓platelets + ↓↓WBC) + retics 0.1% + normal MCV + normal morphology + no splenomegaly + normal PT/PTT → AA → marrow = hypocellular + fat cells

3. Why correct (≤2 lines): Viral trigger → cytotoxic T-cells destroy multipotent HSCs → all 3 cell lines fail → peripheral pancytopenia with ↓↓retics (marrow not responding) + morphologically normal remaining cells. Bone marrow biopsy: markedly hypocellular marrow with fat cell + stromal replacement; aspiration = "dry tap"; no extramedullary hematopoiesis → no splenomegaly.

4. Why others wrong (1 line each):
  • Hypercellular marrow + ↑blasts (AML): Leukocytosis + blasts on peripheral smear expected; pancytopenia possible but smear would show blasts
  • Hypercellular + ↑granulocytes/megakaryocytes (CML): BCR-ABL → dramatic leukocytosis + thrombocytosis + hepatosplenomegaly; opposite of this picture
  • Hypocellular + extensive fibrosis (myelofibrosis): Also hypocellular BUT teardrop cells + nucleated RBCs on smear + massive splenomegaly (extramedullary hematopoiesis); normal morphology here rules out
  • Promyelocytes + Auer rods (APL/AML-M3): DIC (↑PT/↑PTT) + Auer rods on smear; PT/PTT normal here → rules out

5. Buzzword triggers:
  • Pancytopenia + ↓↓retics + normal MCV + normal morphology + no splenomegalyAA
  • Bone marrow biopsy: hypocellular + fat cells + stromal cells = AA
  • "Dry tap" on marrow aspiration → AA or myelofibrosis (fibrosis causes dry tap too)
  • AA causes: idiopathic (most common) > viral (hepatitis, HIV, EBV) > drugs (carbamazepine, chloramphenicol, sulfonamides, NSAIDs) > radiation > toxins (benzene)
  • AA pathogenesis: HSC surface antigen altered → CD8+ T-cell attack + IFN-γ (Th1) → Fas upregulation → HSC apoptosis
  • AA treatment: allogeneic HSCT (young + matched donor) or ATG + cyclosporine (immunosuppression if no donor)
  • AA → clonal evolution to PNH or MDS/AML
  • Fanconi anemia: congenital AA + radial/thumb defects + short stature + café-au-lait spots + chromosomal fragility

6. Trap / trick tested:
  • Myelofibrosis vs AA: Both = hypocellular marrow + pancytopenia + possible dry tap — key pivot = spleen: myelofibrosis = massive splenomegaly (extramedullary hematopoiesis); AA = no splenomegaly; also teardrop cells in myelofibrosis vs normal morphology in AA
  • AML vs AA: Both can cause pancytopenia — key pivot = blasts on smear (AML) vs normal morphology (AA); marrow hypercellular in AML vs hypocellular in AA
  • Normal PT/PTT rules out APL/DIC — important negative finding
  • Viral prodrome → think AA (hepatitis, HIV, EBV trigger); same virus (parvovirus B19) in SCD/HS → aplastic crisis (transient, not true AA)
  • Reticulocytes 0.1% = near-zero = marrow completely failing; not hemolysis (hemolysis = ↑retics)

7. One-liner memory hook:
"Virus triggers T-cells to torch the stem cell factory → empty marrow (fat + stroma, no cells) → pancytopenia + retics flatline + normal morphology + no splenomegaly = AA; fat marrow = AA; fibrotic marrow + teardrops + big spleen = myelofibrosis."

A 56-year-old man is evaluated for increased fatigability.  His past medical history is significant for diabetes mellitus, osteoarthritis, and severe aortic stenosis that required aortic valve replacement.  His peripheral blood smear is shown on the slide below. he fragmented erythrocytes shown on the slide above are called schistocytes or helmet cells.  They are formed by mechanical trauma to erythrocytes as they circulate through the vasculature.  This patient's schistocytes are most likely due to erythrocyte damage caused by his aortic valve prosthesis.  Artificial (mechanical) valves are more traumatic for RBCs than porcine prostheses and frequently cause hemolysis.  Schistocytes can also be formed from narrowing of the microvascular spaces, as seen in disseminated intravascular coagulation, hemolytic-uremic syndrome, and thrombotic thrombocytopenic purpura. Hemolytic anemia due to intravascular erythrocyte destruction results in laboratory findings similar to those in other types of hemolytic anemias, including an increase in serum indirect bilirubin.  Intravascular erythrocyte damage also results in free hemoglobin in serum (hemoglobinemia) and urine (hemoglobinuria) as well as increased serum lactate dehydrogenase (LDH).  Haptoglobin is a serum protein that binds to free hemoglobin and promotes its uptake by the reticuloendothelial system.  Haptoglobin levels decrease when significant quantities of hemoglobin are released into the circulation, as occurs with intravascular hemolysis. (Choice A)  Increased serum iron occurs in hemochromatosis most classically, but increased serum iron can also be iatrogenic.  Hemochromatosis does not cause anemia, but it is associated with cirrhosis and increased incidence of hepatocellular cancer.  Hemolysis does not usually have a significant effect on serum iron because the iron released from lysed RBCs remains bound to hemoglobin. (Choice C)  Increased mean corpuscular volume (MCV) occurs in megaloblastic anemia (eg, folate/vitamin B12 deficiency) due to the presence of enlarged ovoid erythrocytes.  Increased MCV may also occur with other forms of anemia due to a reactive increase in reticulocytes (large, immature RBCs); however, anemia caused by mechanical erythrocyte trauma usually results in decreased MCV due to the presence of small RBC fragments (schistocytes). (Choice D)  A decreased reticulocyte count in the presence of anemia is characteristic of aplastic anemia.  In hemolytic anemias, the reticulocyte count is increased to compensate for the increased destruction of RBCs. (Choice E)  A decreased serum albumin level is associated with cirrhosis (decreased production), nephrotic syndrome (urinary loss), and protein-wasting enteropathy (bowel loss). Educational objective: Schistocytes (helmet cells) are fragmented erythrocytes.  They occur secondary to mechanical trauma from microangiopathic hemolytic anemias or prosthetic cardiac valves (macroangiopathic).  Intravascular hemolytic anemias are characterized by decreased serum haptoglobin levels as well as increased LDH and bilirubin.

Mechanical Hemolytic Anemia (Prosthetic Valve) — Combined Ultra High-Yield USMLE Notes


1. Diagnosis: Macroangiopathic Hemolytic Anemia — mechanical (prosthetic aortic valve) → intravascular RBC destruction → ↓haptoglobin + schistocytes/helmet cells

2. Key clue (1 line): 56M + aortic valve replacement + fatigue + schistocytes/helmet cells on smear + normal platelets → mechanical intravascular hemolysis → ↓haptoglobin (key lab finding)

3. Why correct (≤2 lines): Prosthetic valve → excessive shear/turbulence → RBCs physically fragmented → intravascular hemolysis → free Hgb released → haptoglobin binds free Hgb → haptoglobin consumed → ↓serum haptoglobin. Also: ↑LDH + ↑indirect bilirubin + hemoglobinemia + hemoglobinuria + ↑retics; normal platelets distinguishes from MAHA.

4. Why others wrong (1 line each):
  • ↑Serum iron: Hemochromatosis finding; in hemolysis, iron stays bound to Hgb → serum iron not significantly affected
  • ↑MCV: Megaloblastic anemia (folate/B12); mechanical hemolysis → schistocytes (small fragments) → may actually ↓MCV, not increase it
  • ↓Reticulocyte count: Aplastic anemia pattern; hemolysis → marrow compensates → ↑retics expected
  • ↓Albumin: Cirrhosis/nephrotic syndrome/protein-losing enteropathy; not a feature of mechanical hemolysis

5. Buzzword triggers:
  • Schistocytes + helmet cells + prosthetic valve → macroangiopathic hemolysis
  • Schistocytes + ↓platelets → MAHA (HUS/TTP/DIC)
  • Schistocytes + normal plateletsmechanical/prosthetic valve
  • Intravascular hemolysis labs: ↓haptoglobin + ↑LDH + ↑indirect bili + hemoglobinuria + hemoglobinemia + ↑retics
  • Extravascular hemolysis labs: ↓haptoglobin (mild) + ↑indirect bili + ↑retics; NO hemoglobinuria/hemoglobinemia
  • Haptoglobin: binds free Hgb → cleared by RES → ↓haptoglobin = intravascular hemolysis marker
  • Mechanical > porcine prosthetic valves for RBC trauma risk
  • Schistocyte causes: HUS / TTP / DIC / prosthetic valve / HELLP / malignant HTN

6. Trap / trick tested:
  • ↓MCV trap: Students expect schistocytes to not affect MCV; fragments are small → MCV may ↓ (not ↑); ↑MCV = megaloblastic, not mechanical hemolysis
  • Serum iron trap: Students expect iron to rise with RBC lysis; iron stays bound to Hgb/haptoglobin complex → serum iron not meaningfully elevated
  • Platelet count is the critical pivot: Normal platelets = mechanical/macroangiopathic; low platelets = MAHA (microangiopathic)
  • Intravascular vs extravascular: hemoglobinuria only in intravascular (free Hgb filters through kidney); extravascular = RBCs eaten by macrophages, no free Hgb in urine

7. One-liner memory hook:
"Prosthetic valve = RBC blender → free Hgb floods plasma → haptoglobin mops it up → haptoglobin gone (↓) → hemoglobinuria; platelets fine = valve not clot; schistocytes + normal platelets = macroangiopathic."

A 24-year-old man comes to the clinic due to 2 weeks of progressive generalized weakness.  He has also had significant bruising on his trunk that developed spontaneously without trauma.  The patient has no known medical conditions and takes no medications.  Temperature is 37.1 C (98.8 F), pulse is 120/min, and respirations are 20/min.  Conjunctival pallor is present.  Cardiac examination reveals mild sinus tachycardia with no murmurs.  Skin examination shows truncal ecchymoses but is otherwise normal.  Laboratory results reveal a hemoglobin of 6.8 g/dL and a normal creatinine.  Bone marrow aspiration is grossly pale and histologically appears diluted due to high lipid content.  Which of the following laboratory patterns is most likely present in this patient? Erythropoietin Reticulocytes Mean corpuscular volume Haptoglobin  A. ↑ ↑ Normal Low  (11%)  B. ↑ ↓ Normal Normal  (60%)  C. ↑ ↓ ↓ High  (16%)  D. ↓ ↑ ↓ Low  (4%)  E. ↓ ↓ Normal Normal  (7%) Aplastic anemia Pathogenesis Multipotent hematopoietic stem cells are destroyed by cytotoxic T cells or direct cytotoxic injury → bone marrow aplasia/hypoplasia → lack of circulating peripheral blood cells Common triggers Autoimmune Drugs: cytotoxic chemotherapy, immunosuppressants, idiosyncratic reactions Ionizing radiation & toxins Viral infections (eg, viral hepatitis, HIV) Manifestations Anemia (eg, fatigue, weakness, pallor) Thrombocytopenia (eg, bleeding, bruising) Leukopenia (eg, recurrent infections) Diagnosis Bone marrow biopsy: hypocellular marrow with abundance of stromal & fat cells This patient with a low hemoglobin level has several symptoms of anemia, including generalized weakness, tachycardia, and conjunctival pallor.  The presence of spontaneous bruising in the absence of trauma likely indicates thrombocytopenia.  Bone marrow aspirate reveals an abundance of lipids instead of cells, which is usually seen with bone marrow aplasia or hypoplasia.  This constellation of findings is highly suggestive of aplastic anemia (AA). AA is a form of bone marrow failure primarily caused by cytotoxic T-cell destruction of multipotent hematologic stem cells.  Because multipotent stem cells produce all mature blood cells, patients usually develop pancytopenia (not just anemia as the name suggests) and have manifestations of anemia, thrombocytopenia, and/or leukopenia (eg, infections). As with most forms of anemia, anemia-induced tissue hypoxia stimulates interstitial cells in the kidney to increase the release of erythropoietin.  However, in AA, erythropoietin is unable to stimulate significant new red blood cell production due to the reduced population of functioning hematologic stem cells; therefore, reticulocytes are inappropriately low.  Because the blood cells produced by the remaining undamaged hematopoietic stem cells are normal in morphology, erythrocytes are normal in size and appearance; therefore, mean corpuscular volume is normal.  Because there is no intravascular hemolysis, haptoglobin (binds free hemoglobin in the blood) is also normal. Educational objective: Aplastic anemia (AA) is a form of bone marrow failure associated with pancytopenia and bone marrow aplasia/hypoplasia.  Although erythropoietin levels are high, reticulocytes remain low because the production of new erythrocytes is impaired by a paucity of bone marrow stem cells.  However, the blood cells produced by the remaining stem cells are normal in morphology and red cell indexes (eg, mean corpuscular volume) are usually normal.

Aplastic Anemia — Lab Pattern — Ultra High-Yield USMLE Notes


1. Diagnosis: Aplastic Anemia (AA) — hypocellular marrow (fat/lipid-rich) → pancytopenia → ↑EPO + ↓retics + normal MCV + normal haptoglobin

2. Key clue (1 line): 24M + weakness + spontaneous bruising + Hgb 6.8 + tachycardia + bone marrow pale/lipid-rich (hypocellular) → AA → EPO↑ (trying) + retics↓ (marrow can't respond) + MCV normal + haptoglobin normal

3. Why correct (≤2 lines): HSC destruction → marrow replaced by fat → ↓RBC production → tissue hypoxia → kidney ↑EPO (appropriate response) → but too few HSCs remain to respond → ↓retics despite ↑EPO. No DNA defect → normal MCV; no intravascular hemolysis → free Hgb not released → haptoglobin normal.

4. Why others wrong (1 line each):
  • Choice A (↑EPO + ↑retics + normal MCV + ↓haptoglobin): Pattern of hemolytic anemia (intravascular); marrow responding + haptoglobin consumed; AA marrow cannot respond → retics low
  • Choice C (↑EPO + ↓retics + ↓MCV + ↑haptoglobin): ↓MCV = IDA/thalassemia; ↑haptoglobin = acute phase reaction; AA has normal MCV + normal haptoglobin
  • Choice D (↓EPO + ↑retics + ↓MCV + ↓haptoglobin): ↓EPO = renal failure/PV; ↑retics + ↓haptoglobin = hemolysis; nothing matches AA
  • Choice E (↓EPO + ↓retics + normal MCV + normal haptoglobin): ↓EPO = CKD (EPO deficiency anemia) or PV; AA always has ↑EPO (kidneys sense hypoxia and respond normally)

5. Buzzword triggers:
  • ↑EPO + ↓retics = production failure (marrow can't respond despite hormonal drive) → AA, PRCA
  • ↓EPO + ↓retics = EPO deficiency → CKD (peritubular cell fibrosis)
  • ↑EPO + ↑retics + ↓haptoglobin = hemolytic anemia (marrow compensating + intravascular lysis)
  • Bone marrow = pale + lipid-rich + hypocellular → AA ("fat marrow")
  • Normal haptoglobin → no intravascular hemolysis → not PNH, not mechanical, not MAHA
  • Normal MCV in AA → remaining HSCs produce morphologically normal cells; no DNA synthesis defect
  • AA EPO paradox: EPO ↑↑ but retics ↓↓ = classic pattern; EPO "screaming into empty factory"

6. Trap / trick tested:
  • EPO is always HIGH in AA — kidneys function normally and sense hypoxia → students wrongly pick ↓EPO (that's CKD); the problem is the marrow's inability to respond, not EPO production
  • Normal haptoglobin eliminates hemolysis — distinguishes AA from hemolytic anemias where haptoglobin is consumed
  • Normal MCV eliminates IDA/thalassemia (↓MCV) and megaloblastic (↑MCV) — AA is normocytic
  • Spontaneous bruising = thrombocytopenia (part of pancytopenia); not a platelet function defect

7. One-liner memory hook:
"AA = EPO screams (↑) into an empty fat marrow → retics silent (↓) → normal-sized cells from surviving HSCs → no hemolysis → haptoglobin normal; EPO↑ + retics↓ + MCV normal + haptoglobin normal = AA fingerprint."

A 20-year-old man is evaluated for recurrent episodes of jaundice.  He was separated from his parents at a young age and is unaware of his family medical history.  The patient resided in several foster homes throughout his childhood but currently lives alone.  Temperature is 36.7 C (98.1 F), blood pressure is 120/80 mm Hg, and pulse is 72/min.  Physical examination shows pallor, icterus, and mild splenomegaly.  There is no lymphadenopathy or hepatomegaly.  The remainder of the physical examination is normal.  Laboratory results are as follows: Hemoglobin 9 g/dL Platelets 198,000/mm3 Leukocytes 6,500/mm3 Lactate dehydrogenase increased Total bilirubin 3.4 mg/dL Direct bilirubin 0.2 mg/dL Aspartate aminotransferase (SGOT) 25 U/L Alanine aminotransferase (SGPT) 30 U/L Direct Coombs test negative When the patient's red blood cells are incubated in a hypotonic saline solution, hemoglobin is released.  The control sample does not release hemoglobin.  This patient is at greatest risk for developing which of the following complications? Hereditary spherocytosis Genetics Autosomal dominant inheritance (most cases) Pathogenesis RBC membrane defect (eg, spectrin, ankyrin) Spherocytes with ↓ deformability sequestered in spleen Extravascular hemolysis Clinical presentation Hemolytic anemia Jaundice Splenomegaly Laboratory findings ↑ MCHC Spherocytes on peripheral blood smear Negative Coombs test ↑ Osmotic fragility Treatment Splenectomy Complications Pigmented gallstones Aplastic crisis (with parvovirus B19 infection) RBC = red blood cell; MCHC = mean corpuscular hemoglobin concentration. This patient's anemia, elevated lactate dehydrogenase (LDH), and indirect hyperbilirubinemia is suggestive of hemolytic anemia.  Red cell lysis (ie, hemoglobin release) when incubated in hypotonic saline describes a positive osmotic fragility test, a diagnostic test for hereditary spherocytosis (HS). HS is the most common form of hemolytic anemia caused by an RBC membrane defect.  HS mutations most often affect spectrin and ankyrin (plasma-membrane scaffolding proteins), producing an unstable plasma membrane that loses fragments over time.  As a result, the RBCs acquire an inflexible, spheroid shape (ie, spherocytes).  Because spherocytes have a decreased surface area/volume ratio, they are more prone to rupture when incubated in hypotonic saline (ie, increased osmotic fragility). Patients with HS have the classic findings of chronic extravascular hemolysis, including anemia, jaundice, and splenomegaly (due to increased splenic macrophages and congestion).  They are also at risk for pigmented gallstones (due to increased bilirubin precipitating as calcium bilirubinate in the gallbladder) and aplastic crises with parvovirus B19 infection. (Choice A)  Autoimmune hemolytic anemia (AIHA) results in findings similar to those seen in HS (eg, indirect hyperbilirubinemia, elevated LDH, spherocytes).  In contrast to HS, patients with AIHA have a positive direct antiglobulin (Coombs) test and a propensity for developing other autoimmune disease (eg, systemic lupus erythematosus). (Choices B and C)  The abnormal adhesion of sickled RBCs to the endothelium and the subsequent obstruction of small blood vessels lead to various injuries, including splenic autoinfarction and femoral avascular necrosis.  Although sickle cell disease causes hemolysis (eg, indirect hyperbilirubinemia, elevated LDH), a positive osmotic fragility test classically describes HS. (Choice D)  Hemochromatosis (ie, iron overload) is a potential complication of beta-thalassemia due to ineffective erythropoiesis (stimulates iron absorption) and treatment-related blood transfusions.  Hemolysis is often less severe in HS, and most patients do not develop iron overload. Educational objective: Hereditary spherocytosis results from red blood cell cytoskeleton abnormalities, most commonly in the proteins spectrin and ankyrin.  The diagnosis can be confirmed with a positive osmotic fragility test.  Hemolytic anemia, jaundice, and splenomegaly are classic manifestations.  Complications include pigmented gallstones and aplastic crises.

Hereditary Spherocytosis (HS) — Complications — Combined Ultra High-Yield USMLE Notes


1. Diagnosis: Hereditary Spherocytosis (HS) — spectrin/ankyrin defect → spherocytes → positive osmotic fragility test → greatest risk = pigmented gallstones

2. Key clue (1 line): Young man + recurrent jaundice + hemolytic anemia + splenomegaly + negative Coombs + ↑osmotic fragility (RBCs lyse in hypotonic saline) → HS → complication = pigmented (bilirubin) gallstones

3. Why correct (≤2 lines): HS → chronic extravascular hemolysis → ↑↑unconjugated bilirubin chronically → precipitates as calcium bilirubinate in gallbladder → pigmented gallstones (most common complication of chronic hemolysis). Osmotic fragility ↑ because spherocytes have ↓surface area/volume ratio → cannot expand in hypotonic solution → lyse earlier than normal biconcave RBCs.

4. Why others wrong (1 line each):
  • AIHA (autoimmune hemolytic anemia): Similar findings (spherocytes + hemolysis) but Coombs+; HS = Coombs−; AIHA → SLE risk, not gallstones
  • Splenic autoinfarction: Sickle cell disease complication (repeated vasoocclusion); HS has splenomegaly (not autoinfarction)
  • Femoral avascular necrosis: Sickle cell disease (vasoocclusion of femoral head vessels); not an HS complication
  • Hemochromatosis/iron overload: Beta-thalassemia complication (transfusions + ineffective erythropoiesis); HS hemolysis rarely severe enough to cause iron overload

5. Buzzword triggers:
  • Positive osmotic fragility testHS (spherocytes burst in hypotonic saline)
  • Spherocytes + negative CoombsHS; spherocytes + positive CoombsAIHA
  • HS labs: ↑MCHC + spherocytes + ↑indirect bili + ↑LDH + ↓haptoglobin + normal MCV
  • HS complications: Pigmented gallstones (chronic ↑bilirubin) + aplastic crisis (parvovirus B19, ↓↓retics) + splenomegaly
  • HS treatment: splenectomy (removes site of RBC destruction) → give vaccines first (encapsulated organisms)
  • Autosomal dominant → positive family history (but unknown here due to foster care → unknown history clue)
  • Chronic hemolysis → pigmented gallstones (Ca-bilirubinate); cholesterol gallstones = obesity/estrogen/rapid weight loss

6. Trap / trick tested:
  • Osmotic fragility test is the specific diagnostic clue — students may not recognize "hemoglobin released in hypotonic saline" as osmotic fragility; this = HS
  • Coombs negative is critical — both HS and AIHA show spherocytes; negative Coombs = HS; positive Coombs = AIHA; exam loves this distinction
  • Pigmented vs cholesterol gallstones: Pigmented = chronic hemolysis (HS, SCD, thalassemia); cholesterol = obesity, female, fertile, forty, fasting
  • Parvovirus B19 → aplastic crisis in HS (↓↓retics, sudden severe anemia) — distinct from hemolytic crisis (viral URI → ↑↑retics)
  • Unknown family history in question stem is intentional — autosomal dominant HS usually has family history; absence here tests whether you can diagnose from labs alone

7. One-liner memory hook:
"Spherocytes pop in hypotonic saline (↑osmotic fragility) + Coombs− = HS; chronic bilirubin overflow → pigmented gallstones in the gallbladder; Parvo B19 → aplastic crisis (retics crash); splenectomy cures but vaccinate first."

A 9-year-old boy with beta-thalassemia major is brought to the office for a routine red blood cell transfusion.  He was diagnosed at age 6 months and has since received numerous blood transfusions.  The patient has tolerated each transfusion well with no immediate reactions.  Vital signs are normal.  On physical examination, the patient has mild frontal bossing, hepatosplenomegaly, and jaundice.  A recent liver biopsy showed Kupffer cells containing coarse, yellow-brown cytoplasmic granules.  The granules are most likely composed of which of the following? Patients with chronic hemolytic anemia (eg, beta-thalassemia major) depend on recurrent red blood cell (RBC) transfusions to maintain an adequate hemoglobin level.  Iron overload (hemosiderosis) from increased iron absorption is a common complication resulting from both the primary condition (eg, hemolysis) and its treatment (frequent RBC transfusions). Circulating iron is carried by transferrin.  Once deposited in cells, iron binds to apoferritin to form ferritin micelles.  Because iron is used poorly in patients with thalassemia and cannot be excreted actively, the ferritin micelles accumulate in macrophages of the reticuloendothelial system.  The resulting iron-storage complex is known as hemosiderin and microscopically appears as brown or yellow-brown pigments in either granular or crystalline form.  Hemosiderin can be confirmed histologically with Prussian-blue staining.  In the liver, hemosiderin is typically seen in Kupffer cells (hepatic macrophages that line the walls of the sinusoids and participate in RBC breakdown). Eventually, the iron burden will overwhelm the reticuloendothelial cells' capacity to sequester iron, resulting in parenchymal iron overload in the liver, myocardium, skin, and pancreas (eg, "bronze diabetes").  Patients receiving regular transfusions should undergo routine iron chelation therapy to reduce the overall iron load within the body and improve survival. (Choice A)  Amyloid protein appears as an amorphous, pink, extracellular material that shows apple-green birefringence under polarized light after Congo red staining.  Hepatic amyloid can be seen in primary (eg, multiple myeloma) or secondary (eg, chronic inflammation) amyloidosis. (Choice B)  Bilirubin is the primary pigment found within bile, which has a brown, yellow, or green appearance microscopically.  Accumulation in hepatocytes and canaliculi (ie, cholestasis) is associated with defects in bile production or flow (eg, duct obstruction). (Choice C)  Copper accumulation is seen in Wilson disease, an autosomal recessive disease characterized by cirrhosis and neurologic complications. (Choice D)  Glycogen appears as clear cytoplasmic vacuoles and stains pink-purple with the periodic acid-Schiff reaction.  Glycogen is abundant in the liver shortly after a meal. (Choice E)  Patients with Gaucher disease (glucocerebrosidase enzyme deficiency) have pancytopenia, hepatosplenomegaly, and pathologic fractures.  Gaucher cells, macrophages laden with cerebrosides and other glycolipids, have a "wrinkled tissue paper" appearance microscopically. (Choice G)  Lipofuscin is an insoluble yellow-brown pigment composed of lipids and phospholipids complexed with proteins.  This pigment accumulates with age (ie, typically seen in adults) and "wear and tear" of multiple organs. Educational objective: Iron overload (hemosiderosis) is a common and serious complication of chronic hemolytic anemia and frequent blood transfusions.  Accumulation of yellow-brown hemosiderin pigment is the cardinal histologic finding.  Chelation therapy is indicated to reduce parenchymal iron deposition.

Beta-Thalassemia Major — Iron Overload (Hemosiderosis) — Ultra High-Yield USMLE Notes


1. Diagnosis: Hemosiderosis (iron overload) — secondary to chronic transfusions + hemolysis in Beta-Thalassemia Major → hemosiderin in Kupffer cells (hepatic macrophages)

2. Key clue (1 line): Child + β-thalassemia major + multiple transfusions + frontal bossing + hepatosplenomegaly + jaundice + Kupffer cells with coarse yellow-brown cytoplasmic granuleshemosiderin

3. Why correct (≤2 lines): Chronic hemolysis + repeated transfusions → excess iron → bound to apoferritin → ferritin micelles accumulate in RES macrophages → coalesce into hemosiderin (yellow-brown granular/crystalline deposits in Kupffer cells). Confirmed by Prussian-blue stain; eventually overwhelms RES → parenchymal deposition → "bronze diabetes" + cardiomyopathy + cirrhosis.

4. Why others wrong (1 line each):
  • Amyloid: Amorphous pink extracellular deposits; Congo red + apple-green birefringence; multiple myeloma/chronic inflammation; not iron overload
  • Bilirubin: Brown/yellow/green pigment in hepatocytes/canaliculi (cholestasis); intracellular bile accumulation; not macrophage granules
  • Copper: Wilson disease (AR) → cirrhosis + neuropsychiatric symptoms + Kayser-Fleischer rings; not transfusion-related
  • Glycogen: Clear cytoplasmic vacuoles; PAS stain pink-purple; normal postprandial finding; not coarse granules
  • Glycolipids (Gaucher cells): "Wrinkled tissue paper" macrophages; glucocerebrosidase deficiency; pancytopenia + pathologic fractures; no transfusion link
  • Lipofuscin: Yellow-brown wear-and-tear pigment in adults; age-related; not seen in 9-year-old child

5. Buzzword triggers:
  • Yellow-brown granules in Kupffer cells (hepatic macrophages) → hemosiderin
  • Prussian-blue stain → confirms hemosiderin (iron)
  • β-thalassemia + chronic transfusions → hemosiderosis → chelation therapy
  • Iron overload organs: Heart (CHF/arrhythmia) + Liver (cirrhosis) + Pancreas (diabetes/"bronze diabetes") + Skin (bronzing) + Pituitary (hypogonadism)
  • Hemosiderin = ferritin micelles aggregated in macrophages of RES (Kupffer cells, spleen, bone marrow)
  • Iron chelators: Deferoxamine (IV/SQ, Fe³⁺) + Deferasirox (oral) + Deferiprone (oral)
  • Frontal bossing in thalassemia = marrow expansion (extramedullary erythropoiesis) from ineffective erythropoiesis
  • β-thalassemia major: HbF predominant (compensatory); no/minimal HbA; target cells + microcytic anemia

6. Trap / trick tested:
  • Bilirubin vs hemosiderin: Both yellow-brown pigments in liver — bilirubin = canalicular/hepatocyte cholestasis; hemosiderin = macrophage (Kupffer cell) granules in iron overload
  • Lipofuscin trap: Also yellow-brown pigment — but seen in elderly adults ("wear and tear"); child with thalassemia = hemosiderin, not lipofuscin
  • Gaucher cell trap: Also macrophage storage + hepatosplenomegaly — but "wrinkled tissue paper" appearance + glucocerebrosidase deficiency; no transfusion link
  • Iron overload = two mechanisms in thalassemia: (1) ↑GI iron absorption (ineffective erythropoiesis suppresses hepcidin) + (2) transfusion iron load

7. One-liner memory hook:
"Thalassemia transfusions flood body with iron → ferritin overflows into Kupffer cells → hemosiderin (yellow-brown granules, Prussian-blue+) → Prussian-blue the liver, chelate with Deferoxamine, or rust kills the heart/pancreas/liver."

A 4-year-old boy is admitted to the hospital due to shock and subsequently dies from overwhelming sepsis.  Examination during autopsy shows hepatosplenomegaly.  Clumps of erythroid precursor cells are seen in the liver and spleen.  The presence of these precursor cells is most likely due to which of the following underlying conditions? e presence of erythroid precursor cells in this patient's liver and spleen is indicative of extramedullary hematopoiesis (EMH).  EMH is characterized by the formation and maturation of blood cell precursors (ie, hematopoiesis) outside of the bone marrow, commonly in response to increased destruction of blood cells (eg, severe chronic hemolysis). Throughout fetal development, hematopoiesis normally occurs in the yolk sac, followed by the liver, spleen, and bone marrow; after birth, the bone marrow is the primary hematopoietic site.  However, in response to uncompensated, severe, chronic hemolytic anemia (eg, beta thalassemia, sickle cell disease), elevated erythropoietin can cause some hematopoietic stem and progenitor cells to leave the bone marrow, migrate to other organs (often those involved in fetal hematopoiesis such as the liver and spleen), and initiate compensatory erythropoiesis. EMH can cause enlargement of the involved organs (eg, hepatosplenomegaly).  In some patients, extensive splenic infiltration can impair the spleen's filtration and immune capabilities, increasing the risk for severe infections (eg, sepsis). (Choice B)  Deficiency of cobalamin (vitamin B12), which is required for DNA synthesis, results in megaloblastic anemia; it is not typically associated with EMH. (Choice C)  Erythropoietin deficiency (eg, chronic kidney disease) is associated with anemia but does not cause EMH, since EMH is driven by increased levels of erythropoietin. (Choice D)  Red blood cell transfusions limit EMH by reducing hypoxia and erythropoietin release.  Patients with severe chronic hemolysis often receive regular transfusions to improve anemia and suppress EMH. (Choice E)  Deficiency of iron, which is necessary for hemoglobin production, results in a relative depression of erythropoietic activity; it is not typically associated with EMH. (Choice F)  Patients with primary immunodeficiency disorders may be susceptible to overwhelming sepsis, but these disorders are not frequently associated with severe chronic hemolysis, and EMH is not expected. Educational objective: The presence of erythroid precursors in the liver and spleen is indicative of extramedullary hematopoiesis (EMH), a condition characterized by erythropoietin-stimulated formation and maturation of blood cells outside of the bone marrow.  EMH frequently occurs in response to severe chronic hemolytic anemia (eg, beta thalassemia).

Extramedullary Hematopoiesis (EMH) — Ultra High-Yield USMLE Notes


1. Diagnosis: Extramedullary Hematopoiesis (EMH) — EPO-driven hematopoiesis outside bone marrow → liver + spleen; caused by severe chronic hemolytic anemia (β-thalassemia, SCD)

2. Key clue (1 line): 4-year-old + death from overwhelming sepsis + autopsy = hepatosplenomegaly + erythroid precursors in liver/spleen → EMH from severe chronic hemolysis (β-thalassemia most likely)

3. Why correct (≤2 lines): Severe chronic hemolysis → persistent anemia → ↑↑EPO → HSCs leave marrow → migrate to liver/spleen (sites of fetal hematopoiesis) → compensatory erythropoiesis → hepatosplenomegaly. Massive splenic infiltration impairs splenic filtration/immune function → susceptibility to overwhelming sepsis (encapsulated organisms).

4. Why others wrong (1 line each):
  • B12/cobalamin deficiency: Megaloblastic anemia (↑MCV); impaired DNA synthesis; does NOT drive EMH (no massive hemolysis/↑↑EPO)
  • EPO deficiency (CKD): ↓EPO causes anemia but EMH requires ↑↑EPO to drive HSC migration; EPO deficiency suppresses, not stimulates EMH
  • RBC transfusions: Actually suppress EMH by reducing hypoxia → ↓EPO → HSCs stay in marrow; used therapeutically to limit EMH
  • Iron deficiency: Relative depression of erythropoiesis; insufficient EPO stimulus to drive EMH
  • Primary immunodeficiency: Causes sepsis susceptibility but NO chronic hemolysis → no EMH trigger

5. Buzzword triggers:
  • Erythroid precursors in liver/spleen → EMH
  • EMH causes: β-thalassemia major (most classic) + SCD + myelofibrosis + severe hereditary hemolytic anemias
  • EMH → hepatosplenomegaly + ↑infection risk (splenic dysfunction)
  • Normal hematopoiesis sequence: Yolk sac → Liver → Spleen → Bone marrow (mnemonic: "Young Liver Spleen Bone")
  • EMH driver = ↑↑EPO (chronic hypoxia from hemolysis) → HSCs migrate to fetal hematopoietic sites
  • β-thalassemia major features: frontal bossing + chipmunk facies (marrow expansion) + hepatosplenomegaly (EMH) + severe transfusion-dependent anemia
  • Myelofibrosis also causes EMH but in adults + teardrop cells + massive splenomegaly + fibrotic marrow
  • EMH suppression: regular transfusions (↓EPO → ↓HSC migration)

6. Trap / trick tested:
  • EPO deficiency vs EPO excess: Students confuse direction — EMH requires ↑EPO (driving HSCs out); EPO deficiency (CKD) causes anemia WITHOUT EMH
  • Sepsis cause in EMH: Not from immunodeficiency — spleen is physically overwhelmed by erythroid infiltration → loses filtration capacity → susceptible to encapsulated bacteria (same mechanism as asplenia)
  • Transfusions suppress EMH — counterintuitive; students think transfusions worsen iron overload (true) but they also reduce the hypoxic stimulus driving EMH
  • Fetal hematopoiesis sites are reactivated in EMH — "the body returns to fetal programming under stress"

7. One-liner memory hook:
"Chronic hemolysis → EPO screams → HSCs flee marrow → colonize liver + spleen (fetal sites) → EMH → hepatosplenomegaly; spleen drowns in red cell precursors → can't fight bacteria → sepsis; fix with transfusions (↓EPO → HSCs stay home)."

A 70-year-old female presents to your office complaining of easy fatigability, exertional dyspnea and weight loss.  She also complains of frequent falls.  Physical examination reveals symmetrically decreased vibratory sensation to the lower extremities.  Her hemoglobin is 7.8 g/dL and a peripheral blood smear shows hypersegmented neutrophils.  Which of the following is the best treatment for this patient? Deficiencies of folic acid and vitamin B12 are the most important causes of megaloblastic anemia.  Both of these vitamins are required for DNA synthesis in erythropoiesis.  When there is a deficiency of either of these vitamins, cell division is delayed, though the cytoplasm develops normally.  Thus, the cells enlarge (megaloblasts) but do not divide.  The bone marrow is hypercellular in megaloblastic anemia, but the megaloblastic erythroid precursor cells are rapidly destroyed in the bone marrow and few differentiated large RBCs are released into the circulation.  In severe megaloblastic anemia, 90% of erythroid precursors are destroyed without ever entering the circulation. Vitamin B12 and folic acid deficiencies cause similar hematological pictures.  However, neurological dysfunction is only seen in patients with vitamin B12 deficiency.  This is because B12 deficiency also causes axonal demyelination and degeneration.  In late disease, the neurological dysfunction may be irreversible.  The main sites of neurological involvement include the peripheral nerves, spinal cord (posterior and lateral columns), and the cerebrum.  Decreased vibratory and position sense are early signs of vitamin B12 deficiency.  Patients experience ataxia and recurrent falls because of compromised proprioception.  Importantly, neurologic abnormalities can occur in vitamin B12 deficiency in the absence of frank anemia.  Treating megaloblastic anemia due to vitamin B12 deficiency with folate alone could worsen the neurological dysfunction. An RBC mean corpuscular volume (MCV) of more than 100 fL is suggestive of megaloblastic anemia.  However, RBC macrocytosis can also occur in liver disease, hypothyroidism, and alcohol-induced liver disease.  MCVs greater than 110 fL are typically seen only with vitamin B12 and folic acid anemias.  On peripheral blood smear, there is macrocytosis (large RBCs), hypersegmented neutrophils, and large bizarrely shaped platelets.  The presence of even a single neutrophil with more than 6 lobes should raise the suspicion of megaloblastic anemia. The medications listed in the other answer choices are not used for the treatment of megaloblastic anemia. Educational Objective: Vitamin B12 and folic acid deficiencies cause similar hematological pictures.  However, neurological dysfunction is only seen in patients with vitamin B12 deficiency.  If megaloblastic anemia due to vitamin B12 deficiency is mistakenly treated with folate alone, the neurologic dysfunction can worsen. options : iron preparation, pyridoxine , vit.c , folic acid, EPO, Filgrastim, Il-2 , Antithymocyte globin

Vitamin B12 Deficiency (Pernicious Anemia) — Ultra High-Yield USMLE Notes


1. Diagnosis: Vitamin B12 Deficiency → Megaloblastic Anemia + Subacute Combined Degeneration (posterior + lateral columns); treatment = Vitamin B12 (Cobalamin)

2. Key clue (1 line): 70F + fatigue + exertional dyspnea + weight loss + ↓vibratory sensation (lower extremities) + frequent falls (↓proprioception) + Hgb 7.8 + hypersegmented neutrophils → B12 deficiency → treat with B12, NOT folate

3. Why correct (≤2 lines): B12 deficiency → impaired DNA synthesis → megaloblastic anemia (↑MCV + hypersegmented neutrophils) + axonal demyelination → posterior columns (↓vibration/proprioception) + lateral columns (↑UMN signs) + peripheral nerves. Neurologic dysfunction = B12 only (NOT folate); treating with folate alone corrects anemia but worsens neurologic damage → must give B12.

4. Why others wrong (1 line each):
  • Iron preparation: Treats microcytic/hypochromic IDA (↓MCV); this patient has macrocytic anemia + neuro symptoms → not IDA
  • Pyridoxine (B6): Treats sideroblastic anemia (ring sideroblasts) and B6 deficiency neuropathy; not megaloblastic anemia
  • Vitamin C: Treats scurvy (perifollicular hemorrhage, poor wound healing); no role in megaloblastic anemia
  • Folic acid alone: Corrects hematologic findings ONLY → does NOT fix neuro damage and may mask B12 deficiency → neurologic deterioration worsens
  • EPO: Treats anemia of CKD (EPO deficiency); no role when marrow has adequate EPO but lacks B12 substrate
  • Filgrastim (G-CSF): Stimulates neutrophil production; treats neutropenia (eg, chemotherapy); not megaloblastic anemia
  • IL-2: Immunotherapy for cancer (eg, renal cell carcinoma, melanoma); no hematologic deficiency role
  • Antithymocyte globulin (ATG): Immunosuppression for aplastic anemia (T-cell mediated HSC destruction); not B12 deficiency

5. Buzzword triggers:
  • Hypersegmented neutrophils (≥1 with >6 lobes or ≥5% with ≥5 lobes) → megaloblastic anemia (B12 or folate)
  • ↓Vibration + ↓proprioception + ataxia + fallsB12 deficiency (posterior column)
  • Neurologic symptoms + megaloblastic anemia → B12, never folate alone
  • MCV >110 → megaloblastic (B12 or folate); MCV 100–110 → liver/alcohol/hypothyroid/drugs
  • B12 deficiency causes: pernicious anemia (anti-IF antibodies) + strict veganism + gastric resection + terminal ileum disease (Crohn's) + fish tapeworm (D. latum)
  • Folate deficiency causes: alcoholism + malnutrition + pregnancy (↑demand) + MTX/trimethoprim (DHFR inhibitors)
  • Subacute combined degeneration: posterior columns (vibration/proprioception) + lateral corticospinal tracts (UMN weakness/spasticity)
  • B12 neuro can occur WITHOUT anemia — neurologic damage precedes or exists independently of hematologic changes

6. Trap / trick tested:
  • Folate trap: Folate corrects CBC → anemia resolves → B12 deficiency missed → neurodegeneration continues/worsens; always rule out B12 before giving folate
  • Neuro symptoms = B12 exclusively — folate deficiency NEVER causes neurologic dysfunction; if neuro present → B12 regardless of folate level
  • Falls + decreased vibration in elderly → students think peripheral neuropathy (DM) or cervical myelopathy; hypersegmented neutrophils pivot to B12 deficiency
  • Weight loss in elderly + B12 deficiency → think pernicious anemia (autoimmune gastritis → no intrinsic factor → no B12 absorption in terminal ileum)

7. One-liner memory hook:
"B12 gone → DNA fails (big cells + hyperseg neutrophils) + myelin fails (posterior columns → can't feel; lateral columns → can't walk straight); folate fixes blood NOT nerves → give B12 or the nervous system pays the price."

A 45-year-old man comes to the office for progressive weakness and fatigue over the last year.  The patient was adopted and does not know his family history.  After a comprehensive physical examination and laboratory evaluation, the patient undergoes genetic testing.  A loss of expression mutation is identified in a gene coding for a protein found on the basolateral surface of hepatocytes and enterocytes.  The protein is known to interact with the transferrin receptor.  Which of the following conditions is this patient at greatest risk of developing? Primary hemochromatosis (ie, hereditary hemochromatosis) is most commonly caused by mutations affecting the HFE protein.  This protein normally interacts with the transferrin receptor to form a complex that functions as a sensor of iron stores.  Mutations that inactivate the HFE protein cause enterocytes and hepatocytes to detect falsely low iron levels.  This increases iron accumulation in the body through the following 2 mechanisms: Enterocytes respond by increasing apical expression of divalent metal transporter 1 (DMT1), increasing iron absorption from the intestinal lumen Hepatocytes respond by decreasing hepcidin synthesis; low hepcidin levels result in increased ferroportin expression on the basolateral surface of enterocytes.  This allows increased iron secretion into the circulation, leading to iron overload When body iron levels exceed 20 g, patients typically develop the classic triad of micronodular cirrhosis, diabetes mellitus, and skin pigmentation (ie, "bronze diabetes").  These patients are at an increased risk for hepatocellular carcinoma, congestive heart failure, and testicular atrophy/hypogonadism. (Choice A)  Basal ganglia atrophy is a potential complication commonly seen in Wilson disease (ie, hepatolenticular degeneration). (Choice B)  Exocrine pancreatic function is usually preserved in patients with hemochromatosis.  Therefore, fat malabsorption and osteoporosis (due to decreased vitamin D) would not typically be seen. (Choice C)  Iron deficiency anemia is a potential complication of blood loss, lack of dietary iron, or an inability to absorb iron (eg, celiac disease).  Hemochromatosis results in iron overload, not iron deficiency. (Choice E)  Pulmonary emphysema is a potential complication of alpha-1 antitrypsin deficiency. Educational objective: HFE protein mutations are the most common cause of primary hemochromatosis.  Inactivation of the HFE protein results in decreased hepcidin synthesis by hepatocytes and increased DMT1 expression by enterocytes, leading to iron overload.  Patients with hemochromatosis are at an increased risk for liver cirrhosis and hepatocellular carcinoma.

Hereditary Hemochromatosis (HFE Mutation) — Ultra High-Yield USMLE Notes


1. Diagnosis: Hereditary Hemochromatosis — HFE protein mutation (basolateral hepatocytes/enterocytes, interacts with transferrin receptor) → iron overload → greatest risk = hepatocellular carcinoma (HCC)

2. Key clue (1 line): 45M + weakness/fatigue + loss-of-expression mutation in basolateral hepatocyte/enterocyte protein that interacts with transferrin receptor → HFE protein → hemochromatosis → HCC risk

3. Why correct (≤2 lines): HFE mutation → falsely low iron sensing → ↓hepcidin (hepatocytes) + ↑DMT1 (enterocytes) → ↑iron absorption + ↑ferroportin → systemic iron overload → cirrhosis → HCC (cirrhosis is the strongest HCC risk factor; hemochromatosis-associated cirrhosis carries particularly high HCC risk). Classic triad when iron >20g: micronodular cirrhosis + diabetes mellitus + skin bronzing = "bronze diabetes."

4. Why others wrong (1 line each):
  • Basal ganglia atrophy: Wilson disease (copper accumulation, ATP7B mutation); not iron overload
  • Fat malabsorption/osteoporosis: Exocrine pancreatic function preserved in hemochromatosis; exocrine failure → cystic fibrosis/chronic pancreatitis
  • Iron deficiency anemia: Opposite of hemochromatosis; IDA = ↓iron; hemochromatosis = ↑↑iron overload
  • Pulmonary emphysema: Alpha-1 antitrypsin deficiency (also causes liver disease but via protein misfolding, not iron)

5. Buzzword triggers:
  • HFE protein + transferrin receptor + basolateral surface → hemochromatosis
  • ↓Hepcidin → ↑ferroportin expression → ↑iron release from enterocytes/macrophages → iron overload
  • HFE mutations: C282Y (most common, homozygous) > H63D
  • Hemochromatosis triad: Cirrhosis + Diabetes + Bronze skin = "Bronze Diabetes"
  • Iron overload organs: Liver (cirrhosis → HCC) + Pancreas (diabetes) + Heart (CHF/arrhythmia) + Skin (bronzing) + Gonads (hypogonadism/testicular atrophy) + Joints (arthropathy, 2nd/3rd MCP)
  • ↑Ferritin + ↑transferrin saturation (>45%) → hemochromatosis screening labs
  • Treatment: Phlebotomy (first-line) ± deferoxamine
  • Hemochromatosis inheritance: autosomal recessive (HFE gene, chromosome 6)
  • Wilson vs hemochromatosis: both → liver disease; Wilson = copper + neuro + Kayser-Fleischer rings; hemochromatosis = iron + diabetes + bronze skin

6. Trap / trick tested:
  • Protein location clue: Basolateral surface of hepatocytes + enterocytes + interacts with transferrin receptor = HFE protein specifically; students may not recognize molecular description → connect to hemochromatosis
  • HCC risk: Hemochromatosis → cirrhosis → HCC even after iron removal; HCC risk persists once cirrhosis established
  • Hepcidin is the key regulator: ↓hepcidin = ↑ferroportin = ↑iron export from cells → ↑serum iron; hepcidin is the "iron master switch"
  • Exocrine vs endocrine pancreas: Hemochromatosis → endocrine (β-cell) destruction → diabetes; exocrine function preserved → no fat malabsorption

7. One-liner memory hook:
"HFE broken → liver thinks iron is low → ↓hepcidin → ↑ferroportin → iron floods in → Bronze Diabetes (skin + DM + cirrhosis) → cirrhosis → HCC; phlebotomy drains the iron, but cirrhosis risk for HCC remains."

what is HFE

HFE — Quick Breakdown


HFE = High Iron (Fe) gene — the gene mutated in hereditary hemochromatosis

What it is:

  • A MHC class I-like protein encoded by the HFE gene on chromosome 6
  • Expressed on the basolateral surface of hepatocytes and intestinal enterocytes
  • Structurally similar to HLA proteins but does NOT present antigens

What it does normally:

  • Binds to the transferrin receptor (TfR1) on cell surfaces
  • This HFE–TfR1 complex acts as an iron sensor — it detects how much iron-bound transferrin is circulating
  • When iron is sufficient → HFE signals hepatocytes to produce hepcidin → hepcidin degrades ferroportin → less iron enters blood

What happens when HFE is mutated:

StepNormalMutated HFE
Iron sensingAccurateFalsely reads "low iron"
Hepcidin↑ when iron replete↓ (not made)
FerroportinDegradedStays active
Iron absorptionRegulated↑↑ uncontrolled
ResultIron balanceIron overload

Key mutations (USMLE):

  • C282Y — most common (cysteine → tyrosine at position 282); homozygous = classic hemochromatosis
  • H63D — less severe; compound heterozygote C282Y/H63D can cause mild disease

One-liner:

"HFE is the iron thermostat; broken thermostat = heater never turns off = iron floods the body."

compress more small and simple concept undersy=tanding

HFE — Simple Concept

HFE = Iron thermostat gene (chromosome 6)

Normal: HFE protein + transferrin receptor → senses iron levels → tells liver to make hepcidin → hepcidin destroys ferroportin → iron absorption stops ✅

Mutated (C282Y): HFE broken → can't sense iron → no hepcidin → ferroportin stays open → iron keeps absorbing forever → overload

Simple chain:
HFE broken → no hepcidin → ferroportin open → iron floods in → Bronze Diabetes + HCC

One-liner:
"HFE = iron thermostat; broken = heater never turns off."

A 34-year-old man with obesity comes to the office due to fatigue, daytime sleepiness, and occasional headaches.  When asked to describe his sleeping habits, he reports that he sleeps in a separate room from his wife because she finds his snoring annoying.  Blood pressure is 160/90 mm Hg and pulse is 80/min.  The abdomen is soft and nontender.  The liver span is 9 cm, and the spleen is not palpable.  Laboratory results are as follows: Hematocrit 58% White blood cells 9,000/mm3 Platelets 190,000/mm3 Decreased arterial oxygen content, sensed by which of the following organs, is primarily responsible for this patient's elevated hematocrit? his patient with daytime sleepiness, recurrent headaches, and snoring most likely has obstructive sleep apnea (OSA).  Excess tissue around the extrathoracic upper airways (eg, from obesity) can predispose to upper airway collapse during sleeping.  As a result, patients with OSA may have up to 500 episodes of asphyxia per night. In adults, the main response to hypoxemia is coordinated by the kidneys.  In the renal cortex, peritubular fibroblasts sense hypoxia using the transcription factor hypoxia-inducible factor 1-alpha (HIF-1α).  When oxygen is readily available, HIF-1α is marked for proteasomal degradation.  Under low oxygen conditions, intracellular levels of HIF-1α accumulate, substantially increasing erythropoietin (EPO) production. EPO is secreted into the bloodstream, acting on the bone marrow to accelerate erythrocyte precursor maturation (Choice A).  The rapid rise in the number of mature erythrocytes leads to secondary polycythemia (eg, elevated hematocrit).  As a result, the oxygen-carrying capacity of blood rises, helping to compensate for chronic hypoxemia. (Choice B)  The brain does not regulate erythropoiesis in response to hypoxemia.  Instead, severe cerebral hypoxia drives increased sympathetic tone, increasing respiration, cerebral perfusion pressure, and oxygen delivery. (Choice C)  In response to hypoxemia, the liver helps supply iron (by suppressing hepcidin and upregulating transferrin) to support EPO-driven red blood cell production.  However, iron mobilization alone is insufficient to increase erythropoiesis.  For this reason, patients with severe chronic kidney disease (low EPO production), even when chronically hypoxemic, often have anemia and fail to develop secondary polycythemia. (Choice D)  With OSA, the lungs do not receive adequate oxygen delivery due to recurrent upper airway collapse.  In response to chronic alveolar hypoxemia, HIF-1α activation in the lungs contributes to sustained pulmonary vasoconstriction and pulmonary hypertension.  However, the lungs do not participate in erythropoiesis. (Choice F)  The spleen is the major site of erythrocyte destruction, not production.  In states of chronic hypoxemia, severe anemia, or bone marrow dysfunction, tissues with resident hematopoietic stem cells (eg, spleen, liver) can respond by participating in erythropoiesis (ie, extramedullary hematopoiesis). Educational objective: The kidneys respond to chronic hypoxemia (detected by the transcription factor hypoxia-inducible factor 1-alpha) by substantially increasing production of erythropoietin.  This hormone circulates to the bone marrow, where it accelerates the maturation of erythrocyte precursors, resulting in an elevated hematocrit (secondary polycythemia).

Secondary Polycythemia (OSA) — Ultra High-Yield USMLE Notes


1. Diagnosis: Secondary Polycythemia — chronic hypoxemia from Obstructive Sleep Apnea (OSA) → ↑EPO from kidneys → ↑RBC mass → ↑hematocrit

2. Key clue (1 line): Obese man + snoring + daytime sleepiness + headaches + HTN + Hct 58% + normal WBC/platelets → OSA → chronic hypoxemia → secondary polycythemia

3. Why correct (≤2 lines): Chronic hypoxia → renal cortex peritubular fibroblasts accumulate HIF-1α → ↑↑EPO secretion → bone marrow accelerates RBC maturation → ↑hematocrit (secondary polycythemia). Kidneys are the primary oxygen sensor driving erythropoiesis in adults; EPO = the hormonal messenger.

4. Why others wrong (1 line each):
  • Bone marrow: Responds TO EPO but does not sense hypoxia or initiate EPO production
  • Brain: Responds to hypoxia via ↑sympathetic tone + ↑respiration; does NOT regulate erythropoiesis
  • Liver: Suppresses hepcidin + upregulates transferrin to mobilize iron in support; but without EPO (eg, CKD), iron alone cannot drive secondary polycythemia
  • Lungs: HIF-1α activation → pulmonary vasoconstriction → pulmonary HTN; lungs do NOT produce EPO or participate in erythropoiesis
  • Spleen: Site of RBC destruction (extravascular hemolysis); only participates in erythropoiesis via EMH under extreme stress

5. Buzzword triggers:
  • OSA + obesity + snoring + daytime sleepiness → secondary polycythemia (↑EPO + ↑SaO2 demand)
  • Peritubular fibroblasts (renal cortex) + HIF-1α → EPO → bone marrow → ↑RBCs
  • Secondary polycythemia: ↑Hct + ↑EPO + ↓SaO2 (hypoxic drive)
  • Primary polycythemia (PV): ↑Hct + ↓EPO + normal SaO2 + JAK2 mutation
  • Other causes secondary polycythemia: COPD, high altitude, OSA, CO poisoning, EPO-secreting tumors (RCC/HCC)
  • HIF-1α: O2 present → hydroxylated → VHL targets it for degradation; O2 absent → accumulates → ↑EPO gene transcription
  • VHL mutation → constitutive HIF-1α → ↑EPO → polycythemia (Von Hippel-Lindau disease)

6. Trap / trick tested:
  • Kidney vs liver for EPO: Liver produces EPO in fetus; adult = kidney is primary EPO source; liver contribution minor in adults
  • CKD trap: CKD = chronic hypoxemia possible BUT peritubular fibrosis → can't make EPO → anemia (not polycythemia); demonstrates kidneys are essential, not just oxygen level alone
  • OSA polycythemia vs PV: Both ↑Hct — EPO level is pivot: ↑EPO = secondary (OSA); ↓EPO = primary (PV); also OSA has no ↑WBC/↑platelets
  • HTN in OSA: from repeated sympathetic surges during apneic episodes; not from polycythemia alone

7. One-liner memory hook:
"OSA → hypoxia → kidney HIF-1α wakes up → EPO floods marrow → RBCs multiply → Hct climbs; kidney senses O2, liver moves iron, marrow makes cells — kidney is the BOSS of EPO."

A 10-year-old boy comes to the office for a first visit.  His family recently came to the United States as political refugees.  The patient's mother says that he has required several blood product transfusions due to anemia, but she does not have prior records available with her.  On examination, the patient's temperature is 37.1 C (98.8 F).  BMI is 21 kg/m2.  Examination is notable for conjunctival pallor and moderate splenomegaly.  Laboratory results are as follows: Hemoglobin 9.4 g/dL Platelets 240,000/mm3 Enzyme assays performed on circulating blood cells demonstrate low pyruvate kinase activity.  Which of the following is the most likely cause of this patient's splenomegaly? Pyruvate kinase is a glycolytic pathway enzyme that converts phosphoenolpyruvate to pyruvate, resulting in the generation of a molecule of ATP.  Allosteric stimulation of pyruvate kinase (by fructose 1,6-bisphosphate) stimulates glycolysis.  Mature red blood cells (RBCs), which do not contain mitochondria, rely on lactate as the main metabolite for glycolysis. Most of the ATP produced is used for transport of cations against a concentration gradient in the RBC membrane.  Therefore, pyruvate kinase deficiency, which results in insufficient ATP production, disrupts this gradient, leading to water and potassium loss, defective maintenance of membrane architecture (echinocyte formation), and hemolysis.  As reticuloendothelial cells in the splenic red pulp are involved in removal of damaged RBCs, their increased activity in the setting of pyruvate kinase deficiency causes them to undergo hyperplasia, resulting in splenomegaly. (Choice A)  The spleen is important in fighting infectious pathogens in the body; therefore, many acute and chronic infections lead to enlargement of the spleen due to proliferation of lymphoid tissue. (Choice B)  Disorders such as leukemia and lymphoma result in splenomegaly from neoplastic proliferation of lymphoid tissue within the spleen. (Choice C)  Passive congestion of the spleen with blood occurs in the setting of portal hypertension, splenic vein thrombosis, or congestive heart failure.  Resultant splenic sinusoid dilation can lead to splenomegaly. (Choice D)  In infective endocarditis, circulating immune complexes can deposit in the kidneys and the spleen, likely contributing to splenomegaly. (Choice F)  Splenomegaly in the lysosomal storage diseases Niemann-Pick disease and Gaucher disease is due to the accumulation of sphingomyelin and glucocerebrosides, respectively. Educational objective: Pyruvate kinase deficiency causes hemolytic anemia due to failure of glycolysis and resultant failure to generate sufficient ATP to maintain erythrocyte structure.  In this case, splenic hyperplasia results from increased work of the splenic parenchyma, which must remove these deformed erythrocytes from the circulation.

Pyruvate Kinase (PK) Deficiency — Ultra High-Yield USMLE Notes


1. Diagnosis: Pyruvate Kinase Deficiency — glycolytic enzyme defect → ↓ATP → RBC membrane failure → hemolysis → splenomegaly from reticuloendothelial hyperplasia

2. Key clue (1 line): 10-year-old + refugee + recurrent transfusions + anemia + splenomegaly + ↓pyruvate kinase activity on enzyme assay → PK deficiency → splenomegaly = splenic macrophage hyperplasia (↑RBC removal workload)

3. Why correct (≤2 lines): PK deficiency → ↓ATP (glycolysis fails at last step) → RBC can't maintain cation gradients → K⁺/water loss → echinocytes (spiky RBCs) → deformed RBCs trapped + destroyed by splenic macrophages (extravascular hemolysis) → splenic reticuloendothelial hyperplasia → splenomegaly. Splenomegaly here = work hypertrophy of RBC-clearing macrophages, NOT infection/congestion/infiltration.

4. Why others wrong (1 line each):
  • Lymphoid proliferation (infection): Splenomegaly from immune response to pathogens; no infection signs here
  • Neoplastic proliferation (leukemia/lymphoma): Malignant lymphoid cell infiltration; no leukocytosis/lymphadenopathy here
  • Passive congestion (portal HTN/CHF): Sinusoid dilation from backpressure; no liver disease or heart failure here
  • Immune complex deposition (endocarditis): Circulating immune complexes; no fever/murmur/embolic findings
  • Lysosomal storage (Gaucher/Niemann-Pick): Sphingomyelin/glucocerebroside accumulation in macrophages; no enzyme deficiency of this type here

5. Buzzword triggers:
  • ↓Pyruvate kinase activity + hemolytic anemia → PK deficiency
  • PK deficiency: autosomal recessive + affects RBCs (no mitochondria → purely glycolysis-dependent)
  • PK catalyzes: phosphoenolpyruvate → pyruvate (last glycolytic step, generates ATP)
  • PK deficiency → ↓ATP → ↑2,3-BPG (actually ↑2,3-DPG accumulates) → right-shifts O₂-Hgb curve → better O₂ delivery (partial compensation)
  • RBC smear: echinocytes (spiky, burr cells) in PK deficiency
  • PK deficiency vs G6PD: PK = chronic hemolysis + AR; G6PD = episodic + X-linked + oxidative trigger + Heinz bodies
  • Splenomegaly mechanisms: CHILE → Congestion + Hyperplasia (work) + Infiltration + Lymphoid proliferation + Extra-medullary hematopoiesis

6. Trap / trick tested:
  • PK deficiency = chronic hemolysis (NOT episodic like G6PD); no oxidative trigger needed; constant RBC destruction
  • ↑2,3-DPG in PK deficiency partially compensates by improving O₂ offloading to tissues — patients often tolerate surprisingly low Hgb
  • Splenomegaly cause must match mechanism: this question tests WHY spleen enlarges — answer is hyperplasia of RBC-clearing macrophages (work hypertrophy), not congestion or neoplasm
  • Echinocytes ≠ schistocytes ≠ spherocytes — echinocytes = evenly spiky (ATP loss); schistocytes = fragmented (shear); spherocytes = round no pallor (membrane loss)

7. One-liner memory hook:
"PK gone → no ATP → RBC spikes (echinocyte) → spleen works overtime eating them → macrophages hypertrophy → spleen enlarges; chronic hemolysis, no trigger needed, autosomal recessive — opposite of episodic G6PD."

A 12-year-old girl is brought to the emergency department due to several days of worsening exertional dyspnea and lethargy.  The patient has a history of sickle cell disease and takes hydroxyurea.  Physical examination shows mucosal pallor and a systolic ejection murmur.  Laboratory studies reveal a hemoglobin level of 5.6 g/dL.  Bone marrow biopsy is performed and demonstrates decreased erythroid precursors and giant pronormoblasts containing inclusions, as shown below. this patient's symptomatic anemia (lethargy, exertional dyspnea, mucosal pallor, ejection murmur) and bone marrow biopsy showing decreased erythropoiesis (reduced erythrocyte precursors) raise suspicion for transient aplastic crisis due to acute parvovirus B19 infection. Parvovirus is a small, nonenveloped, DNA virus transmitted via the respiratory route that primarily attacks erythroid progenitor cells due to tropism for an erythrocyte cell surface receptor (P blood group antigen).  Infection of erythroid progenitor cells prevents red blood cell maturation, leading to formation of abnormal giant pronormoblasts (several times larger than surrounding red blood cells) with glassy, intranuclear viral inclusions.  The drop in red cell production often leads to a transient (1-2 week) drop in hematocrit.  Although many patients are asymptomatic, individuals with underlying hemoglobin disorders (eg, sickle cell anemia) sometimes develop symptomatic anemia. (Choice B)  Folate deficiency can be seen in patients with sickle cell disease due to increased erythropoiesis in response to chronic anemia.  However, folate deficiency is characterized by macrocytic anemia and hypersegmented neutrophils; giant pronormoblasts with inclusions would not be seen. (Choice C)  Hydroxyurea can sometimes interfere with normal erythropoiesis and result in macrocytic anemia.  However, it is not associated with giant pronormoblasts with intranuclear inclusions. (Choice D)  Patients with sickle cell disease who require repeated blood transfusion can sometimes develop secondary iron overload.  Bone marrow biopsy would show increased iron stores. (Choice E)  Exposure to toxic chemicals (eg, industrial solvents/chemicals, insecticides) can lead to aplastic anemia.  However, bone marrow biopsy would show hypocellular marrow with a decrease in all cell types; the remaining hematopoietic cells would be morphologically normal. Educational objective: Parvovirus B19 infection can cause transient aplastic crisis, particularly in those with underlying hemoglobin disorders such as sickle cell anemia.  Patients develop symptomatic anemia (eg, exertional dyspnea, fatigue, low hematocrit) due to inhibition of erythropoiesis by the virus.  Bone marrow examination will show giant pronormoblasts with glassy, intranuclear viral inclusions.

Parvovirus B19 — Transient Aplastic Crisis — Ultra High-Yield USMLE Notes


1. Diagnosis: Parvovirus B19 → Transient Aplastic Crisis in Sickle Cell Disease — giant pronormoblasts + intranuclear inclusions on bone marrow biopsy

2. Key clue (1 line): SCD patient + hydroxyurea + sudden severe anemia (Hgb 5.6) + dyspnea/lethargy + marrow = ↓erythroid precursors + giant pronormoblasts with glassy intranuclear inclusions → Parvovirus B19

3. Why correct (≤2 lines): Parvovirus B19 (small DNA virus) → tropism for P blood group antigen on erythroid progenitors → infects + destroys RBC precursors → giant pronormoblasts (viral cytopathic effect) with intranuclear inclusions → transient 1–2 week cessation of erythropoiesis → ↓↓retics + severe anemia in patients dependent on rapid RBC turnover (SCD, HS, thalassemia). Healthy individuals tolerate brief RBC production stop; SCD patients cannot → aplastic crisis.

4. Why others wrong (1 line each):
  • Folate deficiency (SCD): Macrocytic anemia + hypersegmented neutrophils; no giant pronormoblasts or intranuclear viral inclusions
  • Hydroxyurea effect: Can cause macrocytosis; does NOT produce giant pronormoblasts with intranuclear inclusions
  • Iron overload (transfusions): Marrow shows ↑iron stores (hemosiderin); not ↓erythroid precursors or viral inclusions
  • Toxic aplastic anemia (chemicals): Hypocellular marrow with ↓ALL cell lines (pancytopenia); remaining cells morphologically normal — no giant pronormoblasts

5. Buzzword triggers:
  • Giant pronormoblasts + glassy intranuclear inclusionsParvovirus B19 (pathognomonic)
  • Parvovirus B19 receptor = P blood group antigen (globoside) on erythroid progenitors
  • SCD/HS/thalassemia + sudden severe anemia + ↓↓reticsaplastic crisis (Parvo B19)
  • Parvovirus B19 manifestations by host:
    • Healthy children → Erythema infectiosum ("fifth disease," slapped-cheek rash)
    • Hemolytic anemia patients (SCD/HS) → aplastic crisis (↓↓retics)
    • Immunocompromisedpure red cell aplasia (chronic, persistent)
    • Pregnant womenhydrops fetalis (fetal anemia → heart failure)
  • Aplastic crisis vs hemolytic crisis in SCD: ↓retics = aplastic (Parvo); ↑retics = hemolytic (viral URI)
  • Parvovirus B19 = respiratory transmission; small nonenveloped DNA virus

6. Trap / trick tested:
  • Hydroxyurea distractor: Listed as current medication → students may blame drug; hydroxyurea causes macrocytosis NOT viral inclusions/giant pronormoblasts
  • Aplastic crisis ≠ aplastic anemia: Aplastic crisis = transient (1–2 weeks), single cell line (RBC), caused by Parvo B19; aplastic anemia = pancytopenia, persistent, T-cell mediated HSC destruction
  • ↓Retics in SCD = emergency — SCD baseline = ↑retics (compensating for chronic hemolysis); sudden ↓retics = production crisis = Parvo B19 until proven otherwise
  • Marrow shows ↓erythroid precursors (being destroyed) + giant pronormoblasts (the few remaining are virally infected/abnormal)

7. One-liner memory hook:
"Parvo B19 attacks P-antigen on RBC precursors → giant pronormoblasts (viral footprint) + retics crash → SCD patient can't compensate → aplastic crisis; healthy kid gets slapped cheek, SCD patient gets emergency transfusion."

A 12-year-old boy is brought to the emergency room due to high fever, chest pains, and dyspnea.  Medical history is significant for 2 prior hospitalizations for abdominal pain that resolved with analgesics and hydration.  Evaluation today shows a hematocrit of 23% and reticulocyte count of 9%.  Several hours after being admitted to the hospital, the patient dies.  At autopsy, the spleen is small and firm.  This patient's autopsy finding is most likely related to which of the following Sickle cell disease Pathophysiology β-globin mutation (Glu → Val) → HbS Deoxygenation → HbS polymerization → sickled RBCs → hemolysis & vasoocclusion Clinical features Hemolysis Chronic hemolytic anemia Aplastic crisis* Vasoocclusion Pain Acute chest syndrome† Stroke Avascular necrosis Splenic sequestration crisis‡ (early childhood), autosplenectomy Infection (eg, osteomyelitis) Laboratory findings ↓ Hematocrit ↑ Reticulocyte count Peripheral smear: sickled RBCs Hemoglobin electrophoresis: ↑ HbS, ↓ HbA  *Aplastic crisis: temporary arrest of erythropoiesis due to infection (eg, parvovirus B19). †Acute chest syndrome: pulmonary infiltrates, fever, chest pain, hypoxemia, and dyspnea due to pulmonary vasoocclusion. ‡Splenic sequestration crisis: worsening anemia with enlarging spleen due to splenic vasoocclusion and RBC pooling. HbA = hemoglobin A; HbS = hemoglobin S; RBCs = red blood cells. This patient's hematologic findings (eg, anemia, reticulocytosis) and medical history (eg, recurrent episodes of abdominal pain that resolved with analgesics and hydration) are suggestive of sickle cell disease (SCD).  SCD is a hemoglobinopathy characterized by sickle hemoglobin (HbS), an abnormal hemoglobin that can polymerize in deoxygenated conditions.  HbS polymerization leads to sickle-shaped erythrocytes that can occlude small vessels.  This patient's most recent presentation (eg, fever, chest pain, dyspnea) was most likely due to small-vessel occlusion localized to the pulmonary vasculature (ie, acute chest syndrome). Vascular occlusion can also cause splenic infarctions.  Repeated infarctions produce a shrunken, fibrotic spleen.  By adulthood, most patients with SCD have undergone autosplenectomy and have a small, scarred splenic remnant.  As a result, these patients have functional asplenia and are susceptible to infection with encapsulated organisms (eg, Streptococcus pneumoniae). (Choice A)  Extramedullary hematopoiesis (EMH) can develop in patients with hemolytic anemias (eg, beta-thalassemia, SCD) or myeloproliferative neoplasms (eg, primary myelofibrosis) and typically occurs in the liver and spleen.  Splenic EMH would result in splenomegaly, not splenic atrophy. (Choice B)  Splenic follicular hyperplasia can be seen with systemic infections and can result in an enlarged, not small and firm, spleen. (Choice C)  Intrasplenic lipid accumulation may occur in lysosomal storage disorders such as Gaucher disease.  Although such patients can have bone pain and anemia, they typically have splenomegaly. (Choice D)  Pressure atrophy of the splenic parenchyma can be seen when a lesion (eg, a cyst) compresses the spleen, which would likely have been detected during autopsy. Educational objective: In patients with sickle cell disease, repetitive splenic infarctions caused by microvessel occlusion result in a small, firm splenic remnant (ie, autosplenectomy).

Sickle Cell Disease — Autosplenectomy & Acute Chest Syndrome — Ultra High-Yield USMLE Notes


1. Diagnosis: Sickle Cell Disease (HbSS) — Autosplenectomy (small/firm spleen at autopsy) from repeated splenic infarctions; death from Acute Chest Syndrome

2. Key clue (1 line): 12-year-old + recurrent abdominal pain crises + Hct 23% + retics 9% + fever + chest pain + dyspnea → SCD + acute chest syndrome → autopsy = small, firm spleen = autosplenectomy

3. Why correct (≤2 lines): HbS polymerizes when deoxygenated → sickled RBCs occlude splenic microvasculature repeatedly → progressive infarction → fibrosis + scarring → small, firm splenic remnant (autosplenectomy) by adolescence. Functional asplenia → unable to clear encapsulated bacteria → overwhelming sepsis; acute presentation = acute chest syndrome (pulmonary vasoocclusion → fever + chest pain + dyspnea + ↓O₂).

4. Why others wrong (1 line each):
  • Extramedullary hematopoiesis: HSCs colonize spleen → splenomegaly (enlarged); opposite of small/firm
  • Follicular hyperplasia (infection): Immune response → enlarged spleen; not small/atrophic
  • Lipid accumulation (Gaucher disease): Glucocerebrosides in macrophages → splenomegaly + bone pain; not SCD
  • Pressure atrophy (cyst): External compression → would be detected at autopsy as discrete lesion; no cyst history

5. Buzzword triggers:
  • Small + firm spleen at autopsy → autosplenectomy = SCD
  • SCD + fever + chest pain + dyspnea + pulmonary infiltrate → Acute Chest Syndrome (#1 cause of death in SCD)
  • SCD spleen timeline: infant = sequestration crisis (enlarged, congested) → adolescent/adult = autosplenectomy (small, fibrotic)
  • Autosplenectomy → encapsulated bacteria susceptibility: S. pneumoniae, H. influenzae, N. meningitidis, Salmonella
  • SCD complications mnemonic "HASCHIP": Hemolysis + Acute chest syndrome + Stroke + Chronic organ damage + Hemarthrosis/avascular necrosis + Infection (encapsulated) + Pain crisis (vaso-occlusive)
  • SCD osteomyelitis: Salmonella (most common) vs general population = Staph aureus
  • Acute chest syndrome treatment: O₂ + hydration + analgesics + exchange transfusion (severe) + antibiotics

6. Trap / trick tested:
  • Age of spleen findings matters: 12-year-old dying of SCD → spleen should be small/firm (autosplenectomy complete); younger child (infant/toddler) → sequestration crisis = enlarged spleen
  • Abdominal pain + analgesics/hydration resolution = prior vaso-occlusive crises (not surgical abdomen); establishes SCD diagnosis before the acute chest presentation
  • Retics 9% = hemolytic pattern (marrow compensating) → NOT aplastic crisis (which would show ↓↓retics); confirms ongoing hemolysis not Parvo B19
  • Acute chest syndrome can be triggered by: infection, fat embolism from infarcted bone marrow, pulmonary vasoocclusion — all cause same presentation

7. One-liner memory hook:
"SCD sickles clog the spleen repeatedly → spleen scars into a shriveled raisin (autosplenectomy) → encapsulated bugs take over → Pneumococcus kills; meanwhile lungs clog too → Acute Chest Syndrome = #1 killer in SCD."

A 23-year-old man comes to the emergency department due to 4 days of cramping abdominal pain.  He has been feeling weak for the past 2 weeks.  The patient tried over-the-counter antacids without relief.  He is an industrial laborer with no significant medical history or known allergies.  The patient lives in Massachusetts.  The patient's parents have hypertension, and his siblings are healthy.  Temperature is 37.1 C (98.8 F).  Physical examination is unremarkable.  The patient's peripheral blood smear is shown in the image below: This patient likely has lead poisoning.  Lead poisoning (ie, plumbism) is often a pediatric condition that results from children ingesting lead-containing paint chips.  However, lead poisoning can also occur in adults.  Affected individuals are usually miners or industrial workers (especially those in battery manufacturing) who inhale particulate lead while working. Adults with lead poisoning experience weakness, abdominal pain, and constipation.  In severe cases, there may be neurologic manifestations (eg, headache, cognitive symptoms, peripheral neuropathy).  On physical examination, patients may have blue "lead lines" at the junction of the teeth and gingivae. The classic findings on peripheral blood smear are coarse basophilic stippling and hypochromic, microcytic anemia.  Basophilic stippling results from impaired degradation of ribosomal RNA, which is normally degraded and eliminated during reticulocyte maturation.  Lead inhibits an enzyme involved in this process, resulting in ribosomal precipitates that appear as dark blue-purple granules throughout red blood cells (RBCs).  Hypochromic microcytic anemia results from inhibition of delta-aminolevulinate dehydratase (delta-ALA dehydratase) and ferrochelatase, which are involved in heme synthesis.  This causes decreased hemoglobin synthesis, which gives the RBCs a pale appearance. (Choice A)  Acute intermittent porphyria is characterized by reduced activity of porphobilinogen deaminase (an enzyme in the heme synthesis pathway) in the liver, causing buildup of neurotoxic heme pathway intermediates.  It can cause attacks of abdominal pain (without abdominal tenderness) due to autonomic neuropathy.  Erythropoiesis is not affected, and the peripheral blood smear is normal. (Choice B)  Myeloblasts containing cytoplasmic Auer rods on peripheral blood smear are a characteristic finding of acute myeloid leukemia, which typically presents with complications of pancytopenia (eg, bruising from thrombocytopenia, infection from neutropenia). (Choice C)  Autoimmune destruction of gastric parietal cells causes atrophic gastritis, which can lead to pernicious anemia (a type of megaloblastic anemia) due to vitamin B12 malabsorption.  Megaloblastic anemia is characterized by hypersegmented neutrophils and macro-ovalocytes (large, oval RBCs). (Choice E)  Babesiosis is endemic in the northeastern United States and commonly presents with fever, fatigue, and myalgia.  Although it can be detected in a peripheral blood smear, Babesia typically appears as a ring or tetrad form (ie, Maltese cross) within RBCs. (Choice F)  Patients with splenic dysfunction (eg, functional asplenia, splenectomy) may have Howell-Jolly bodies (nuclear remnants normally removed by the spleen), which typically appear as solitary, dark blue-purple inclusions at the periphery of RBCs. Educational objective: Coarse basophilic stippling (dark blue-purple granules throughout red blood cells) and hypochromic, microcytic anemia are common peripheral blood smear findings in lead poisoning.  High-risk groups include young children ingesting paint chips and industrial workers inhaling particulate lead.

Lead Poisoning (Plumbism) — Ultra High-Yield USMLE Notes


1. Diagnosis: Lead Poisoning — industrial worker + coarse basophilic stippling + hypochromic microcytic anemia + abdominal pain/weakness

2. Key clue (1 line): 23M + industrial laborer + abdominal cramping + weakness + coarse basophilic stippling on smear + microcytic/hypochromic anemia → lead poisoning

3. Why correct (≤2 lines): Lead inhibits δ-ALA dehydratase + ferrochelatase → blocks heme synthesis → microcytic/hypochromic anemia; also inhibits RBC pyrimidine 5'-nucleotidase → ribosomal RNA not degraded → precipitates as coarse basophilic stippling (dark blue-purple granules throughout RBCs). Adults: industrial inhalation (battery workers, miners); children: paint chip ingestion.

4. Why others wrong (1 line each):
  • Acute intermittent porphyria: ↓porphobilinogen deaminase → abdominal pain (autonomic neuropathy) + neuropsychiatric symptoms; smear normal (erythropoiesis unaffected)
  • Auer rods (AML): Myeloblasts with cytoplasmic rods → AML; pancytopenia + bruising/infection; not microcytic anemia
  • Hypersegmented neutrophils + macro-ovalocytes (pernicious anemia): B12 deficiency/atrophic gastritis → megaloblastic; macrocytic not microcytic; no basophilic stippling
  • Babesia (Maltese cross): Endemic NE USA + fever/fatigue; ring or tetrad forms inside RBCs ("Maltese cross"); not stippling
  • Howell-Jolly bodies (asplenia): Solitary dark blue-purple nuclear remnant at RBC periphery; seen post-splenectomy; not diffuse stippling throughout cell

5. Buzzword triggers:
  • Coarse basophilic stipplinglead poisoning (also thalassemia but coarser in lead)
  • Industrial worker + abdominal pain + weakness → lead poisoning
  • Lead inhibits: δ-ALA dehydratase (early heme) + ferrochelatase (final step, Fe insertion into protoporphyrin)
  • Lead poisoning labs: ↑urine δ-ALA + ↑urine coproporphyrin + ↑blood lead level + ↑free erythrocyte protoporphyrin (FEP)
  • Blue "lead lines" at gum-tooth junction (Burton lines) = pathognomonic adult finding
  • Lead poisoning treatment: EDTA (severe) or dimercaprol or succimer (oral, children)
  • Lead inhibits pyrimidine 5'-nucleotidase → rRNA not cleared → basophilic stippling
  • Basophilic stippling also in: thalassemia, sideroblastic anemia (but coarse + clinical context = lead)

6. Trap / trick tested:
  • Basophilic stippling ≠ Howell-Jolly bodies: Stippling = diffuse blue granules throughout cell (rRNA) = lead/thalassemia; Howell-Jolly = single peripheral dark inclusion (nuclear remnant) = asplenia
  • Babesia location: NE USA + industrial worker → students may confuse geographic clue; Babesia = fever + ring/Maltese cross; lead = no fever + stippling + occupation
  • Two enzyme targets of lead: δ-ALA dehydratase (early) + ferrochelatase (late) — both block heme synthesis; remember lead "bookends" the heme pathway
  • Microcytic anemia in lead poisoning can mimic IDA — differentiate by basophilic stippling + occupation + ↑FEP + normal ferritin

7. One-liner memory hook:
"Lead blocks heme (δ-ALA + ferrochelatase) → pale small RBCs; blocks RNA cleanup → rRNA clumps = coarse basophilic stippling; industrial worker + gut pain + blue gum lines + stippling = LEAD."

A 37-year-old man comes to the emergency department due to blood-tinged vomiting and abdominal discomfort.  Six months ago, he lost his job as an investment banker and began drinking large amounts of whiskey on a daily basis.  He has since been hospitalized several times with alcohol intoxication.  His temperature is 36.7 C (98 F), blood pressure is 110/70 mm Hg, pulse is 84/min, and respirations are 18/min.  Physical examination shows a firm, enlarged liver.  Peripheral blood smear results show neutrophils with 6-8 nuclear lobes.  Which of the following is the most likely explanation for this patient's abnormal hematologic findings? lcohol use disorder is one of the most common causes of folate deficiency anemia due to poor dietary intake and impaired folate absorption, utilization, and enterohepatic recycling.  A normal individual with a folate-deficient diet can maintain normal red blood cell (RBC) production for months due to folate recycling, whereas a patient who consumes large amounts of alcohol will experience anemia within a few weeks. A reduced form of folic acid, tetrahydrofolic acid, is necessary for the synthesis of amino acids, thymidine, and purines.  Impaired nucleotide synthesis leads to defective DNA production in blood cell precursors, resulting in abnormal cell division and megaloblastic hyperplasia of the bone marrow.  The peripheral blood smear shows pancytopenia and hypersegmented neutrophils containing nuclei with >5 lobes.  RBC abnormalities include ovalocytosis and macrocytosis, with a mean corpuscular volume (MCV) >100 µm3. (Choice A)  Lipid abnormalities such as extreme hypertriglyceridemia can cause acute pancreatitis. (Choice B)  Chronic blood loss causes iron deficiency anemia, which is not characterized by hypersegmented neutrophils. (Choice C)  Chronic alcohol use can deplete vitamin B12 levels; however, depletion would take place over a period of years, not weeks (in contrast to folate deficiency).  In addition, this patient does not have any of the classic neurologic symptoms that accompany B12 deficiency (eg, subacute combined degeneration). (Choice E)  Myelodysplasia is a premalignant condition that manifests with pancytopenia, impaired blood cell differentiation, and clonal expansion of mutated hematopoietic cells in the bone marrow.  Elevated MCV can be present, but hypersegmented neutrophils are not commonly seen. Educational objective: Folic acid deficiency anemia commonly occurs in alcoholism.  It is a megaloblastic anemia that can develop within weeks.  Peripheral blood smear shows macrocytosis, ovalocytosis, and neutrophils with hypersegmented nuclei.

Folate Deficiency Anemia (Alcoholism) — Ultra High-Yield USMLE Notes


1. Diagnosis: Folate Deficiency → Megaloblastic Anemia — secondary to chronic alcohol use (↓intake + ↓absorption + ↓enterohepatic recycling)

2. Key clue (1 line): 37M + heavy daily alcohol x6 months + enlarged liver + hypersegmented neutrophils (6–8 lobes) + no neuro symptoms → folate deficiency megaloblastic anemia (NOT B12)

3. Why correct (≤2 lines): Alcohol → ↓folate intake + ↓absorption + ↓enterohepatic recycling → folate depleted within weeks → ↓tetrahydrofolate → impaired thymidine/purine synthesis → defective DNA → megaloblastic marrow → ↑MCV + macro-ovalocytes + hypersegmented neutrophils. No neurologic symptoms (subacute combined degeneration absent) → distinguishes folate from B12 deficiency.

4. Why others wrong (1 line each):
  • Hypertriglyceridemia: Causes acute pancreatitis; no hematologic/neutrophil abnormalities
  • Chronic blood loss (IDA): Microcytic/hypochromic anemia + ↓ferritin; no hypersegmented neutrophils
  • B12 deficiency (alcohol): Takes years to deplete (large hepatic stores); this patient = 6 months; also B12 → subacute combined degeneration (posterior/lateral columns) — absent here
  • Myelodysplasia: Pancytopenia + clonal marrow expansion; ↑MCV possible but hypersegmented neutrophils not typical; premalignant condition

5. Buzzword triggers:
  • Alcoholism + hypersegmented neutrophilsfolate deficiency (weeks to deplete)
  • Hypersegmented neutrophils (≥1 with >5 lobes OR ≥5% with ≥5 lobes) → megaloblastic anemia
  • Folate deficiency: ↓THF → ↓thymidine + ↓purines → ↓DNA synthesis → megaloblasts
  • Folate depletes in weeks; B12 depletes in years (hepatic stores last 3–5 years)
  • Folate deficiency causes: alcoholism + malnutrition + pregnancy (↑demand) + MTX/trimethoprim/phenytoin (DHFR inhibitors)
  • B12 deficiency causes: pernicious anemia + veganism + gastrectomy + terminal ileum resection + fish tapeworm
  • Folate vs B12: Both → identical CBC/smear findings; only B12 → subacute combined degeneration (posterior + lateral columns)
  • Folate food sources: green leafy vegetables (destroyed by cooking); B12: animal products only

6. Trap / trick tested:
  • B12 vs folate trap: Both cause identical megaloblastic picture — differentiate by: (1) timeline (weeks = folate; years = B12) and (2) neurology (present = B12; absent = folate)
  • Alcohol + B12: Students assume alcohol depletes B12; alcohol mainly depletes folate rapidly; B12 stores are too large to deplete in months
  • Myelodysplasia trap: Also has ↑MCV + pancytopenia; but MDS = clonal + dysplastic cells + no hypersegmented neutrophils + not caused by alcohol nutritional deficiency
  • Never treat suspected megaloblastic anemia with folate alone without ruling out B12 — folate corrects CBC but worsens B12 neurologic damage

7. One-liner memory hook:
"Alcohol drains folate in weeks (not B12 — that takes years) → no THF → DNA synthesis fails → big cells + hyperseg neutrophils; no neuro = folate not B12; treat folate, but rule out B12 first or the spine pays."

A 32-year-old man comes to the office due to progressive fatigue, easy bruising, and recurring episodes of gum bleeding.  Physical examination shows several ecchymoses in his lower extremities.  Laboratory studies are as follows: Complete blood count     Hemoglobin 7.8 g/dL     Platelets 65,000/mm3     Leukocytes 3,000/mm3 Coagulation studies     Prothrombin time 22 sec     Activated partial thromboplastin time 53 sec     Plasma fibrinogen 134 mg/dL (normal: 200-400 mg/dL)     D-dimer 4.1 µg/dL (normal: <0.5 µg/dL) Bone marrow biopsy is performed and fluorescence in situ hybridization studies reveal a balanced translocation between the long arms of chromosomes 15 and 17.  Which of the following proteins is most likely to be abnormal in the hematopoietic cells of this patient? cute myelogenous leukemia (AML), characterized by failure of immature myeloid precursors (myeloblasts) to differentiate into mature granulocytes, is divided into 8 types (M0 through M7).  Acute promyelocytic leukemia (APML), the M3 variant of AML, is associated with the t(15;17) cytogenetic translocation involving the promyelocytic leukemia (PML) gene on chromosome 15 and the retinoic acid receptor alpha (RARA) gene on chromosome 17.  Fusion of these 2 genes produces PML/RARA, a chimeric gene (illustrated in this fluorescence in situ hybridization image) that codes for an abnormal retinoic acid receptor, which then inhibits myeloblast differentiation.  Abnormal promyelocytes and Auer rods are seen on the smear. The clinical manifestations of AML, including anemia (fatigue, pallor), thrombocytopenia (petechiae, hemorrhages), and neutropenia (fever, opportunistic infections), result from marrow replacement by leukemic cells.  As seen in this patient, APML is associated with disseminated intravascular coagulation (DIC), which is characterized by activation of the coagulation cascade.  Laboratory findings seen in DIC include thrombocytopenia, elevated D-dimer due to fibrinolysis, and prolonged coagulation profile times (eg, prothrombin time, activated partial thromboplastin time) and low fibrinogen due to consumption. All-trans retinoic acid is used for treatment of APML. (Choice A)  Mutations in the genes that code for the epidermal growth factor receptors are associated with certain lung (ERBB1), breast (ERBB2, also known as HER2/neu), ovarian, and gastric tumors. (Choice B)  GTP-binding proteins are involved in cellular signal transduction. (Choice C)  A defective platelet-derived growth factor receptor plays a role in the pathogenesis of several cancers, including ovarian cancers. (Choice D)  An abnormal RB gene predisposes to development of retinoblastoma and osteosarcoma. Educational objective: The cytogenetic defect t(15;17) is associated with acute promyelocytic leukemia (APML).  A translocation involving the retinoic acid receptor alpha (RARA) gene from chromosome 17 and the promyelocytic leukemia (PML) gene on chromosome 15 leads to the formation of PML/RARA, a fusion gene whose product inhibits differentiation of myeloblasts and triggers the development of APML.

Acute Promyelocytic Leukemia (APML/AML-M3) — Ultra High-Yield USMLE Notes


1. Diagnosis: Acute Promyelocytic Leukemia (APML, AML-M3) — t(15;17) → PML-RARA fusion → abnormal retinoic acid receptor → differentiation block + DIC

2. Key clue (1 line): 32M + fatigue + bruising + gum bleeding + pancytopenia + ↑PT/↑aPTT + ↓fibrinogen + ↑D-dimer (DIC) + t(15;17) on FISH → APML → abnormal protein = retinoic acid receptor (RARA)

3. Why correct (≤2 lines): t(15;17) fuses PML gene (chr 15) + RARA gene (chr 17) → PML-RARA chimeric protein → abnormal retinoic acid receptor → blocks promyelocyte differentiation → accumulation of abnormal promyelocytes → marrow replacement (pancytopenia) + DIC (promyelocyte granules activate coagulation cascade). Treatment: All-trans retinoic acid (ATRA) → overcomes differentiation block → promyelocytes mature.

4. Why others wrong (1 line each):
  • EGF receptor (ERBB1/ERBB2): Lung (ERBB1/EGFR) + breast/gastric (HER2/ERBB2) cancers; not hematologic malignancy
  • GTP-binding protein (RAS): Signal transduction mutations in various cancers; not the APML-specific translocation product
  • PDGF receptor: Ovarian/other solid tumors; not t(15;17) leukemia
  • RB gene (retinoblastoma protein): Tumor suppressor; retinoblastoma + osteosarcoma; not myeloid leukemia

5. Buzzword triggers:
  • t(15;17)APML (AML-M3); PML-RARA fusion → abnormal retinoic acid receptor
  • APML + DIC → classic association (↑PT/aPTT + ↓fibrinogen + ↑D-dimer + ↓platelets)
  • Auer rods (pink cytoplasmic rods) on smear → AML (especially APML — "faggot cells" = bundles of Auer rods)
  • APML treatment: ATRA (all-trans retinoic acid) ± arsenic trioxide → induces differentiation
  • AML translocations summary:
    • t(15;17) → APML (M3) → ATRA treats
    • t(8;21) → AML-M2 → good prognosis
    • t(16;16) or inv(16) → AML-M4Eo → good prognosis
    • t(9;22) → CML (BCR-ABL) → imatinib treats
  • DIC labs: ↓platelets + ↑PT + ↑aPTT + ↓fibrinogen + ↑D-dimer + ↑fibrin split products
  • ATRA mechanism: pharmacologic doses of retinoic acid overcome PML-RARA block → differentiation resumes → promyelocytes mature → DIC resolves

6. Trap / trick tested:
  • DIC in leukemia = APML until proven otherwise — promyelocyte granules are highly thrombogenic; DIC + AML = t(15;17) on exam
  • RARA is a nuclear receptor (transcription factor) — not a growth factor receptor (EGF/PDGF) or kinase; question asks protein TYPE → answer = nuclear transcription factor/retinoic acid receptor
  • ATRA is vitamin A derivative — not chemotherapy; it induces differentiation not cell killing; unique mechanism in oncology
  • Faggot cells (bundles of Auer rods in single cell) = pathognomonic for APML specifically

7. One-liner memory hook:
"t(15;17) = PML meets RARA → fusion receptor blocks differentiation → promyelocytes pile up + release granules → DIC; ATRA unlocks the block → cells mature → DIC resolves; Auer rod bundles (faggot cells) = APML stamp."

A 34-year-old man with an unremarkable past medical history is evaluated for an enlarged lymph node in his anterior cervical chain that measures 4 cm in diameter.  The patient first felt the lymph node several weeks ago and states that it has been steadily increasing in size.  He is concerned about whether or not he “has cancer.”  The patient is referred to a specialist for surgical removal of the enlarged node.  Biopsy reveals abnormal lymph node architecture and numerous lymphocytes.  Which of the following, if present, would be most consistent with malignancy in this patient? ymphadenopathy can represent inflammatory changes within the lymph node (reactive hyperplasia) or malignant transformation.  Reactive hyperplasia is a broad term that encompasses all benign, reversible enlargement of the lymphoid tissue secondary to an antigenic stimulus.  The nodal response to antigenic stimuli is highly variable and can be classified as follicular hyperplasia, sinus hyperplasia, or diffuse hyperplasia.  Follicular hyperplasia occurs when the follicles increase in size and number, whereas sinus hyperplasia occurs when the sinuses enlarge and fill with histiocytes.  Diffuse hyperplasia is observed when the nodal architecture is diffusely effaced by sheets of lymphocytes, immunoblasts, and macrophages.  When malignant transformation occurs (as in lymphomas), the normal lymph node architecture is distorted or effaced by the proliferation of malignant lymphoid cells, often to a greater extent than that seen with reactive hyperplasia.  Malignancy-associated effacement of nodal architecture may be follicular or diffuse. Reactive lymphoid hyperplasia is polyclonal in that it consists of a proliferation of many different cell types within the lymph node.  For each type of lymphocyte responding to an antigenic stimulus, multiple genetically-distinct cells of that variety undergo limited monoclonal expansion, leading to an overall polyclonal response.  Malignant transformation, in contrast, is monoclonal in that it results from the unchecked proliferation of a single genetically unique cell from only one cell line. Evaluation for monoclonality of the lymphocyte population is important when lymphoma is suspected.  The clonality of a T-cell population is assessed by molecular methods, such as PCR, that examine the rearrangement of T-cell receptor (TCR) genes.  If a single allele for the V region of the T-cell receptor predominates in a lymphocytic population, monoclonal proliferation is suspected.  The same principle applies when assessing B-cell clonality.  Monoclonal rearrangement of the genes for immunoglobulin variable regions is suggestive of a B-cell lymphoma.  Of the choices given, monoclonal TCR gene rearrangement is most indicative of malignant processes, especially in the context of appropriate clinical features (i.e., weight loss, night sweats, fever, anorexia). (Choices A, B, & C)  Pleomorphism, increased mitoses, and nuclear changes are all commonly seen in the lymphocytes of a reactive hyperplastic lymph node.  These findings do not automatically classify the specimen as malignant. (Choice E)  An admixture of several lymphoid cell types in a lymph node is suggestive of a benign process.  A predominantly monomorphic cell population is indicative of malignancy and is characteristic of non-Hodgkin’s lymphoma.  Hodgkin’s lymphoma does demonstrate an admixture of several lymphoid cell types within the lymph nodes; however, this finding does not distinguish Hodgkin’s lymphoma from reactive hyperplasia.  Additionally, genetic analysis of Reed-Sternberg cells most often reveals monoclonal characteristics. Educational objective: Benign lymph node enlargement in response to antigenic stimulation is associated with a polyclonal proliferation of lymphocytes.  A monoclonal lymphocytic proliferation is strong evidence of malignancy.

Lymphadenopathy — Malignancy vs Reactive — Ultra High-Yield USMLE Notes


1. Diagnosis: Lymph Node Malignancy (Lymphoma) — key feature = monoclonal TCR gene rearrangement (single clone predominates) vs reactive hyperplasia (polyclonal)

2. Key clue (1 line): 34M + enlarging cervical LN + biopsy = distorted architecture + numerous lymphocytes → monoclonal TCR/Ig gene rearrangement = malignancy; polyclonal = reactive/benign

3. Why correct (≤2 lines): Malignancy = unchecked proliferation of single genetically unique cell → monoclonal → all lymphocytes share identical TCR (T-cell) or immunoglobulin variable region (B-cell) gene rearrangement → detected by PCR. Reactive hyperplasia = many clones responding to antigen → polyclonal → diverse TCR/Ig rearrangements → benign.

4. Why others wrong (1 line each):
  • Pleomorphism: Commonly seen in reactive hyperplasia; does NOT distinguish malignant from benign
  • Increased mitoses: Also seen in reactive nodes (actively dividing immune cells); not specific for malignancy
  • Nuclear changes: Seen in both reactive and malignant nodes; not definitive for malignancy alone
  • Admixture of cell types: Suggests benign (polyclonal immune response); monomorphic population = malignant (exception: Hodgkin's lymphoma has mixed cells but Reed-Sternberg cells are still monoclonal)

5. Buzzword triggers:
  • Monoclonal proliferation → malignancy (lymphoma/leukemia)
  • Polyclonal proliferation → reactive/benign (infection, autoimmune)
  • TCR gene rearrangement (PCR) → T-cell lymphoma clonality
  • Ig variable region rearrangement → B-cell lymphoma clonality
  • B-cell clonality also assessed by: single light chain restriction (κ only OR λ only) on flow cytometry → monoclonal B-cell proliferation
  • Lymphoma B symptoms: fever + night sweats + weight loss >10% → poor prognosis
  • Hodgkin lymphoma: Reed-Sternberg cells (owl-eye nuclei) + mixed cellularity → monoclonal despite mixed background
  • Non-Hodgkin lymphoma: predominantly monomorphic cell population

6. Trap / trick tested:
  • Pleomorphism/mitoses/nuclear changes trap: Students associate these with cancer; but all three are seen in reactive hyperplasia (rapidly dividing immune cells are pleomorphic with high mitoses)
  • Admixture of cells trap: Mixed cells suggest benign; but Hodgkin lymphoma also has mixed cellularity — distinguish by finding Reed-Sternberg cells
  • Monoclonality = strongest malignancy indicator — the single most reliable feature; everything else (size, mitoses, necrosis) is suggestive but not definitive
  • Light chain restriction (κ:λ ratio >3:1 or <1:3) = practical flow cytometry marker of B-cell monoclonality

7. One-liner memory hook:
"One clone = cancer; many clones = immune response; PCR finds the single TCR/Ig fingerprint → monoclonal = malignant; pleomorphism/mitoses fool you — only clonality tells the truth."

A 15-month-old boy is brought to the clinic for evaluation of recurrent mouth ulcers.  Over the past 5 months, his mother has noted that he has had periodic episodes of mouth pain and oral ulcers.  She says the episodes usually last for a couple of days and then resolve without intervention.  The boy has no known medical conditions and takes no medications.  Vital signs are normal.  Examination shows mucositis.  The rest of the examination is unremarkable.  Complete blood count (CBC) reveals an absolute neutrophil count of 390/mm3.  Hemoglobin level and platelet count are normal.  Serial CBC results are documented over the next 6 weeks, revealing the pattern shown below: his patient has isolated, severe neutropenia defined by an absolute neutrophil count (ANC) <500/mm3.  It resolves and recurs in a predictable pattern, a finding characteristic of cyclic neutropenia.  Cyclic neutropenia occurs due to a mutation in the gene encoding neutrophil elastase.  This enzyme is normally packaged within neutrophil granules and plays a role in the degradation of virulence factors on bacterial pathogens. Misfolded neutrophil elastase increases endoplasmic reticulum stress, causing a portion of the neutrophil precursors in the bone marrow to undergo apoptosis.  Bone marrow aspirate would show myeloid progenitor cells with features characteristic of apoptosis (eg, nuclear fragmentation, membrane blebbing).  The depressed ANC is thought to transiently upregulate granulocyte colony-stimulating factor (G-CSF), which stimulates neutrophil production from the hematopoietic stem cells that did not undergo apoptosis.  As neutrophil numbers normalize, G-CSF production decreases, allowing neutrophil counts to decline again. Clinical manifestations of cyclic neutropenia correlate with neutrophil nadirs, which typically occur every 3 weeks, and include recurrent episodes of fever, fatigue, and mucositis (eg, gingival ulcers, inflammation) in young children.  Life-threatening infection in cyclic neutropenia is rare due to the brief duration of neutropenic periods, and patients are typically asymptomatic between episodes.  Serial ANC measurements over 6-8 weeks showing predictable oscillations support the diagnosis, and genetic testing is confirmatory. (Choice A)  Increased adipocytes and stroma relative to hematopoietic cells describes aplastic anemia, in which severe, chronic neutropenia can occur but would be accompanied by other cytopenias (eg, anemia, thrombocytopenia). (Choice B)  Hypersegmented neutrophils and megaloblastic erythroid cells are characteristic of vitamin B12 or folate deficiency.  Neutropenia is common but would be persistent.  In addition, a macrocytic anemia would be expected. (Choice C)  Lymphoid cells with eccentrically located round nuclei and pale perinuclear area describes plasma cells seen in multiple myeloma.  Neutropenia can occur due to bone marrow infiltration but would be nonoscillating, and anemia is usually present.  Moreover, this diagnosis is extremely unlikely in patients age <40. (Choice D)  A hypercellular marrow revealing myeloblasts with open chromatin and prominent nucleoli is seen in acute myeloid leukemia.  Persistently low, not oscillating, ANCs are often seen along with anemia and/or thrombocytopenia. Educational objective: Cyclic neutropenia occurs as a result of a mutation in the gene encoding neutrophil elastase.  This leads to accelerated apoptosis of neutrophil precursors with characteristic bone marrow findings of nuclear fragmentation and membrane blebbing.  Cyclic neutropenia is characterized by episodic (every 3 weeks), severe neutropenia that causes recurrent fever and mucositis.

Cyclic Neutropenia — Ultra High-Yield USMLE Notes


1. Diagnosis: Cyclic Neutropenia — neutrophil elastase gene (ELANE) mutation → periodic neutrophil precursor apoptosis → ANC nadir every ~3 weeks

2. Key clue (1 line): 15-month-old boy + recurrent oral ulcers/mucositis every few weeks + isolated severe neutropenia (ANC <500) + normal Hgb + normal platelets + predictable oscillating ANC pattern on serial CBC → cyclic neutropenia

3. Why correct (≤2 lines): ELANE mutation → misfolded neutrophil elastase → ↑ER stress → neutrophil precursor apoptosis (nuclear fragmentation + membrane blebbing on marrow biopsy) → ANC drops → ↑G-CSF (compensatory) → ANC recovers → cycle repeats every ~3 weeks. Episodes brief → life-threatening infection rare; asymptomatic between nadirs.

4. Why others wrong (1 line each):
  • ↑Adipocytes/stroma (aplastic anemia): Chronic persistent pancytopenia (all 3 lines); not isolated oscillating neutropenia
  • Hypersegmented neutrophils + megaloblastic cells (B12/folate): Persistent neutropenia + macrocytic anemia; not episodic/isolated
  • Plasma cells with eccentric nuclei (multiple myeloma): Marrow infiltration → persistent neutropenia + anemia; age <40 extremely unlikely; not oscillating
  • Hypercellular marrow + myeloblasts (AML): Persistent neutropenia + anemia + thrombocytopenia; blasts on smear; never oscillating

5. Buzzword triggers:
  • Recurrent oral ulcers/mucositis + fever every ~3 weeks in child → cyclic neutropenia
  • ELANE mutation → misfolded elastase → ER stress → apoptosis of myeloid precursors
  • Serial CBC over 6–8 weeks showing oscillating ANC → diagnostic of cyclic neutropenia
  • Bone marrow in cyclic neutropenia: nuclear fragmentation + membrane blebbing (apoptotic myeloid precursors)
  • G-CSF (filgrastim) = treatment for cyclic neutropenia (reduces nadir depth + frequency)
  • ANC calculation: ANC = WBC × (% neutrophils + % bands)
  • ANC thresholds: <1500 = neutropenia; <500 = severe; <200 = profound
  • Cyclic neutropenia vs congenital neutropenia (Kostmann syndrome): cyclic = oscillating; Kostmann = persistent severe neutropenia + ELANE or HAX1 mutation

6. Trap / trick tested:
  • Isolated neutropenia + oscillating pattern = cyclic neutropenia; pancytopenia = aplastic anemia/AML/MDS
  • Normal Hgb + normal platelets rules out aplastic anemia, AML, multiple myeloma, megaloblastic anemia — all affect multiple cell lines
  • Episodic = key word: Persistent neutropenia → structural/infiltrative/suppressive cause; episodic/oscillating → cyclic neutropenia
  • G-CSF paradox: during nadir, G-CSF rises (↑neutrophil production drive); as ANC recovers, G-CSF falls → feedback cycle drives the oscillation

7. One-liner memory hook:
"ELANE broken → misfolded elastase → ER stress → neutrophil precursors self-destruct every 3 weeks → ANC crashes → mouth ulcers + fever → G-CSF rescues → ANC climbs → repeat; oscillating isolated neutropenia in a child = cyclic neutropenia."

A 42-year-old previously healthy woman comes to the office due to fever and sore throat.  She has no cough.  Physical examination shows tonsillar exudate and a nontender cervical lymph node that measures 3.5 cm in diameter.  Oral antibiotic therapy is started and on a follow-up visit a week later, the patient reports that her symptoms have resolved.  The previously enlarged cervical lymph node has decreased slightly in size.  On several follow-up visits over the following year, the patient remains asymptomatic and the size of the lymph node fluctuates but does not disappear completely.  Referral to a surgeon is made and excisional biopsy of the lymph node is performed.  Which of the following is the most likely diagnosis? his patient with persistent fluctuating lymphadenopathy, who may have had an unrelated pharyngitis (treated with antibiotics) on initial presentation, most likely has follicular lymphoma.  Follicular lymphoma is the most common indolent non-Hodgkin lymphoma (NHL) in adults and the second most common NHL overall (after diffuse Large B cell lymphoma).  It derives from germinal center B cells and typically has a long, waxing and waning clinical course. The condition most often presents in middle-aged patients with painless lymph node enlargement or abdominal discomfort from an abdominal mass.  Histology is notable for a nodular pattern, and the neoplastic follicles are composed of a mixture of centrocytes (cleaved cells) and centroblasts (noncleaved cells).  The majority of tumors exhibit a t(14;18) translocation, resulting in overexpression of the BCL2 oncogene that blocks programmed cell death. (Choice A)  Acute lymphoblastic leukemia/lymphoma is the most common malignancy in children.  It presents with lymphadenopathy, hepatosplenomegaly, fever, bleeding, and bone pain.  Neoplastic cells are pre-B or pre-T cells (lymphoblasts). (Choice B)  Burkitt lymphoma is a highly aggressive (but generally chemotherapy-responsive) B-cell NHL associated with chronic Epstein-Barr virus infection and/or deregulation of the MYC proto-oncogene.  Patients typically develop rapidly growing tumor masses in the facial bones, jaw, or abdomen.  Tumor doubling time is very rapid and spontaneous tumor lysis can occur. (Choice C)  Diffuse large B-cell lymphoma typically presents with a rapidly enlarging nodal (neck, abdomen, mediastinum) or extranodal symptomatic mass.  The Waldeyer's ring (oropharyngeal lymphoid tissue) and gastrointestinal tract are commonly involved, and systemic "B" symptoms (fever, weight loss, drenching night sweats) can also be seen. (Choice E)  Hairy cell leukemia, a mature B-cell neoplasm, presents with splenomegaly and pancytopenia most often in older men.  Lymph node enlargement is not characteristic.  Leukemic cells have hairlike cytoplasmic projections and are positive for tartrate-resistant acid phosphatase (TRAP). (Choice F)  Mycosis fungoides is a cutaneous T-cell lymphoma.  Proliferating CD4+ atypical lymphocytes infiltrate the dermis and epidermis, where they form Pautrier microabscesses.  This condition manifests with plaques (often on trunk or buttocks) that may be confused with eczema or psoriasis.  Generalized erythema and scaling and thickening of the skin (erythroderma) may result. Educational objective: Follicular lymphoma is the most common indolent non-Hodgkin lymphoma in adults.  It is of B-cell origin and presents with painless waxing and waning (ie, fluctuating) lymphadenopathy.  The cytogenetic change t(14;18) is characteristic and results in overexpression of the BCL2 oncogene.

Follicular Lymphoma — Ultra High-Yield USMLE Notes


1. Diagnosis: Follicular Lymphoma — most common indolent NHL in adults; germinal center B-cell origin; t(14;18) → BCL2 overexpression

2. Key clue (1 line): 42F + painless cervical LN + waxing and waning over 1 year + no B symptoms + partially responsive → follicular lymphoma (indolent, fluctuating course)

3. Why correct (≤2 lines): Follicular lymphoma = indolent B-cell NHL with waxing/waning painless lymphadenopathy over months-years in middle-aged adults; t(14;18) → BCL2 overexpression → blocks apoptosis → neoplastic germinal center B-cells (centrocytes + centroblasts) accumulate slowly. Histology: nodular/follicular pattern on biopsy; BCL2+ follicles (normal germinal center B-cells are BCL2−).

4. Why others wrong (1 line each):
  • ALL/lymphoblastic lymphoma: Children + pre-B/pre-T lymphoblasts + hepatosplenomegaly + bone pain; not indolent fluctuating LN in adult
  • Burkitt lymphoma: Highly aggressive + rapidly growing jaw/abdominal mass + EBV + MYC deregulation + t(8;14); does NOT wax/wane over a year
  • Diffuse large B-cell lymphoma (DLBCL): Rapidly enlarging nodal/extranodal mass + B symptoms; aggressive not indolent
  • Hairy cell leukemia: Older men + splenomegaly + pancytopenia + TRAP+ hairlike projections; no lymphadenopathy
  • Mycosis fungoides: Cutaneous T-cell lymphoma (CD4+) + skin plaques/erythroderma + Pautrier microabscesses; not nodal disease

5. Buzzword triggers:
  • Waxing and waning painless lymphadenopathy in middle-aged adult → follicular lymphoma
  • t(14;18) → BCL2 overexpression → anti-apoptosis → indolent accumulation
  • Normal germinal center B-cells = BCL2−; follicular lymphoma cells = BCL2+ (key immunohistochemistry finding)
  • Histology: nodular pattern + mixture of centrocytes (small cleaved) + centroblasts (large noncleaved)
  • 2nd most common NHL overall (after DLBCL); most common indolent NHL
  • Follicular lymphoma can transform to DLBCL ("Richter-like transformation") → aggressive behavior
  • BCL2 normally located on chromosome 18; IgH locus on chromosome 14 → juxtaposition → BCL2 constitutively expressed
  • Treatment: watch-and-wait (asymptomatic) → rituximab (anti-CD20) ± chemotherapy

6. Trap / trick tested:
  • Fluctuating LN size = follicular lymphoma — students may think LN shrinking = resolving infection; partial response to antibiotics + persistence = not reactive
  • Pharyngitis was coincidental/unrelated — antibiotics treated tonsillitis, not the lymphoma; LN decreased slightly (spontaneous fluctuation of follicular lymphoma), not antibiotic response
  • BCL2+ in follicle = abnormal: Normal germinal center cells downregulate BCL2 to allow apoptosis; follicular lymphoma reverses this → cells immortalized
  • t(14;18) vs t(8;14): t(14;18) = follicular lymphoma (BCL2); t(8;14) = Burkitt lymphoma (MYC); both involve IgH locus on chromosome 14

7. One-liner memory hook:
"Waxing/waning painless LN in middle-aged adult = follicular lymphoma; t(14;18) puts BCL2 next to IgH → BCL2 always ON → B-cells never die → slowly accumulate; indolent but incurable without transplant."

A 36-year-old man presents to your office with persistent fever, bleeding gums, and a sore throat.  Peripheral blood microscopy findings are shown in the image below. his peripheral blood smear shows myeloblasts, which are large myelogenous cells with abundant basophilic cytoplasm and large nuclei that can be folded or bilobed.  Myeloblasts often have a number of coarse rod/needle-shaped intracytoplasmic granules (eg, Auer rods) that stain positive for myeloperoxidase.  Auer rods indicate myeloid differentiation. Acute promyelocytic leukemia (APL) is a variant of acute myeloid leukemia (AML), in which immature cells of myeloid origin are unable to differentiate and mature.  They proliferate in the bone marrow and suppress the growth and multiplication of other hematopoietic precursors.  The clinical manifestations of APL, such as anemia (fatigue, pallor), thrombocytopenia (petechiae, hemorrhages), and neutropenia (fever, opportunistic infections), result from marrow replacement by leukemic cells. (Choice A)  Major basic protein is found in eosinophil granules and helps to defend against parasites. (Choice C)  Platelet-derived growth factor receptor mutations play a role in gastrointestinal stromal tumors. (Choice D)  Hairy cell leukemia stains positively for tartrate resistant acid phosphatase (TRAP).  The neoplastic cells are mature B cells and are CD20+.  Hairy cell leukemia presents with splenomegaly, fatigue ,and pancytopenia. (Choice E)  Terminal deoxynucleotidyl transferase (TdT) is responsible for adding nucleotides to the V, D and J regions of the antibody gene for antibody diversity.  It is a marker of immature lymphocytes, both B and T cells.  Neoplastic cells in acute lymphoblastic leukemia (ALL) are TdT positive.  ALL mainly affects children. Educational Objective: Auer rods are deformed azurophilic granules found in the cytoplasm of myeloblasts that stain positively for myeloperoxidase.  Auer rods are found in abundance in AML M3 (acute promyelocytic leukemia).

Acute Promyelocytic Leukemia (AML-M3) — Auer Rods — Ultra High-Yield USMLE Notes


1. Diagnosis: Acute Promyelocytic Leukemia (APL/AML-M3) — myeloblasts with Auer rodsmyeloperoxidase positive; t(15;17) → PML-RARA fusion

2. Key clue (1 line): 36M + fever + bleeding gums + sore throat + smear = large myeloblasts with cytoplasmic Auer rods → AML-M3 → myeloperoxidase+ stain confirms myeloid origin

3. Why correct (≤2 lines): Auer rods = deformed azurophilic (pink) cytoplasmic granules in myeloblasts → stain myeloperoxidase (MPO) positive → confirms myeloid differentiation. APL (AML-M3): t(15;17) → PML-RARA → differentiation block at promyelocyte stage; "faggot cells" (bundles of Auer rods) = pathognomonic for APL; granules activate coagulation → DIC.

4. Why others wrong (1 line each):
  • Major basic protein: Eosinophil granule protein; antiparasitic defense; not myeloblast marker
  • PDGFR mutation: Gastrointestinal stromal tumors (GISTs); not hematologic leukemia
  • TRAP+ (tartrate-resistant acid phosphatase): Hairy cell leukemia (mature B-cell, CD20+, splenomegaly, pancytopenia); hairlike projections; not myeloid blasts
  • TdT+ (terminal deoxynucleotidyl transferase): Marks immature lymphocytesALL (children, pre-B/pre-T cells); TdT− in AML

5. Buzzword triggers:
  • Auer rodsAML (any subtype); abundant Auer rods/"faggot cells" → APL (AML-M3)
  • MPO positive → myeloid origin (AML); TdT positive → lymphoid origin (ALL)
  • AML-M3 + DIC → classic (promyelocyte granules thrombogenic)
  • t(15;17) → PML-RARA → ATRA treatment
  • AML markers: MPO+ + CD13+ + CD33+ + CD34+
  • ALL markers: TdT+ + CD10+ (CALLA) + CD19+ (B-ALL) or CD3+ (T-ALL)
  • AML key translocations:
    • t(15;17) → APL-M3 → ATRA
    • t(8;21) → AML-M2 → good prognosis
    • inv(16) → AML-M4Eo → good prognosis
  • Hairy cell leukemia: TRAP+ + CD20+ + CD11c+ + CD25+ → treat with cladribine

6. Trap / trick tested:
  • Auer rods = myeloid, NEVER lymphoid — TdT+ cells (ALL) never have Auer rods; finding Auer rods automatically = AML
  • MPO stain is the confirmatory test — when smear shows large blasts with granules/Auer rods → MPO+ = AML; MPO− + TdT+ = ALL
  • DIC in AML = APL until proven otherwise — only M3 (promyelocytic) causes DIC due to granule content
  • Hairy cell leukemia trap: also causes pancytopenia + fatigue but = mature B-cell + TRAP+ + no Auer rods + splenomegaly (no lymphadenopathy)

7. One-liner memory hook:
"Auer rods = myeloid pink needles in blasts → MPO+ = AML confirmed; faggot cells (Auer rod bundles) = APL-M3 = DIC danger; treat with ATRA not chemo; TdT+ = ALL (kids, no Auer rods)."

A 60-year-old man undergoes lymph node biopsy due to persistent cervical lymphadenopathy.  Histologic examination reveals a population of small lymphoid cells arranged in a follicular pattern.  The cells demonstrate overexpression of the BCL2 gene.  The protein encoded by this gene normally inhibits which of the following processes? poptosis (ie, programmed cell death) is a strictly controlled method of cell death that allows for the degradation and removal of cells without evoking an inflammatory response.  BCL2 protein functions as an inhibitor of the intrinsic (ie, mitochondrial) apoptotic pathway. Apoptosis involves triggering a cascade of proteolytic caspase enzymes.  In the mitochondrial pathway, caspase activation occurs via the movement of cytochrome c protein from the mitochondrial intermembrane space to the cytoplasm.  The BCL2 protein family regulates the ability of cytochrome c to permeate the mitochondrial outer membrane.  This protein family includes both proapoptotic members (eg, BAX, BAK), which increase the permeability of the membrane via pore formation, and antiapoptotic members (eg, BCL2, BCL-XL), which preserve membrane integrity and prevent the release of cytochrome c. The characteristic cytogenetic abnormality associated with follicular lymphoma, a mature B-cell lymphoma, is a translocation involving the BCL2 gene on chromosome 18 and the immunoglobulin heavy-chain gene on chromosome 14 [t(14;18)].  This results in overexpression of BCL2 protein, which allows the neoplastic cells to evade apoptosis. (Choice B)  Mutations of genes responsible for DNA mismatch repair (eg, MSH2) can be seen in disorders such as hereditary nonpolyposis colon cancer (ie, Lynch syndrome).  This condition is characterized by a familial predisposition to colon cancer and other visceral malignancies (eg, endometrial cancer). (Choice C)  Retinoblastoma (Rb) is a tumor suppressor protein that regulates cell cycle progression.  When active, Rb binds E2F transcription factors, prevents transcription, and blocks progression through the G1/S checkpoint. (Choice D)  RAS protein is a component of the mitogen-activated protein (MAP) kinase pathway, a signaling system that regulates cell proliferation via transmission of stimuli from the cell surface receptor to the nucleus.  Neurofibromin, encoded by the NF1 gene, is a tumor suppressor protein that inhibits RAS function. (Choice E)  Telomeres are DNA sequences found at the ends of chromosomes that are shortened with cellular division, eventually leading to growth arrest.  Telomerase is an RNA-dependent DNA polymerase that prevents shortening of telomeres.  The majority of cancer cells show increased telomerase activity, thereby avoiding growth arrest and facilitating continuous cell proliferation. Educational objective: BCL2 protein inhibits apoptosis by blocking the release of proapoptotic factors (eg, cytochrome c protein) from the mitochondria.  BCL2 is overexpressed in follicular lymphoma secondary to the t(14;18) translocation involving BCL2 and immunoglobulin heavy-chain genes.

BCL2 & Follicular Lymphoma — Ultra High-Yield USMLE Notes


1. Diagnosis: Follicular Lymphoma — t(14;18) → BCL2 overexpression → inhibits apoptosis (intrinsic/mitochondrial pathway)

2. Key clue (1 line): 60M + persistent cervical LN + follicular pattern + small lymphoid cells + BCL2 overexpression → follicular lymphoma → BCL2 inhibits apoptosis (cytochrome c release from mitochondria)

3. Why correct (≤2 lines): BCL2 = antiapoptotic protein → preserves mitochondrial outer membrane integrity → prevents cytochrome c release → no caspase activation → no cell death. t(14;18) places BCL2 (chr 18) next to IgH promoter (chr 14) → BCL2 constitutively overexpressed → neoplastic B-cells evade apoptosis → accumulate slowly (indolent).

4. Why others wrong (1 line each):
  • DNA mismatch repair (MSH2): Lynch syndrome → hereditary nonpolyposis colon cancer; not BCL2 function
  • Cell cycle G1/S checkpoint (Rb): Rb binds E2F → blocks G1/S progression; tumor suppressor; not apoptosis regulator
  • RAS/MAP kinase signaling: Cell proliferation pathway; neurofibromin (NF1) inhibits RAS; not BCL2 pathway
  • Telomerase/telomere shortening: Prevents growth arrest in cancer cells; RNA-dependent DNA polymerase; not mitochondrial apoptosis

5. Buzzword triggers:
  • BCL2anti-apoptotic → inhibits cytochrome c release → no caspase cascade
  • t(14;18) → BCL2 overexpression → follicular lymphoma
  • BAX/BAK = pro-apoptotic (pore-forming) → oppose BCL2
  • BCL2 family balance: BCL2/BCL-XL (anti) vs BAX/BAK (pro) → determines cell fate
  • Intrinsic apoptosis pathway: stress → BAX/BAK pores → cytochrome c release → apoptosome → caspase 9 → caspase 3 → cell death
  • Extrinsic apoptosis pathway: Fas-FasL / TNF → caspase 8 → caspase 3 → cell death
  • BCL2 acts on intrinsic (mitochondrial) pathway ONLY
  • Tumor suppressor genes vs oncogenes: BCL2 = proto-oncogene (overexpression → cancer); Rb/p53 = tumor suppressors (loss → cancer)

6. Trap / trick tested:
  • BCL2 inhibits apoptosis, NOT promotes proliferation — follicular lymphoma cells don't divide faster; they simply fail to die; subtle but tested distinction
  • t(14;18) vs t(8;14): Both involve IgH (chr 14); t(14;18) = BCL2 = follicular lymphoma (indolent); t(8;14) = MYC = Burkitt (aggressive)
  • Normal germinal center B-cells are BCL2− (they need to undergo apoptosis for selection); follicular lymphoma = BCL2+ follicles = abnormal finding on IHC
  • BCL2 overexpression ≠ mutation; it's a translocation bringing BCL2 under IgH promoter control

7. One-liner memory hook:
"t(14;18) = IgH turbocharges BCL2 → BCL2 plugs the mitochondrial drain → cytochrome c stays inside → caspases never fire → B-cells immortal → waxing/waning lymphoma; BAX tries to poke holes, BCL2 patches them."

A 15-year-old boy is brought to the emergency department due to progressive shortness of breath.  The patient has no chronic medical conditions.  Temperature is 37.1 C (98.8 F), pulse is 130/min, and respirations are 32/min.  Pulse oximetry is 94% on room air.  Lung examination demonstrates diffusely diminished breath sounds.  Clusters of enlarged cervical lymph nodes are palpable bilaterally.  A large mediastinal mass is visualized on chest x-ray.  The leukocyte count is elevated, and a peripheral blood smear shows abnormal white blood cells, as shown in the image below: his patient's peripheral blood smear demonstrates blast cells characterized by large nuclei, scant cytoplasm, visible nucleoli, and immature (ie, fine) chromatin.  These early hematologic precursors normally comprise a small percentage in the bone marrow but, with malignant transformation, can proliferate and be detected in peripheral blood (eg, acute leukemia). The presence of myeloperoxidase (MPO) helps determine whether blasts are lymphoid or myeloid in origin.  Because MPO is an enzyme involved in microbial killing by myeloid derivatives (eg, neutrophils), it is absent in lymphoid cells.  In addition, positive terminal deoxynucleotidyl transferase (TdT) indicates lymphoblasts; TdT is a DNA polymerase involved in V(D)J recombination, which generates antigen receptor diversity during early lymphoid maturation.  Therefore, negative MPO and positive TdT confirm that these are lymphoblasts. Lymphoblasts are further differentiated by markers unique to B (eg, CD19) or T (eg, CD3) cells.  This patient's CD3-positive lymphoblasts indicate T-lymphoblastic leukemia (T-ALL).  Unlike B-lymphoblastic leukemia (B-ALL), which usually occurs in early childhood, T-ALL is most common in adolescence.  Tumors classically develop in the thymus, the site of T-cell development, and often result in the formation of a mediastinal mass that compresses the airway, causing cough and dyspnea, or the nearby blood vessels, causing superior vena cava syndrome. (Choice A)  Acute myeloid leukemia arises from myeloid precursors (myeloblasts), and cells therefore express MPO, not CD3 and TdT. (Choice B)  B-ALL, the most common ALL subtype, expresses TdT.  However, expression of B-cell surface markers (eg, CD19) would be expected.  In addition, presentation usually involves signs of bone marrow failure (eg, pallor, bruising) in young children, not a mediastinal mass in an adolescent. (Choice C)  Burkitt lymphoma, a malignancy derived from mature B cells, can present with disseminated disease involving the bone marrow.  An enlarging mass can be seen, but it is usually in the abdomen or jaw, not the mediastinum.  Cells express B-cell, not T-cell, markers.  Because Burkitt lymphoma is composed of mature B cells, TdT is negative. (Choice D)  Hodgkin lymphoma can present with a mediastinal mass and painless lymphadenopathy.  Circulating blasts are not typical.  Instead, Reed-Sternberg cells (large cells with multilobated nuclei and eosinophilic nucleoli) within lymph nodes are characteristic.  Because they arise from mature germinal or post–germinal center B cells, TdT is negative. Educational objective: T-lymphoblastic leukemia (T-ALL) is characterized by circulating lymphoblasts that express terminal deoxynucleotidyl transferase (TdT) and CD3.  T-ALL often presents in adolescents/young adults with a mediastinal mas

T-Cell Acute Lymphoblastic Leukemia (T-ALL) — Ultra High-Yield USMLE Notes


1. Diagnosis: T-ALL (T-Lymphoblastic Leukemia/Lymphoma) — TdT+ + CD3+ + MPO− + mediastinal mass in adolescent male

2. Key clue (1 line): 15-year-old boy + dyspnea + bilateral cervical LN + large mediastinal mass + ↑WBC + lymphoblasts on smear → T-ALL (TdT+ + CD3+ + MPO−)

3. Why correct (≤2 lines): T-ALL = malignant transformation of immature T-cell precursors in thymus → mediastinal mass (thymic origin) compresses airway → dyspnea/SVC syndrome; lymphoblasts circulate in blood. TdT+ (V(D)J recombination marker = immature lymphocyte) + CD3+ (T-cell marker) + MPO− (not myeloid) = T-ALL fingerprint.

4. Why others wrong (1 line each):
  • AML: Myeloblasts → MPO+ + CD3− + TdT−; Auer rods; not mediastinal mass
  • B-ALL: TdT+ but CD19+/CD10+ (not CD3+); young children (not adolescent); bone marrow failure signs; no mediastinal mass
  • Burkitt lymphoma: Mature B-cell → TdT− + CD20+; rapidly growing jaw or abdominal mass; t(8;14)/MYC; not mediastinal
  • Hodgkin lymphoma: Mediastinal mass + painless LN but Reed-Sternberg cells (not circulating blasts); TdT−; mature B-cell origin

5. Buzzword triggers:
  • Adolescent male + mediastinal mass + lymphoblastsT-ALL
  • TdT+ = immature lymphocyte (B or T precursor) → ALL (not AML, not mature lymphoma)
  • MPO+ = myeloid origin → AML
  • CD3+ = T-cell; CD19+/CD10+ = B-cell
  • T-ALL mediastinal mass → can cause SVC syndrome (facial swelling, arm edema, distended neck veins)
  • T-ALL vs B-ALL:
    • B-ALL: Young children + CD10/CD19 + bone marrow failure; most common childhood malignancy
    • T-ALL: Adolescent males + CD3 + mediastinal mass + thymic origin
  • ALL treatment: vincristine + prednisone + asparaginase ± intrathecal MTX (CNS prophylaxis)
  • Mediastinal mass "4 T's": Thymoma, Teratoma, Terrible lymphoma (Hodgkin/NHL), Thyroid — T-ALL falls under terrible lymphoma category

6. Trap / trick tested:
  • Mediastinal mass in adolescent = T-ALL first (not thymoma — that's adults >40); Hodgkin also causes mediastinal mass but no circulating blasts
  • TdT+ alone doesn't specify B vs T — need CD markers: TdT + CD3 = T-ALL; TdT + CD19/CD10 = B-ALL
  • Burkitt trap: Also aggressive lymphoma in young + EBV + B-cell but TdT− (mature B-cell) + jaw/abdomen NOT mediastinum
  • SVC syndrome in young male with mediastinal mass → think T-ALL (not lung cancer which causes SVC in older smokers)

7. One-liner memory hook:
"Teen boy + mediastinal mass + lymphoblasts = T-ALL from thymus; TdT+ (immature) + CD3+ (T-cell) + MPO− (not myeloid) = T-ALL trinity; thymoma = adult, T-ALL = teenager; SVC compressed = face swells."

A 24-year-old, previously healthy woman comes to the hospital due to a 3-day history of fever, dyspnea, and cough productive of yellow sputum.  Temperature is 38.8 C (101.8 F), blood pressure is 110/66 mm Hg, and pulse is 110/min.  The patient has bronchial breath sounds and crackles over the right lower lung.  Laboratory results are as follows: Hemoglobin 13 g/dL Platelets 350,000/mm3 Leukocytes 54,000/mm3     Neutrophils 65%     Band forms 10%     Myelocytes 3%     Metamyelocytes 1%     Lymphocytes 15% The leukocyte alkaline phosphatase test score is elevated.  Which of the following is the most likely finding on this patient's peripheral blood smear? his patient most likely has pneumonia with sepsis and an associated leukemoid reaction, a significant leukocytosis (may exceed 50,000/mm3) that occurs in response to an underlying inflammatory condition (eg, severe infection, hemorrhage, solid tumors).  Release of colony-stimulating factors and inflammatory mediators into the circulation causes the bone marrow to increase the production of leukocytes, resulting in leukocytosis. Blood smear typically shows numerous mature neutrophils, which may have reactive morphologic features, such as Döhle bodies (blue cytoplasmic inclusions of rough endoplasmic reticulum), toxic granulation, and cytoplasmic vacuoles.  Increased neutrophil precursors (eg, bands, metamyelocytes, myelocytes) are also typically present (referred to as "left shift") due to early release from the marrow in response to the increased demand of the inflammatory condition. Assessment of leukocyte alkaline phosphatase (an enzyme found in maturing neutrophils) can be used to distinguish marked leukocytosis due to leukemoid reaction from chronic myeloid leukemia (CML).  Values are typically normal or increased in leukemoid reaction; in contrast, they are usually low in CML because the abnormal maturing neutrophils have decreased levels of this enzyme. (Choice B)  Basophilic stippling refers to small, blue granules (ribosomal precipitates) in the cytoplasm of red blood cells.  It is most often seen in thalassemia, alcohol use disorder, and lead/heavy metal poisoning.  This patient's acute presentation and laboratory results are more consistent with leukemoid reaction. (Choice C)  Hypersegmented neutrophils show ≥6 nuclear lobes and are a feature of megaloblastic anemia, often due to vitamin B12 or folate deficiency.  This patient's normal hemoglobin makes this unlikely. (Choice D)  The presence of numerous blasts with cytoplasmic Auer rods (fused azurophilic granules) in the blood smear would be concerning for acute myeloid leukemia.  This patient's laboratory results show mainly mature neutrophils with increased neutrophil precursors (eg, bands, metamyelocytes, myelocytes) but not blasts. (Choice E)  Small lymphoid cells with cleaved nuclei are seen in certain types of lymphoma, particularly follicular lymphoma, a mature B-cell neoplasm.  This patient's clinical symptoms and neutrophilia with left shift are more consistent with leukemoid reaction. Educational objective: Leukemoid reaction is a significant leukocytosis (may exceed 50,000/mm3) that occurs in response to an underlying condition, commonly severe infection.  Blood smear often shows neutrophilia with reactive features (eg, Döhle bodies), as well as increased neutrophil precursors (eg, bands, metamyelocytes, myelocytes).  The leukocyte alkaline phosphatase score is normal or increased.

Leukemoid Reaction — Ultra High-Yield USMLE Notes


1. Diagnosis: Leukemoid Reaction — severe infection (pneumonia/sepsis) → WBC >50,000 + left shift + ↑LAP score + toxic neutrophil changes; NOT CML

2. Key clue (1 line): 24F + fever + productive cough + pneumonia + WBC 54,000 + bands/metamyelocytes/myelocytes + ↑LAP score → leukemoid reaction → smear = mature neutrophils + Döhle bodies + toxic granulation + left shift

3. Why correct (≤2 lines): Severe infection → colony-stimulating factors + inflammatory mediators → marrow releases mature neutrophils + precursors early (left shift) → reactive neutrophils show Döhle bodies (blue RER inclusions) + toxic granulation + cytoplasmic vacuoles. ↑LAP score = leukemoid reaction; ↓LAP score = CML (abnormal neutrophils have less LAP).

4. Why others wrong (1 line each):
  • Basophilic stippling: Ribosomal precipitates in RBCs → thalassemia/lead poisoning/alcohol; not neutrophil reaction to infection
  • Hypersegmented neutrophils: Megaloblastic anemia (B12/folate deficiency); normal Hgb here rules out
  • Auer rods + blasts: AML finding; this patient has mature neutrophils + precursors, not blasts
  • Small cleaved lymphoid cells: Follicular lymphoma (mature B-cells); not acute infection/neutrophilia picture

5. Buzzword triggers:
  • WBC >50,000 + infection/inflammation + ↑LAPleukemoid reaction
  • WBC >50,000 + splenomegaly + ↓LAP + t(9;22) → CML
  • Left shift = ↑bands + metamyelocytes + myelocytes in blood = marrow working hard
  • Döhle bodies = blue cytoplasmic inclusions (retained RER) in neutrophils = reactive/toxic change
  • Toxic granulation = coarse dark primary granules in neutrophils = severe infection marker
  • LAP (Leukocyte Alkaline Phosphatase): ↑ in leukemoid reaction; ↓ in CML
  • Leukemoid reaction causes: severe infection + hemorrhage + solid tumors + G-CSF administration
  • CML: BCR-ABL (t(9;22)/Philadelphia chromosome) → constitutive tyrosine kinase → treat with imatinib

6. Trap / trick tested:
  • Leukemoid reaction vs CML: Both WBC >50,000 + left shift — LAP is the pivot: ↑LAP = leukemoid; ↓LAP = CML; also CML has basophilia + splenomegaly + chronic course
  • Left shift ≠ leukemia: Bands/metamyelocytes/myelocytes in blood = reactive marrow response; blasts = leukemia
  • Döhle bodies trap: Students may confuse with Auer rods; Döhle = blue RER inclusions in reactive neutrophils (infection); Auer rods = pink fused granules in myeloblasts (AML)
  • Young patient + acute presentation + elevated LAP = leukemoid reaction; do NOT jump to CML without checking LAP + Philadelphia chromosome

7. One-liner memory hook:
"Infection screams → marrow dumps mature neutrophils + precursors (left shift) + toxic Döhle bodies → WBC >50k = leukemoid; ↑LAP = reactive body fight; ↓LAP + t(9;22) = CML; Döhle = RER blue blobs, not Auer pink rods."

A 65-year-old man comes to the office due to 4 months of worsening fatigue.  The patient feels tired with simple household chores.  He has a 15-pack-year smoking history and drinks 2 or 3 beers daily.  Temperature is 37 C (98.6 F), blood pressure is 134/86 mm Hg, and pulse is 76/min.  Physical examination reveals a late systolic ejection murmur with a soft S2.  The lungs are clear to auscultation.  The abdomen is soft and nontender with no hepatosplenomegaly.  There are no focal neurological deficits.  Laboratory testing reveals hemoglobin is 9 g/dL and mean corpuscular volume is 93 µm3.  Peripheral blood smear is shown below: his patient's peripheral blood smear shows rows of erythrocytes stacked on one another like coins (rouleaux formation).  This occurs due to elevated levels of circulating proteins, which disrupts the repulsive electrostatic charge on the erythrocyte surface and causes stacked aggregation.  Although rouleaux formation can be seen with inflammatory conditions (eg, infection, rheumatic disease) that increase acute-phase reactants (eg, fibrinogen), it is classically linked to lymphoproliferative/plasma cell disorders such as multiple myeloma and Waldenstrom macroglobulinemia, which generate high levels of monoclonal paraprotein (immunoglobulins). Multiple myeloma is a plasma cell malignancy often associated with normocytic anemia, osteolytic bone lesions, and hypercalcemia due to proliferation of neoplastic cells in the bone marrow.  Patients also frequently have renal insufficiency (due to immunoglobulin light-chain cast nephropathy) and nonspecific symptoms (eg, fatigue).  Diagnosis is generally made using serum/urine protein electrophoresis (monoclonal M-spike) and bone marrow biopsy. (Choice A)  Chronic gastrointestinal blood loss is a leading cause of iron-deficiency anemia, which usually results in microcytosis and hypochromia on peripheral smear (sometimes with target cells).  Rouleaux formation and normocytic erythrocytes would be atypical. (Choice B)  Cold agglutinins are cross-reactive IgM antibodies that form with some infections (particularly Mycoplasma pneumoniae) and hematologic malignancies.  Cold agglutinins typically cause clumping agglutination (not stacked-coin agglutination) and hemolysis. (Choice D)  Mechanical erythrocyte injury is common in patients with damaged or artificial heart valves.  Although this patient has a cardiac murmur that indicates possible aortic stenosis, mechanical erythrocyte injury is usually associated with schistocytes on peripheral blood smear, not rouleaux formation. (Choice E)  Vitamin B12 deficiency causes abnormal hematologic cell nuclear maturation, which leads to macrocytic anemia and hypersegmented neutrophils on peripheral blood smear. Educational objective: Multiple myeloma is associated with elevated circulating paraproteins (monoclonal immunoglobulins), which causes erythrocytes to stack like coins (rouleaux formation).  Patients classically have normocytic anemia, hypercalcemia, bone pain, and renal insufficiency.

Multiple Myeloma — Ultra High-Yield USMLE Notes


1. Diagnosis: Multiple Myeloma — plasma cell malignancy → rouleaux formation on smear + normocytic anemia + monoclonal paraprotein (M-spike)

2. Key clue (1 line): 65M + fatigue + normocytic anemia (Hgb 9, MCV 93) + rouleaux formation on smear (stacked-coin RBCs) → multiple myeloma → ↑monoclonal immunoglobulin disrupts RBC surface charge

3. Why correct (≤2 lines): Neoplastic plasma cells produce massive amounts of monoclonal paraprotein (M-protein) → coats RBC surface → neutralizes repulsive electrostatic charge → RBCs stack like coins (rouleaux). Multiple myeloma = normocytic anemia + hypercalcemia + osteolytic bone lesions + renal insufficiency (light-chain cast nephropathy) + ↑ESR + M-spike on SPEP.

4. Why others wrong (1 line each):
  • GI blood loss (IDA): Microcytic + hypochromic smear ± target cells; not normocytic rouleaux
  • Cold agglutinins (Mycoplasma/IgM): Clumping/agglutination pattern (not stacked coins) + hemolysis; triggered by cold
  • Mechanical RBC injury (valve/schistocytes): Aortic murmur present but mechanical hemolysis → schistocytes/helmet cells; not rouleaux
  • B12 deficiency: Macrocytic (↑MCV) + hypersegmented neutrophils; MCV 93 (normal) here → rules out

5. Buzzword triggers:
  • Rouleaux formation → ↑circulating proteins → multiple myeloma (most classic) or Waldenström macroglobulinemia
  • Multiple myeloma mnemonic "CRAB": Calcium ↑ + Renal failure + Anemia (normocytic) + Bone lesions (osteolytic, punched-out)
  • M-spike on SPEP → monoclonal gammopathy → myeloma vs MGUS vs Waldenström
  • Bence Jones proteins = free light chains (κ or λ) in urine → cast nephropathy → renal failure
  • Bone marrow biopsy: >10% plasma cells = myeloma (MGUS = <10%)
  • Multiple myeloma plasma cells: CD138+ + CD38+ (flow cytometry)
  • ↑ESR in myeloma (elevated due to paraprotein) — most elevated ESR of any condition
  • Lytic bone lesions (not blastic) → pathologic fractures + back pain + hypercalcemia
  • Waldenström macroglobulinemia: IgM paraprotein + lymphoplasmacytic lymphoma + hyperviscosity syndrome (no lytic lesions)

6. Trap / trick tested:
  • Aortic stenosis murmur (late systolic ejection + soft S2) is a distractor → students may think mechanical hemolysis/schistocytes; but smear shows rouleaux → myeloma unrelated to valve
  • Rouleaux ≠ agglutination: Rouleaux = orderly stacked coins (paraprotein); agglutination = irregular clumping (cold IgM/infection)
  • Normal MCV in myeloma — myeloma causes normocytic anemia (marrow replacement); not micro or macro; B12 deficiency trap = macrocytic
  • Smoking + alcohol history → distractors for lung cancer or liver disease; normocytic anemia + rouleaux = plasma cell disorder not GI blood loss

7. One-liner memory hook:
"Myeloma M-protein coats RBCs → stacked coins (rouleaux); CRAB = Calcium up + Renal failure + Anemia (normocytic) + Bone lytic lesions; M-spike on SPEP + Bence Jones in urine + plasma cells >10% in marrow = MYELOMA."

rouleux formation seen in what all other DD

Rouleaux Formation — All Causes (Quick Reference)


Mechanism: ↑circulating proteins (immunoglobulins, fibrinogen, acute phase reactants) → neutralize negative RBC surface charge → stacking

Causes by Category:

Plasma Cell / Lymphoproliferative (Classic)
  • Multiple myeloma ← most classic USMLE cause
  • Waldenström macroglobulinemia (IgM paraprotein)
  • MGUS (monoclonal gammopathy of undetermined significance)
Inflammatory / Acute Phase
  • Chronic infections (TB, osteomyelitis)
  • Autoimmune disease (SLE, rheumatoid arthritis)
  • Inflammatory bowel disease
  • Malignancy (solid tumors)
Other
  • Pregnancy (↑fibrinogen)
  • Diabetes mellitus
  • Hyperlipidemia/hypercholesterolemia
  • Severe burns

Quick Pivot Table:

Rouleaux +Think
Bone pain + hypercalcemia + renal failureMultiple myeloma
Hyperviscosity + no lytic lesions + IgMWaldenström
Chronic infection + fever + ↑ESRReactive/inflammatory
Elderly + no symptoms + small M-spikeMGUS

One-liner:
"Rouleaux = too much protein in blood; myeloma = most tested; but any cause of ↑ESR/↑fibrinogen/↑immunoglobulin can stack the coins."

A 59-year-old man comes to the office due to 3 months of progressive fatigue and back pain.  The back pain occurs mainly with movement or positional changes.  Physical examination reveals midline tenderness over the middle and lower back.  Laboratory evaluation shows a hemoglobin level of 10.2 g/dL and serum calcium level of 12 mg/dL.  A bone marrow aspirate is performed, and the histopathologic findings are shown below. his patient's bone marrow aspirate shows numerous plasma cells, which can be identified by abundant basophilic cytoplasm, eccentric nuclei, well-developed Golgi apparatus (perinuclear paleness), and "clock-face" (peripheral) chromatin.  A bone marrow sample with >10% plasma cells is strongly suggestive of multiple myeloma (MM), a clonal plasma cell malignancy. In MM, neoplastic plasma cells: Replicate in the bone marrow and choke out normal hematopoiesis, leading to normocytic, normochromic anemia (impaired erythropoiesis) and increased risk of infection (impaired B-cell lymphopoiesis). Secrete osteolytic cytokines, leading to bone pain, osteolytic (radiolucent) bone lesions, and hypercalcemia. Produce large quantities of monoclonal immunoglobulin (paraprotein) composed of heavy and light chains (eg, IgG, IgA) or light chains alone.  Light chains can deposit in the renal tubules, leading to light-chain cast nephropathy, which is usually characterized by mild renal insufficiency and waxy, laminated urinary casts (Bence Jones). Light chains can also form insoluble fibrils and deposit in major organs, leading to amyloid light-chain amyloidosis.  This can contribute to the already elevated risk of renal failure as well as heart failure and neurologic dysfunction.  Amyloidosis can often be identified on biopsy using hematoxylin and eosin stain (eosinophilic extracellular deposits) or Congo red stain viewed under polarized light (apple-green birefringence). (Choice B)  Cardiac tamponade can be associated with some neoplasms (eg, lung, breast) due to tumor invasion of the pericardium.  MM does not typically cause pericardial disease; therefore, it is not associated with cardiac tamponade. (Choice C)  Hepatic failure is most often linked to viral hepatitis or chronic alcohol use.  It occasionally occurs due to malignant infiltration of the liver (eg, lymphoma, breast cancer); however, risk of hepatic failure with MM is low; amyloidosis is a far more common complication. (Choice D)  Hyperthyroidism is most often due to Graves disease, an autoimmune disorder that generates TSH-receptor antibodies.  It can also be seen with medications (eg, lithium) and tumors that produce TSH (eg, pituitary adenoma).  MM is not linked to hyperthyroidism. (Choice E)  Meningeal carcinomatosis is a rare condition associated with some solid tumors (eg, breast cancer, lung cancer, melanoma).  Tumor spread to the leptomeninges can cause mass effect (eg, headache, hydrocephalus), cranial/spinal nerve dysfunction, and focal neurologic issues.  MM does not typically spread to the leptomeninges. (Choice F)  Atraumatic splenic rupture can occur with leukemia and lymphoma due to massive splenomegaly from extramedullary hematopoiesis and/or underlying tumor infiltration.  MM does not typically cause significant extramedullary hematopoiesis and usually replicates in the bone marrow, not the spleen. Educational objective: Amyloid light-chain amyloidosis is associated with multiple myeloma and other monoclonal plasma cell dyscrasias due to the deposition of insoluble immunoglobulin light-chain fibrils in major organs (eg, kidneys, heart, neurologic system).  A bone marrow sample with >10% plasma cells is strongly suggestive of multiple myeloma.

Multiple Myeloma — Complications & Amyloidosis — Ultra High-Yield USMLE Notes


1. Diagnosis: Multiple Myeloma (MM) — clonal plasma cell malignancy (>10% plasma cells in marrow) → complication = AL Amyloidosis (light-chain fibril deposition)

2. Key clue (1 line): 59M + fatigue + back pain (movement-related) + midline tenderness + Hgb 10.2 + Ca²⁺ 12 (hypercalcemia) + marrow = plasma cells >10% with clock-face chromatin + perinuclear halo → MM → risk = AL amyloidosis

3. Why correct (≤2 lines): MM plasma cells produce excess monoclonal light chains → some form insoluble amyloid fibrils (AL type) → deposit in kidneys (nephrotic syndrome/renal failure) + heart (restrictive cardiomyopathy) + nerves (peripheral neuropathy) + tongue (macroglossia). Congo red stain → apple-green birefringence under polarized light = amyloid confirmation.

4. Why others wrong (1 line each):
  • Cardiac tamponade: Requires pericardial invasion (lung/breast cancer); MM does not invade pericardium
  • Hepatic failure: Viral hepatitis/alcohol/malignant infiltration (lymphoma); MM rarely causes significant hepatic infiltration
  • Hyperthyroidism: Graves disease/TSH-secreting pituitary adenoma; no link to MM
  • Meningeal carcinomatosis: Breast/lung/melanoma spread to leptomeninges; MM does not typically spread to meninges
  • Splenic rupture: Lymphoma/leukemia with massive splenomegaly + EMH; MM stays in marrow, no significant splenomegaly

5. Buzzword triggers:
  • Clock-face/cartwheel chromatin + eccentric nucleus + perinuclear halo (Golgi) = plasma cell morphology
  • >10% plasma cells on marrow biopsy → multiple myeloma
  • MM "CRAB": Calcium↑ + Renal failure + Anemia (normocytic) + Bone lytic lesions
  • AL amyloidosis (light chain) → kidneys + heart + nerves + tongue (macroglossia)
  • AA amyloidosis (serum amyloid A) → chronic inflammation (RA, IBD, TB) → kidneys predominantly
  • Congo red + apple-green birefringence under polarized light = amyloid (any type)
  • Bence Jones proteins = free light chains in urine → cast nephropathy (waxy laminated casts) ≠ AL amyloidosis (different renal mechanisms)
  • MM renal injury mechanisms: (1) cast nephropathy (Bence Jones) + (2) AL amyloidosis + (3) hypercalcemia + (4) hyperviscosity

6. Trap / trick tested:
  • Cast nephropathy vs AL amyloidosis — both are MM renal complications but different: cast nephropathy = tubular light-chain casts → waxy urinary casts; AL amyloidosis = fibril deposition → Congo red+ → nephrotic syndrome
  • Clock-face chromatin is the plasma cell hallmark on histology — distinguish from lymphocytes (condensed chromatin, scant cytoplasm, no Golgi)
  • Macroglossia in myeloma patient = AL amyloid deposition in tongue; also seen in hypothyroidism but different context
  • Splenic rupture trap: MM stays in marrow → no splenomegaly → no splenic rupture; lymphoma/CML = splenomegaly = rupture risk

7. One-liner memory hook:
"Myeloma plasma cells overproduce light chains → some become amyloid fibrils (AL) → Congo red apple-green → kidneys fail + heart stiffens + nerves tingle + tongue enlarges; CRAB = the myeloma damage footprint; clock-face nucleus = plasma cell on marrow biopsy."

A 63-year-old man comes to the office due to fatigue and easy bruising.  He has no lymphadenopathy on physical examination.  Laboratory results are as follows: Complete blood count     Hemoglobin 8.0 g/dL     Platelets 40,000/mm3     Leukocytes 20,500/mm3 The patient's peripheral blood smear is shown in the image below: this patient's peripheral blood smear shows very large nucleated cells (see red cell size for comparison) with scant cytoplasm.  These are blast cells, the finding of which makes acute leukemia likely.  Closer examination of the smear reveals linear, purple-red inclusions in some of the cells, called Auer rods.  These represent fused granules and may be single or multiple within immature myeloid precursors.  Auer rods are highly suggestive of acute myeloid leukemia (AML) but not of acute lymphoblastic leukemia (ALL) (Choice A).  Although Auer rods are most commonly associated with the M1, M2, and M3 subtypes of AML, they may be found in any type of AML. The vast majority of AML cases occur in adults, with a median age of 65 and median white blood cell count of about 15,000/mm3 at diagnosis.  Most patients present with complications of pancytopenia (eg, fatigue from anemia, bruising/bleeding from thrombocytopenia, infection from functional neutropenia [despite leukocytosis]).  Diagnostic criteria generally require the presence of >20% myeloblasts in the bone marrow or peripheral blood. (Choices C and D)  Chronic leukemia causes a prevalence of mature cells in the peripheral blood.  In chronic myeloid leukemia (CML), peripheral smears usually show many mature granulocytes and few blasts (generally <2%).  In chronic lymphocytic leukemia (CLL), smears show many mature lymphocytes. (Choice E)  Patients with hairy cell leukemia have splenomegaly, cytopenias, and circulating hairy cells.  On peripheral blood smear, hairy cells take the appearance of small- to medium-sized lymphoid cells with circumferential "hairy" projections. (Choice F)  Patients with Hodgkin lymphoma generally present with a mass (eg, mediastinal mass, enlarged lymph nodes).  The finding of circulating neoplastic cells is extremely rare.  Histologically, Reed-Sternberg cells are characteristic.  These are large cells with abundant basophilic cytoplasm and >2 nuclear lobes or nuclei. (Choice G)  Patients with infectious mononucleosis have fatigue, lymphadenopathy, and splenomegaly.  Thrombocytopenia can be a complication of this infection.  Peripheral blood smear will show few circulating atypical lymphocytes, not numerous blasts. Educational objective: The finding of Auer rods (linear purple-red inclusions within immature myeloid precursors) is helpful in making the diagnosis of acute myeloid leukemia.  Auer rods are not found in acute lymphoblastic leukemia.  In chronic myeloid leukemia, there are more mature cells and fewer blasts.

Acute Myeloid Leukemia (AML) — Ultra High-Yield USMLE Notes


1. Diagnosis: Acute Myeloid Leukemia (AML) — blasts >20% + Auer rods on smear; median age 65; MPO+

2. Key clue (1 line): 63M + fatigue + easy bruising + Hgb 8 + platelets 40k + WBC 20,500 + smear = large blasts with scant cytoplasm + linear purple-red Auer rods → AML

3. Why correct (≤2 lines): AML = myeloid blast transformation; Auer rods (fused azurophilic granules) = pathognomonic for myeloid origin → MPO+; diagnosis requires >20% myeloblasts in marrow/blood. Pancytopenia (fatigue + bruising + functional neutropenia despite leukocytosis) from marrow replacement by blasts.

4. Why others wrong (1 line each):
  • ALL: Lymphoblasts → TdT+ + MPO−; no Auer rods ever; children predominant; CD19/CD10 (B) or CD3 (T)
  • CML: Mature granulocytes dominant + <2% blasts; ↓LAP + t(9;22)/BCR-ABL; chronic course + splenomegaly
  • CLL: Mature small lymphocytes + smudge cells; elderly; no blasts; CD5+CD19+CD23+
  • Hairy cell leukemia: Small lymphoid cells with circumferential hairy projections + TRAP+; splenomegaly + pancytopenia; no blasts
  • Hodgkin lymphoma: Reed-Sternberg cells in LN biopsy; circulating neoplastic cells extremely rare; no Auer rods
  • Infectious mononucleosis: EBV + fatigue + splenomegaly + atypical lymphocytes (few); heterophile antibody+; not blasts

5. Buzzword triggers:
  • Auer rodsAML (any subtype); never ALL
  • Faggot cells (bundles of Auer rods) → APL/AML-M3 + DIC
  • >20% blasts in marrow → AML diagnosis threshold
  • AML markers: MPO+ + CD13+ + CD33+ + CD34+
  • AML subtypes (USMLE favorites):
    • M3 (APL): t(15;17) + DIC + Auer rod bundles → ATRA
    • M4/M5 (monocytic): Gum infiltration + skin involvement
    • M7 (megakaryoblastic): Down syndrome children
  • AML vs ALL pivot: Auer rods + MPO+ = AML; TdT+ + MPO− = ALL
  • Functional neutropenia despite high WBC = myeloblasts don't function as mature neutrophils → infection risk despite leukocytosis

6. Trap / trick tested:
  • High WBC ≠ no infection risk — blasts are nonfunctional; patient is effectively neutropenic despite WBC 20,500
  • CML vs AML: Both myeloid origin; CML = chronic + mature cells + BCR-ABL + ↓LAP; AML = acute + blasts >20% + Auer rods + ↑LDH
  • CLL smudge cells vs AML blasts: CLL = mature small lymphocytes that smear easily (smudge cells); AML = large immature blasts with Auer rods
  • Auer rods = only in myeloid cells; finding even ONE Auer rod = AML until proven otherwise

7. One-liner memory hook:
"Auer rods = AML's purple-red signature; blasts >20% + MPO+ + Auer rods = AML; no Auer rods in ALL ever; faggot cells + DIC = APL-M3 → ATRA saves; high WBC but all useless blasts = patient still infected."

A 30-year-old man comes to the emergency department due to rapidly increasing abdominal distention and anorexia.  The patient has a history of HIV infection and intravenous drug use.  CT scan of the abdomen shows ascites and a large mass involving the small intestine.  Biopsy of the mass reveals sheets of uniform, round, medium-sized tumor cells with basophilic cytoplasm and a very high rate of proliferation and apoptosis.  Which of the following infectious agents is most closely associated with the development of this patient's condition? this patient with rapidly increasing abdominal distention and abdominal mass has histopathology consistent with Burkitt lymphoma (BL), an aggressive B-cell malignancy.  Epstein-Barr virus (EBV) is the infectious agent most strongly associated with BL pathogenesis. EBV infects B cells via the CD21 complement receptor.  Infected cells produce viral proteins that stimulate signaling pathways (eg, JAK/STAT), triggering proliferation.  This proliferation of infected B cells is usually limited by T cells, but some B cells may reduce production of EBV antigens and escape recognition.  An impaired immune response (eg, HIV, persistent malaria) can also enable continuous B-cell division.  Proliferating B cells are more likely to acquire genetic abnormalities (eg, chromosomal translocations), resulting in a neoplastic clone.  BL cells harbor the translocation t(8;14), which causes MYC overexpression, uncontrolled cell growth, and rapid enlargement. Nonendemic BL often involves the gastrointestinal tract, which can present as an enlarging abdominal mass with ascites (due to lymph obstruction) and distention.  Histopathology shows uniform, medium-sized lymphoid cells with basophilic cytoplasm and numerous mitotic figures (indicating high proliferation rate) and apoptotic bodies.  Scattered macrophages, which digest the apoptotic debris, produce the characteristic "starry sky" appearance. (Choice B)  Helicobacter pylori is associated with gastric lymphoma (eg, marginal zone lymphoma of mucosa-associated lymphoid tissue [ie, MALT lymphoma]).  Gastrointestinal MALT lymphomas may cause abdominal discomfort but are typically indolent and slow growing (ie, would have lower proliferation rate).  Rapid abdominal distention would be unusual. (Choice C)  Chronic hepatitis B can cause hepatocellular carcinoma.  Although patients may have abdominal distention and ascites, imaging would reveal a liver mass, not an intestinal lesion.  Histopathology often shows thickened plates of malignant hepatocytes (eg, polygonal cells, eosinophilic cytoplasm). (Choice D)  Human herpesvirus 8 can cause Kaposi sarcoma (KS), a vascular tumor seen in HIV-positive individuals.  Although it can involve the gastrointestinal tract in later stages, KS typically presents initially with cutaneous lesions.  Histopathology often shows spindle-shaped endothelial cells and slit-like vascular spaces. (Choice E)  High-risk human papillomavirus types (eg, 16, 18) have been identified in cervical squamous cell carcinoma.  Histopathology often shows invasive nests of malignant cells with squamous differentiation (eg, intercellular bridges). Educational objective: Burkitt lymphoma, an aggressive B-cell malignancy, can be associated with Epstein-Barr virus infection.  It typically presents as a rapidly growing mass (eg, abdomen).  Histopathology shows sheets of uniform, medium-sized lymphoid cells with numerous mitotic figures (ie, high proliferation rate) and apoptotic bodies.

Burkitt Lymphoma — Ultra High-Yield USMLE Notes


1. Diagnosis: Burkitt Lymphoma — aggressive mature B-cell NHL; EBV association; t(8;14) → MYC overexpression; "starry sky" histology

2. Key clue (1 line): 30M + HIV + rapidly enlarging abdominal mass + ascites + biopsy = uniform medium-sized cells + basophilic cytoplasm + high proliferation + apoptotic bodies → Burkitt lymphoma → EBV

3. Why correct (≤2 lines): EBV infects B-cells via CD21 → stimulates proliferation → immune evasion (especially in HIV/malaria) → B-cells acquire t(8;14) → MYC (chr 8) under IgH promoter (chr 14) → constitutive MYC overexpression → uncontrolled proliferation → nearly 100% proliferation index (Ki-67 ~100%). Histology: sheets of uniform lymphoid cells + numerous mitoses + apoptotic bodies + scattered macrophages = "starry sky" appearance.

4. Why others wrong (1 line each):
  • H. pylori: Gastric MALT lymphoma (marginal zone); indolent/slow growing; low proliferation rate; not rapidly growing intestinal mass
  • Hepatitis B: Hepatocellular carcinoma → liver mass; polygonal cells + eosinophilic cytoplasm; not intestinal lymphoma
  • HHV-8: Kaposi sarcoma → spindle cells + slit-like vascular spaces; starts as skin lesions; not uniform round lymphoid cells
  • HPV 16/18: Cervical squamous cell carcinoma; squamous differentiation + intercellular bridges; not abdominal lymphoma

5. Buzzword triggers:
  • "Starry sky" histologyBurkitt lymphoma (macrophages = stars engulfing apoptotic debris against blue lymphocyte background)
  • t(8;14) → MYC overexpression → Burkitt
  • Ki-67 ~100% = highest proliferation index of any tumor → Burkitt
  • EBV + CD21 (complement receptor) → B-cell tropism
  • Burkitt variants:
    • Endemic (African): EBV+, jaw/facial bones in children
    • Sporadic (non-endemic): Abdominal mass (GI); HIV patients
    • Immunodeficiency-associated: HIV → abdominal/CNS involvement
  • Burkitt markers: CD20+ + CD10+ + BCL6+ + TdT− (mature B-cell → TdT negative)
  • MYC translocations: t(8;14) most common; t(2;8) or t(8;22) variants (other Ig loci)
  • Treatment: intensive chemotherapy (CODOX-M/IVAC); highly curable despite aggressiveness

6. Trap / trick tested:
  • TdT− in Burkitt — mature B-cell lymphoma; students confuse with ALL (TdT+); Burkitt = TdT− + CD20+
  • BCL2− in Burkitt — t(14;18)/BCL2 = follicular lymphoma; Burkitt = t(8;14)/MYC; both involve IgH on chr 14 — different partner genes
  • Starry sky ≠ always malignant — pattern can be seen in other high-turnover lymphomas; but Burkitt + starry sky + t(8;14) + ~100% Ki-67 = classic USMLE combination
  • Jaw mass = endemic Burkitt (EBV+, Africa); abdominal mass = sporadic Burkitt (HIV/immunocompromised)

7. One-liner memory hook:
"EBV enters B-cell via CD21 → t(8;14) gives MYC a megaphone → cells divide madly (Ki-67 100%) + die fast → macrophages eat debris = starry sky; jaw = African/endemic; abdomen = sporadic/HIV; TdT− BCL2− MYC+ = Burkitt."

A 15-year-old girl is evaluated due to persistent fever, fatigue, and sore throat.  Physical examination reveals splenomegaly and symmetric posterior cervical lymphadenopathy.  Peripheral blood smear results are shown in the image below: his patient's fever, fatigue, sore throat, splenomegaly, symmetric posterior cervical lymphadenopathy, and atypical lymphocytosis are characteristic of infectious mononucleosis (IM).  After entering the bloodstream through the pharyngeal mucosa and tonsillar crypts, the Epstein-Barr virus (EBV) preferentially infects B lymphocytes by binding to CD21 cell surface receptors.  EBV-infected B lymphocytes then activate cytotoxic T lymphocytes (CD8+) through the presentation of viral antigens on major histocompatibility complex class I molecules.  These reactive (atypical) CD8+ T lymphocytes are the primary immune response to EBV and clonally expand to destroy virus-infected cells. Atypical lymphocytes make up more than 10% of the cells in a peripheral blood smear in IM, and most (>95%) of those cells are CD8+ T lymphocytes.  They classically appear much larger than quiescent lymphocytes, with abundant basophilic cytoplasm and a cell membrane that conforms to the borders of neighboring cells.  Although activated CD21+ B lymphocytes and CD4+ helper T lymphocytes can have a similar appearance in response to EBV infection, they make up <5% of the atypical lymphocytes in the peripheral circulation (Choices A and D). (Choice C)  Monocytosis can be seen with chronic infections and may be associated with persistent fever, fatigue, and splenomegaly; however, monocytes typically have vacuolated, grayish cytoplasm. (Choice E)  Activated plasma cells appear as ovoid cells with abundant cytoplasm and an eccentric nucleus with a spoke-wheel chromatin pattern.  A zone of perinuclear clearing within the cytoplasm may also be noted, corresponding to the active Golgi body. Educational objective: The primary immune response to Epstein-Barr virus is mediated by CD8+ T lymphocytes, which are activated through the presentation of viral antigens on infected CD21+ B lymphocytes.  These reactive (atypical) CD8+ T lymphocytes can be observed in the peripheral blood smears of patients with infectious mononucleosis.

Infectious Mononucleosis (EBV) — Ultra High-Yield USMLE Notes


1. Diagnosis: Infectious Mononucleosis (EBV) — atypical lymphocytes on smear = reactive CD8+ T lymphocytes (NOT infected B-cells)

2. Key clue (1 line): 15F + fever + fatigue + sore throat + posterior cervical lymphadenopathy + splenomegaly + smear = large atypical lymphocytes with abundant basophilic cytoplasm conforming to neighboring cells → EBV/IM → atypical cells = CD8+ T-cells

3. Why correct (≤2 lines): EBV binds CD21 on B-cells → infects B-cells → viral antigens presented on MHC class I → activates CD8+ cytotoxic T-cells → CD8+ T-cells clonally expand → appear as atypical lymphocytes (>10% of WBCs, >95% are CD8+) on peripheral smear. Atypical lymphocytes = large + abundant basophilic cytoplasm + cell membrane molds to neighboring cells (classic morphology).

4. Why others wrong (1 line each):
  • Activated B-cells (CD21+): EBV infects B-cells but they make up <5% of atypical lymphocytes in circulation; T-cells dominate the response
  • CD4+ helper T-cells: Also activated but comprise <5% of atypical lymphocytes; CD8+ cytotoxic response dominates
  • Monocytes: Vacuolated grayish cytoplasm; chronic infection marker; do NOT mold to neighboring cells
  • Plasma cells: Eccentric nucleus + perinuclear halo (Golgi) + spoke-wheel chromatin; not the atypical lymphocyte of IM

5. Buzzword triggers:
  • Posterior cervical lymphadenopathy → EBV/IM (anterior = bacterial pharyngitis)
  • Atypical lymphocytes (>10%) → IM = reactive CD8+ T-cells
  • EBV receptor: CD21 on B-cells
  • EBV → MHC class I presentation → CD8+ cytotoxic T-cell activation
  • IM diagnosis: heterophile antibody test (Monospot) → IgM agglutinating horse/sheep RBCs
  • IM complications: splenic rupture (avoid contact sports) + airway obstruction + hemolytic anemia + thrombocytopenia + hepatitis
  • Ampicillin/amoxicillin + IMdiffuse maculopapular rash (not true penicillin allergy)
  • EBV associations: IM + Burkitt lymphoma (t(8;14)/MYC) + Hodgkin lymphoma + nasopharyngeal carcinoma + CNS lymphoma (HIV)
  • Atypical lymphocyte morphology: large + basophilic + "hugging" neighboring RBCs (molds to cell borders)

6. Trap / trick tested:
  • Atypical lymphocytes = CD8+ T-cells, NOT infected B-cells — most common USMLE trap; EBV infects B-cells but the atypical cells seen on smear are the reactive T-cell response
  • Posterior vs anterior cervical LN: Posterior = viral (EBV); anterior = bacterial (Strep); USMLE tests location
  • Splenomegaly = rupture risk → no contact sports for 3–4 weeks; splenic rupture = most dangerous acute complication
  • Monospot false negatives: Early infection (<1 week) or young children (<4 years); confirm with EBV-specific antibodies (VCA IgM)
  • Ampicillin rash in IM ≠ penicillin allergy — mechanism unclear; avoid beta-lactams in suspected IM

7. One-liner memory hook:
"EBV infects B-cells (CD21) → B-cells show viral flags (MHC I) → CD8+ T-cells go berserk → atypical lymphocytes flood the blood (>10%); they hug neighboring cells = CD8 T-cells, not B-cells; Monospot + posterior LN + splenomegaly = EBV."

A 28-year-old previously healthy man comes to the office due to episodic fevers, night sweats, and weight loss for several months.  He emigrated from Kenya with his family at age 14.  He does not use tobacco, alcohol, or illicit drugs.  The patient works as a driving instructor and volunteers at a homeless shelter.  His temperature is 37.2 C (99 F).  Physical examination is normal with the exception of cervical lymphadenopathy.  A lymph node biopsy is performed, and histopathologic findings are shown in the image below. his patient most likely has classic Hodgkin lymphoma (HL).  The typical presentation is either nontender lymphadenopathy or lymphadenopathy incidentally detected on routine chest x-ray.  Many patients develop associated systemic B symptoms (fevers, night sweats, weight loss).  HL has a bimodal age distribution with a peak in the 20s (or younger in some countries) and another in the 60s.  The complete blood count and peripheral blood smear are usually unremarkable. A lymph node biopsy can distinguish HL from benign causes of lymphadenopathy.  The key to diagnosing classic HL is detecting the characteristic Reed-Sternberg (RS) cell on hematoxylin and eosin preparation.  RS cells have ample cytoplasm, a multilobed nucleus or multiple nuclei, and inclusion-like nucleoli.  RS cells are seen against a background of lymphocytes, histiocytes, and eosinophils in classic HL. (Choice A)  Burkitt lymphoma often presents as a mass in the abdomen/pelvis (or the jaw in the endemic [African] form, which has a peak incidence in boys around age 5).  However, histology would show a monotonous population of medium-sized lymphoid cells with many tingible body macrophages, giving a "starry sky" appearance.  High numbers of mitotic cells and apoptotic bodies would be seen. (Choice B)  Follicular lymphoma shows aggregates of closely packed, neoplastic lymph node follicles.  Two major cell types, centrocytes (small cleaved cells) and centroblasts (large noncleaved cells), are observed.  Older adults tend to be affected.  Waxing and waning painless lymphadenopathy (typically without B symptoms) is common. (Choice D)  Large B-cell lymphoma is characterized by diffuse sheets of large, atypical lymphoid cells with nuclei at least 5 times the size of small lymphocytes.  RS cells against a background of mixed inflammation is not a characteristic histologic feature of large B-cell lymphoma. (Choice E)  Multiple myeloma, a plasma cell dyscrasia characterized by proliferation of clonal plasma cells, is predominantly a disease of the elderly.  It is characterized by osteolytic lesions, although spread to nodal and extranodal sites can occur. (Choice F)  Tuberculosis is on the differential diagnosis for this patient, who is from Kenya, volunteers at homeless shelters, and has had night sweats and weight loss.  However, histology in tuberculosis would show caseating granulomas, not RS cells. Educational objective: The presence of Reed-Sternberg (RS) cells on lymph node biopsy is a diagnostic feature of classic Hodgkin lymphoma.  RS cells have abundant cytoplasm, a multilobed nucleus or multiple nuclei, and inclusion-like nucleoli.

Hodgkin Lymphoma (Classic) — Ultra High-Yield USMLE Notes


1. Diagnosis: Classic Hodgkin Lymphoma (HL) — Reed-Sternberg (RS) cells on LN biopsy; bimodal age distribution (20s + 60s); B symptoms

2. Key clue (1 line): 28M + episodic fever + night sweats + weight loss (B symptoms) + cervical lymphadenopathy + biopsy = RS cells (owl-eye nucleoli) against mixed inflammatory background → classic Hodgkin lymphoma

3. Why correct (≤2 lines): Classic HL diagnosed by Reed-Sternberg cells: large cells + abundant cytoplasm + bilobed/multilobed nucleus + prominent eosinophilic owl-eye nucleoli + seen against background of lymphocytes + histiocytes + eosinophils. RS cells are malignant transformed B-cells (CD15+ + CD30+) but surrounded by reactive inflammatory cells.

4. Why others wrong (1 line each):
  • Burkitt lymphoma: "Starry sky" + medium uniform cells + high mitoses + t(8;14)/MYC; abdominal/jaw mass; no RS cells
  • Follicular lymphoma: Neoplastic follicles + centrocytes + centroblasts; older adults; waxing/waning LN without B symptoms; t(14;18)/BCL2
  • Diffuse large B-cell lymphoma: Sheets of large atypical lymphoid cells; rapidly enlarging mass; no RS cells or mixed inflammation
  • Multiple myeloma: Elderly + plasma cells + CRAB; osteolytic lesions; not lymphadenopathy
  • Tuberculosis: Caseating granulomas (Langhans giant cells + central necrosis); from Kenya + homeless shelter = TB on differential; no RS cells

5. Buzzword triggers:
  • Reed-Sternberg cells = "owl eyes" (bilobed nucleus + prominent nucleoli) → Hodgkin lymphoma
  • RS cell markers: CD15+ + CD30+ (CD45−, CD20−)
  • B symptoms: fever + night sweats + weight loss >10% = adverse prognosis
  • HL bimodal age: 20s (young adults, EBV-associated) + 60s (elderly)
  • HL spreads contiguously (node to node) → treated with radiation (localized) or ABVD chemo
  • HL subtypes (most → least common):
    • Nodular sclerosis (most common, young women, mediastinal mass, lacunar RS cells)
    • Mixed cellularity (EBV+, older, B symptoms)
    • Lymphocyte rich (best prognosis)
    • Lymphocyte depleted (worst prognosis, HIV)
  • Nodular lymphocyte predominant HL: RS variant = "popcorn cells" (LP cells); CD20+ CD15− CD30−
  • EBV association: strongest in mixed cellularity subtype

6. Trap / trick tested:
  • TB trap: Patient from Kenya + homeless shelter volunteer + B symptoms → TB classic; but RS cells ≠ granulomas; TB = caseating granulomas; HL = RS cells; biopsy differentiates
  • RS cells are not pathognomonic alone — RS-like cells seen in IM, NHL, solid tumors; must be in correct clinical + histologic context (mixed inflammatory background)
  • CD30+ in HL AND anaplastic large cell lymphoma (ALCL) — ALCL also CD30+ but RS-like cells in sheets, not mixed background; ALCL = ALK+ (young) or ALK− (older)
  • NHL spreads non-contiguously (skips nodes); HL spreads contiguously → affects staging and treatment

7. One-liner memory hook:
"Owl eyes (RS cells = CD15+CD30+) in mixed eosinophil/lymphocyte background = Hodgkin; B symptoms + young adult + cervical LN + bimodal age = HL; TB has granulomas not RS cells; HL spreads node-to-node, treat with ABVD."

A 45-year-old man comes to the office due to a week of purulent nasal discharge, headache, sore throat, and nonproductive cough.  He has no significant past medical history except for an episode of infectious mononucleosis at age 22.  The patient smokes a pack of cigarettes daily.  His temperature is 38 C (100.4 F).  He has maxillary sinus tenderness, pharyngeal erythema, and tender anterior cervical lymphadenopathy.  Laboratory results are as follows: Leukocytes 58,000/mm3     Neutrophils 42%     Myelocytes 30%     Metamyelocytes 8%     Band forms 1%     Blast cells 1%     Eosinophils 6%     Basophils 4% is patient with sinusitis is found to have a markedly elevated white blood cell (WBC) count with an increase in myeloid precursor forms on peripheral blood smear.  The differential diagnosis is chronic myelogenous leukemia (CML) (uncontrolled mature granulocyte production, mostly neutrophils but also basophils and eosinophils) or leukemoid reaction (over-exuberant WBC response associated with bacterial infection or malignancy, among others).  Both cause an elevated WBC count (>50,000/mm3) with an increase in precursor forms (eg, bands, metamyelocytes, myelocytes).  However, the enzyme leukocyte (neutrophil) alkaline phosphatase is decreased in CML (as seen in this patient) because the WBCs are cytochemically abnormal; by contrast, it is normal or elevated in a leukemoid reaction (Choice I). Other clues to the diagnosis of CML are the predominance of myelocytes compared to more mature forms such as metamyelocytes ("myelocytic bulge") and the absolute basophilia and eosinophilia.  CML is confirmed by demonstration of the Philadelphia chromosome (translocation between chromosomes 9 and 22) or the BCR-ABL1 fusion gene or mRNA.  Immature blast cells (eg, myeloblasts, promyelocytes) are typically <2%.  Management generally includes a tyrosine kinase inhibitor. (Choice A)  This patient has an abnormality of myeloid (not lymphoid) cells and his smear shows only 1% blasts.  In general, >25% bone marrow lymphoblasts are seen in acute lymphoblastic leukemia, which is much more common in young children. (Choice B)  Acute myelogenous leukemia is the most common acute leukemia in adults.  However, the mean age at diagnosis is around 65, and most patients will have a WBC count of about 15,000-20,000/mm3 with a significant increase in blast cells (eg, >20%) rather than the 1% seen in this patient. (Choices C, F, and G)  Follicular lymphoma, Burkitt lymphoma, and diffuse large B-cell lymphoma cause lymph node and/or soft-tissue (not peripheral blood) abnormalities.  In addition, these cancers are all lymphoid, not myeloid, in nature. (Choice D)  Patients with chronic lymphocytic leukemia have increased circulating mature lymphoid cells, not increased myeloid cells. (Choices H and J)  Parasitic superinfection (which can lead to eosinophilia) and fungal infection would not explain the predominance of myeloid neutrophil precursor forms in this patient. Educational objective: Chronic myelogenous leukemia (CML) and leukemoid reaction can have presentations similar to leukocytosis; however, leukocyte (neutrophil) alkaline phosphatase level is normal or elevated in a leukemoid reaction but decreased in CML.  The definitive diagnosis of CML requires demonstration of the Philadelphia chromosome t(9;22) or BCR-ABL fusion gene or mRNA.

Chronic Myelogenous Leukemia (CML) — Ultra High-Yield USMLE Notes


1. Diagnosis: Chronic Myelogenous Leukemia (CML) — t(9;22) Philadelphia chromosome → BCR-ABL fusion → constitutive tyrosine kinase → ↓LAP + basophilia + myelocytic bulge

2. Key clue (1 line): 45M + WBC 58,000 + myelocytes 30% > metamyelocytes 8% (myelocytic bulge) + basophilia 4% + eosinophilia 6% + blasts only 1% + ↓LAP → CML (not leukemoid reaction)

3. Why correct (≤2 lines): CML = BCR-ABL constitutive tyrosine kinase → uncontrolled mature granulocyte production; smear shows "myelocytic bulge" (myelocytes > metamyelocytes) + absolute basophilia + eosinophilia + <2% blasts + ↓LAP (cytochemically abnormal WBCs). Confirmed by t(9;22)/Philadelphia chromosome or BCR-ABL PCR; treat with imatinib (tyrosine kinase inhibitor).

4. Why others wrong (1 line each):
  • ALL: Lymphoblasts >25% in marrow; lymphoid not myeloid; children predominantly; no basophilia/myelocytic bulge
  • AML: Mean age 65 + blasts >20%; this patient has only 1% blasts; acute not chronic presentation
  • Follicular/Burkitt/DLBCL: Lymphoid + nodal/soft tissue; not peripheral blood myeloid proliferation
  • CLL: ↑mature lymphocytes + smudge cells; CD5+CD19+; not myeloid precursors
  • Leukemoid reaction: WBC >50k + left shift BUT ↑LAP (normal neutrophil enzyme); also no basophilia; triggered by infection

5. Buzzword triggers:
  • t(9;22) Philadelphia chromosome → BCR-ABL → constitutive TK → CML
  • ↓LAP → CML; ↑LAP → leukemoid reaction ← THE KEY PIVOT
  • Myelocytic bulge (myelocytes > metamyelocytes) → CML
  • Absolute basophilia → CML hallmark (basophils release histamine → pruritus)
  • CML blasts <2% chronic phase; blasts 10-19% = accelerated phase; blasts >20% = blast crisis (= AML or ALL)
  • CML treatment: Imatinib (Gleevec) = first-line TKI; inhibits BCR-ABL kinase
  • CML → blast crisis = transformation to AML (myeloid) or ALL (lymphoid)
  • Philadelphia chromosome also in ALL (worse prognosis; 25% adult ALL)
  • Splenomegaly = classic CML finding (extramedullary hematopoiesis)

6. Trap / trick tested:
  • Sinusitis in this patient is a distractor — students diagnose leukemoid reaction from infection; but ↓LAP + basophilia + myelocytic bulge = CML; infection coincidentally present
  • CML vs leukemoid: LAP is the decisive test — both WBC >50k + left shift; basophilia + ↓LAP = CML; no basophilia + ↑LAP = leukemoid
  • Myelocytic bulge: in normal left shift, bands > metamyelocytes > myelocytes; in CML, myelocytes DOMINATE (30% here) = "bulge" at myelocyte stage
  • Philadelphia chromosome ≠ only CML — also in ALL (especially adult ALL, poor prognosis); context determines

7. One-liner memory hook:
"CML = Philadelphia t(9;22) BCR-ABL → myelocytes bulge + basophils appear + LAP disappears; LAP down = CML; LAP up = fighting infection (leukemoid); blast crisis >20% = CML turned AML; imatinib blocks the kinase, kills the clone."

A 52-year-old man comes to the office due to a progressively enlarging neck mass, fatigue, and weight loss over the past 2 months.  Physical examination shows enlarged, firm, and nontender cervical lymph nodes.  The patient also has enlarged tonsils, bilateral axillary lymphadenopathy, and splenomegaly.  Excisional lymph node biopsy reveals diffuse sheets of atypical, large B cells that have replaced the normal tissue architecture.  In situ hybridization of the tissue specimen is positive for Epstein-Barr virus.  Which of the following risk factors is most strongly associated with development of this patient's condition his patient likely has non-Hodgkin lymphoma (NHL).  Depending on the subtype, NHL may present with a rapidly progressive mass, lymphadenopathy, splenomegaly, and B symptoms (eg, night sweats, weight loss).  Diagnosis is typically made with excisional lymph node biopsy, which usually demonstrates a loss of normal tissue architecture with expansion of abnormal lymphocytes (most often B cells, as in this patient with large, atypical B cells). Lymphoma is frequently associated with Epstein-Barr virus (EBV), a ubiquitous herpesvirus that primarily infects B lymphocytes and causes persistent latent infections.  Although viral reactivation is uncommon, the latent EBV genome still transcribes viral gene products that can result in malignant transformation of infected cells.  EBV is particularly associated with nasopharyngeal carcinoma, Hodgkin lymphoma, and some forms of NHL (eg, Burkitt lymphoma). Patients with HIV are at greatest risk for EBV-associated lymphomas (risk is up to 60-fold greater).  This is likely due to HIV-related immune dysregulation, which decreases recognition of EBV-infected cells and promotes B-cell proliferation.  Some types of NHL (eg, primary central nervous system lymphoma) are considered AIDS-defining conditions and can sometimes be the presenting manifestation of HIV infection. (Choice B)  Aspirin and nonsteroidal anti-inflammatory drugs may decrease the risk of colorectal cancer.  Their use is not linked to an increased risk of NHL. (Choice C)  Cigarette smoking is a strong risk factor for the development of many types of cancer (eg, lung, bladder, pancreas) but is not closely linked with the development of NHL. (Choice D)  The link between radiation exposure and the development of NHL is controversial.  However, most studies indicate that this is not a strong risk factor. (Choice E)  Although lower socioeconomic status may be associated with worse outcomes in patients with NHL, this marker has not been closely linked with the development of NHL. Educational objective: Patients with HIV have much higher rates of lymphoma than the general population.  Many cases are due to underlying Epstein-Barr virus infection, which acts synergistically with HIV to promote uncontrolled B lymphocyte proliferation.

EBV-Associated NHL in HIV — Ultra High-Yield USMLE Notes


1. Diagnosis: Diffuse Large B-Cell Lymphoma (DLBCL) — EBV-associated; strongest risk factor = HIV infection (↑risk 60-fold)

2. Key clue (1 line): 52M + enlarging neck mass + fatigue + weight loss + firm nontender cervical/axillary LN + splenomegaly + biopsy = diffuse sheets of large atypical B-cells + EBV in situ hybridization+ → NHL → risk factor = HIV

3. Why correct (≤2 lines): HIV → immune dysregulation → ↓CD8+ T-cell surveillance of EBV-infected B-cells → EBV latent genome transcribes transforming viral proteins → uncontrolled B-cell proliferation → EBV-associated NHL (DLBCL, Burkitt, primary CNS lymphoma). HIV-associated NHL risk = 60x general population; some NHL subtypes (CNS lymphoma) are AIDS-defining conditions.

4. Why others wrong (1 line each):
  • Aspirin/NSAIDs: May ↓colorectal cancer risk; no association with NHL development
  • Cigarette smoking: Strong risk for lung/bladder/pancreatic cancer; not closely linked to NHL
  • Radiation exposure: Link to NHL controversial; not a strong risk factor in most studies
  • Lower socioeconomic status: Associated with worse NHL outcomes; not linked to NHL development

5. Buzzword triggers:
  • HIV + EBV + NHL → ↑60-fold lymphoma risk
  • EBV-associated malignancies: Burkitt lymphoma (t(8;14)/MYC) + Hodgkin lymphoma (mixed cellularity) + Nasopharyngeal carcinoma + DLBCL (HIV) + Primary CNS lymphoma (AIDS-defining)
  • Primary CNS lymphoma = EBV+ + HIV/AIDS + ring-enhancing lesion on MRI (also seen in toxoplasmosis — differentiate by Toxo serology + empiric treatment response)
  • DLBCL: most common NHL overall; rapidly enlarging nodal/extranodal mass; CD20+; treat with R-CHOP (rituximab + cyclophosphamide + doxorubicin + vincristine + prednisone)
  • EBV mechanism: latent infection → LMP1/LMP2A viral proteins → mimic CD40/BCR signaling → B-cell survival + proliferation without antigen
  • AIDS-defining lymphomas: Primary CNS lymphoma + Burkitt lymphoma + immunoblastic lymphoma

6. Trap / trick tested:
  • Smoking trap: Common cancer risk factor but NOT NHL — students reflexively choose smoking for any cancer question; NHL risk factors = immunosuppression/HIV, EBV, autoimmune disease, prior chemotherapy
  • Radiation trap: Strong risk for many cancers (leukemia, thyroid, breast) but NOT strongly linked to NHL — commonly tested misconception
  • Primary CNS lymphoma vs toxoplasmosis (both ring-enhancing in HIV): toxo = multiple lesions + positive serology + responds to empiric pyrimethamine/sulfadiazine; CNS lymphoma = single lesion + EBV in CSF + SPECT/PET positive
  • EBV establishes latent infection (not lytic) in B-cells → latent proteins drive transformation; immune suppression removes T-cell check on latently infected B-cells

7. One-liner memory hook:
"HIV removes T-cell guards → EBV-infected B-cells run wild → NHL (DLBCL/Burkitt/CNS lymphoma); HIV = 60x NHL risk; CNS lymphoma = AIDS-defining + EBV+ + ring-enhancing; R-CHOP treats DLBCL; smoking kills lungs not lymph nodes."

A 46-year-old smoker presents to your office with a three week history of low-grade fever, weakness and neck swelling. Biopsy of the affected tissue reveals the following histologic findings: order to answer this question, you must be able to recognize the characteristic histology.  The tissue biopsy shows numerous lymphocytes (small cells with dark, round nuclei and a small rim of cytoplasm), meaning that it was most likely taken from a lymph node.  The key finding is the giant binucleated cell, a Reed-Sternberg (RS) cell, in the center of the slide.  RS cells are derived from germinal center B-lymphocytes and are the neoplastic cells of Hodgkin lymphoma (HL).  RS cells must be present in order to make the diagnosis of HL.  The two mirror-image nuclei of RS cells are often described as having the appearance of "owl's eyes." (Choice A)  The respiratory epithelium is a pseudostratified columnar ciliated epithelium that extends down to the level of the bronchioles.  At the bronchioles, the epithelium gradually becomes cuboidal and then transitions to a flat, single-celled alveolar lining of Type I pneumocytes. (Choice B)  A goiter may cause neck swelling.  Histologically, Hashimoto thyroiditis has the appearance of lymphocytes infiltrating between thyroid follicles. (Choice D)  Reed-Sternberg cells are not associated with leukemia.  The classic finding in patients with leukemia is a peripheral blood smear with leukemic cells, leukocytosis and thrombocytopenia. (Choice E)  Both melanoma and squamous cell carcinoma can metastasize from the skin causing lymphadenopathy.  The cells on this tissue biopsy show no evidence of squamous or melanocytic differentiation, however. Educational Objective: Reed-Sternberg cells are large binucleated cells with an "owl's eyes" appearance that appear on a background of lymphocytic infiltrates.  Reed-Sternberg cells must be present histopathologically in order to make the diagnosis of Hodgkin lymphoma.

Hodgkin Lymphoma — Reed-Sternberg Cells — Combined Ultra High-Yield USMLE Notes


1. Diagnosis: Hodgkin Lymphoma (HL) — Reed-Sternberg (RS) cells = large binucleated "owl-eye" cells from germinal center B-cells; required for diagnosis

2. Key clue (1 line): 46M + smoker + 3 weeks fever + weakness + neck swelling + biopsy = giant binucleated cell (RS cell) with prominent eosinophilic owl-eye nucleoli against lymphocyte background → Hodgkin lymphoma

3. Why correct (≤2 lines): RS cells = malignant transformed germinal center B-cells (CD15+ + CD30+ + CD45−) → must be present in appropriate inflammatory background (lymphocytes + histiocytes + eosinophils) to diagnose classic HL. Bimodal age peak (20s + 60s); B symptoms (fever + night sweats + weight loss) = adverse prognosis marker.

4. Why others wrong (1 line each):
  • Respiratory epithelium: Pseudostratified ciliated columnar → bronchioles → cuboidal → Type I pneumocytes; no RS cells; not lymph node
  • Hashimoto thyroiditis: Lymphocytes infiltrating thyroid follicles; causes neck swelling/goiter; no RS cells; thyroid not lymph node
  • Leukemia: Peripheral blood blasts + leukocytosis + thrombocytopenia; RS cells NOT associated with leukemia
  • Metastatic melanoma/SCC: Squamous or melanocytic differentiation on biopsy; no RS cells; different morphology entirely

5. Buzzword triggers:
  • Reed-Sternberg cell = "owl eyes" = binucleated + prominent eosinophilic nucleoli → Hodgkin lymphoma
  • RS cell markers: CD15+ + CD30+ (CD20− + CD45−) ← classic HL
  • Nodular lymphocyte predominant HL: RS variant = "popcorn/LP cells"CD20+ CD15− CD30−
  • HL subtypes + RS cell variants:
    • Nodular sclerosis (most common): lacunar RS cells + collagen bands; young women + mediastinal mass
    • Mixed cellularity: classic RS cells + EBV+; older adults + B symptoms
    • Lymphocyte rich: sparse RS cells; best prognosis
    • Lymphocyte depleted: many RS cells + few lymphocytes; worst prognosis; HIV
  • HL spreads contiguously (node-to-node) → Ann Arbor staging guides treatment
  • Treatment: ABVD (Adriamycin + Bleomycin + Vinblastine + Dacarbazine) ± radiation
  • Pel-Ebstein fever = cyclical fever pattern (high then afebrile) = classic HL B symptom
  • Alcohol-induced pain at lymph node sites = pathognomonic HL symptom (rare but USMLE favorite)

6. Trap / trick tested:
  • RS cells alone ≠ HL diagnosis — RS-like cells seen in IM, ALCL, solid tumors; must have correct clinical context + inflammatory background
  • CD20− in classic HL (despite B-cell origin) → rituximab (anti-CD20) NOT used in classic HL; used in nodular lymphocyte predominant HL (CD20+)
  • Smoking as distractor: Strong risk for lung/bladder cancer; NOT a risk factor for HL; demographic detail only
  • Hashimoto thyroiditis trap: Also causes neck swelling + lymphocytes; biopsy distinguishes — thyroid follicles vs RS cells in lymph node

7. One-liner memory hook:
"Owl eyes = RS cells = CD15+CD30+ malignant B-cells = Hodgkin lymphoma; must see RS cells to diagnose HL; B symptoms + bimodal age + contiguous spread + ABVD treatment; alcohol hurts the nodes = pathognomonic HL clue."

A 6-year-old boy is brought to the clinic due to recurrent nosebleeds over the last couple of weeks.  The patient has no chronic medical conditions and takes no medications.  Vital signs are normal.  On physical examination, there is conjunctival pallor.  The nares have dried, crusted blood with no active bleeding.  The oropharynx is clear.  Neck examination shows enlarged, palpable lymph nodes bilaterally.  Cardiopulmonary examination is unremarkable.  The abdomen is soft and nontender, with the liver measuring 4 cm below the costal margin.  There are scattered petechiae along the trunk.  Complete blood count is as follows: Hemoglobin 9.0 g/dL Platelets 20,000/mm3 Leukocytes 35,500/mm3 Flow cytometry of the peripheral blood demonstrates a distinct population of cells that express terminal deoxynucleotidyl transferase (TdT), CD10, and CD19.  Myeloperoxidase (MPO) is negative.  Which of the following is the most likely diagnosis? his child with marked leukocytosis has lymphadenopathy, hepatomegaly, and signs of bone marrow failure (eg, pallor from anemia, bleeding/petechiae from thrombocytopenia).  These findings are concerning for acute leukemia, which occurs due to clonal expansion of hematopoietic progenitor cells (ie, blast cells).  Blasts may be either lymphoid or myeloid in origin.  Immunophenotyping (eg, flow cytometry) is used to characterize blast cells and classify acute leukemia. This patient's cells are lymphoid in origin.  Lymphoid cells typically lack myeloperoxidase (MPO), an enzyme involved in microbial killing by myeloid derivatives (eg, neutrophils).  Immature lymphocytes (lymphoblasts) can be differentiated from mature lymphocytes by the presence of terminal deoxynucleotidyl transferase (TdT); TdT is a DNA polymerase involved in V(D)J recombination, which generates antigen receptor diversity during early lymphoid maturation.  Therefore, this patient has acute lymphoblastic leukemia (ALL). ALL can be subdivided into B-lymphoblastic leukemia (B-ALL) or T-lymphoblastic leukemia (T-ALL) based on the following markers: B lymphoblasts:  CD10, CD19, CD20, CD22, CD79a (typically CDs ≥10) T lymphoblasts:  CD2, CD3, CD4, CD5, CD7, CD8 (typically CDs <10) This patient's cells express both CD10 and CD19, findings consistent with B-ALL. (Choice A)  Acute promyelocytic leukemia (APML), a type of acute myeloid leukemia, can also present with bone marrow failure.  However, APML would not express TdT, CD19, and CD10.  Blast features that indicate a myeloid lineage include the expression of MPO and presence of Auer rods (needle-like cytoplasmic structures representing fused granules). (Choice C)  Burkitt lymphoma can present with lymphadenopathy and disseminated disease, including bone marrow failure.  Although the malignant cells express B-cell markers (eg, CD19), they do not express TdT because the cell of origin is a mature, not a progenitor, B cell. (Choice D)  Mature T-cell leukemia is derived from mature or postthymic T cells, and immunophenotyping would reveal the presence of T-cell markers (eg, CD3) and the absence of TdT.  Moreover, this is an uncommon neoplasm typically seen in adults, not young children. (Choice E)  Immunophenotyping of cells in T-ALL, which typically presents in adolescents with a mediastinal mass, would show expression of TdT but would also express T-cell, not B-cell, markers. Educational objective: Acute lymphoblastic leukemia typically presents with signs/symptoms of bone marrow failure (eg, bleeding due to thrombocytopenia).  Immunophenotyping by flow cytometry establishes the specific subtype; B-lymphoblastic leukemia shows expression of terminal deoxynucleotidyl transferase (TdT) (marker expressed in lymphoblasts) and B-cell markers (eg, CD10, CD19).

B-Cell Acute Lymphoblastic Leukemia (B-ALL) — Ultra High-Yield USMLE Notes


1. Diagnosis: B-ALL (B-Lymphoblastic Leukemia) — TdT+ + CD10+ + CD19+ + MPO−; most common childhood malignancy

2. Key clue (1 line): 6-year-old boy + recurrent epistaxis + pallor + petechiae + lymphadenopathy + hepatomegaly + ↑WBC + ↓Hgb + ↓↓platelets + TdT+ + CD10+ + CD19+ + MPO−B-ALL

3. Why correct (≤2 lines): B-ALL = clonal expansion of immature B-cell precursors; TdT+ (V(D)J recombination marker = lymphoblast) + CD19/CD10 (B-cell markers) + MPO− (not myeloid) = B-ALL fingerprint. Bone marrow replacement → pancytopenia (anemia + thrombocytopenia + functional neutropenia) + hepatosplenomegaly + lymphadenopathy from blast infiltration.

4. Why others wrong (1 line each):
  • APML (AML-M3): Myeloid → MPO+ + Auer rods + TdT−; t(15;17) + DIC; no CD10/CD19
  • Burkitt lymphoma: Mature B-cell → TdT− + CD19+; jaw/abdominal mass; t(8;14)/MYC; high Ki-67
  • Mature T-cell leukemia: TdT− + T-cell markers (CD3+); uncommon; adults not children
  • T-ALL: TdT+ but CD3+ (not CD19/CD10); adolescent males + mediastinal mass; not young child

5. Buzzword triggers:
  • TdT+ + CD10+ + CD19+ + MPO−B-ALL
  • TdT+ + CD3+ + CD7+ + MPO−T-ALL
  • MPO+ + CD13/33 + TdT− + Auer rodsAML
  • CD10 = CALLA (common ALL antigen) → B-ALL marker
  • B-ALL most common in children age 2–5; best prognosis of all leukemias in children
  • B-ALL associations: Down syndrome (↑risk) + t(12;21) ETV6-RUNX1 (most common translocation, good prognosis) + t(9;22) BCR-ABL (worst prognosis B-ALL)
  • ALL CNS involvement → intrathecal methotrexate prophylaxis
  • ALL treatment: induction (vincristine + prednisone + asparaginase) → consolidationmaintenance
  • B-ALL immunophenotype: TdT + CDs ≥10 (CD10, 19, 20, 22); T-ALL = TdT + CDs <10 (CD2, 3, 4, 5, 7, 8)

6. Trap / trick tested:
  • TdT distinguishes ALL from mature lymphomas: Burkitt (mature B-cell) = TdT−; ALL (immature precursor) = TdT+; key concept
  • B-ALL vs T-ALL by CD markers: Both TdT+; B = CD≥10 (CD10/19/20); T = CD<10 (CD2/3/4/5/7/8)
  • Down syndrome + leukemia: <5 years = AML (specifically AML-M7, megakaryoblastic); >5 years = ALL (B-ALL) — age matters
  • Hepatomegaly + lymphadenopathy in child with cytopenias = leukemia until proven otherwise; do NOT diagnose reactive without ruling out blast infiltration

7. One-liner memory hook:
"Child + petechiae + pallor + lymphadenopathy + TdT+(immature) + CD10/19+(B-cell) + MPO−(not myeloid) = B-ALL; CDs ≥10 = B-ALL; CDs <10 + mediastinal mass = T-ALL; TdT− + CD19 = mature B (Burkitt); MPO+ + Auer rods = AML."

A 64-year-old man is brought to the hospital by ambulance after being found unresponsive by his brother.  Despite resuscitative efforts, he dies shortly thereafter.  The family reports that the patient had 2 months of progressive fatigue and an unintentional weight loss prior to the episode.  Autopsy examination reveals a massive pulmonary embolus, and a cross-section of the liver shows the following: he cross-section of the liver shows a large, solid, yellow-green nodule with multiple smaller nodules, consistent with hepatocellular carcinoma (HCC).  Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections dramatically increase the risk of HCC.  Ongoing infection with either virus leads to increased hepatocyte turnover, which increases the risk for genetic mutations and malignant transformation.  However, HBV has several additional mechanisms that promote HCC, including the following: Integration into the host genome – Nearly 90% of patients with chronic HBV who develop HCC have evidence of HBV DNA in the chromosomes of tumor cells.  HBV is a partially double-stranded DNA virus that is repaired to form a closed circular DNA strand.  HBV DNA is often inserted into the cellular genome, although this is not required for viral replication (unlike HIV).  Integration into regions that control cell growth and differentiation can result in tumorigenesis. Production of oncogenic viral proteins – HBV produces a viral protein called HBx that is a transcriptional activator of several genes associated with cellular growth.  It also interferes with the function of p53, an important tumor-suppressor protein. (Choices A and C)  Cytomegalovirus and Epstein-Barr virus are members of the Herpesviridae family.  Both have double-stranded DNA genomes and cause acute infection followed by latent infection.  Cytomegalovirus is not particularly associated with cancer, but Epstein-Barr infection is linked to nasopharyngeal carcinoma and hematologic malignancies.  However, neither virus is strongly associated with development of HCC. (Choice B)  Entamoeba histolytica is a protozoal infection that is typically acquired by ingesting contaminated food or water in developing countries.  A minority of patients develop invasive disease with liver abscess.  This usually presents with fever and right-upper quadrant pain; the organism does not incorporate its genome into host cells. (Choice E)  Chronic HCV infection dramatically increases the risk of HCC.  However, HCV is an RNA virus (that does not have reverse transcriptase) and is unable to integrate into the host genome. (Choice F)  Human papilloma virus is a double-stranded DNA virus of the papillomavirus family.  HPV produces oncogenic proteins and is able to integrate into the host chromosome.  However, HPV is not linked with liver cancer; it typically causes cervical and oropharyngeal cancer. Educational objective: Both hepatitis B (HBV) and hepatitis C virus infections increase the risk of hepatocellular carcinoma due to chronic hepatic inflammation and cell turnover.  HBV is also carcinogenic due to the production of oncogenic proteins and the insertion of the HBV genome into host chromosomes.

Hepatocellular Carcinoma (HCC) — HBV Mechanism — Ultra High-Yield USMLE Notes


1. Diagnosis: Hepatocellular Carcinoma (HCC) — caused by Hepatitis B virus (HBV); mechanisms = genome integration + HBx oncogenic protein + p53 inhibition

2. Key clue (1 line): 64M + 2 months fatigue + weight loss + autopsy = large solid yellow-green liver nodule + smaller satellite nodules + massive PE → HCC → caused by HBV (genome integrating DNA virus)

3. Why correct (≤2 lines): HBV = partially double-stranded DNA virus → repaired to cccDNA → integrates into host genome (90% of HBV-associated HCC) → disrupts growth control genes + produces HBx protein (transcriptional activator of growth genes + inhibits p53 tumor suppressor) → malignant transformation. Chronic HBV → ↑hepatocyte turnover → ↑mutation rate → HCC (even without cirrhosis).

4. Why others wrong (1 line each):
  • CMV: dsDNA herpesvirus; latent infection; not strongly associated with any cancer; no liver carcinogenesis
  • EBV: dsDNA herpesvirus; linked to nasopharyngeal carcinoma + HL + Burkitt; not HCC
  • Entamoeba histolytica: Protozoan → liver abscess (fever + RUQ pain); no genome integration; no malignant transformation
  • HCV: RNA virus → cannot integrate into host genome (no reverse transcriptase); causes HCC via inflammation/cirrhosis only; not via genome insertion
  • HPV: dsDNA + integrates into host chromosome + oncogenic proteins (E6/E7); causes cervical + oropharyngeal cancer; not liver cancer

5. Buzzword triggers:
  • HBV → HCC via: (1) genome integration + (2) HBx protein + (3) p53 inhibition + (4) chronic inflammation
  • HCV → HCC via: chronic inflammation + cirrhosis only (RNA virus, no integration)
  • HCC risk factors: HBV > HCV > alcoholic cirrhosis > hemochromatosis > aflatoxin (Aspergillus)
  • HBV unique: Can cause HCC without cirrhosis (direct genomic integration); HCV usually requires cirrhosis first
  • HCC tumor marker: ↑AFP (alpha-fetoprotein)
  • HCC appearance: yellow-green (bile-producing) + vascular (hepatic artery supply) → prone to vascular invasion → PE/tumor emboli
  • HBV genome: partially dsDNA → repaired to cccDNA (covalently closed circular DNA) → template for viral transcription + integration
  • HBV vaccination: prevents HCC (only vaccine that prevents a cancer)
  • AFP monitoring: cirrhotic patients → AFP + ultrasound every 6 months → HCC surveillance

6. Trap / trick tested:
  • HCV ≠ genome integration — RNA virus without reverse transcriptase; students confuse HBV and HCV mechanisms; HCV causes HCC but ONLY through inflammation/cirrhosis, never integration
  • HBV can cause HCC without cirrhosis — important distinction; direct oncogenic mechanisms (HBx + p53 inhibition + integration) act independently of fibrosis
  • Massive PE in HCC = tumor invades hepatic veins/IVC → tumor emboli → pulmonary emboli; classic HCC complication explaining sudden death
  • HPV trap: Also integrates + inhibits p53 (E6 degrades p53); but causes cervical/oropharyngeal not liver cancer

7. One-liner memory hook:
"HBV DNA burrows into liver chromosomes → HBx silences p53 + activates growth genes → HCC without needing cirrhosis; HCV = RNA, no integration, needs cirrhosis first; only HBV vaccine prevents its cancer; AFP monitors for HCC."

A 43-year-old man comes to the hospital due to recurrent episodes of fever and sore throat despite multiple antibiotic courses.  For the past several months, he has also felt "run down" and fatigued all the time.  His wife adds that he bruises easily and has had bleeding gums on several occasions.  Temperature is 37.8 C (100.2 F).  On physical examination, he has mucosal pallor, pharyngeal erythema, and multiple ecchymoses on his extremities.  Peripheral blood smear is shown in the image below: his patient has recurrent infections (likely reflecting neutropenia), pallor (anemia), and ecchymoses (thrombocytopenia), with a peripheral blood smear that shows several abnormal myeloid precursors containing rod-shaped intracytoplasmic granules called Auer rods.  This presentation is characteristic of acute myeloid leukemia (AML).  The M3 variant of AML, acute promyelocytic leukemia (APML), is characterized by the presence of abnormal promyelocytes on smear, typically containing abundant cytoplasmic granules, multiple Auer rods, and bilobed nuclei. Affected cells exhibit the cytogenetic abnormality t(15;17).  This cytogenetic change represents a translocation between the retinoic acid receptor alpha (RARα) gene on chromosome 17 and the promyelocytic leukemia (PML) gene on chromosome 15.  Fusion of these 2 genes produces a chimeric gene product, PML/RARα, which codes for an abnormal retinoic acid receptor.  This abnormal fusion gene inhibits promyelocyte differentiation and triggers the development of APML. APML is associated with disseminated intravascular coagulation (ie, bleeding, thrombocytopenia, prolonged prothrombin and activated thromboplastin time).  Prompt management with all-trans retinoic acid is essential. (Choice A)  Burkitt lymphoma is associated with t(8;14).  This translocation between the MYC protooncogene on chromosome 8 and the Ig heavy chain region on chromosome 14 leads to increased production of the MYC oncoprotein.  In the blood smear, the neoplastic cells show basophilic cytoplasm with lipid vacuoles. (Choice B)  Translocation of the ABL1 gene from chromosome 9 to chromosome 22 is characteristic of chronic myeloid leukemia.  t(9;22) forms the Philadelphia chromosome and results in the formation of a new gene, BCR-ABL1, whose product has constitutive tyrosine kinase activity.  Blood smear typically shows numerous mature and immature myeloid cells. (Choice C)  Mantle cell lymphoma is a B-cell malignancy associated with t(11;14).  This translocation results in activation of the cyclin D1 gene.  Blood smear shows lymphoid cells with irregular nuclei. (Choice E)  Deletion of 13q is one of the molecular defects seen in chronic lymphocytic leukemia, which is characterized by small, mature lymphocytes as well as smudge cells in the blood smear. Educational objective: The presence of rod-shaped intracytoplasmic inclusions (known as Auer rods) is characteristic of many forms of acute myeloid leukemia (AML).  The M3 variant of AML, acute promyelocytic leukemia, is associated with the cytogenetic abnormality t(15;17) and typically shows abnormal promyelocytes with abundant cytoplasmic granules, multiple Auer rods, and bilobed nuclei.

Acute Promyelocytic Leukemia (APML/AML-M3) — Combined Ultra High-Yield USMLE Notes


1. Diagnosis: Acute Promyelocytic Leukemia (APML, AML-M3) — t(15;17) → PML-RARα → differentiation block + DIC; treat with ATRA

2. Key clue (1 line): 43M + recurrent infections + fatigue + easy bruising + bleeding gums + smear = abnormal promyelocytes + abundant granules + multiple Auer rods (faggot cells) + bilobed nuclei → APML → t(15;17)

3. Why correct (≤2 lines): t(15;17) fuses PML (chr 15) + RARα (chr 17) → chimeric PML-RARα receptor → blocks promyelocyte differentiation → accumulation of granule-laden promyelocytes → marrow failure (pancytopenia) + DIC (granules activate coagulation cascade). ATRA (pharmacologic retinoic acid) → overcomes PML-RARα block → promyelocytes differentiate → DIC resolves.

4. Why others wrong (1 line each):
  • t(8;14) — Burkitt lymphoma: MYC + IgH → mature B-cell NHL; basophilic cytoplasm + lipid vacuoles on smear; not myeloid
  • t(9;22) — CML: BCR-ABL constitutive TK → mature granulocytes + left shift; chronic course + ↓LAP; not APML
  • t(11;14) — Mantle cell lymphoma: Cyclin D1 activation → B-cell NHL; irregular lymphoid nuclei on smear; not myeloid blasts
  • Del(13q) — CLL: Mature small lymphocytes + smudge cells; CD5+CD19+; indolent; not acute myeloid

5. Buzzword triggers:
  • t(15;17) + Auer rod bundles (faggot cells)APML (AML-M3)
  • DIC + AML → APML until proven otherwise
  • ATRA = all-trans retinoic acid → differentiation therapy (not cytotoxic)
  • Key translocations summary:
    • t(15;17) → APML → ATRA + arsenic trioxide
    • t(8;21) → AML-M2 → good prognosis
    • t(8;14) → Burkitt → MYC
    • t(9;22) → CML → imatinib
    • t(14;18) → Follicular lymphoma → BCL2
    • t(11;14) → Mantle cell → cyclin D1
    • t(11;22) → Ewing sarcoma
  • APML DIC labs: ↑PT + ↑aPTT + ↓fibrinogen + ↑D-dimer + ↓platelets
  • Faggot cells = multiple Auer rods in single promyelocyte = pathognomonic APML
  • RARα normal function: retinoic acid binds → promotes myeloid differentiation; PML-RARα blocks this

6. Trap / trick tested:
  • DIC in leukemia = APML — any AML + DIC on USMLE → think M3 first; granule contents (tissue factor-like) activate clotting cascade
  • ATRA mechanism: Not chemotherapy — induces differentiation of blocked promyelocytes; unique "differentiation therapy" concept in oncology
  • Faggot cells vs single Auer rod: Single Auer rod = any AML subtype; multiple Auer rods (faggot cells) = APML specifically
  • DIC paradox: bleeding + clotting simultaneously — consumption of clotting factors + platelets → bleeding; microvascular thrombi → organ ischemia

7. One-liner memory hook:
"t(15;17) = PML meets RARα → promyelocytes frozen with granule bundles (faggot cells) → DIC from granule release; ATRA unlocks the freeze → cells mature → DIC resolves; Auer rod bundles = APML stamp; DIC + leukemia = always think M3."

A 54-year-old, previously healthy man comes to the clinic due to progressive, generalized weakness and easy fatigability that started 2 months ago.  He also describes abdominal discomfort and early satiety.  The patient works as a security advisor and has not traveled recently.  He is afebrile, and other vital signs are normal.  Examination is significant for pallor, abdominal distension, and massive splenomegaly with the spleen tip crossing the midline.  No peripheral lymphadenopathy is present.  Peripheral blood cell count shows pancytopenia.  Bone marrow aspiration is attempted, but no marrow can be obtained.  Which of the following findings is most likely to be seen in this patient? Explanation Hairy cell leukemia Epidemiology Indolent mature B-cell neoplasm Middle-aged men Pathogenesis BRAF activating mutation → ↑ cell survival & proliferation Clinical manifestations Pancytopenia (due to bone marrow fibrosis) Fatigue & weakness Recurrent infections Bleeding & bruising Splenomegaly (may be massive) Diagnosis Peripheral blood: lymphocytes with hair-like cytoplasmic projections Bone marrow biopsy with flow cytometry This patient's presentation is concerning for hairy cell leukemia (HCL), an indolent B-cell neoplasm predominantly diagnosed in middle-aged men.  Most cases are due to a BRAF activating mutation that increases B-cell survival, leading to increased cellular proliferation and infiltration of the bone marrow and reticuloendothelial system. Bone marrow infiltration and cytokine production cause fibrosis and bone marrow failure, resulting in pancytopenia.  Bone marrow aspiration is usually unsuccessful (ie, dry tap), but peripheral blood smear often shows neoplastic lymphocytes with characteristic cytoplasmic projections (ie, hairy cells).  Splenic red pulp infiltration can result in massive splenomegaly (ie, crossing midline or extending into the left lower quadrant).  Common manifestations include left upper quadrant pain as well as fatigue, recurrent infections, and bleeding (due to pancytopenia). The diagnosis is made using bone marrow biopsy along with immunophenotyping by flow cytometry.  These studies can distinguish HCL from other causes of massive splenomegaly and marrow fibrosis, such as primary myelofibrosis (a myeloproliferative neoplasm that shows circulating immature neutrophils, nucleated erythrocytes, and teardrop cells).  Flow cytometry has generally replaced tartrate-resistant acid phosphatase (TRAP) activity testing. (Choice A)  Intraerythrocytic ring forms are seen in malaria, which may cause splenomegaly.  However, this patient has no travel history and no fever to suggest malaria. (Choice C)  Myeloid cells with azurophilic rod-like granules (Auer rods) can be found in acute myeloid leukemia (AML).  Although AML often presents with pancytopenia, it does not typically cause splenomegaly. (Choice D)  Heterophile antibodies are found in most patients with Epstein-Barr virus–induced infectious mononucleosis, which commonly affects young adults and presents with low-grade fever, pharyngitis, and cervical lymphadenopathy.  Mild hepatosplenomegaly may be present; massive splenomegaly is uncommon. (Choice E)  Ring sideroblasts are abnormal erythrocyte precursors characterized by mitochondrial iron accumulation surrounding the nucleus; they can be found in myelodysplastic syndrome (MDS).  Patients with MDS typically have petechiae, weakness, and recurrent infections due to pancytopenia, but splenomegaly is uncommon. Educational objective: Hairy cell leukemia is an indolent B-cell neoplasm predominantly found in middle-aged men.  It is characterized by bone marrow failure and infiltration into the reticuloendothelial system, causing massive splenomegaly.  Other typical features include a dry tap (unsuccessful bone marrow aspiration) and the presence of lymphocytes with cytoplasmic projections.

Hairy Cell Leukemia (HCL) — Ultra High-Yield USMLE Notes


1. Diagnosis: Hairy Cell Leukemia (HCL) — indolent mature B-cell neoplasm; BRAF V600E mutation; middle-aged men; dry tap + massive splenomegaly + hairy cells

2. Key clue (1 line): 54M + progressive weakness + massive splenomegaly (crossing midline) + pancytopenia + dry tap (no marrow obtained) → HCL → smear = lymphocytes with circumferential hairy cytoplasmic projections

3. Why correct (≤2 lines): BRAF V600E mutation → ↑B-cell survival/proliferation → infiltrate bone marrow → fibrosis (dry tap) + infiltrate splenic red pulp → massive splenomegaly; hairy cells = neoplastic B-cells with irregular cytoplasmic projections visible on peripheral smear. Diagnosis: flow cytometry (CD19+ + CD20+ + CD11c+ + CD25+ + CD103+) + bone marrow biopsy; formerly confirmed by TRAP staining (tartrate-resistant acid phosphatase).

4. Why others wrong (1 line each):
  • Intraerythrocytic ring forms (malaria): Requires travel history + fever; no travel here; no pancytopenia/dry tap from malaria
  • Auer rods (AML): Myeloid blasts + pancytopenia; no massive splenomegaly typically; acute not indolent
  • Heterophile antibodies (EBV/IM): Young adults + fever + pharyngitis + mild hepatosplenomegaly; massive splenomegaly uncommon; not middle-aged man
  • Ring sideroblasts (MDS): Mitochondrial iron accumulation around nucleus; pancytopenia + petechiae; splenomegaly uncommon in MDS

5. Buzzword triggers:
  • Middle-aged man + massive splenomegaly + pancytopenia + dry tapHCL
  • Hairy cells = lymphocytes with circumferential cytoplasmic projections on smear
  • BRAF V600E mutation → HCL (same mutation in melanoma)
  • TRAP+ (tartrate-resistant acid phosphatase) → HCL (historical test; replaced by flow cytometry)
  • HCL flow cytometry: CD19+ CD20+ CD11c+ CD25+ CD103+ (CD103 = most specific)
  • Dry tap causes: HCL + myelofibrosis + aplastic anemia + metastatic marrow
  • HCL vs myelofibrosis (both dry tap + splenomegaly): HCL = mature B-cells + hairy projections; myelofibrosis = teardrop cells + immature granulocytes + nucleated RBCs + JAK2 mutation
  • HCL treatment: cladribine (2-CdA) = purine analog; single course → durable remission
  • HCL: no lymphadenopathy (distinguishes from lymphoma) + splenic red pulp infiltration (vs white pulp in lymphoma)

6. Trap / trick tested:
  • No lymphadenopathy in HCL — students expect lymphadenopathy in any B-cell neoplasm; HCL specifically causes splenomegaly without lymphadenopathy
  • Dry tap differential: Both HCL and myelofibrosis give dry taps; myelofibrosis = teardrop cells + leukoerythroblastic picture; HCL = hairy cells + no teardrop cells
  • TRAP stain replaced by flow cytometry — exam may still test TRAP+ as HCL marker; both are correct
  • AML trap: pancytopenia present but no massive splenomegaly; HCL has massive splenomegaly as defining feature

7. One-liner memory hook:
"Middle-aged man + spleen crosses midline + pancytopenia + dry tap + hairy cytoplasmic projections = HCL; BRAF V600E + CD103+ + TRAP+ = HCL fingerprint; no lymph nodes, just a giant spleen; one course of cladribine = cured."

Certain patients with non-small cell lung cancer develop constitutive tumor kinase activity due to the production of echinoderm microtubule-associated protein-like 4 - anaplastic lymphoma kinase (EML4-ALK), a fusion protein that contributes to carcinogenesis.  This is most similar to the molecular pathophysiology of which of the following disorders?  A. Burkitt lymphoma  (11%)  B. Chronic myelogenous leukemia  (66%)  C. Follicular lymphoma  (8%)  D. Li-Fraumeni syndrome  (8%)  E. Mantle cell lymphoma  (5%) proximately four percent of patients with non-small cell lung carcinoma (NSCLC) have an inversion of the short arm of chromosome 2 that creates a fusion gene between EML4 (echinoderm microtubule-associated protein-like 4) and ALK (anaplastic lymphoma kinase).  This results in a constitutively active tyrosine kinase that causes malignancy.  Interestingly, patients who harbor this gene fusion are usually young non-smokers, often with adenocarcinoma, who lack mutations in either the epidermal growth factor receptor gene or the K-ras gene.  The kinase activity of this fusion protein is a target of the protein kinase inhibitor, crizotinib. The pathophysiology of EML4-ALK NSCLC is most similar to the pathophysiology of chronic myelogenous leukemia (CML).  In CML, the classic and most common cause is a translocation between chromosomes 9 and 22.  The ABL proto-oncogene is transported from chromosome 9 to chromosome 22 where it is placed adjacent to the BCR gene.  The resulting oncogene, BCR-ABL, codes for a fusion protein with constitutive tyrosine kinase activity.  This protein stimulates the proliferation of granulocytic precursors and leads to the development of CML.  The kinase activity of this fusion protein is a target of the protein kinase inhibitor, imatinib. (Choice A)  Burkitt lymphoma is characterized by a translocation of the c-myc oncogene on the long arm of chromosome 8 to the Ig heavy chain region on chromosome 14.  This causes constitutive overproduction of c-myc, a nuclear phosphoprotein that functions as a transcription activator. (Choice C)  Patients with follicular lymphoma have a t(14;18) translocation that causes overexpression of the antiapoptotic BCL2 gene product. (Choice D)  Li-Fraumeni syndrome is an autosomal dominant predisposition to a variety of cancers, particularly sarcomas and tumors of the breast, brain, and adrenal cortex.  This syndrome is associated with a mutation of the tumor suppressor gene, p53. (Choice E)  Translocation between the cyclin D1 locus on chromosome 11 and the immunoglobulin heavy chain locus on chromosome 14 is characteristic of mantle cell lymphoma.  This abnormality results in increased production of cyclin D1, a promoter of the G1 to S-phase transition during the cell cycle. Educational objective: Some patients with non-small cell lung carcinoma (NSCLC) harbor a chromosomal rearrangement that creates a fusion gene between EML4 (echinoderm microtubule-associated protein-like 4) and ALK (anaplastic lymphoma kinase).  This results in a constitutive active tyrosine kinase that causes malignancy.

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

purchased

EML4-ALK Fusion (NSCLC) vs CML — Ultra High-Yield USMLE Notes


1. Diagnosis: EML4-ALK NSCLC (non-small cell lung cancer) — most similar to CML (BCR-ABL) — both = chromosomal rearrangement → fusion protein → constitutive tyrosine kinase activity

2. Key clue (1 line): EML4-ALK = chromosomal inversion → fusion gene → constitutively active tyrosine kinase → malignancy → same mechanism as BCR-ABL in CML → both targeted by TK inhibitors

3. Why correct (≤2 lines): EML4-ALK (NSCLC) and BCR-ABL (CML) share identical molecular mechanism: chromosomal rearrangement → fusion protein with constitutive tyrosine kinase activity → uncontrolled cell proliferation. Both targeted by TKIs: crizotinib (EML4-ALK) and imatinib (BCR-ABL).

4. Why others wrong (1 line each):
  • Burkitt lymphoma t(8;14): MYC → constitutive transcription factor overexpression (not kinase); nuclear phosphoprotein not TK
  • Follicular lymphoma t(14;18): BCL2 overexpression → anti-apoptosis (not kinase activity)
  • Li-Fraumeni (p53 mutation): Tumor suppressor loss (not fusion kinase); autosomal dominant; sarcomas/breast/brain
  • Mantle cell lymphoma t(11;14): Cyclin D1 overexpression → cell cycle promotion (G1→S); not kinase fusion

5. Buzzword triggers — All Key Translocations/Mechanisms:
DisorderChangeMechanism
CMLt(9;22) BCR-ABLConstitutive TK → imatinib
EML4-ALK NSCLCchr 2 inversionConstitutive TK → crizotinib
EGFR-mutant NSCLCEGFR mutationConstitutive receptor TK → erlotinib/gefitinib
Burkittt(8;14) MYCConstitutive transcription factor
Follicular lymphomat(14;18) BCL2Anti-apoptosis
Mantle cellt(11;14) cyclin D1Cell cycle G1→S
APLt(15;17) PML-RARαDifferentiation block → ATRA
Li-Fraumenip53 mutationTumor suppressor loss
  • EML4-ALK patient profile: young + non-smoker + adenocarcinoma + no EGFR/K-ras mutation
  • ALK inhibitors: crizotinib (1st gen) → alectinib/ceritinib (2nd gen)

6. Trap / trick tested:
  • Constitutive TK = CML/BCR-ABL analog — any question about fusion protein with constitutive kinase activity → BCR-ABL is the prototype
  • Mechanism matters more than cancer type — question tests molecular mechanism not disease category; lung cancer ≠ always different from leukemia mechanistically
  • Burkitt trap: t(8;14) involves transcription factor (MYC) not kinase — students confuse "oncogene activation" with "kinase activation"

7. One-liner memory hook:
"Fusion gene + constitutive TK = CML (BCR-ABL/imatinib) = EML4-ALK NSCLC (crizotinib); same trick, different tissue; Burkitt = MYC yells; BCL2 = won't die; cyclin D1 = can't stop cycling; p53 gone = Li-Fraumeni."

An 8-year-old boy comes to the office due to a mass in the right mandible.  His family first noticed it a few months ago, and it has grown rapidly.  He has had no fevers, chills, cough, or weight loss.  The patient and his family recently immigrated to the United States from East Africa.  He has no known medical problems.  Temperature is 37 C (98.6 F).  Physical examination shows a large tumor on the right mandible with palpable regional lymphadenopathy.  A biopsy of the lesion is performed.  Histopathologic examination shows a diffuse infiltrate of lymphoid cells with numerous mitotic figures; interspersed macrophages with clear cytoplasm are also seen.  These lymphoid cells most likely have a chromosomal translocation that directly alters which of the following processes? his patient likely has the endemic African form of Burkitt lymphoma, which primarily affects children and typically presents as a maxillary or mandibular mass.  This type of lymphoma is strongly associated with Epstein-Barr virus (EBV) infection. On histopathologic examination, Burkitt lymphoma consists of monomorphic, intermediate-sized lymphoid cells with round nuclei, multiple nucleoli, and basophilic cytoplasm.  A high mitotic index and high cell death rate are typically seen.  Benign macrophages that phagocytize the resulting cellular debris ("tingible body macrophages") are distributed throughout the malignant tissue.  The clear cytoplasm of the macrophages contributes to the characteristic "starry sky" appearance of Burkitt lymphoma. Most Burkitt lymphomas demonstrate a translocation between the c-Myc oncogene on the long arm of chromosome 8 and the Ig heavy chain region on chromosome 14 [t(8;14)]; this results in Myc overexpression due to the highly active immunoglobulin promoter in B cells.  The product of c-Myc is a nuclear phosphoprotein that functions as a transcription activator, stimulating cell growth and proliferation. (Choice A)  Follicular lymphoma is often characterized by a translocation between the long arm of chromosome 18 near the BCL2 gene and the Ig heavy chain gene on chromosome 14 [t(14;18)].  This translocation leads to overexpression of the apoptosis inhibitor protein Bcl-2. (Choice B)  Mutations of DNA repair enzymes (eg, BRCA1, BRCA2) are associated with breast cancer, ovarian cancer, Lynch syndrome, xeroderma pigmentosum, Fanconi anemia, and many other diseases. (Choice C)  Translocation between the cyclin D1 locus on chromosome 11 and the Ig heavy chain locus on chromosome 14 [t(11;14)] is characteristic of mantle cell lymphoma.  This abnormality results in increased production of cyclin D1, a promoter of G1 to S-phase transition during the cell cycle. (Choice E)  Translocation of the ABL gene from chromosome 9 to 22 [t(9;22)] results in the Philadelphia chromosome, a typical finding in chronic myeloid leukemia.  BCR-ABL, the resulting fusion gene, encodes a protein with increased tyrosine kinase activity that inhibits apoptosis while promoting mitogenesis. Educational objective: Burkitt lymphoma is characterized by aggressive rapid growth and a "starry sky" microscopic appearance.  Translocation between the c-Myc oncogene on the long arm of chromosome 8 with the Ig heavy chain region on chromosome 14 leads to overexpression of Myc, a nuclear phosphoprotein that functions as a transcription activator.

Burkitt Lymphoma — t(8;14) MYC — Ultra High-Yield USMLE Notes


1. Diagnosis: Endemic Burkitt Lymphoma — t(8;14) → MYC overexpression → constitutive transcription factor activation → uncontrolled cell growth; EBV-associated

2. Key clue (1 line): 8-year-old boy + East Africa + rapidly growing mandibular/jaw mass + biopsy = uniform lymphoid cells + high mitoses + tingible body macrophages = "starry sky" → Burkitt → t(8;14) alters transcription

3. Why correct (≤2 lines): t(8;14) places MYC proto-oncogene (chr 8) under control of IgH promoter (chr 14) → constitutive MYC overexpression → MYC = nuclear phosphoprotein transcription activator → drives cell growth + proliferation genes → Ki-67 ~100%. Tingible body macrophages (phagocytizing apoptotic debris) create "starry sky" pattern against blue lymphocyte background.

4. Why others wrong (1 line each):
  • Apoptosis (BCL2/follicular lymphoma t(14;18)): BCL2 = anti-apoptosis protein; Burkitt alters transcription not apoptosis directly
  • DNA repair (BRCA1/2, MMR): Breast/ovarian/Lynch/Fanconi; no lymphoma translocation; repair enzyme mutations not Burkitt
  • Cell cycle G1→S (cyclin D1/mantle cell t(11;14)): Cyclin D1 = cell cycle progression; Burkitt = transcription factor (MYC), not cell cycle regulator directly
  • Tyrosine kinase (BCR-ABL/CML t(9;22)): Constitutive TK activity → CML; Burkitt = transcription factor not kinase

5. Buzzword triggers:
  • Jaw/mandible mass + African child + EBVendemic Burkitt
  • Abdominal mass + immunocompromised/HIVsporadic Burkitt
  • t(8;14) → MYC = transcription activator → Burkitt
  • "Starry sky" = tingible body macrophages (stars) + dense blue lymphocytes (sky)
  • Ki-67 ~100% = highest proliferation of any tumor
  • TdT− (mature B-cell) + CD20+ + CD10+ + BCL2− = Burkitt immunophenotype
  • MYC function: transcription factor → activates genes for ribosome biogenesis + cell cycle entry + metabolism
  • Burkitt MYC translocations: t(8;14) (90%, IgH) > t(2;8) (Igκ) > t(8;22) (Igλ)
  • EBV + Burkitt: EBV infection → B-cell proliferation → ↑chance of acquiring t(8;14) translocation

6. Trap / trick tested:
  • MYC = transcription factor NOT kinase — students confuse with BCR-ABL (TK); MYC works in nucleus activating gene transcription; BCR-ABL works in cytoplasm phosphorylating proteins
  • BCL2− in Burkitt — students expect B-cell lymphoma = BCL2+; Burkitt specifically = BCL2− (high apoptosis actually occurs alongside proliferation → balance favors net growth); BCL2+ = follicular lymphoma
  • TdT− distinguishes Burkitt from ALL (both B-cell, CD19+); Burkitt = mature B-cell = TdT−; ALL = immature = TdT+
  • Starry sky ≠ only Burkitt — high-grade lymphomas with rapid turnover can show it; but jaw mass + African child + starry sky + t(8;14) = Burkitt

7. One-liner memory hook:
"t(8;14) = MYC meets IgH megaphone → MYC shouts transcription ON forever → cells divide at 100% speed + die fast → macrophages eat debris = starry sky; jaw = Africa/EBV; belly = sporadic/HIV; TdT− BCL2− Ki-67 100% = Burkitt's stamp."

A 42-year-old man is hospitalized due to fever and persistent sore throat.  Temperature is 38.3 C (100.9 F), blood pressure is 120/80 mm Hg, pulse is 94/min, and respirations are 16/min.  There are several bruises on his trunk, and blood oozes from his intravenous catheter venipuncture sites.  Blood fibrinogen level is 110 mg/dL (normal: 150-400).  Bone marrow aspirate shows a predominance of immature myeloid cells with numerous azurophilic, needle-shaped cytoplasmic granules.  Chromosomal analysis of these immature cells is most likely to show which of the following abnormalities? Explanation Chromosomal translocations associated with hematologic malignancies Malignancy Pathogenesis Acute promyelocytic leukemia t(15;17) involving PML & RARA → PML-RARα oncoprotein → myeloid differentiation inhibited RARα: nuclear receptor involved in myeloid differentiation PML: fusion forms receptor with dominant negative activity Burkitt lymphoma t(8;14) involving MYC & IGH → MYC overexpression → cell growth MYC: transcription factor regulating cell growth IGH: immunoglobulin heavy chain (high expression in B cells) Chronic myeloid leukemia t(9;22) involving ABL1 & BCR → BCR-ABL1 oncoprotein → cell proliferation ABL1: nonreceptor tyrosine kinase BCR: fusion leads to activation Follicular lymphoma t(14;18) involving IGH & BCL2 → BCL2 overexpression → apoptosis evasion BCL2: antiapoptotic protein Mantle cell lymphoma t(11;14) involving CCND1 & IGH → cyclin D1 overexpression → cell cycle progression Cyclin D1: regulates cell cycle This patient with a predominance of immature myeloid cells containing numerous azurophilic, needle-shaped cytoplasmic granules likely has acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia.  Acute leukemia can present with persistent fever and sore throat due to increased risk of infection conferred by fewer functional leukocytes. APL is microscopically characterized by abnormal promyelocytes (immature myeloid cells) that may contain numerous needle-shaped cytoplasmic inclusions known as Auer rods (fused lysosomal granules) and often have bilobed nuclei.  Cytogenetic studies show t(15;17) chromosomal translocation, which causes fusion of the retinoic acid receptor-alpha (RARA) gene to the promyelocytic leukemia (PML) gene. A classic presentation of APL is bleeding in the setting of disseminated intravascular coagulation (DIC) (eg, oozing at venipuncture sites), as the malignant cells express prothrombotic factors (eg, tissue factor) that lead to widespread consumptive coagulopathy.  DIC is characterized by decreased fibrinogen levels, increased fibrin degradation products, prolonged PT and PTT, and thrombocytopenia that is generally not low enough to result in spontaneous bleeding by itself.  Prompt treatment of APL with all-trans retinoic acid is essential. (Choice A)  t(8;14) occurs in approximately 80% of cases of Burkitt lymphoma and results in movement of the MYC protooncogene from chromosome 8 to a region near the immunoglobulin promoter site on chromosome 14.  In blood and bone marrow, Burkitt lymphoma cells often have basophilic, vacuolated cytoplasm. (Choice B)  t(9;22) forms the Philadelphia chromosome associated with chronic myeloid leukemia (CML).  Most patients seek medical attention in the chronic, stable phase (eg, nonspecific symptoms, abdominal fullness, leukocytosis), in which mature and immature myeloid forms are seen.  Auer rods are not typically present in CML. (Choice C)  Mantle cell lymphoma, a mature B-cell malignancy characterized by lymphoid cells with irregular nuclei, is associated with t(11;14).  This translocation results in overexpression of cyclin D1. (Choice D)  t(14;18) is associated with follicular lymphoma.  This abnormality places the BCL2 protooncogene from chromosome 18 near the immunoglobulin heavy-chain promoter region on chromosome 14.  Circulating follicular lymphoma cells are typically small lymphoid cells with cleaved nuclei. Educational objective: Acute promyelocytic leukemia (APL) can present with persistent infection and coagulopathy, causing hemorrhagic signs and symptoms.  Bone marrow examination classically reveals abnormal promyelocytes with intracytoplasmic Auer rods.  APL is associated with a t(15;17) chromosomal translocation that fuses the retinoic acid receptor-alpha and promyelocytic leukemia genes.

APML (AML-M3) — Chromosomal Translocations Master Table — Ultra High-Yield USMLE Notes


1. Diagnosis: Acute Promyelocytic Leukemia (APML/AML-M3) — t(15;17) → PML-RARα → differentiation block + DIC; answer = t(15;17)

2. Key clue (1 line): 42M + fever + sore throat + bruises + oozing from IV sites (DIC) + ↓fibrinogen (110) + marrow = immature myeloid cells + numerous needle-shaped azurophilic granules (Auer rods) → APML → t(15;17)

3. Why correct (≤2 lines): APML = immature promyelocytes blocked at differentiation stage (PML-RARα inhibits RARα-driven myeloid maturation) → granule-laden promyelocytes release tissue factor → consumptive coagulopathy → DIC (↓fibrinogen + ↑PT/PTT + ↑D-dimer + oozing). t(15;17) = pathognomonic for APML; ATRA overcomes the block.

4. Why others wrong (1 line each):
  • t(8;14) — Burkitt: MYC + IgH → transcription factor overexpression; B-cell lymphoma; basophilic vacuolated cytoplasm; no Auer rods/DIC
  • t(9;22) — CML: BCR-ABL TK; chronic course + mature myeloid cells; no Auer rods; treated with imatinib
  • t(11;14) — Mantle cell: Cyclin D1 + IgH; B-cell lymphoma; irregular lymphoid nuclei; no myeloid blasts
  • t(14;18) — Follicular lymphoma: BCL2 + IgH; anti-apoptosis; small cleaved B-lymphocytes; no myeloid blasts

5. Master Translocation Table — USMLE High-Yield:
TranslocationMalignancyGene/MechanismTreatment
t(15;17)APML (AML-M3)PML-RARα → differentiation blockATRA + arsenic
t(9;22)CML (also B-ALL)BCR-ABL → constitutive TKImatinib
t(8;14)Burkitt lymphomaMYC → transcription ONIntensive chemo
t(14;18)Follicular lymphomaBCL2 → anti-apoptosisRituximab ± chemo
t(11;14)Mantle cell lymphomaCyclin D1 → G1→SAggressive chemo
t(8;21)AML-M2AML1-ETO → good prognosisChemo
inv(16)AML-M4EoCBFβ-MYH11 → good prognosisChemo
t(12;21)B-ALL (children)ETV6-RUNX1 → best prognosisChemo
t(1;14)T-ALLTAL1 overexpressionChemo

6. Trap / trick tested:
  • DIC + leukemia = APML until proven otherwise — tissue factor from promyelocyte granules is the mechanism; no other leukemia routinely causes DIC at presentation
  • ↓Fibrinogen = DIC (consumption of clotting factors); normal fibrinogen = thrombocytopenia alone
  • Oozing at IV sites = coagulopathy (not just thrombocytopenia); combined DIC picture
  • ATRA works because it provides supraphysiologic retinoic acid → overcomes dominant-negative PML-RARα → differentiation resumes → granules clear → DIC resolves

7. One-liner memory hook:
"t(15;17) = PML-RARα freezes promyelocytes → granule avalanche → DIC (oozing everywhere, fibrinogen gone); ATRA melts the freeze → cells mature → bleeding stops; Auer rods + DIC = APML = t(15;17) always."

A 57-year-old male presents to your office complaining of fatigue and low energy.  He also notes experiencing intermittent back pain that responds to ibuprofen.  He has no significant past medical history.  His family history is significant for his father dying of a heart attack at age 60.  Fecal occult blood testing is negative.  Laboratory studies reveal: Hematocrit 36% MCV 86 fl WBC 7,000/mm3 Platelets 170,000/mm3 Sodium 136 mEq/L Potassium 4.5 mEq/L AST 34 U/L ALT 18 U/L Bilirubin 0.8 mg/dL Creatinine 2.0 mg/dL Plasma protein electrophoresis reveals a high peak corresponding to gamma-globulins.  The most likely diagnosis is: multiple myeloma, neoplastic B-lymphocytes mature into plasma cells that synthesize abnormal (typically large) amounts of monoclonal immunoglobulin or immunoglobulin fragments (e.g. light chains).  Clinical manifestations of multiple myeloma include impaired hematopoiesis leading to a normochromic, normocytic anemia and weakness; lytic bone lesions classically affecting the vertebral column and causing back pain and pathologic fractures; and hypercalcemia and AL amyloidosis, which contribute to renal dysfunction.  Severe amyloidosis can also cause cardiac and cutaneous findings. The classic laboratory abnormalities in multiple myeloma include erythrocyte rouleaux formation on peripheral blood smear and Bence-Jones proteins in the urine.  Serum protein electrophoresis (SPEP) is a more specific laboratory test used to determine if excessive monoclonal immunoglobulins are present in the serum.  An "M peak" on SPEP indicates the presence of such an immunoglobulin.  (An M peak may also be found in Waldenstrom macroglobulinemia and some lymphomas.) (Choices A and B) Iron deficiency can cause weakness due to a hypochromic, microcytic anemia and vitamin B12 (cobalamin) deficiency can cause weakness due to a macrocytic anemia.  Vitamin B12 deficiency can also cause neurologic signs. (Choice C) CLL is a lymphocytic malignancy that may cause a normochromic, normocytic anemia, but immunoglobulin production is classically depressed, not increased, in CLL. (Choice D) Aplastic anemia would cause a uniform depression of all hematologic cell lines, including leukocytes and platelets. (Choice F) Hodgkin lymphoma is a B-cell malignancy characterized by the presence of Reed-Sternberg cells on lymph node histology.  There may be anemia of chronic disease in patients with this condition, but a monoclonal gammopathy would not be expected. (Choice G) Patients with hypothyroidism may be anemic due to associated iron deficiency or pernicious anemia.  However, monoclonal gammopathy would not be expected. Educational Objective: The finding of a high peak in the gamma-globulin region on serum protein electrophoresis (SPEP) usually represents an M protein consisting of an overproduced monoclonal immunoglobulin.  Multiple myeloma causes an M protein peak on SPEP as well as anemia (weakness), lytic bone lesions (back pain, pathologic fractures), and renal insufficiency (related to amyloid deposition and hypercalcemia).

Multiple Myeloma — SPEP M-Spike — Ultra High-Yield USMLE Notes


1. Diagnosis: Multiple Myeloma (MM) — clonal plasma cell malignancy → M-spike (gamma region) on SPEP + CRAB = Calcium↑ + Renal failure + Anemia (normocytic) + Bone lytic lesions

2. Key clue (1 line): 57M + fatigue + back pain (responds to ibuprofen) + normocytic anemia + Cr 2.0 (renal failure) + SPEP = high gamma-globulin M-spike → multiple myeloma

3. Why correct (≤2 lines): Neoplastic plasma cells → overproduce monoclonal immunoglobulin (M-protein) → appears as sharp M-spike in gamma region on SPEP + Bence Jones proteins (free light chains) in urine → lytic bone lesions (back pain) + renal failure (cast nephropathy/amyloid) + normocytic anemia (marrow replacement). Diagnosis confirmed: SPEP M-spike + bone marrow biopsy >10% plasma cells.

4. Why others wrong (1 line each):
  • Iron deficiency: Microcytic/hypochromic anemia (↓MCV); no M-spike; normal Cr; FOBT negative here but IDA = GI cause
  • B12 deficiency: Macrocytic anemia (↑MCV) + neuro symptoms; no M-spike; normal Cr
  • CLL: Normocytic anemia possible but immunoglobulin production ↓ (hypogammaglobulinemia), not ↑; no M-spike; mature lymphocytes + smudge cells
  • Aplastic anemia: Pancytopenia (all 3 lines ↓); WBC and platelets normal here → rules out
  • Hodgkin lymphoma: Reed-Sternberg cells + B symptoms; anemia of chronic disease; no monoclonal gammopathy
  • Hypothyroidism: IDA or pernicious anemia association; no M-spike/monoclonal protein

5. Buzzword triggers:
  • M-spike on SPEP (gamma region) → myeloma, Waldenström, or MGUS
  • SPEP M-spike differential:
    • Multiple myeloma: IgG (most common) or IgA + CRAB + >10% plasma cells
    • Waldenström macroglobulinemia: IgM + hyperviscosity + no lytic lesions
    • MGUS: M-spike + <10% plasma cells + no CRAB + stable
  • Bence Jones proteins = free κ or λ light chains in urine → cast nephropathy
  • Rouleaux formation on smear = stacked coins from excess M-protein
  • MM bone lesions: osteolytic (punched-out) NOT osteoblastic → bone scan often negative (no osteoblast activity) → use skeletal survey X-ray or PET
  • Back pain + normocytic anemia + elevated Cr + M-spike = MM classic presentation
  • MM treatment: bortezomib (proteasome inhibitor) + lenalidomide + dexamethasone → ASCT if eligible

6. Trap / trick tested:
  • Back pain + ibuprofen response = distracts toward musculoskeletal/degenerative; M-spike + renal failure = myeloma lytic lesions not mechanical back pain
  • Normal WBC + normal platelets rules out aplastic anemia and acute leukemia; myeloma = isolated normocytic anemia early
  • FOBT negative rules out GI blood loss/IDA; M-spike confirms plasma cell dyscrasia
  • CLL = hypogammaglobulinemia (B-cells dysfunctional, make less Ig) vs MM = hypergammaglobulinemia (plasma cells make too much monoclonal Ig) — opposite immunoglobulin patterns
  • Bone scan negative in MM = classic trap; lytic lesions have NO osteoblastic activity → bone scan relies on osteoblast uptake → must use plain X-ray or MRI/PET

7. One-liner memory hook:
"MM = plasma cells spam one antibody → M-spike on SPEP + Bence Jones in urine + CRAB (Calcium up, Renal fail, Anemia normocytic, Bones lyric/punched-out); back pain + M-spike + Cr 2.0 = myeloma not muscle strain; bone scan negative = X-ray instead."

A 66-year-old woman comes to the office due to 2 months of worsening fatigue and dyspnea with moderate exertion.  The patient has a history of breast cancer treated with surgery and combination chemotherapy 6 years ago.  She has no other medical conditions.  Vital signs are within normal limits.  Physical examination reveals normal jugular venous pressure, clear lungs, and normal heart sounds; there is no hepatosplenomegaly, lymphadenopathy, or extremity edema.  Laboratory results are as follows: Hemoglobin 7.2 g/dL Mean corpuscular volume 108 µm3 Reticulocytes 1% Platelets 90,000/mm3 Leukocytes 3,800/mm3 Peripheral blood smear shows oval macrocytic red cells and hyposegmented neutrophils.  Bone marrow biopsy of this patient is most likely to reveal which of the following? Explanation Myelodysplastic syndrome Epidemiology Clonal hematopoietic malignancy Seen primarily with advanced age or previous chemotherapy or radiation treatment Can transform to acute myelogenous leukemia Manifestations ≥1 types of cytopenia: Anemia: weakness, fatigue Leukopenia: infections Thrombocytopenia: bruising, bleeding Hepatosplenomegaly & lymphadenopathy are uncommon Evaluation Peripheral blood smear: dysplastic erythrocytes (eg, oval macrocytosis) & neutrophils (eg, hyposegmentation, hypogranulation) Bone marrow biopsy: single or multilineage dysplasia with hypercellularity This patient's previous chemotherapy, pancytopenia, and cellular dysplasia (eg, hyposegmented neutrophils, oval macrocytic erythrocytes) indicate likely myelodysplastic syndrome (MDS).  MDS is a clonal hematologic malignancy associated with the development of driver mutations due to advanced age, previous chemo-/radiotherapy, or exposure to environmental toxins. MDS is marked by the following: ≥1 cytopenias:  normal hematopoiesis is impaired due to neoplastic cell replication in the bone marrow; therefore, patients usually present with symptoms of ≥1 cytopenia such as fatigue/dyspnea on exertion (anemia), bleeding/bruising (thrombocytopenia), or infections (leukopenia).  Because erythrocyte production is impaired, reticulocyte count will be low despite significant anemia.  However, significant extramedullary hematopoiesis does not occur, so hepatosplenomegaly is rare. Dysplasia of erythrocytes and neutrophils:  peripheral blood smear usually shows normocytic or macrocytic erythrocytes with a variety of abnormalities (eg, oval macrocytes).  Neutrophils are typically hypolobulated and hypogranular. Bone marrow biopsy typically reveals a hypercellular marrow with dysplasia of ≥1 cell lines.  Myeloblasts are increased (but <20% of total cells), and granulocytes show evidence of impaired maturation such as abnormalities in size, granulation, or lobulation.  Erythrocytes also show signs of abnormal development, including large size and nuclear lobation/budding. (Choice A)  Metastatic adenocarcinoma (atypical gland-forming cells) can infiltrate the bone marrow, leading to pancytopenia.  Although reticulocytes would be diminished, peripheral blood smear would not show signs of abnormal granulocyte development (eg, hyposegmentation). (Choice C)  Hypercellular marrow with sheets of plasma cells is seen in multiple myeloma.  Although it occasionally causes pancytopenia (anemia alone is more common), peripheral smear shows rouleaux formation due to increased monoclonal proteins; dysmorphic granulocytes would not be seen.  In addition, multiple myeloma is not strongly associated with chemotherapy exposure. (Choice D)  Anemia of chronic disease is associated with increased retention of iron in reticuloendothelial macrophages.  Although low reticulocyte count is common, patients usually have normocytic anemia and relatively normal peripheral smear findings (eg, no dysplasia).  In contrast, MDS can be associated with ringed sideroblasts (iron-laden erythrocyte precursors) in the bone marrow. (Choice E)  Collagen deposition in the bone marrow is associated with myelofibrosis, a chronic myeloproliferative disorder that causes anemia and variable platelet/leukocyte counts.  However, patients typically have marked splenomegaly due to extramedullary hematopoiesis. Educational objective: Myelodysplastic syndrome is a clonal hematologic neoplasm marked by ≥1 cytopenias and cellular dysplasia (eg, oval macrocytic erythrocytes, hyposegmented granulocytes).  Bone marrow evaluation usually reveals a hypercellular marrow, a mild or moderate increase in myeloblasts (<20% of total cells), and dysplastic erythrocytes/granulocytes.

Myelodysplastic Syndrome (MDS) — Ultra High-Yield USMLE Notes


1. Diagnosis: Myelodysplastic Syndrome (MDS) — clonal hematopoietic malignancy; prior chemotherapy → driver mutations → dysplasia + cytopenias → hypercellular marrow + dysplastic cells + blasts <20%

2. Key clue (1 line): 66F + prior breast cancer chemo 6 years ago + pancytopenia + ↑MCV 108 + ↓retics 1% + smear = oval macrocytes + hyposegmented neutrophils → MDS → marrow = hypercellular + multilineage dysplasia + blasts <20%

3. Why correct (≤2 lines): Prior chemotherapy → clonal HSC mutations → ineffective hematopoiesis → cytopenias with low retics (marrow failing, not absent) + dysplastic cells on smear (oval macrocytes + hypolobulated/hypogranular neutrophils). Bone marrow: hypercellular (cells present but dysfunctional) + dysplasia ≥1 lineage + myeloblasts increased but <20% (≥20% = transformation to AML).

4. Why others wrong (1 line each):
  • Metastatic adenocarcinoma (marrow infiltration): Atypical gland-forming cells + pancytopenia; no dysplastic granulocytes on smear; leukoerythroblastic picture (teardrop cells)
  • Plasma cell sheets (multiple myeloma): Rouleaux + CRAB; anemia alone usually; no dysmorphic granulocytes; not chemo-related
  • Iron-laden macrophages (ACD): Normocytic + no dysplasia; iron retained in macrophages; relatively normal smear; no hyposegmented neutrophils
  • Collagen deposition (myelofibrosis): Hypocellular/fibrotic marrow + massive splenomegaly (EMH) + teardrop cells; MDS has no significant splenomegaly

5. Buzzword triggers:
  • Prior chemo/radiation + elderly + pancytopenia + dysplastic cellsMDS
  • Hyposegmented neutrophils (pseudo-Pelger-Huët) → MDS hallmark on smear
  • Oval macrocytes (not round macrocytes of B12) + ↓retics → MDS
  • MDS marrow: hypercellular + dysplasia + blasts <20% (≥20% = AML)
  • MDS → AML transformation: "preleukemia" concept; risk ↑ with % blasts
  • MDS ring sideroblasts: iron-laden mitochondria around erythroid precursor nucleus → MDS with ring sideroblasts (MDS-RS)
  • MDS treatment: supportive (transfusions, EPO) + azacitidine/decitabine (hypomethylating agents) + allogeneic HSCT (only cure)
  • MDS cytogenetics: del(5q) (most common; good prognosis; responds to lenalidomide) + del(7q) + trisomy 8
  • Therapy-related MDS: Alkylating agents (cyclophosphamide) → del(5q)/del(7q); topoisomerase II inhibitors → balanced translocations

6. Trap / trick tested:
  • Hypercellular marrow ≠ normal — MDS marrow is packed with cells that are dysfunctional; students expect hypocellular marrow in cytopenias; MDS = cells present but dysplastic/non-functional
  • MDS vs megaloblastic anemia: Both macrocytic + ↓retics; distinguish by: MDS = hyposegmented neutrophils (Pelger-Huët) + chemotherapy history; megaloblastic = hypersegmented neutrophils + B12/folate deficiency
  • Blasts <20% = MDS; blasts ≥20% = AML — critical threshold for diagnosis and management
  • Myelofibrosis trap: both MDS and myelofibrosis cause cytopenias + dry tap possible; myelofibrosis = massive splenomegaly + teardrop cells; MDS = no splenomegaly + dysplastic granulocytes

7. One-liner memory hook:
"Chemo damages HSC DNA → clone grows but can't mature right → dysplastic oval macrocytes + hypolobulated neutrophils (pseudo-Pelger-Huët) + cytopenias + low retics; marrow hypercellular but broken; blasts <20% = MDS; hit 20% = AML; azacitidine buys time, HSCT cures."

A 66-year-old woman comes to the emergency department due to abdominal cramps and watery diarrhea for the past day.  The patient was hospitalized 2 weeks ago due to acute pyelonephritis and was treated with broad-spectrum antibiotics.  She has a remote history of Hodgkin disease treated with chemotherapy and radiation treatment but no other chronic medical conditions.  The patient's only home medication is a multivitamin supplement.  Temperature is 38.3 C (100.9 F), blood pressure is 124/72 mm Hg, and pulse is 92/min.  There is mild generalized abdominal tenderness with no guarding or rebound.  The remainder of the physical examination shows no abnormalities.  Laboratory results are as follows: Hemoglobin 12.8 g/dL Platelets 380,000/mm3 Leukocytes 32,000/mm3 Neutrophils 80% Bands 8% Metamyelocytes 2% Lymphocytes 10% Prior blood cell count at the time of hospital discharge was normal.  Stool testing for Clostridioides difficile is positive.  Which of the following is the most likely underlying cause of this patient's leukocytosis? his patient with Clostridioides difficile colitis has profound leukocytosis due to increased circulating mature and juvenile (eg, bands) neutrophils.  Although neutrophils are normally the most prevalent leukocyte in the blood, the vast majority of mature neutrophils are held in reserve in the bone marrow or are reversibly attached to the endothelial wall (marginated pool). However, infection, inflammation, and certain medications (eg, glucocorticoids, androgens) can rapidly mobilize bone marrow and marginated neutrophils, leading to leukocytosis.  This process is mediated by endotoxin, certain complement components (eg, C3a, C5a), and cytokines such as TNF-alpha and granulocyte-macrophage colony-stimulating factor (GM-CSF); these compounds trigger neutrophils, bands, and immature granulocyte cells (eg, metamyelocytes, late myelocytes) to undergo transcellular migration out of the bone marrow sinusoids into the circulation.  Primed neutrophils then rapidly localize to areas of inflammation by using L-selectin to bind E-selectin on the endothelial surface of nearby blood vessels. (Choice A)  In myeloid leukemia, myeloid precursor cells undergo clonal proliferation unlinked to cytokine stimulation or growth signals.  This patient is unlikely to have developed myeloid leukemia in the 2 weeks since her last admission. (Choice C)  Leukocytes leave the circulation by transmigrating through the endothelial wall near areas of infection or inflammation.  Defective leukocyte transmigration can cause leukocytosis in patients with leukocyte adhesion deficits, but is not a component of leukocytosis in those with acute infection (eg, C difficile colitis). (Choice D)  Stress hormones (eg, epinephrine) cause leukocytosis due to "demarginalization," or liberation of marginated neutrophils from the endothelial wall (ie, shift from marginated to circulating pool, rather than from circulating to marginated pool). (Choice E)  Hematologic stem cells and their immediate progenitors can differentiate into either myeloid or lymphoid cells.  Once a cell is committed to a myeloid or lymphoid lineage, it cannot generally revert. Educational objective: Infection triggers increased circulating neutrophils by stimulating the release of neutrophils, bands, and late granulocyte precursors from the bone marrow.  This is mediated by increased cytokines (eg, TNF-alpha) and complement activation.  Demarginalization of neutrophils from endothelial attachment also contributes to leukocytosis.

Reactive Leukocytosis (C. difficile Infection) — Ultra High-Yield USMLE Notes


1. Diagnosis: Reactive Leukocytosis — C. difficile colitis → cytokine/complement-mediated bone marrow neutrophil release + demarginalization → WBC 32,000 + left shift

2. Key clue (1 line): 66F + recent antibiotics + C. diff positive + WBC 32,000 + neutrophils 80% + bands 8% + metamyelocytes 2% + normal CBC 2 weeks ago → acute reactive leukocytosis from infection (not malignancy)

3. Why correct (≤2 lines): C. diff infection → endotoxin + TNF-α + GM-CSF + C3a/C5a → mobilize neutrophils + bands + immature granulocytes from bone marrow sinusoids into circulation → leukocytosis with left shift; also demarginalization (epinephrine/stress → neutrophils detach from endothelial wall → circulating pool ↑). Normal CBC 2 weeks ago = cannot be leukemia (too acute onset); reactive cause confirmed.

4. Why others wrong (1 line each):
  • Clonal myeloid proliferation (leukemia): Autonomous unlinked to cytokines; cannot develop in 2 weeks; CML/AML = chronic progression
  • Defective leukocyte transmigration (LAD): Leukocyte adhesion deficiency → leukocytes can't leave blood → leukocytosis; but this is a genetic disorder; not infection-driven mobilization
  • Demarginalization (epinephrine): Stress hormones → neutrophils detach from endothelium → marginated → circulating pool shift; contributes to leukocytosis but this is a secondary mechanism, not the primary driver in active infection
  • Lymphoid→myeloid lineage switch: Committed lymphoid cells cannot revert to myeloid; lineage commitment is irreversible; not a mechanism of leukocytosis

5. Buzzword triggers:
  • C. diff + recent antibiotics + leukocytosis + left shift → reactive leukocytosis
  • C. diff leukocytosis = WBC often dramatically elevated (>30,000) = marker of severe C. diff colitis
  • Neutrophil pools: bone marrow reserve (largest) + marginated pool (endothelial attached) + circulating pool
  • Infection mobilizes: bone marrow → blood (cytokine-mediated: TNF-α, GM-CSF, C3a/C5a)
  • Stress/epinephrine mobilizes: marginated pool → blood (demarginalization; rapid, transient)
  • Glucocorticoids: ↑neutrophils via demarginalization + ↓apoptosis + ↓margination + ↑marrow release
  • Reactive leukocytosis vs CML: LAP↑ (reactive) vs LAP↓ (CML); prior normal CBC + acute onset = reactive
  • L-selectin binds E-selectin on endothelium → neutrophil rolling → then tight adhesion (ICAM/LFA-1) → transmigration to infection site

6. Trap / trick tested:
  • Hodgkin disease history → students may think relapse/secondary malignancy causing leukocytosis; but normal CBC 2 weeks ago + acute C. diff infection = reactive, not malignant
  • Demarginalization vs marrow release: Both increase circulating neutrophils; epinephrine/stress = demarginalization (fast, no left shift); infection = marrow release (slower, WITH left shift/bands); left shift here confirms marrow release
  • C. diff WBC >30,000 = severe/fulminant colitis marker → risk for toxic megacolon; leukocytosis is both diagnostic and prognostic
  • Leukocyte adhesion deficiency (LAD) trap: also causes leukocytosis but = recurrent infections from birth + delayed umbilical cord separation + no pus formation (neutrophils can't transmigrate)

7. One-liner memory hook:
"C. diff toxin → TNF/GM-CSF/complement → marrow dumps neutrophils + bands into blood → WBC spikes with left shift; epinephrine demarginates the wall-huggers (fast, no left shift); LAP↑ + acute onset + normal CBC weeks ago = reactive not CML."

A 67-year-old woman is evaluated for worsening fatigue and exertional dyspnea.  She has no prior medical conditions and takes no medications.  The patient does not use tobacco, alcohol, or illicit drugs and consumes a balanced diet.  Vital signs are within normal limits.  Physical examination is notable for mucosal pallor.  Stool testing for occult blood is negative.  Laboratory studies reveal that hemoglobin is 6.7 g/dL, white blood cell count is 35,000/mm3, and platelets are 45,000/mm3.  Peripheral blood flow cytometry of the white blood cell population is shown below. his patient's symptomatic anemia (eg, fatigue, weakness), thrombocytopenia, and leukocytosis are associated with a predominance of CD20-positive cells (a B-cell surface marker), raising strong suspicion for chronic lymphocytic leukemia (CLL).  In CLL, mature B cells progressively accumulate in the bone marrow and peripheral blood due to oncogenic mutations that inhibit apoptosis.  Although most patients are asymptomatic for years, accumulation of B cells in the bone marrow eventually chokes out normal hematopoiesis, leading to symptomatic anemia, thrombocytopenia, and infections (due to neutropenia). Patients with CLL usually have dramatic elevations in peripheral leukocyte count (often >100,000/mm3) and characteristic findings on peripheral blood smear (eg, numerous small lymphocytes, smudge cells).  The diagnosis is supported by flow cytometry of peripheral blood revealing a clonal population of leukocytes with expression of B-cell surface markers such as CD19, CD20, and CD23. (Choice A)  T-cell leukemia is marked by the clonal expansion of a leukocyte population with T-cell surface markers such as CD2, CD3, and CD4.  However, this patient's flow cytometry shows very few CD3-positive cells. (Choice B)  Aplastic anemia is characterized by bone marrow failure and is usually triggered by an infection, medication, radiation, toxic substance, or autoimmune disease.  Patients have pancytopenia (not leukocytosis) and bone marrow biopsy shows a hypocellular marrow with morphologically normal hematopoietic cells; a clonal population of B cells would not be seen. (Choice D)  Chronic myeloid leukemia is a myeloproliferative neoplasm characterized by peripheral leukocytosis due to numerous circulating granulocytes (eg, neutrophils in different stages of maturation).  Diagnosis is generally made when cytogenetic studies reveal the BCR-ABL fusion gene.  A predominant population of CD20-positive cells (B cells) would not be seen. (Choice E)  Classic Hodgkin lymphoma usually causes localized peripheral lymphadenopathy and B-symptoms (eg, fever, night sweats).  The diagnosis is made by lymph node excision, which usually reveals Reed-Sternberg cells that are characteristically positive for CD15 and CD30 immunohistochemical stains.  Anemia, thrombocytopenia, and leukocytosis would be atypical. Educational objective: Chronic lymphocytic leukemia is a lymphoproliferative disorder marked by the progressive accumulation of mature B cells.  Most patients are asymptomatic for years but eventually develop anemia, thrombocytopenia, and/or neutropenia.  The diagnosis is generally made when complete blood count reveals dramatic leukocytosis, and flow cytometry subsequently shows a clonal population of leukocytes with B-cell markers such as CD19, CD20, and CD23.

Chronic Lymphocytic Leukemia (CLL) — Ultra High-Yield USMLE Notes


1. Diagnosis: Chronic Lymphocytic Leukemia (CLL) — mature B-cell accumulation; CD19+ CD20+ CD23+ CD5+; smudge cells; indolent → eventual marrow failure

2. Key clue (1 line): 67F + fatigue + dyspnea + mucosal pallor + Hgb 6.7 + WBC 35,000 + platelets 45,000 + flow cytometry = predominant CD20+ B-cell population → CLL

3. Why correct (≤2 lines): CLL = clonal mature B-cells accumulate (anti-apoptotic oncogenic mutations) → progressively infiltrate bone marrow → choke normal hematopoiesis → anemia + thrombocytopenia + neutropenia; peripheral blood: dramatic lymphocytosis + smudge cells. Flow cytometry: CD19+ + CD20+ + CD23+ + CD5+ (CD5 = T-cell marker aberrantly co-expressed on CLL B-cells) = diagnostic fingerprint.

4. Why others wrong (1 line each):
  • T-cell leukemia: CD2+ CD3+ CD4+; flow cytometry shows T-cell markers; this patient = very few CD3+ cells → rules out
  • Aplastic anemia: Pancytopenia (↓all 3 lines); leukocytosis absent; hypocellular marrow; no clonal B-cell population
  • CML: Myeloproliferative → granulocytes (neutrophils/myeloid forms) + BCR-ABL t(9;22) + ↓LAP; no CD20+ B-cell predominance
  • Hodgkin lymphoma: Localized LN + B symptoms + Reed-Sternberg (CD15+/CD30+); leukocytosis + anemia + thrombocytopenia = atypical; circulating RS cells not seen

5. Buzzword triggers:
  • CLL = CD5+ + CD19+ + CD20+ + CD23+ (CD5 co-expression on B-cells = pathognomonic)
  • Smudge cells (fragile CLL lymphocytes crushed on smear) → CLL
  • CLL = most common leukemia in Western adults (>60 years)
  • CLL complications:
    • Hypogammaglobulinemia → ↑infection risk (pneumococcal pneumonia)
    • Autoimmune hemolytic anemia (AIHA) → Coombs+ warm IgG → ↓Hgb
    • Immune thrombocytopenia (ITP) → ↓platelets
    • Richter transformation → transforms to DLBCL (aggressive) → sudden worsening
  • CLL del(13q) = most common cytogenetic abnormality (good prognosis); del(17p)/p53 = worst prognosis
  • CLL treatment: watch-and-wait (asymptomatic) → ibrutinib (BTK inhibitor) or venetoclax (BCL2 inhibitor) when symptomatic
  • CLL vs SLL (small lymphocytic lymphoma): same disease; CLL = blood/marrow predominant; SLL = nodal predominant

6. Trap / trick tested:
  • CD5+ on B-cells = CLL or mantle cell lymphoma; distinguish: CLL = CD23+; mantle cell = CD23− + cyclin D1+
  • Leukocytosis + anemia + thrombocytopenia = students think AML or MDS; but mature small lymphocytes + CD20+ = CLL (chronic, not acute)
  • Hypogammaglobulinemia in CLL — despite massive B-cell proliferation, dysfunctional B-cells produce LESS antibody; opposite of myeloma (↑immunoglobulin)
  • Smudge cells = fragile CLL lymphocytes; lab technicians add albumin to prevent smudging = confirms CLL when seen

7. One-liner memory hook:
"CLL = old B-cells refuse to die (anti-apoptosis) → flood blood + marrow → smudge cells on smear + CD5+CD20+CD23+ on flow; marrow gets crowded → anemia + low platelets; can't make real antibodies → infections; Richter = CLL turning evil (DLBCL)."

A 68-year-old man comes to the office due to severe fatigue for the last few months.  He has also had 6.8-kg (15-lb) of unintentional weight loss over the same period.  The patient has no significant medical history and has not seen a physician in many years.  He takes no medications and does not use tobacco, alcohol, or illicit drugs.  Physical examination shows mucosal pallor with no scleral icterus.  The lungs are clear on auscultation, and heart sounds are normal.  Abdominal examination shows mild hepatomegaly and a markedly enlarged spleen.  Stool guaiac testing is negative.  Laboratory results show pancytopenia, and peripheral blood smear is shown below. his patient with pancytopenia, hepatosplenomegaly, and teardrop cells on peripheral blood smear likely has primary myelofibrosis, a hematopoietic stem cell malignancy associated with the clonal expansion of megakaryocytes.  Neoplastic megakaryocytes secrete the cytokine transforming growth factor-beta, which stimulates bone marrow fibroblasts to fill the medullary space with collagen.  Subsequent bone marrow fibrosis usually leads to the following: Extramedullary hematopoiesis – Because the bone marrow is destroyed by fibrotic tissue, hematopoiesis occurs in secondary hematopoietic tissue such as the spleen and liver.  This typically results in marked splenomegaly and a palpable liver edge on examination. Cytopenias – Extramedullary hematopoiesis is much less efficient than medullary hematopoiesis.  Therefore, patients often have deficits in 1 or more cell lines (eg, anemia, pancytopenia). Dacrocytes on peripheral blood smear – The red cell membrane is damaged when squeezing out of the fibrotic bone marrow or passing through the enlarged spleen, which leads to the formation of teardrop-shaped red cells. The diagnosis of primary myelofibrosis requires bone marrow examination.  Bone marrow aspiration frequently results in a dry tap (no marrow) due to significant bone marrow fibrosis.  Therefore, bone marrow biopsy is usually required; the presence of a diffusely fibrotic marrow with occasional clusters of atypical megakaryocytes confirms the diagnosis. (Choice B)  Multiple myeloma, a clonal disorder of plasma cells, is marked by a monoclonal spike (M-spike) on protein electrophoresis.  Patients typically have anemia, hypercalcemia, bone pain (osteolytic lesions), and renal insufficiency.  Bone marrow biopsy usually shows a clusters of monoclonal plasma cells. (Choice C)  Anemia of chronic disease is associated with hepcidin-induced changes in iron metabolism that cause iron trapping within macrophages.  Bone marrow biopsy with Prussian blue stain demonstrates increased iron within macrophages.  Hepatosplenomegaly and teardrop cells would be unexpected. (Choice D)  Myelodysplastic syndrome is a malignant stem cell cancer associated with the production of dysplastic, atypical blood cells.  Although most patients with myelodysplasia have cytopenias, the bone marrow is usually hypercellular with multi-lineage dysplasia. (Choice E)  Aplastic anemia results from injury (eg, drugs, radiation, viruses) to multipotent hematologic stem cells.  It is usually associated with pancytopenia and a profoundly hypocellular bone marrow predominantly composed of adipose tissue.  Extramedullary hematopoiesis is minimal and hepatosplenomegaly and dacrocytes are not typically present. Educational objective: Primary myelofibrosis is a myeloproliferative disorder associated with the clonal expansion of megakaryocytes.  Bone marrow fibrosis accounts for most of the major manifestations, including hepatosplenomegaly, cytopenias, and blood smear evidence of dacrocytes.  Bone marrow aspiration is usually dry, but bone marrow biopsy will show marked fibrosis with occasional clusters of atypical megakaryocytes.

Primary Myelofibrosis — Ultra High-Yield USMLE Notes


1. Diagnosis: Primary Myelofibrosis — clonal megakaryocyte expansion → TGF-β → bone marrow collagen fibrosis → teardrop cells + massive splenomegaly + dry tap

2. Key clue (1 line): 68M + severe fatigue + 15-lb weight loss + mucosal pallor + massive splenomegaly + hepatomegaly + pancytopenia + smear = teardrop cells (dacrocytes) → primary myelofibrosis → marrow = fibrotic + atypical megakaryocyte clusters

3. Why correct (≤2 lines): Neoplastic megakaryocytes → secrete TGF-β → bone marrow fibroblasts fill medullary space with collagen → HSCs flee to spleen/liver → extramedullary hematopoiesis (massive splenomegaly + hepatomegaly); RBCs squeezed through fibrotic marrow/enlarged spleen → membrane damaged → teardrop cells (dacrocytes). Bone marrow aspiration = dry tap (fibrosis); biopsy = fibrotic marrow + atypical megakaryocyte clusters.

4. Why others wrong (1 line each):
  • Multiple myeloma: M-spike on SPEP + CRAB; plasma cell clusters on marrow; no teardrop cells or massive splenomegaly
  • Anemia of chronic disease: Iron trapped in macrophages (↑hepcidin); normocytic; no teardrop cells or splenomegaly; Prussian blue = ↑macrophage iron
  • MDS: Hypercellular marrow + dysplastic cells + blasts <20%; cytopenias; no teardrop cells or massive splenomegaly
  • Aplastic anemia: Profoundly hypocellular marrow (fat cells); pancytopenia; minimal EMH → no splenomegaly; no teardrop cells

5. Buzzword triggers:
  • Teardrop cells (dacrocytes) + massive splenomegaly + dry tap → primary myelofibrosis
  • TGF-β from neoplastic megakaryocytes → collagen fibrosis
  • Leukoerythroblastic picture = teardrop cells + nucleated RBCs + immature granulocytes = marrow stress response
  • Dry tap causes: myelofibrosis + HCL + aplastic anemia + metastatic marrow
  • Myelofibrosis vs HCL (both dry tap + splenomegaly): myelofibrosis = teardrop cells + immature granulocytes; HCL = hairy cells + mature B-cells (CD103+)
  • JAK2 V617F mutation in ~50% of primary myelofibrosis (also PV + essential thrombocythemia)
  • CALR mutation (calreticulin) = second most common in myelofibrosis
  • Primary myelofibrosis treatment: ruxolitinib (JAK1/2 inhibitor) for symptom control; allogeneic HSCT = only cure
  • Myelofibrosis is one of the chronic myeloproliferative neoplasms (with PV + ET + CML)

6. Trap / trick tested:
  • Massive splenomegaly = key distinguisher: myelofibrosis (EMH) vs aplastic anemia (no EMH → no splenomegaly) vs MDS (no significant splenomegaly)
  • Teardrop cells = myelofibrosis — also seen in thalassemia/severe IDA but in those contexts no dry tap/splenomegaly; always interpret in clinical context
  • Hypercellular marrow (MDS) vs fibrotic marrow (myelofibrosis) — both can have cytopenias + abnormal cells; key = splenomegaly + teardrop cells = myelofibrosis
  • TGF-β drives fibrosis (not EPO, not GM-CSF); megakaryocytes are the source → explains why fibrosis is myeloid-origin disease

7. One-liner memory hook:
"Megakaryocytes gone rogue → TGF-β fills marrow with collagen → HSCs flee to spleen (massive) + liver → teardrop cells from fibrotic squeeze + dry tap on aspiration; JAK2 mutation + ruxolitinib = treatment; teardrop + huge spleen + dry tap = myelofibrosis."

A 67-year-old man comes to the office due to severe fatigue for the past several months.  The patient cannot eat as much as he used to and has lost nearly 10 kg (22 lb) in the past 6 months.  Physical examination shows mucosal pallor, hepatomegaly, and massive splenomegaly.  Further evaluation reveals a gain-of-function mutation of a non-receptor tyrosine kinase protein in hematopoietic cells, leading to persistent activation of signal transducers and activators of transcription (STAT) proteins.  This patient is most likely suffering from which of the following disorders? Explanation Chronic myeloproliferative disorders Disorder Diagnostic features Mutation Chronic myelogenous leukemia Constitutional symptoms (eg, fatigue, weight loss, excessive sweating), splenomegaly & leukocytosis with marked left shift (eg, myelocytes, metamyelocytes, band forms) Philadelphia chromosome t(9:22) BCR-ABL fusion protein Essential thrombocytosis Hemorrhagic & thrombotic symptoms (eg, easy bruising, microangiopathic occlusion), thrombocytosis & megakaryocytic hyperplasia JAK2 Polycythemia vera Pruritus, erythromelalgia, splenomegaly, thrombotic complications, erythrocytosis & thrombocytosis Primary myelofibrosis Severe fatigue, splenomegaly (often causing early satiety/abdominal discomfort), hepatomegaly, anemia & bone marrow fibrosis The chronic myeloproliferative disorders are bone marrow diseases characterized by overproduction of myeloid cells.  Primary myelofibrosis is caused by atypical megakaryocytic hyperplasia, which stimulates fibroblast proliferation, resulting in progressive replacement of the marrow space by extensive collagen deposition.  In the early stages, there is marrow hypercellularity with minimal fibrosis, but as the disease progresses, pancytopenia can result.  Hepatomegaly and massive splenomegaly develop because the loss of bone marrow hematopoiesis is compensated for by extramedullary hematopoiesis.  The peripheral smear characteristically shows teardrop-shaped red blood cells (dacrocytes) and nucleated red blood cells. With the exception of chronic myelogenous leukemia, the chronic myeloproliferative disorders (especially polycythemia vera) frequently harbor a mutation in the nonreceptor cytoplasmic tyrosine kinase, Janus kinase 2 (JAK2).  This mutation results in constitutive tyrosine phosphorylation activity, and consequently, in the cytokine-independent activation of the signal transducers and activators of transcription (STAT) pathway.  Once they are activated, STAT proteins translocate to the nucleus and promote transcription.  A JAK2 inhibitor (ruxolitinib) has been approved for treatment of primary myelofibrosis. (Choice A)  In acute promyelocytic leukemia, t(15;17) leads to the formation of a fusion gene between the promyelocytic leukemia (PML) and the retinoic acid receptor alpha (RARA) genes.  The abnormal PML/RARα fusion protein blocks differentiation of myeloid precursors. (Choice B)  Chronic lymphocytic leukemia is a lymphoproliferative disorder involving B lymphocytes.  The most significant laboratory finding is marked lymphocytosis, with "smudge cells" seen on peripheral blood smear.  The majority of cases exhibit increased expression of the proto-oncogene BCL2; a similar finding occurs in follicular lymphomas. (Choices C and D)  Several high-grade non-Hodgkin lymphomas (NHLs) are associated with cytogenetic abnormalities.  The t(8;14) translocation involves the c-Myc oncogene and is common in Burkitt lymphoma, which is associated with Epstein-Barr virus infection and classically has a "starry sky" histological appearance.  Mantle cell lymphoma is a low grade NHL characterized by t(11;14), leading to cyclin D1 overexpression. Educational objective: The chronic myeloproliferative disorders (polycythemia vera, essential thrombocytosis, and primary myelofibrosis) often have a mutation in Janus kinase 2 (JAK2), a cytoplasmic tyrosine kinase.  This results in constitutive tyrosine kinase activity, and consequently, in the cytokine-independent activation of signal transducers and activators of transcription (STAT) proteins (JAK-STAT signaling pathway).

Chronic Myeloproliferative Disorders — JAK2 Mutation — Ultra High-Yield USMLE Notes


1. Diagnosis: Primary Myelofibrosis — JAK2 V617F mutation (non-receptor cytoplasmic TK) → constitutive STAT activation → massive splenomegaly + hepatomegaly + teardrop cells

2. Key clue (1 line): 67M + fatigue + 10kg weight loss + early satiety + massive splenomegaly + hepatomegaly + gain-of-function non-receptor TK mutation → constitutive STAT activation → primary myelofibrosis (JAK2)

3. Why correct (≤2 lines): JAK2 V617F = non-receptor (cytoplasmic) tyrosine kinase → gain-of-function → cytokine-independent STAT phosphorylation → STAT translocates to nucleus → transcription of growth genes → autonomous myeloid proliferation → myelofibrosis (TGF-β → collagen) + EMH (spleen/liver). JAK2 mutation found in PV (~95%) > Primary myelofibrosis (~50%) > Essential thrombocythemia (~50%) but NOT CML (= BCR-ABL).

4. Why others wrong (1 line each):
  • APML t(15;17) — PML-RARα: Nuclear receptor fusion → differentiation block; not TK/STAT pathway; presents with DIC + Auer rods
  • CLL — BCL2 overexpression: Anti-apoptotic; lymphoid (B-cell); smudge cells; no splenomegaly/teardrop cells; not TK mutation
  • Burkitt t(8;14) — MYC: Transcription factor overexpression; aggressive B-cell lymphoma; starry sky; not STAT pathway
  • Mantle cell t(11;14) — cyclin D1: Cell cycle G1→S; B-cell lymphoma; not TK/STAT pathway

5. Buzzword triggers — Myeloproliferative Disorders Master Table:
DisorderKey FeatureMutationTreatment
PV↑RBC + pruritus + plethora + ↓EPOJAK2 (~95%)Phlebotomy ± hydroxyurea
Essential thrombocythemia↑↑platelets + thrombosis/hemorrhageJAK2 (~50%)Aspirin ± hydroxyurea
Primary myelofibrosisTeardrop cells + massive splenomegaly + dry tapJAK2 (~50%)Ruxolitinib
CMLLeft shift + basophilia + ↓LAPBCR-ABL t(9;22)Imatinib
  • JAK-STAT pathway: Cytokine → receptor → recruits JAK2 → JAK phosphorylates STAT → STAT dimerizes → nucleus → transcription; JAK2 mutation = always ON without cytokine
  • Ruxolitinib = JAK1/2 inhibitor → approved for myelofibrosis + PV
  • JAK2 ≠ CML — CML uses BCR-ABL (also TK but receptor-associated fusion, not JAK family); key distinction

6. Trap / trick tested:
  • JAK2 = non-receptor TK (cytoplasmic) — question specifically states "non-receptor tyrosine kinase → STAT activation" = JAK2; BCR-ABL is also non-receptor TK but activates different pathway (not JAK-STAT)
  • CML excluded from JAK2 group — CML = BCR-ABL; all OTHER chronic myeloproliferative disorders (PV, ET, myelofibrosis) = JAK2
  • Massive splenomegaly = distinguishing feature; CML also has splenomegaly but myelofibrosis = most massive
  • STAT proteins: once phosphorylated by JAK → dimerize → translocate to nucleus → transcription factors; JAK inhibition = blocks this entire downstream cascade

7. One-liner memory hook:
"JAK2 stuck ON → STAT always activated → myeloid cells grow without cytokine signal; PV = too many RBCs; ET = too many platelets; myelofibrosis = too much collagen; all JAK2 (except CML = BCR-ABL); ruxolitinib blocks JAK → shrinks spleen."

A 9-year-old girl is brought to the emergency department due to prolonged epistaxis.  The girl says that she picked her nose immediately before the bleeding started.  Her parents decided to bring her to the emergency department after the epistaxis persisted for 20 minutes despite constant compression of the nasal alae.  The patient has had frequent nosebleeds that often last >10 minutes.  Her family history is significant for a grandfather who had an unspecified bleeding disorder.  Given the history of prolonged, recurrent nosebleeds, laboratory tests are ordered, and results are as follows: Hematocrit 43% Bleeding time prolonged Partial thromboplastin time (PTT) prolonged Prothrombin time (PT) normal Thrombin time (TT) normal D-dimer normal Which of the following is the most likely diagnosis? his patient has a normal prothrombin time (PT) and thrombin time (TT) and a prolonged partial thromboplastin time (PTT), indicating a defect in the intrinsic pathway (coagulation factors VIII, IX, XI, or XII).  Bleeding time is a test of platelet function and is prolonged by qualitative and quantitative platelet defects.  The term "bleeding time" refers to this particular test and not the duration of bleeding, which can be prolonged from other coagulopathies. von Willebrand disease (vWD) will cause both a prolonged PTT and bleeding time.  von Willebrand factor (vWF) is produced by endothelial cells and megakaryocytes and functions as a carrier protein for factor VIII and as a mediator of platelet adhesion to the endothelium.  Absence of vWF leads to impaired platelet function and coagulation pathway abnormalities.  vWD is inherited in an autosomal dominant fashion with variable penetrance and is the most common heritable bleeding disorder. (Choice A)  Disseminated intravascular coagulopathy (DIC) is a consumptive coagulopathy most commonly seen in septic shock.  PT, PTT, and bleeding time are prolonged, and the D-dimer, a degradation product of cross-linked fibrin, is elevated. (Choice B)  Dysfibrinogenemias are inherited abnormalities in the fibrinogen molecule that can cause excessive bleeding or thrombophilia.  TT, PT, and PTT are abnormal in this condition, but bleeding time is unaffected. (Choice C)  Factor XIII is a transglutaminase that cross-links fibrin polymers, thereby stabilizing clots.  Factor XIII deficiency causes spontaneous or excessive bleeding, but it would not prolong the bleeding time, PT, or PTT. (Choice D)  Hemophilia A is an X-linked hereditary deficiency of factor VIII that causes coagulopathy with a prolonged PTT but shows normal bleeding time. (Choice E)  Hemophilia B is an X-linked hereditary deficiency of factor IX that causes coagulopathy with a prolonged PTT but shows normal bleeding time. (Choice F)  Vitamin K is required for activation of clotting factors II, VII, IX, and X.  Vitamin K deficiency causes a coagulopathy that primarily prolongs PT, with PTT prolongation occurring in severe cases.  Bleeding time is not affected. Educational objective: von Willebrand disease is the most common inherited bleeding disorder.  It has an autosomal dominant pattern of inheritance and variable penetrance.  Absence of von Willebrand factor leads to impaired platelet function (prolonged bleeding time) and coagulation pathway abnormalities due to decreased factor VIII activity (prolonged partial thromboplastin time).

Von Willebrand Disease (vWD) — Ultra High-Yield USMLE Notes


1. Diagnosis: Von Willebrand Disease (vWD) — most common inherited bleeding disorder; autosomal dominant; ↑bleeding time + ↑PTT + normal PT/TT/D-dimer

2. Key clue (1 line): 9-year-old girl + recurrent prolonged epistaxis + family history bleeding disorder + ↑bleeding time + ↑PTT + normal PT + normal TT + normal D-dimer → vWD (not hemophilia = normal bleeding time)

3. Why correct (≤2 lines): vWF = carrier for Factor VIII + mediates platelet adhesion to endothelium (via GpIb); absent/deficient vWF → ↑bleeding time (platelet plug fails) + ↑PTT (↓Factor VIII activity → intrinsic pathway impaired) + normal PT/TT (extrinsic + fibrinogen pathways intact). Autosomal dominant + variable penetrance → family history (grandfather); mucocutaneous bleeding (epistaxis, gum bleeding, menorrhagia).

4. Why others wrong (1 line each):
  • DIC: ↑PT + ↑PTT + ↑bleeding time + ↑D-dimer + ↓fibrinogen; consumptive coagulopathy; D-dimer normal here
  • Dysfibrinogenemia: Abnormal fibrinogen → ↑TT + ↑PT + ↑PTT; TT normal here → rules out
  • Factor XIII deficiency: Cross-links fibrin; deficiency → delayed bleeding/wound dehiscence; PT/PTT/bleeding time all normal
  • Hemophilia A (Factor VIII↓): ↑PTT only + normal bleeding time (platelet plug forms normally); X-linked recessive; males only
  • Hemophilia B (Factor IX↓): Same as Hemophilia A — ↑PTT + normal bleeding time; X-linked; males
  • Vitamin K deficiency: Primarily ↑PT (Factor VII short half-life); PTT prolonged only in severe cases; bleeding time normal

5. Buzzword triggers:
  • ↑Bleeding time + ↑PTT + normal PTvWD (only condition with both platelet AND coagulation defect)
  • Most common inherited bleeding disorder = vWD
  • vWF functions: (1) carrier/chaperone for Factor VIII (↓Factor VIII degradation) + (2) platelet adhesion (GpIb-vWF-collagen bridge)
  • vWD types:
    • Type 1 (most common, 75%): quantitative ↓vWF; AD; mild; responds to DDAVP
    • Type 2: qualitative vWF defect; various subtypes; DDAVP variable
    • Type 3 (most severe): near-absent vWF; AR; treat with vWF concentrate
  • DDAVP (desmopressin) → releases vWF from endothelial Weibel-Palade bodies → treats Type 1 vWD + mild Hemophilia A
  • vWD diagnosis: ↓vWF antigen + ↓vWF activity (ristocetin cofactor assay) + ↓Factor VIII activity
  • Ristocetin agglutination test: ristocetin causes platelet aggregation via vWF-GpIb; ↓agglutination in vWD

6. Trap / trick tested:
  • vWD vs Hemophilia A: Both ↑PTT; pivot = bleeding time: vWD = (platelet dysfunction); Hemophilia = normal (platelet plug intact); also vWD = AD (females affected); Hemophilia = X-linked (males)
  • Bleeding time = platelet function test — not literally "how long bleeding lasts"; prolonged in platelet disorders + vWD; normal in pure coagulation factor deficiencies (hemophilia A/B, factor XIII)
  • Family history in female child + mucocutaneous bleeding = vWD (AD); hemophilia in females is extremely rare (X-linked recessive)
  • ↑PTT in vWD because vWF carries Factor VIII; without vWF → Factor VIII degraded → ↓Factor VIII → intrinsic pathway slowed → ↑PTT

7. One-liner memory hook:
"vWF does two jobs: hold Factor VIII (↑PTT when gone) + stick platelets to collagen (↑bleeding time when gone); two abnormal tests = vWD; Hemophilia = only ↑PTT (platelets fine); bleeding time = platelet proxy; DDAVP releases stored vWF for Type 1."

A 29-year-old woman comes to the emergency department due to fever and headache for the last week.  The patient has a generalized tonic-clonic seizure while being evaluated.  Laboratory results are as follows: Hemoglobin 6.1 g/dL Platelets 16,000/mm3 Creatinine 2.2 mg/dL Total bilirubin 4.3 mg/dL Serum haptoglobin undetectable PT 11 sec (INR 1.1) Activated PTT 30 sec Peripheral blood smear is shown in the exhibit.  Which of the following is the most likely underlying cause of this patient's current condition? Explanation Thrombotic thrombocytopenic purpura Pathophysiology ↓ ADAMTS13 level → uncleaved vWF multimers → platelet trapping & activation Acquired (autoantibody) or hereditary Clinical features Hemolytic anemia (↑ LDH, ↓ haptoglobin) with schistocytes on peripheral smear Thrombocytopenia (↑ bleeding time, normal PT/PTT) Sometimes with: Renal failure Neurologic manifestations Fever LDH = lactate dehydrogenase; vWF = von Willebrand factor. This patient has the classic pentad of manifestations for acquired thrombotic thrombocytopenic purpura (TTP): Severe thrombocytopenia:  Platelet-rich clots form in the microvasculature, leading to rapid platelet consumption. Microangiopathic hemolytic anemia (MAHA):  Erythrocytes are mechanically sheared by the microvascular thrombi, leading to intravascular hemolytic anemia.  This typically causes an elevated indirect bilirubin level and an undetectable haptoglobin level (haptoglobin binds free hemoglobin in the circulation), but confirmation of MAHA requires identification of schistocytes (eg, triangle cells, helmet cells) on peripheral blood smear. Neurologic manifestations (eg, headache, seizure), renal insufficiency, and fever (the remainder of the pentad) occur in a minority of patients Unlike patients who have disseminated intravascular coagulation (a consumptive coagulopathy also associated with MAHA and thrombocytopenia), those with TTP have normal coagulation studies because coagulation factors are not significantly consumed by the formation of platelet-rich clots (Choice A). TTP is triggered by the formation of autoantibody inhibitors against ADAMTS-13, a protease that cleaves ultralarge von Willebrand factor (VWF) multimers in the circulation, reducing their prothrombotic activity.  Patients with TTP have very low levels of ADAMTS-13, which increases the proportion of ultralarge VWF multimers and leads to the aggregation and activation of platelets.  Plasma exchange, which removes the autoantibody inhibitors against ADAMTS-13, is generally curative. (Choice C)  Expansion of neoplastic myeloid precursors in the bone marrow is seen in acute myeloid leukemia, which can cause anemia and thrombocytopenia due to bone marrow infiltration.  However, peripheral blood smear would show leukemic blast cells, not schistocytes. (Choice D)  Inherited deficiency of glucose-6-phosphate dehydrogenase typically causes hemolytic anemia during times of oxidative stress (eg, infection, medication exposure, certain foods).  High bilirubin and low haptoglobin are often present due to hemolytic anemia; however, thrombocytopenia is not seen, and peripheral smear would show bite cells and Heinz bodies, not schistocytes. (Choice E)  A missense mutation at the sixth position of the hemoglobin beta chain is seen in sickle cell anemia, which is marked by periods of acute on chronic hemolytic anemia (eg, elevated bilirubin, low haptoglobin).  However, peripheral smear would show sickled erythrocytes, not schistocytes; in addition, thrombocytopenia is not generally seen. Educational objective: Thrombotic thrombocytopenic purpura classically presents with the pentad of severe thrombocytopenia, microangiopathic hemolytic anemia (eg, schistocytes on peripheral smear), renal insufficiency, neurologic symptoms, and fever.  However, all these signs and symptoms are rarely present.  Diagnosis is often made by identifying severe deficiency of ADAMTS-13, a protease that cleaves large von Willebrand factor multimers off the endothelium.

Thrombotic Thrombocytopenic Purpura (TTP) — Ultra High-Yield USMLE Notes


1. Diagnosis: Thrombotic Thrombocytopenic Purpura (TTP) — ↓ADAMTS-13 → uncleaved ultralarge vWF multimers → platelet microthrombi → MAHA + thrombocytopenia + normal PT/PTT

2. Key clue (1 line): 29F + fever + headache + seizure + Hgb 6.1 + platelets 16k + Cr 2.2 + ↑bili + ↓haptoglobin + schistocytes on smear + normal PT/PTT → TTP (classic pentad)

3. Why correct (≤2 lines): Autoantibody against ADAMTS-13 (vWF-cleaving protease) → ultralarge vWF multimers accumulate → platelet trapping → platelet-rich microthrombi → RBCs sheared = schistocytes (MAHA) + thrombocytopenia + organ ischemia (neuro + renal). Normal PT/PTT = coagulation factors NOT consumed (platelet-rich clots only) → distinguishes TTP from DIC.

4. Why others wrong (1 line each):
  • DIC (consumptive coagulopathy): MAHA + thrombocytopenia BUT ↑PT + ↑PTT + ↑D-dimer + ↓fibrinogen; coagulation factors consumed; PT/PTT normal here → rules out DIC
  • AML (bone marrow infiltration): Anemia + thrombocytopenia possible but blasts on smear (not schistocytes); no MAHA/hemolysis markers
  • G6PD deficiency: Hemolysis (↑bili + ↓haptoglobin) but bite cells + Heinz bodies (not schistocytes) + no thrombocytopenia; requires oxidative trigger
  • Sickle cell anemia: Hemolysis (↑bili + ↓haptoglobin) + sickled RBCs (not schistocytes); no thrombocytopenia typically

5. Buzzword triggers:
  • TTP classic pentad: FAT RN = Fever + Anemia (MAHA) + Thrombocytopenia + Renal failure + Neurologic symptoms
  • Schistocytes + ↓platelets + normal PT/PTT → TTP (or HUS)
  • TTP vs HUS pivot:
    • TTP: Adults + neuro dominant + mild renal; ADAMTS-13 ↓↓; treat = plasma exchange
    • HUS: Children + renal dominant + STEC O157:H7 diarrhea; normal ADAMTS-13; treat = supportive
  • ADAMTS-13 = "A Disintegrin And Metalloproteinase with ThromboSpondin motifs 13" → cleaves vWF multimers
  • TTP treatment: plasma exchange (plasmapheresis) = removes autoantibody + replaces ADAMTS-13; do NOT give platelets (fuels thrombosis)
  • TTP associations: pregnancy, HIV, quinine, clopidogrel, ticlopidine, autoimmune disease
  • ↓Haptoglobin + ↑LDH + ↑indirect bilirubin + schistocytes = intravascular hemolysis confirmation

6. Trap / trick tested:
  • Normal PT/PTT = TTP/HUS, NOT DIC — most critical distinguishing feature; coagulation cascade intact in TTP; DIC consumes everything
  • Do NOT transfuse platelets in TTP — adding platelets = more fuel for microthrombi = worsens ischemia; treat cause (plasma exchange)
  • Pentad rarely all present — exam may show only 2-3 features; schistocytes + thrombocytopenia + normal coags = enough to diagnose TTP
  • Young woman + neurologic symptoms + MAHA = TTP until proven otherwise; HUS = child + post-diarrheal

7. One-liner memory hook:
"No ADAMTS-13 → vWF strings too long → platelets tangle → microthrombi everywhere → RBCs shredded (schistocytes) + platelets eaten + brain/kidney suffer; PT/PTT fine (no coag factor loss) = TTP not DIC; plasma exchange removes the antibody = cure; never give platelets."

A 26-year-old woman, gravida 2 para 1, at 8 weeks gestation comes to the office due to pain and swelling of her left leg for the past day.  The patient had a pulmonary embolism during her previous pregnancy, and prophylactic low-molecular-weight heparin therapy was initiated 6 days ago.  She has no other medical conditions and takes prenatal vitamins.  Physical examination shows left lower extremity edema and calf tenderness but no other abnormalities.  Venous duplex ultrasonography reveals acute left femoral vein thrombosis.  Platelet count, which was normal prior to anticoagulant therapy initiation, is 84,000/mm3.  Other blood cell counts and renal and liver function studies are within normal limits.  Which of the following most likely predisposed this patient to her current condition? his patient with a significant drop in platelet count and acute venous thromboembolism following recent exposure to low molecular weight heparin likely has heparin-induced thrombocytopenia and thrombosis (HITT), also known as heparin-induced thrombocytopenia type 2.  HITT typically occurs 5-10 days following exposure to heparin products and is characterized by a large drop in platelet count.  It is more common following exposure to unfractionated heparin but can occur following exposure to low-molecular weight heparin as well. Platelet factor 4 (PF4) is a protein released from the alpha granules of platelets that plays a role in platelet aggregation.  It also binds heparin and helps inactivate the molecule.  The mechanism of HITT involves the generation of IgG antibodies to these complexes of heparin and PF4.  The Fc component of the activated IgG antibodies then binds to additional platelets, resulting in further PF4 release and widespread platelet activation.  This leads to a prothrombotic state that places patients at high risk for both arterial and venous thrombosis. (Choice A)  Acquired protein C deficiency occurs early in the course of warfarin therapy, as the inhibition of protein C by warfarin occurs more rapidly than the inhibition of other factors (ie, factors II, VII, IX, X).  If not bridged with heparin when starting therapy, patients may develop warfarin-induced skin necrosis due to localized cutaneous thrombus formation. (Choice C)  Idiopathic thrombocytopenic purpura (ITP) results from splenic destruction of platelets labeled by IgG antibodies to glycoprotein IIb/IIIa receptors.  ITP often causes very low platelet levels and is associated with bleeding complications rather than thrombosis. (Choice D)  Cryoglobulinemia can occur in the setting of autoimmune disease (eg, systemic lupus erythematosus) or viral infection (eg, hepatitis C) and causes systemic vasculitis characterized by fatigue, arthralgia, and purpuric rash.  Marked thrombocytopenia is not typical. (Choice E)  Thrombotic thrombocytopenic purpura (TTP) results from decreased levels of the von Willebrand factor-cleaving protease ADAMTS13.  The classic presentation of TTP is the pentad of fever, thrombocytopenia, microangiopathic hemolytic anemia, renal insufficiency, and neurologic dysfunction. Educational objective: Heparin-induced thrombocytopenia and thrombosis results from the production of IgG antibodies against complexes of heparin and platelet factor 4.  The Fc component of these antibodies binds to platelets, resulting in widespread platelet activation and a prothrombotic state.

Heparin-Induced Thrombocytopenia (HIT Type 2) — Ultra High-Yield USMLE Notes


1. Diagnosis: Heparin-Induced Thrombocytopenia + Thrombosis (HITT/HIT Type 2) — IgG antibodies vs heparin-PF4 complex → platelet activation → thrombocytopenia + thrombosis (paradox)

2. Key clue (1 line): Pregnant woman + LMWH started 6 days ago + new DVT + platelets dropped to 84k (from normal) → HITT — IgG anti-heparin/PF4 → widespread platelet activation → prothrombotic state

3. Why correct (≤2 lines): Heparin binds platelet factor 4 (PF4) → heparin-PF4 complex → IgG antibodies form → Fc region of IgG binds platelet Fc receptors → platelet activation → more PF4 released → amplification → platelet consumption (↓platelets) + massive thrombin generation → paradoxical thrombosis despite thrombocytopenia. Occurs 5–10 days after heparin exposure; more common with UFH > LMWH.

4. Why others wrong (1 line each):
  • Protein C deficiency (warfarin-induced): Early warfarin → ↓protein C faster than other factors → skin necrosis (cutaneous thrombosis); not heparin-related; no platelet drop
  • ITP (anti-GpIIb/IIIa IgG): Splenic platelet destruction → ↓↓platelets + bleeding (not thrombosis); no heparin association; no new clot formation
  • Cryoglobulinemia: SLE/hepatitis C → vasculitis (purpura + arthralgia + fatigue); marked thrombocytopenia not typical; no heparin link
  • TTP (↓ADAMTS-13): MAHA + thrombocytopenia + neuro + renal + fever pentad; schistocytes on smear; no heparin association

5. Buzzword triggers:
  • Heparin + 5–10 days + ↓platelets + NEW thrombosisHIT Type 2
  • Thrombocytopenia + THROMBOSIS (paradox) = HIT Type 2 hallmark
  • PF4-heparin complex + IgG → Fc binds platelets → activation cascade
  • 4T score for HIT diagnosis: Thrombocytopenia + Timing (5-10 days) + Thrombosis + oTher cause excluded
  • HIT Type 1 vs Type 2:
    • Type 1: Direct heparin effect → mild ↓platelets → first 2 days → no antibodies → benign, self-limiting
    • Type 2: Immune (IgG) → ↓↓platelets + thrombosis → 5-10 days → dangerous
  • HIT treatment: STOP heparin immediately → switch to non-heparin anticoagulant (argatroban, bivalirudin, fondaparinux); do NOT give platelets
  • Do NOT use warfarin acutely in HIT → protein C drops first → worsens thrombosis (skin necrosis)
  • LMWH can cause HIT but less commonly than UFH; fondaparinux = safest alternative (no cross-reactivity)

6. Trap / trick tested:
  • Thrombocytopenia + thrombosis = HIT — students expect bleeding with low platelets; HIT causes clotting not bleeding; this paradox is the key USMLE concept
  • Stop heparin + no warfarin immediately — warfarin in acute HIT → ↓protein C → worsening thrombosis + skin necrosis; must bridge with direct thrombin inhibitor first
  • Platelet transfusion contraindicated in HIT (same as TTP) — adding platelets = more activation substrate = more thrombosis
  • Timing clue: 5–10 days = immune (Type 2); <2 days = direct effect (Type 1); re-exposure = can occur within hours

7. One-liner memory hook:
"Heparin sticks to PF4 → IgG forms → antibody Fc grabs platelets → platelets explode (activate) → clots everywhere despite low platelets; STOP heparin + give argatroban (not warfarin, not platelets); thrombocytopenia + thrombosis after 5-10 days of heparin = HIT Type 2."

A 35-year-old woman comes to the hospital due to sudden-onset numbness in her left arm and face.  The patient has had generalized headache, dyspnea on exertion, and easy fatigability for several days but no weakness.  She has a history of well-controlled asthma.  Temperature is 37.7 C (99.9 F), blood pressure is 110/60 mm Hg, and pulse is 80/min.  Light touch sensation is decreased in the left upper extremity and the lower left side of the face.  Strength and reflexes are normal.  Cardiopulmonary and abdominal examinations are unremarkable.  There is no skin rash.  Laboratory results are as follows: Hemoglobin 8.6 g/dL Platelets 24,000/mm3 Blood urea nitrogen 32 mg/dL Creatinine 1.9 mg/dL PT and PTT are normal.  Peripheral blood smear shows numerous schistocytes.  Urinalysis is positive for mild proteinuria.  Which of the following is the most likely underlying cause of this patient's current condition? xplanation Thrombotic thrombocytopenic purpura Pathophysiology ↓ ADAMTS13 level → uncleaved vWF multimers → platelet trapping & activation Acquired (autoantibody) or hereditary Clinical features Hemolytic anemia (↑ LDH, ↓ haptoglobin) with schistocytes on peripheral smear Thrombocytopenia (↑ bleeding time, normal PT/PTT) Sometimes with: Renal failure Neurologic manifestations Fever LDH = lactate dehydrogenase; vWF = von Willebrand factor. This patient's severe thrombocytopenia and schistocytes on peripheral blood smear indicate microangiopathic hemolytic anemia (MAHA).  The presence of normal coagulation studies indicate that there is no systemic activation of the coagulation cascade, which makes disseminated intravascular coagulation unlikely (Choice E).  Therefore, a platelet-activated thrombotic microangiopathy such as thrombotic thrombocytopenic purpura (TTP) or hemolytic uremic syndrome is most likely. In this case, the patient has 4 of the 5 classic findings of acquired TTP: Severe thrombocytopenia, which may cause bruising or bleeding MAHA, which may cause symptomatic anemia (eg, fatigue, dyspnea on exertion) Renal damage, which may cause renal insufficiency (eg, elevated creatinine) and mild proteinuria Neurologic damage, which may cause confusion, headache, and transient focal findings (eg, numbness, weakness) Fever (not present) Although this pentad of findings is classic, all 5 manifestations are rarely seen.  In addition, a purpuric rash (due to subcutaneous bleeding) is sometimes, but not always, present. Acquired TTP occurs due to the formation of an autoantibody inhibitor against ADAMTS-13, a von Willebrand factor (vWF)–cleaving protease.  Circulating vWF (produced by megakaryocytes and endothelial cells) normally is released as large vWF multimers that are cleaved to their regular size by ADAMTS-13.  These vWF multimers support hemostasis by bridging platelets and subendothelial components to sites of vascular injury.  In TTP, the large uncleaved vWF multimers are significantly more prothrombotic and result in diffuse microvascular thrombosis. (Choice A)  Henoch-Schönlein purpura (IgA vasculitis) is characterized by IgA immune complex deposition.  Typical manifestations include palpable purpura, renal disease, and arthritis/arthralgias.  Platelet counts are usually normal. (Choice C)  Some features of this patient's presentation could be explained by plasma cell dyscrasias such as multiple myeloma (renal failure, anemia due to bone marrow replacement) and Waldenström macroglobulinemia (neurologic symptoms due to hyperviscosity, autoimmune hemolytic anemia).  However, microangiopathic hemolytic anemia would be atypical. (Choice D)  A cerebrovascular accident caused by plaque rupture could cause neurologic deficits but would not account for the patient's hematologic and renal abnormalities. Educational objective: Thrombotic thrombocytopenic purpura frequently results from impaired function of the von Willebrand factor (vWF)–cleaving protease ADAMTS-13, which causes the accumulation of uncleaved vWF multimers that are significantly more prothrombotic.  Patients develop diffuse microvascular thrombosis, which leads to thrombocytopenia and microangiopathic hemolytic anemia.

TTP — Combined Ultra High-Yield USMLE Notes


1. Diagnosis: Thrombotic Thrombocytopenic Purpura (TTP) — ↓ADAMTS-13 (autoantibody) → ultralarge vWF multimers → platelet microthrombi → MAHA + thrombocytopenia + normal PT/PTT

2. Key clue (1 line): 35F + headache + dyspnea + arm/face numbness + Hgb 8.6 + platelets 24k + Cr 1.9 + schistocytes + normal PT/PTT → TTP (4/5 pentad: MAHA + thrombocytopenia + neuro + renal; afebrile)

3. Why correct (≤2 lines): Autoantibody inhibits ADAMTS-13 → ultralarge vWF multimers accumulate → hyperprothrombotic → diffuse microvascular platelet-rich thrombi → shear RBCs (schistocytes) + consume platelets + occlude vessels in brain/kidney. Normal PT/PTT = coagulation factors intact (only platelet-rich clots, NOT fibrin-rich) → rules out DIC.

4. Why others wrong (1 line each):
  • IgA vasculitis (HSP): Palpable purpura + arthritis + renal; IgA immune complex deposition; normal platelet count → not thrombocytopenic MAHA
  • Plasma cell dyscrasia (myeloma/Waldenström): Renal failure + anemia (marrow replacement) + neuro (hyperviscosity); MAHA/schistocytes atypical; rouleaux not schistocytes
  • CVA from plaque rupture: Neurologic deficits only; cannot explain MAHA + thrombocytopenia + renal failure
  • DIC: MAHA + thrombocytopenia but ↑PT + ↑PTT + ↑D-dimer + ↓fibrinogen; coagulation cascade activated; PT/PTT normal here → rules out

5. Buzzword triggers:
  • TTP pentad = FAT RN: Fever + Anemia (MAHA) + Thrombocytopenia + Renal failure + Neurologic symptoms
  • Schistocytes + ↓platelets + normal PT/PTT → TTP or HUS
  • TTP vs HUS:
FeatureTTPHUS
AgeAdultsChildren
Dominant featureNeuroRenal
TriggerAutoantibody vs ADAMTS-13STEC O157:H7 (bloody diarrhea)
ADAMTS-13↓↓ (<10%)Normal
TreatmentPlasma exchangeSupportive
  • ADAMTS-13 normal function: cleaves ultralarge vWF multimers → reduces prothrombotic activity
  • vWF produced by: megakaryocytes + endothelial cells (stored in Weibel-Palade bodies)
  • TTP treatment: plasma exchange (removes autoantibody + replenishes ADAMTS-13) ± rituximab (refractory)
  • Never give platelets in TTP → fuels thrombosis

6. Trap / trick tested:
  • Not all 5 pentad features needed for diagnosis — exam presents 3-4 features; schistocytes + thrombocytopenia + normal coags = sufficient to diagnose TTP
  • Neurologic symptoms in TTP are transient/fluctuating — stroke-like but reversible; caused by microvascular occlusion not large vessel thrombosis; MRI often negative
  • Asthma + mild fever = distractors; focus on schistocytes + thrombocytopenia + normal coags
  • Plasma exchange ≠ platelet transfusion — exchange removes antibody AND provides fresh ADAMTS-13; platelets worsen outcome

7. One-liner memory hook:
"ADAMTS-13 antibody = vWF strings uncleaved = platelet mega-nets everywhere = schistocytes + low platelets + normal coags (no factor consumption) = TTP; brain + kidney suffer most; plasma exchange cures; platelets kill; pentad = FAT RN but rarely all 5."
This is a shared conversation. Sign in to Orris to start your own chat.